{"id": 0, "claim": "Several studies have also shown the association of non-coding RNAs in colorectal carcinogenesis through the stimulation or inhibition of apoptosis, cell proliferation, differentiation, invasion and metastasis [<|multi_cit|>].", "evidence": {"66000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66000]}
{"id": 1, "claim": "Recent studies have uncovered long noncoding RNAs as novel targets of p53 tumor suppression [<|multi_cit|>,7].", "evidence": {"66001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66001]}
{"id": 2, "claim": "For example, loc285194 is a p53-regulated tumor suppressor, which acts in part through repression of miR-211 [<|cit|>], they are able to regulate other non-coding RNAs, in particular microRNAs.", "evidence": {"66002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66002]}
{"id": 3, "claim": "There exists a competitive endogenous RNA regulatory network where lncRNA loc285194 may exert functions through targeting miR-211.<|cit|> Liu et al. show that as a p53-regulated tumor suppressor, lncRNA loc285194, inhibits colon cancer cell growth, which acts in part via negative modulation of miR-211.", "evidence": {"66003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66003]}
{"id": 4, "claim": "Accumulating evidence suggest that lncRNAs act as miR sponges and inhibit miR functions [<|cit|>].", "evidence": {"66004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66004]}
{"id": 5, "claim": "Like proteins, various lncRNAs are attributed to oncogenic or tumor-suppressive activities exerting various cellular functions [<|multi_cit|>].", "evidence": {"66005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66005]}
{"id": 6, "claim": "Hence, the two regulatory ncRNAs and their intertwined effects on cell death are incorporated into an even more complicated p53 signaling network by the p53–lncRNA connection<|cit|> (<|other_cit|>).", "evidence": {"66006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66006]}
{"id": 8, "claim": "The long nucleotide chain of lncRNAs can either form a complex spatial structure that interacts with protein factors or provide a large region for the concurrent binding of many molecules that collectively participate in genomic imprinting, X-chromosome silencing, chromosome modification, intranuclear transport, and transcriptional activation and interference [<|other_cit|>],thereby regulating cell growth, differentiation, development, senescence and death [<|multi_cit|>].", "evidence": {"66007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66007]}
{"id": 9, "claim": "Long noncoding RNAs (lncRNAs), a large class of non-protein-coding transcripts that are over 200 nt in length<|other_cit|>, have emerged as key regulators of important biological processes involved in the development and progression of human cancers<|multi_cit|>.", "evidence": {"66008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66008]}
{"id": 10, "claim": "In situ hybridization used to detect Linc-RoR in breast cancer tissue microarrays (TMAs) was performed according to a previously described method (<|cit|>).", "evidence": {"66009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66009]}
{"id": 11, "claim": "Moreover, combined with the experimental results obtained by Silva et al,<|other_cit|> we assumed that LSINCT5, similar to LOC285194,<|cit|> and growth arrest-specific transcript 5 (GAS5),<|other_cit|> ERIC,<|other_cit|> and JADE<|other_cit|>, may be a product from cancer progress, for example, in response to DNA damage.", "evidence": {"66010": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [66010]}
{"id": 12, "claim": "Protein coding genes are usually regarded as tumor markers in ESCC pathology,<|other_cit|> but only ~1.2% of the human genome encodes for protein-coding genes, and the large majority is transcribed into non-coding RNAs (ncRNAs).<|other_cit|> Long non-coding RNAs (lncRNAs), which are longer than 200 nucleotides without protein coding capability, can regulate the expression of genes in various biological processes.<|other_cit|> Aberrant lncRNA expression participates in carcinogenesis by disrupting the major biological processes,<|other_cit|> and could also serve as a potential diagnostic or prognostic biomarker for diverse human malignancies.<|multi_cit|> For example, HOTAIR is a well-known lncRNA, whose expression levels powerfully predict metastases and survival in different cancer types,<|other_cit|> including ESCC.<|other_cit|> However, the understanding of these lncRNAs is insufficient, and the functional implications of most lncRNAs remain to be explored.", "evidence": {"66011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66011]}
{"id": 13, "claim": "Accumulating evidence indicates that lncRNAs may play roles in regulating oncogenes or suppressors in human cancer (<|multi_cit|>), and as regulators in physiological and pathological responses (<|other_cit|>).", "evidence": {"66012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66012]}
{"id": 15, "claim": "Our own studies also indicate that a number of lncRNAs can participate in ceRNA regulatory network [<|multi_cit|>,31].", "evidence": {"66013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66013]}
{"id": 16, "claim": "Although the majority of MGS-related studies mainly deal with the protein-coding genes, a handful of studies have examined the interaction between miRNA and long non-coding RNA (lncRNA), which is the other class of non-coding RNA longer than 200 nt (<|multi_cit|>).", "evidence": {"66014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66014]}
{"id": 17, "claim": "Accumulating evidences have been reported that several epigenetic regulators and key transcription factors (TFs) contributed to lncRNAs dysregulation in human cancers, such as Stat3<|other_cit|>, p53<|cit|>, EZH2<|other_cit|>.", "evidence": {"66015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [66015]}
{"id": 19, "claim": "Evidence of anticancer effects by Complex I inhibition on several cancer cell lines of Food and Drug Administration-approved drugs with known safety profile and pharmacokinetics such as canagliflozin (<|other_cit|>), fenofibrate (<|other_cit|>), and metformin (<|cit|>), and metformin (86) provides strong incentive for further preclinical and clinical studies.", "evidence": {"52000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52000]}
{"id": 20, "claim": "Notably, a number of mitochondrial toxins have been successfully used to restrict tumor growth in vivo, such as doxorubicin [<|other_cit|>] and metformin [<|cit|>] and metformin [46], although not in combination with metabolic stress-inducing agents.", "evidence": {"52001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52001]}
{"id": 22, "claim": "We used 2-Deoxy-D-glucose (2-DG, 50 mM), a glucose analog which competitively inhibits glucose uptake and blocks the first critical step of glucose metabolism [<|other_cit|>], and the mitochondrial respiration poison Metformin, a well-known antidiabetic drug that targets the complex I of the respiratory chain [<|cit|>].", "evidence": {"52002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52002]}
{"id": 23, "claim": "IR increased mitochondrial O •− levels, which was prevented by N-acetylcysteine (NAC), an ROS scavenger, or metformin, an inhibitor of complex I<|cit|> (Fig. <|other_cit|>), suggesting that complex I contributes to IR-induced O •− production.", "evidence": {"52003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52003]}
{"id": 24, "claim": "This included work on permeabilized cells and cancer cells that do not express complex I (<|cit|>), isolated mitochondria (<|other_cit|>) and purified complex I (<|other_cit|>).", "evidence": {"52004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52004]}
{"id": 26, "claim": "Metformin, a clinically approved drug by the FDA to treat type II diabetes, targets the mitochondrial complex I and thereby reducing ATP synthesis [<|multi_cit|>].", "evidence": {"52005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52005]}
{"id": 27, "claim": "The discovery of CI as the functional target of metformin (<|cit|>).", "evidence": {"52006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52006]}
{"id": 28, "claim": "The drug was also demonstrated to reduce tumorigenesis through metabolic alteration as a result of the mitochondrial respiratory complex I inhibition [<|multi_cit|>,4].", "evidence": {"52007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52007]}
{"id": 29, "claim": "Regarding its anti-cancer activity, it has been reported that metformin, by interfering with complex I, inhibits the oxygen consumption rate and growth in human colon cancer cells (<|cit|>).", "evidence": {"52008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52008]}
{"id": 30, "claim": "Nevertheless, the growth of OXPHOS-deficient tumors is still challenged, as seen in complex I-deficient xenograft models (<|multi_cit|>) and in oncocytoma patients, who develop slowly proliferating masses, which rarely progress to malignancy (<|other_cit|>).", "evidence": {"52009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [52009]}
{"id": 34, "claim": "By inhibiting ETC complex I (Figure <|other_cit|>), metformin decreases mitochondrial ATP provision (<|multi_cit|>, 178).", "evidence": {"52010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52010]}
{"id": 35, "claim": "Therefore, pyruvate alters redox metabolism and indirectly affects dependence on the electron transport chain, explaining why electron transport inhibitors like metformin (<|cit|>) are less efficacious when pyruvate is available.", "evidence": {"52011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52011]}
{"id": 37, "claim": "In this regard, a recent study demonstrated that metformin reduces tumorigenesis by inhibiting mitochondrial Complex I in cancer cells <|cit|>.", "evidence": {"52012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52012]}
{"id": 38, "claim": "To this end we expressed the yeast NDI1 transgene, which can drive electron flux in the ETC (<|cit|>) but is insensitive to CI inhibitors, including rotenone (<|other_cit|>).", "evidence": {"52013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52013]}
{"id": 39, "claim": "Clinical drugs with ETC-targeting effects, such as metformin [<|cit|>] and papaverine [<|other_cit|>], will need to be examined for their abilities to replace DPI in the combination therapy.", "evidence": {"52014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52014]}
{"id": 40, "claim": "Previous studies have reported that metformin acts through multiple different protein targets, including the mitochondrial complex I in the electron transport chain (ETC) (<|cit|>), an intracellular energy starvation responder AMP-activated kinase (AMPK) (<|other_cit|>), an organic cation entry gateway OCT1 (<|other_cit|>), a succinate G-protein-coupled receptor (<|other_cit|>), a mitochondrial glycerophosphate dehydrogenase (<|other_cit|>), and glucagon receptor-mediated PKA signaling (<|other_cit|>).", "evidence": {"52015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52015]}
{"id": 41, "claim": "Generation of reactive oxygen species (ROS) stabilizes HIF-1α in a wide range of cells (<|multi_cit|>).", "evidence": {"52016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52016]}
{"id": 42, "claim": "The direct target for metformin is not clearly defined, however it is believed to act via inhibition of Complex I of the mitochondrial respiratory chain [<|cit|>].", "evidence": {"52017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [52017]}
{"id": 43, "claim": "As metformin is an inhibitor of complex I<|cit|>.", "evidence": {"52018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52018]}
{"id": 44, "claim": "Elucidation of a key molecular target of metformin came in 2014 when three groups, using differential approaches and experimental conditions published novel and conclusive evidence on the inhibitory properties of metformin on complex I (<|multi_cit|>).", "evidence": {"52019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52019]}
{"id": 45, "claim": "Given that metformin targeted mitochondrial complex I to perform its biological function,<|multi_cit|> the Seahorse system was used to evaluate the effect of metformin on mitochondrial respiratory chain complex I in AML12 cells.", "evidence": {"52020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52020]}
{"id": 46, "claim": "Metformin has been shown to block a variety of cellular and metabolic processes including CI activity [<|multi_cit|>, 48].", "evidence": {"52021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52021]}
{"id": 47, "claim": "Despite the fact that mitochondrial dysfunction has long been considered a metabolic hallmark of cancer cells, studies have also indicated that tumor cells not only have functional mitochondria but also that their activity is essential for tumorigenesis.<|other_cit|> By regulating the generation of ROS, ATP and other metabolites driving bioenergetic and biosynthetic processes, mitochondria have a key role in cancer progression.<|other_cit|> Oncogenic activation of MYC and KRAS promote increased glucose utilization and addiction in different types of tumors,<|other_cit|> while also enhancing the mitochondrial-dependent biosynthesis of macromolecules through increased ATP levels and TCA cycle intermediates.<|other_cit|> To replenish the TCA cycle substrates and fuel their uncontrolled growth, cancer cells utilize specific mechanisms of anaplerosis on the basis of the oxidation of glutamine to α-ketoglutarate and its conversion to oxaloacetate.<|other_cit|> As a consequence of oxidative metabolism, physiological amounts of ROS are produced at the level of the mETC, inducing the pro-tumoral activation of redox-sensitive pathways.<|other_cit|> To prevent ROS-induced toxicity, cancer cells redirect the metabolic intermediates coming from glutamine and one-carbon metabolism into alternative pathways that generate NADPH and GSH, antioxidants molecules readily used by several ROS-scavenging enzymes.<|other_cit|> Interestingly, tumors with impaired TCA cycle activity (or mutations in the mETC complexes) and that rely on glycolysis for ATP synthesis, shift to reductive glutaminolysis to mediate biosynthetic processes and cell survival.<|other_cit|> Such tumor cells depend on mitochondrial-derived ROS to promote cell proliferation and metastasis formation.<|other_cit|> In contrast to what is generally assumed, many tumors still use mitochondria for ATP production, despite the Warburg effect should provide sufficient amounts of ATP for their biological needs.<|other_cit|> Indeed, poorly vascularized and other subsets of tumors growing under limited glucose conditions heavily rely on oxidative phosphorylation for ATP synthesis,<|other_cit|> a weakness that might be targeted with drugs that limit glucose utilization and block mitochondrial bioenergetics.<|other_cit|> With this respect, two anti-diabetic biguanides, such as metformin and phenformin, show promising antitumoral effects.<|other_cit|> Epidemiological studies have shown that metformin decreases the incidence of cancer and prolongs the survival rate of patients with solid tumors.<|other_cit|> More studies have reported also that the in vivo antitumorigenic effects of metformin depended on the inhibition of the mETC complex-I activity and the decrease of circulating glucose and insulin levels.<|multi_cit|> Metformin was also able to impair the growth of NSCLCs by blocking the activation of the Akt/mammalian target of rapamycin (mTOR) pathway and by potentiating the pro-apoptotic efficacy of ionizing radiation.<|other_cit|> Also, metformin selectively killed breast cancer stem cells through profound depletion of triphosphate nucleotides presumably reflecting a major impairment of the energetic metabolism.<|other_cit|> Therefore, another biguanide, called phenformin, has emerged as a potential anticancer agent due to its liposolubility, higher affinity for mETC complex-I and stronger antineoplastic activity.<|other_cit|> Phenformin enhanced the efficacy of the BRAF inhibitor PLX4270 both in vitro and in genetic models of melanoma driven by BRAFV600E mutations triggering apoptotic cell death upon inhibition of the mTOR pathway.<|other_cit|> Phenformin also induced selective apoptosis in a subset of NSCLCs with loss of the tumor suppressor LKB1 and oncogenic mutations in K-ras lowering the ATP levels and eliciting the activation of caspase 3.<|other_cit|> Despite the encouraging results, it should also be mentioned that the use of phenformin has been associated with lactic acidosis, an important pitfall that might limit its clinical applicability.<|other_cit|> For this reason, novel compounds that target the mETC complex-I (i.e., VLX600) or alternative strategies based on the translation of specific mitochondrial proteins (i.e., tigecycline) have been designed and currently successfully employed in preclinical studies.<|other_cit|> Although the potential utility of these compounds still needs to be validated in long-term clinical trials, encouraging evidences suggest that targeting the bioenergetics function of the mitochondria might represent a valid therapeutic option for cancer treatment.", "evidence": {"52022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52022]}
{"id": 48, "claim": "Interestingly, the anti-diabetic drug metformin, which has been repurposed as an anti-cancer agent, was recently shown to inhibit mitochondrial complex I to exert its’ anti-tumorigenic properties [<|cit|>].", "evidence": {"52023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52023]}
{"id": 49, "claim": "Metformin prevents the respiratory chain complex 1 in hepatocytes<|cit|> and it destroys the consumption of oxygen in colon cancer cells,<|other_cit|> which is incompatible with the prevention of oxidative phosphorylation.", "evidence": {"52024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [52024]}
{"id": 50, "claim": "Inhibition of mitochondrial complex 1 by gene knockdown has been reported to promote migration.<|other_cit|> However, metformin, a complex 1 inhibitor,<|cit|> was found to suppress metastasis of breast cancer,<|other_cit|> ovarian cancer<|other_cit|> and melanoma.<|other_cit|> In this study, Rotenone, a specific inhibitor of complex 1,<|other_cit|> inhibited the migration/invasion of not only the overall population but also the drug-resistant population of lung adenocarcinoma cells.", "evidence": {"52025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52025]}
{"id": 51, "claim": "These effects are presumably due, at least in part, to complex I inhibition of the ETC, which significantly perturbs mitochondrial function [<|multi_cit|>,83].", "evidence": {"52026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52026]}
{"id": 53, "claim": "Likewise, the inhibition of the mitochondrial complex I through the repositioning of the antidiabetic drug Metformin was recently proposed with encouraging results (<|cit|>).", "evidence": {"52027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [52027]}
{"id": 54, "claim": "The polygenic model assumes a large number of disease-causing mutations, each with small effect size and low penetrance, which, when combined with environmental factors, cumulatively suffice to cause disease [<|cit|>].", "evidence": {"96000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96000]}
{"id": 55, "claim": "Available genetic data based on family studies and twin studies have highlighted high heritability for ASD between 40 and 90% (<|multi_cit|>) and a strong polygenic contribution, but single major genetic risk factors are identified in at best 20% of cases (<|other_cit|>).", "evidence": {"96001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96001]}
{"id": 57, "claim": "A large number of familial studies demonstrate that ASD is a heritable disorder (<|other_cit|>), with estimated genetic contributions accounting for >50–60% of ASD risk (<|cit|>).", "evidence": {"96002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96002]}
{"id": 58, "claim": "It has been shown that single nucleotide polymorphisms (SNPs) can explain up to 40% of the variance in liability to ASD [<|multi_cit|>]; thus common genetic polymorphisms can be a major risk factor for autism.", "evidence": {"96003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96003]}
{"id": 59, "claim": "There are indications that certain gene variants confer genetic susceptibility [<|cit|>].", "evidence": {"96004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96004]}
{"id": 60, "claim": "With an estimated heritability of around 64–91% in twin studies (Tick et al., <|other_cit|>) and 31–71% in whole-genome genotyping studies (<|cit|>), compelling evidence suggests that the etiology of ASD bears a strong genetic influence (Szatmari et al., <|other_cit|>; Abrahams and Geschwind, <|other_cit|>).", "evidence": {"96005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96005]}
{"id": 61, "claim": "Most cases of ASD have unknown genetic underpinnings (<|cit|>), and models of unidentified etiology have been characterized with behavioral tests assessing autistic symptomatology.", "evidence": {"96006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [96006]}
{"id": 62, "claim": "Nongenetic (likely including environment and gene-environment interplay) contributions to the emergence of autism have been highlighted recently [<|multi_cit|>].", "evidence": {"96007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96007]}
{"id": 63, "claim": "Like many complex diseases, individual genetic variants associated with autism explain only a small proportion of an individual’s risk [<|multi_cit|>].", "evidence": {"96008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96008]}
{"id": 64, "claim": "Recent studies have indicated that a substantial proportion of inherited liability to autism spectrum disorders (ASD) can be attributed to common, inherited variants [<|multi_cit|>].", "evidence": {"96009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96009]}
{"id": 65, "claim": "Intra-family recurrence rates of autism are high (estimated to be up to 50%; [<|multi_cit|>], although the genetic links have not been scientifically established [<|other_cit|>].", "evidence": {"96010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96010]}
{"id": 66, "claim": "Microscopically visible chromosomal alterations and copy-number variations (CNVs) account for 3–10% of cases.<|other_cit|> Finally, de novo disruptive variants are more frequent in patients with ASD than in their unaffected siblings and controls.<|other_cit|> The role of inherited variants remains unclear, but it was estimated that at least 6% of cases could be caused by rare recessive variants affecting both alleles and that common variants act in an additive manner to increase the genetic risk to autism.<|multi_cit|> Based on current findings, the genetic architecture of ASD is highly heterogeneous, with many genes/loci and possibly gene–gene interactions involved.<|other_cit|>", "evidence": {"96011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [96011]}
{"id": 67, "claim": "Much progress has been made in unravelling the genetics of ASD with large copy number variation [<|other_cit|>] and de novo mutations in a subset of genes [<|other_cit|>] as well as inherited mutations being associated with ASD [<|cit|>].", "evidence": {"96012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96012]}
{"id": 68, "claim": "Recent studies indicate that shared environmental influences are negligible in autism, and the genetic risk is predominantly due to common variants ([<|multi_cit|>] but see [<|other_cit|>]).", "evidence": {"96013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [96013]}
{"id": 69, "claim": "In line with this, the genetic aetiology of autism is heterogeneous and hundreds of genes are hypothesised to be implicated [<|other_cit|>], with about 50% of the genetic effect attributed to common genetic variations [<|cit|>].", "evidence": {"96014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96014]}
{"id": 71, "claim": "Substantial heterogeneity also exists for the genetic component of ASD, where the interplay between commonly inherited variants (single nucleotide polymorphism or SNPs) and highly penetrant rare variations results with a complex genetic architecture [<|cit|>].", "evidence": {"96015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96015]}
{"id": 72, "claim": "Despite the large body of research investigating the etiology of ASD, there is relatively limited understanding of the pathophysiology of the disorder aside from complex interactions between genetic and environmental contributors being involved (<|cit|>).", "evidence": {"96016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [96016]}
{"id": 73, "claim": "The second study examined the detailed structure of the type of genetic liability in ASD and showed that inherited common variants contributed to 49.4% heritability, whereas rare de novo variants accounted for only 2.6% (<|cit|>).", "evidence": {"96017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [96017]}
{"id": 74, "claim": "Genetic modeling has suggested that at least 50% of the variance of the disorder may be due to common inherited variants [<|cit|>], although the results of genome-wide association studies have been largely disappointing [<|other_cit|>], with only one signal detected and replicated in a recent meta-analysis [<|other_cit|>].", "evidence": {"96018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [96018]}
{"id": 75, "claim": "Inhibition of Interferons may indicate defects in the hematopoietic capacity of quiescent stem cells, as studied in response to infection [<|cit|>, shows the predicted states of upstream regulators of gene expression that were not categorized as transcription factors or direct repressors of transcription factors, and included G-protein receptors, ligand-mediated and transmembrane receptor proteins, kinases and phosphatase types of molecules.", "evidence": {"61000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61000]}
{"id": 79, "claim": "The stimuli for HSPC activation include chronic bacterial infection [<|multi_cit|>], psychosocial stress [<|other_cit|>], injury, such as myocardial infarction [<|other_cit|>], and hypercholesterolemia [<|other_cit|>].", "evidence": {"61001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61001]}
{"id": 80, "claim": "Subsequently, it was shown that only chronic IFN-γ exposure leads to HSC depletion (<|cit|>).", "evidence": {"61002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61002]}
{"id": 81, "claim": "Chronic infection, as seen in the presence of the Mycobacterium avium, results in the activation of quiescent HSCs through the release of the inflammatory mediator interferon-γ (<|cit|>).", "evidence": {"61003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61003]}
{"id": 82, "claim": "In acute stress situations such as infection, chemotherapy, and transplantation, proinflammatory cytokines such as IFN-α act as an emergency signal to recruit quiescent HSCs into an active cell cycle to replenish the compromised blood supply (<|multi_cit|>; Baldridge et al., 2010).", "evidence": {"61004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61004]}
{"id": 83, "claim": "Using a mouse model of Mycobacterium avium infection, Baldridge et al. (<|cit|>) showed that this infection resulted in an IFN-γ-dependent increase in proliferation of HSCs (CD150+ KLS cells), and treatment of mice with IFN-γ alone was sufficient to induce HSC proliferation and mobilization.", "evidence": {"61005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61005]}
{"id": 86, "claim": "For instance, constitutive expression of endogenous IFN-γ contributes to the homeostasis of immune cell functions (<|other_cit|>), maintenance of the hematopoietic stem cell niche (<|cit|>), and bone formation (<|other_cit|>).", "evidence": {"61006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61006]}
{"id": 87, "claim": "For example, IFN-γ released by T cells can either induce IL-6 production by BM stromal cells, in turn augmenting myelopoiesis (<|other_cit|>), or also act directly on HSC (<|multi_cit|>).", "evidence": {"61007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61007]}
{"id": 88, "claim": "Specifically, basal production of IFNγ in the absence of infection drives HSC cycling and the elevated levels occurring during infection can activate HSC proliferation and myelopoiesis to replenish monocytes and other immune cells (<|multi_cit|>).", "evidence": {"61008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61008]}
{"id": 91, "claim": "In addition to the properties of pluripotency and self-renewal, adult long-term HSCs were found to reside in a specific niche environment in the bone marrow, which was closely associated with endosteum,<|other_cit|> and where they exist in conditions of relative hypoxia.<|other_cit|> Here, HSC exists predominantly in a non-replicative and quiescent state,<|other_cit|> in which signalling by the cytokine thrombopoietin<|other_cit|> and the presence of megakaryocytes are recognised to have an important role.<|other_cit|> In contexts that place the haematopoietic system under stress, such as chronic infection, these quiescent stem cells are recruited into cell cycle, for example, via interferon signalling, which is associated with a numerical increase in downstream progenitor cells.<|cit|> Evidence increasingly suggests that lineage specification can occur very early in the haematopoietic hierarchy in immunophenotypically defined ‘stem cell’ populations<|other_cit|>), supporting findings that self-renewing lineage-restricted progenitors may emerge directly from HSC.<|other_cit|> A significant degree of complexity may therefore exist in the pathways via which mature haematopoietic lineages develop from HSC and progenitor populations.", "evidence": {"61009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61009]}
{"id": 93, "claim": "This finding is intriguing because several prior studies have linked inflammatory cytokine signaling to loss of adult HSC self-renewal capacity and myeloid differentiation (<|multi_cit|>).", "evidence": {"61010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61010]}
{"id": 94, "claim": "In the context of hematopoiesis, STAT1 signaling via IFN-α stimulation controls dormant HSC’s entry into the cell cycle (<|other_cit|>) whilst STAT1 signaling downstream of IFN-γ promotes the expansion of HSCs (<|cit|>).", "evidence": {"61011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61011]}
{"id": 95, "claim": "Similarly, our data indicate that the effects of obesity on the HSC compartment do not mimic the effects of acute and chronic inflammatory conditions, which are associated with HSC cell cycle activation and rapid functional exhaustion (<|multi_cit|>).", "evidence": {"61012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [61012]}
{"id": 97, "claim": "This has demonstrated how the gut intestinal (GI) microbes respond and adapt to different situations [<|cit|>], how alterations of the microbial community impact on the development and functioning of the immune and metabolic systems [<|other_cit|>], and, globally, how divergences from homeostasis (eubiosis) in this district are predictive of diseases (dysbiosis).", "evidence": {"80000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80000]}
{"id": 98, "claim": "Important IBD multi-omics projects already exist in the longitudinal integrative Human Microbiome Project [<|other_cit|>] (iHMP or HMP2), the PRISM-cohort [<|cit|>], and the RISK-cohort [<|other_cit|>] in the United States.", "evidence": {"80001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [80001]}
{"id": 99, "claim": "The identification of microbial taxa that were significantly associated with the incubation time was conducted using multivariate association with a linear model (<|cit|>) identified with 97% similarity.", "evidence": {"80002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80002]}
{"id": 100, "claim": "Relative increases in Proteobacteria with or without a concurrent reduction in Firmicutes have been observed in several species in cases of metabolic gastrointestinal disorders, such as genetically-related and diet-induced obesity [<|other_cit|>], as well as in chronic intestinal inflammation, such as inflammatory bowel disease and ulcerative colitis [<|multi_cit|>].", "evidence": {"80003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80003]}
{"id": 101, "claim": "Disease related studies that involve microbiome analysis using metagenomics include obesity [<|other_cit|>], Crohn’s disease [<|multi_cit|>], type 2 diabetes [<|other_cit|>] and many others [<|other_cit|>].", "evidence": {"80004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80004]}
{"id": 102, "claim": "Dysbiosis of the gut microbiota, including alterations in frequency, diversity and richness of microbial populations (<|other_cit|>), has been associated with IBD (<|multi_cit|>).", "evidence": {"80005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [80005]}
{"id": 104, "claim": "Multivariate analysis by linear models (MaAsLin) (<|cit|>).", "evidence": {"80006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80006]}
{"id": 105, "claim": "MaAsLin was used for adjustment of covariates when determining the significance of OTUs contributing to a specific variable, while accounting for potentially confounding covariates [<|cit|>].", "evidence": {"80007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80007]}
{"id": 106, "claim": "as well as a number of dedicated R packages (Phyloseq, metagenomeSeq,, and MaAsLin [<|cit|>], BhGLM [<|other_cit|>], as well as R packages primarily used for RNA-Seq data and adapted to microbiome analysis (DESeq2, edgeR [<|other_cit|>], limma-voom [<|other_cit|>] and web applications (Metastats); QIIME and MEGAN aim to integrate many analysis steps into a pipeline, which may also include functional analysis.", "evidence": {"80008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80008]}
{"id": 108, "claim": "To gain insight into the GM functions, gut metagenomes structures were inferred from the respective phylogenetic profiles using PICRUSt( <|other_cit|> ), as previously performed by David et al.( <|other_cit|> ) and Morgan et al.( <|cit|> ) and Morgan et al.(  33  ).", "evidence": {"80009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [80009]}
{"id": 109, "claim": "Reduction in members of these two genera has been suggested to enhance inflammation by decreasing SCFA availability [<|multi_cit|>].", "evidence": {"80010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80010]}
{"id": 110, "claim": "A multivariate analysis between the relative abundance of microbiota and clinical metadata will be done using MaAsLin.<|cit|>", "evidence": {"80011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80011]}
{"id": 111, "claim": "Some approaches rely on the arcsine square root transformation to stabilise the variance and normalise proportional data, such as in the MaAsLiN multivariate statistical framework (<|cit|>).", "evidence": {"80012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80012]}
{"id": 112, "claim": "In ileal Crohn's disease, there were notable increases in virulence and secretion pathways( <|cit|> ).", "evidence": {"80013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80013]}
{"id": 113, "claim": "Growing literature demonstrating microbial dysbiosis in patients with IBD with reduced diversity [<|multi_cit|>], decreased representation of potentially protective bacteria like Faecalibacterium prausnitzii [<|other_cit|>] and increased frequency of potentially pathogenic bacteria in certain disease subsets like ileal CD [<|other_cit|>] suggests that one possible mechanism through which the environment influences disease risk may be through the microbiome.", "evidence": {"80014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80014]}
{"id": 114, "claim": "IBD (ulcerative colitis-UC and Crohn's Disease-CD) are chronic idiopathic diseases, prone to relapse in the digestive tract, and considered at the moment to be a result of the interaction between intestinal microbiome and intestinal immune system [<|multi_cit|>].", "evidence": {"80015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80015]}
{"id": 115, "claim": "The gastrointestinal microbiome of healthy humans is predominated by members of the phyla Firmicutes and Bacteroidetes, whereas IBD is associated with an imbalance mainly characterized by a lower proportion of Firmicutes, as well as by increased bacteria from the Proteobacteria phylum [<|multi_cit|>].", "evidence": {"80016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [80016]}
{"id": 116, "claim": "An altered microbiota in the intestine can lead to altered immune functions of hosts, and also increase the risk of disease [<|multi_cit|>].", "evidence": {"80017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80017]}
{"id": 117, "claim": "Alternations in the metabolism of these metabolites in intestinal bacteria were reported to affect host physiology (<|other_cit|>); changes in arginine and proline metabolism were associated with coronary heart disease (<|other_cit|>), whereas perturbations of butyrate and methane metabolism were related to inflammatory diseases (<|cit|>) and Type I diabetes (<|other_cit|>).", "evidence": {"80018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [80018]}
{"id": 119, "claim": "These SCFAs are known to confer many health benefits; individuals lacking bacterial families producing SCFAs suffer from many diseases (<|cit|>).", "evidence": {"80019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80019]}
{"id": 120, "claim": "Multivariate association tests for taxa that were differentially abundant between field-collected cockroaches were performed using MaAsLin, with default parameters (<|cit|>).", "evidence": {"80020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [80020]}
{"id": 121, "claim": "Based on 14 studies, a meta-analysis estimated a pooled risk ratio of 1.5 for insecticides (<|other_cit|>); few studies, however, have considered quantitative measures of exposure (<|multi_cit|>).", "evidence": {"50000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50000]}
{"id": 122, "claim": "Epidemiological data suggest that, although the risk for developing PD is significant following a short-term (<8 day) environmental exposure to PQ, PD is even more significantly linked with chronic/low-dose PQ exposure (<|cit|>).", "evidence": {"50001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50001]}
{"id": 123, "claim": "Exposure to pesticides such as rotenone may be associated with increased risk of PD (Ascherio et al. <|other_cit|>; Costello et al. <|other_cit|>; Wang et al. <|multi_cit|>).", "evidence": {"50002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50002]}
{"id": 124, "claim": "The pesticides rotenone and paraquat (<|cit|>), and the toxin MPTP (<|other_cit|>) (1-methyl-4-fenyl-1,2,3,6-tetrahydropyridine; a toxic byproduct of the opioid analgesic desmethylprodine, MPPP, a synthetic heroin), are known to cause PD in humans, explaining some cases of sporadic PD.", "evidence": {"50003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50003]}
{"id": 125, "claim": "Epidemiological studies demonstrated that chronic exposure to pesticides, such as PQ and rotenone, is associated with a higher risk of developing PD [<|multi_cit|>].", "evidence": {"50004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50004]}
{"id": 126, "claim": "Paraquat (PQ, methyl viologen dichloride; or 1,10-dimethyl-4,40-bipyridinium dichloride) is among the most consistently associated environmental risk factors for PD (<|multi_cit|>).", "evidence": {"50005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50005]}
{"id": 127, "claim": "In fact, recent studies have demonstrated that those exposed to PQ or fungicides like maneb or ziram experience a greater risk of developing PD [<|multi_cit|>, 82].", "evidence": {"50006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50006]}
{"id": 129, "claim": "These include the herbicides rotenone and paraquat (<|cit|>).", "evidence": {"50007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50007]}
{"id": 130, "claim": "Parkinsonism, Parkinson's Disease and use of 2,4-D have been evaluated in four independent studies and five publications (<|multi_cit|>).", "evidence": {"50008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50008]}
{"id": 134, "claim": "In 2011, a study funded by the U.S. National Institutes of Health showed a link between PQ exposure and Parkinson’s disease in farm workers [<|cit|>].", "evidence": {"50009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50009]}
{"id": 135, "claim": "History of recent cranial trauma (Fang et al. <|other_cit|>) and CNS infections (Fang et al. <|other_cit|>) as well as environmental factors such as exposure to fungicides and pesticides, e.g., maneb, rotenone and paraquat (Costello et al. <|multi_cit|>) seem to be involved in the pathogenic process.", "evidence": {"50010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50010]}
{"id": 136, "claim": "A case report described skin burns resulting from minimal accidental paraquat exposure, which subsequently lead to acute renal and respiratory failure and ultimately death.<|other_cit|> Another report described prolonged dermal paraquat exposure as a result of a crop-dusting accident, also resulting in death.<|other_cit|> Epidemiology studies have also associated self-reported paraquat usage with Parkinson’s disease, most likely because of the increased production of reactive oxygen species resulting from the toxicity of the herbicide.<|cit|> Epidemiology studies have also associated self-reported paraquat usage with Parkinson’s disease, most likely because of the increased production of reactive oxygen species resulting from the toxicity of the herbicide.86", "evidence": {"50011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50011]}
{"id": 137, "claim": "In a meta-analysis by Tanner et al. (<|cit|>), pesticides were classified by their presumed mechanism and not only by their chemical class.", "evidence": {"50012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50012]}
{"id": 138, "claim": "Further supported by epidemiological studies, a link between the use of these pesticides and the incidence of PD was established [<|cit|>].", "evidence": {"50013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50013]}
{"id": 139, "claim": "If a<|other_cit|>ailable on PubMed, we included the 22 articles listed in <|multi_cit|>] and used the results that controlled for the age, sex, and smoking behavior of the individuals.", "evidence": {"50014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50014]}
{"id": 140, "claim": "Exposure to the herbicide paraquat is a risk factor for neurodegeneration and is commonly employed to model oxidative stress, as it inhibits complex 1 of the electron transport chain and increases superoxide levels (<|multi_cit|>).", "evidence": {"50015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50015]}
{"id": 141, "claim": "The pesticide rotenone has been directly linked to idiopathic PD (<|cit|>) and chronic administration in rats was reported to induce microglia activation (Sherer et al., <|other_cit|>) and selective degeneration of DA neurons in SN (Betarbet et al., <|other_cit|>).", "evidence": {"50016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50016]}
{"id": 142, "claim": "Among the various models for PD, the rotenone model has recently drawn particular attention for two reasons: 1) it reproduces most of the motor symptoms and the histopathological features of PD, including Lewy bodies [<|other_cit|>]; and 2) rotenone and other pesticides are powerful inhibitors of mitochondrial respiration and associated with the higher incidence of sporadic Parkinsonism among the population of rural areas [<|multi_cit|>-26].", "evidence": {"50017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50017]}
{"id": 144, "claim": "In the adult phenotype, paraquat has been linked to Parkinson's disease in farm workers through an increased production of reactive oxygen species exerting their toxicity on neurons (<|cit|>).", "evidence": {"50018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50018]}
{"id": 145, "claim": "Rot is able to induce selective degeneration of dopaminergic neurons and PD-like features in animals (Inden et al., <|multi_cit|>; Tanner et al., 2011).", "evidence": {"50019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50019]}
{"id": 146, "claim": "Whereas the genesis of sporadic PD and PD with dementia is still under debate, a correlation between PD cases and the extent of the use of herbicides and pesticides has been described (<|multi_cit|>).", "evidence": {"50020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50020]}
{"id": 148, "claim": "Recent case-control and epidemiological evidence confirms that PD is positively correlated with lifetime use of the pesticide, rotenone (ROT; <|cit|>).", "evidence": {"50021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50021]}
{"id": 149, "claim": "Previous studies have reported associations between PD and certain types of pesticides<|cit|> or lifetime exposure to metals such as lead.<|other_cit|> Exposures to other neurotoxic chemicals, such as polychlorinated biphenyls and methylmercury, have been implicated as potential risk factors for PD, although the current body of data for these exposures remains too weak to assess.<|other_cit|>", "evidence": {"50022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [50022]}
{"id": 150, "claim": "To our knowledge, only one study has compared clinical features of PD patients occupationally exposed to pesticides with those of unexposed patients, but without considering PD subtypes, and reported no major differences (<|cit|>).", "evidence": {"50023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50023]}
{"id": 151, "claim": "In adult mice, chronic, low-dose systemic exposure to PQ recapitulates several important hallmarks of the disease, including selective loss of dopaminergic (DAergic) SNpc neurons and reduced motor function (<|multi_cit|>).", "evidence": {"50024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50024]}
{"id": 152, "claim": "Comparisons between our parameters and those used widely in the literature are shown in <|multi_cit|> It must be noted that the physical interpretations of some of the parameters differ from one model to another, although the overall picture appears plausible.", "evidence": {"11000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11000]}
{"id": 153, "claim": "Such knowledge would also help in predicting the timing and degree of potential slowing of transmission in the summer and resurgence of the virus during winter [<|cit|>].", "evidence": {"11001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11001]}
{"id": 154, "claim": "Consequently, prolonged continuation of social distancing policies might be needed for the foreseeable future to avoid an overburdening of the health care system [<|cit|>].", "evidence": {"11002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11002]}
{"id": 155, "claim": "Scientists anticipate a similar pattern for COVID-19: while the virus could develop seasonal oscillations if it becomes endemic<|cit|> (i.e., if pandemic control fails in the long term), current susceptibility to SARS-CoV-2 is high enough that summer weather is unlikely to be protective<|other_cit|>.", "evidence": {"11003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11003]}
{"id": 156, "claim": "Waning of humoral immunity within a year [<|other_cit|>] and re-infection of immunocompetent patients [<|other_cit|>] have been demonstrated for SARS-CoV-2, suggesting the possibility of annual outbreaks [<|multi_cit|>].", "evidence": {"11004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11004]}
{"id": 157, "claim": "Mechanistic models with multiple compartments [<|cit|>] and with time-dependent rates [<|other_cit|>], may be more realistic for COVID-19 outbreaks that in some places exhibit multiple peaks early on, but such models contain more parameters, require much more data, and are statistically harder to infer reliably.", "evidence": {"11005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11005]}
{"id": 159, "claim": "Intermittent social distancing may remain in place until 2022, and a resurgence of COVID-19 is possible until 2024 [<|cit|>].", "evidence": {"11006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11006]}
{"id": 160, "claim": "Depending on the level of contagion in different countries, various strategies combining different NPI measures have been used [<|multi_cit|>].", "evidence": {"11007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11007]}
{"id": 161, "claim": "COVID-19 (Coronavirus disease 2019), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was acknowledged by the World Health Organization (WHO) as a pandemic outbreak in March 2020<|other_cit|>, causing over 6.5 million deaths worldwide as of October 2022<|other_cit|>, with worldwide health and economic effects that are expected to persist for years to come<|cit|>.", "evidence": {"11008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11008]}
{"id": 162, "claim": "Therefore, for future building renovations, it is highly recommended that the hospital infection control department is consulted in order to ensure a safe working environment for all employees and patients during infectious outbreaks, especially as there are concerns COVID-19 might become a recurring seasonal affliction [<|cit|>].", "evidence": {"11009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11009]}
{"id": 164, "claim": "Over the course of the COVID-19 pandemic, numerous forecasting and simulation tools have been developed which combine diverse types of data (eg, COVID-19 testing rates, COVID-19-specific hospitalisation or death rates, symptom surveillance, evidence of community-level social distancing, biometrics) to identify emerging hotspots.<|multi_cit|> 12–20 24 34 43 While these tools have proven valuable at an aggregate level, they often lack the geographic and temporal specificity that reflects heterogeneous emerging patterns within local communities.", "evidence": {"11010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11010]}
{"id": 165, "claim": "Recent data suggest that the scenarios described in <|other_cit|> and <|other_cit|> are possible in the context of SARS-CoV-2 and prior exposures with hCoVs (<|multi_cit|>).", "evidence": {"11011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11011]}
{"id": 166, "claim": "Given that such changes are global, they may be captured by a time-dependence of the rate β(t) [<|multi_cit|>].", "evidence": {"11012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11012]}
{"id": 167, "claim": "Immune antibodies that neutralize SARS-CoV-2, which were produced against earlier related human coronaviruses, may exist in people who have not been exposed to SARS-CoV-2 due to immunological cross-reactivity (<|other_cit|>), which could explain decreased susceptibility (<|multi_cit|>).", "evidence": {"11013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11013]}
{"id": 168, "claim": "Therefore, given the lack of data at the early stages of the pandemic, the predictions of these models were almost impossible to validate.<|multi_cit|> At the forefront of these epidemiological models that have played a pivotal role in guiding national public health policy and healthcare responses that include the current social distancing, contact tracing and quarantine measures is the well-documented Imperial College London model.<|other_cit|> The societal and economic impacts of the aforementioned decisions have hardly been quantified; only estimates in the range of trillions of dollars of loss to the world economy are reported.<|other_cit|> A few models dealing with decision-making within the COVID-19 crisis have been reported;<|other_cit|> however, these lack the power of model prediction and forecasting based on appropriate variables and data sets.", "evidence": {"11014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11014]}
{"id": 169, "claim": "In addition, these estimates are essential for developing accurate mathematical models of virus transmission dynamics, which provide the foundation for policies to reopen societies (<|multi_cit|>).", "evidence": {"11015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11015]}
{"id": 170, "claim": "Moreover, the framework could be extended to geographic heterogeneity as well as longitudinal sampling if, for example, one wanted to compare whether the estimated quantities of interest (e.g., seroprevalence,  ) differ across locations or time (<|multi_cit|>; Kissler et al., 2020a).", "evidence": {"11016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11016]}
{"id": 171, "claim": "Infected individuals incubate the disease first and are not infectious in this state, denoted by E(t), and after an incubation time, they become infectious<|cit|>.", "evidence": {"11017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11017]}
{"id": 172, "claim": "Some early models did not calibrate parameters to data, and instead simulated from models parameterized using published estimates from early observational studies or other infections with similar properties [<|multi_cit|>].", "evidence": {"11018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11018]}
{"id": 173, "claim": "For example, Kissler et al. assume that the reduction of SARS-CoV-2 R  between winter and summer peaks ranges from 10% to 40% [<|cit|>], while Neher et al. [<|other_cit|>] assume values of γ between 0.3 and 0.7.", "evidence": {"11019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11019]}
{"id": 174, "claim": "Since the framework is built around an SEIR-D model, introducing vaccinations into the model is not mathematically difficult provided we have a good understanding of the vaccination programme with reliable data sets.<|other_cit|> Similarly, with the emergence of the new COVID-19 variants (the UK, South Africa, Brazil), e.g. the UK VOC 202012/01 variant that emerged in the Southeast of England in November 2020, we can adapt the work by Kissler et al. (2020)6 to provide a multi-strain model whereby an individual catches either one strain or the other.<|multi_cit|> Understanding the impact of these will be vitally important in the progression of dealing with the disease, although it is not clear what data will be readily available and our observational model will need to be adapted accordingly.", "evidence": {"11020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11020]}
{"id": 176, "claim": "The transmission of both SARS-CoV and MERS-CoV, however, remained very limited<|multi_cit|> unlike the SARS-CoV-2, which has spread to nearly every corner of the globe and has lasted, so far, for a little over a year.", "evidence": {"11021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11021]}
{"id": 177, "claim": "The rate of transmission in the course of a pandemic is typically cyclical<|multi_cit|> due to government interventions36,<|other_cit|>, behavioural changes<|other_cit|>, and environmental<|other_cit|> and other factors<|other_cit|>.", "evidence": {"11022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11022]}
{"id": 178, "claim": "Several analyses have projected that SARS-CoV-2 transmission will likewise be faster in temperate zone winters (<|multi_cit|>).", "evidence": {"11023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11023]}
{"id": 179, "claim": "The transmission of SARS-COV-2 has been likened to that of pandemic influenza due to its rapid surge across the globe and likelihood for it to circulate seasonally <|multi_cit|>.", "evidence": {"11024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11024]}
{"id": 180, "claim": "The rate of transmission in the course of a pandemic is typically cyclical<|other_cit|>–36 due to government interventions<|multi_cit|>, behavioural changes<|other_cit|>, and environmental<|other_cit|> and other factors<|other_cit|>.", "evidence": {"11025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11025]}
{"id": 181, "claim": "Epidemiologists had anticipated such a seasonal increase (<|multi_cit|>) based on observations from other enveloped respiratory viruses, such as endemic human coronaviruses (<|other_cit|>) and influenza viruses (<|other_cit|>).", "evidence": {"11026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11026]}
{"id": 182, "claim": "Some models produced simulated future outcomes under hypothetical behavioral or interventional scenarios [<|multi_cit|>].", "evidence": {"11027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11027]}
{"id": 183, "claim": "Since the onset of the COVID-19 pandemic, the role of seasonal variation in SARS-CoV-2 transmission has received significant scientific and political attention [<|cit|>].", "evidence": {"11028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11028]}
{"id": 185, "claim": "In order to understand the temporal dynamics of COVID-19, a lot of modelling work has been undertaken, focusing primarily on national data sets from China, Italy, Spain, the UK and the USA.<|other_cit|>,6,<|other_cit|> Given the inhomogeneous nature of such data sets, accurate predictions and forecasting of the spread of COVID-19 are challenging.<|other_cit|> Where such predictions were made, caveats accompanied these predictions simply because of the lack of rigorous mathematical and statistical validation of the models and the lack of robust data on which mathematical assumptions are based.<|multi_cit|> Forecasting requires ample historical information/data sets, which were lacking during the first wave of COVID-19.", "evidence": {"11029": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11029]}
{"id": 186, "claim": "Kissler et al. (<|cit|>) suggested a short duration of immunity after SARS-CoV-2 infection, while Long et al. (<|other_cit|>) suggested that asymptomatic individuals had a weaker immune response to SARS-CoV-2 infection.", "evidence": {"11030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11030]}
{"id": 189, "claim": "This framework can be used in conjunction with any model, including ODE models (<|multi_cit|>), agent-based simulations (<|other_cit|>), or network simulations (<|other_cit|>), and can be used to estimate   or to simulate transmission dynamics.", "evidence": {"11031": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11031]}
{"id": 190, "claim": "This time dependence could correspond to seasonal changes or mitigation measures [<|multi_cit|>, 27].", "evidence": {"11032": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11032]}
{"id": 191, "claim": "This is not a problem if the memory response produces neutralizing antibodies to antigens associated with the secondary exposure; however, problems do arise if memory B cells produce nonneutralizing antibodies to the antigens shared between primary and secondary exposures as reported recently in humans exposed to related human coronaviruses (hCoVs) and later infected with SARS-CoV-2 (<|multi_cit|>).", "evidence": {"11033": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11033]}
{"id": 192, "claim": "Intermittent social distancing may remain in place until 2022 [<|cit|>].", "evidence": {"11034": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11034]}
{"id": 193, "claim": "Strategies implemented in order to mitigate this disease include various Non-Pharmacological Interventions (NPIs) such as travel restrictions, curfews, lockdowns, social distancing regulations, and tracking of positive contacts [<|cit|>].", "evidence": {"11035": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11035]}
{"id": 194, "claim": "Current state-of-the-art forecasting models are based, on the one hand, on time-series analysis without an underlying dynamic epidemiological model.6,<|other_cit|> On the other hand, where forecasting is based on epidemiological models,<|multi_cit|> these lack rigorous validation, sensitivity analysis and analysis with respect to the identifiability of parameters, and therefore have limited forecasting power.", "evidence": {"11036": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11036]}
{"id": 195, "claim": "There is evidence of cross-protection within the same genera of HCoVs [<|multi_cit|>], but not between genera [<|other_cit|>].", "evidence": {"11037": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11037]}
{"id": 196, "claim": "susceptible-exposed-infectious-recovered-susceptible) [<|multi_cit|>], social network [<|other_cit|>], or time-varying [<|other_cit|>] models.", "evidence": {"11038": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11038]}
{"id": 197, "claim": "Since the framework is built around an SEIR-D model, introducing vaccinations into the model is not mathematically difficult provided we have a good understanding of the vaccination programme with reliable data sets.<|other_cit|> Similarly, with the emergence of the new COVID-19 variants (the UK, South Africa, Brazil), e.g. the UK VOC 202012/01 variant that emerged in the Southeast of England in November 2020, we can adapt the work by Kissler et al. (2020)<|multi_cit|> to provide a multi-strain model whereby an individual catches either one strain or the other.6,<|other_cit|> Understanding the impact of these will be vitally important in the progression of dealing with the disease, although it is not clear what data will be readily available and our observational model will need to be adapted accordingly.", "evidence": {"11039": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11039]}
{"id": 199, "claim": "During the early stages of COVID-19, parallels between COVID-19 and the Spanish flu (among other influenza diseases) that killed more than 50 million people with an average age of 28 years were drawn.<|multi_cit|> As a result, to mitigate and prepare for COVID-19 hospitalizations and deaths, national governments and hospitals suspended or postponed important critical diagnostic procedures/treatments, such as cancer diagnosis and treatment.", "evidence": {"11040": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11040]}
{"id": 200, "claim": "Current state-of-the-art forecasting models are based, on the one hand, on time-series analysis without an underlying dynamic epidemiological model.<|multi_cit|> On the other hand, where forecasting is based on epidemiological models,6,<|other_cit|> these lack rigorous validation, sensitivity analysis and analysis with respect to the identifiability of parameters, and therefore have limited forecasting power.", "evidence": {"11041": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11041]}
{"id": 201, "claim": "To understand the seasonal dependence of SARS-CoV-2 infections in the absence of year-long incidence data, we examined the effect of atmospheric temperature, the main variable with season [<|cit|>], on SARS CoV-2 transmissibility using currently available data on the rates of SARS-CoV-2 infection during winter and spring from fifty representative countries in the Northern Hemisphere.", "evidence": {"11042": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11042]}
{"id": 202, "claim": "It is thought that ongoing surveillance of SARS-CoV-2 is warranted as a re-emergence of the disease could still occur over the following years [<|cit|>].", "evidence": {"11043": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [11043]}
{"id": 204, "claim": "This is further supported by the differential expression of PPAR signaling, which has been implicated in T cell differentiation (<|other_cit|>) and linking the host’s lipid metabolism with differentiation of tissue-resident Treg cells (<|cit|>).", "evidence": {"53000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53000]}
{"id": 206, "claim": "Intriguingly, PPARγ expression by Treg cells is necessary to restore insulin sensitivity in obese mice (<|cit|>).", "evidence": {"53001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53001]}
{"id": 208, "claim": "In obesity, the expanding adipose tissue attracts immune cells, creating an inflammatory environment within this fatty acid storage organ.<|cit|> Inflammatory mediators, such as TNF-α and IL-1, are induced by saturated fatty acids, and disrupt insulin signaling and metabolic switch in their function.", "evidence": {"53002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53002]}
{"id": 209, "claim": "From a mechanistic point of view, the peroxisome proliferator-activated receptor PPARγ represents a central regulatory pathway for Treg infiltration into the visceral fat (<|cit|>).", "evidence": {"53003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53003]}
{"id": 210, "claim": "In addition to the effects on adipocytes, TZDs also have potent anti-inflammatory effects and suppress adipose macrophage gene expression in vitro and in vivo, as well as inhibit proinflammatory mononuclear cells.<|other_cit|> In a macrophage-specific PPARγ deficient mouse model, TZD only partially improves insulin sensitivity, suggesting that the antidiabetic effect of TZD is partially attributable to PPARγ activation in macrophages.<|other_cit|> Existing evidence has demonstrated that PPARγ activation promotes alternative macrophage activation through switching phenotype from proinflammatory M1 to antiinflammatory M2.<|other_cit|> Furthermore, a unique regulatory T cell population has been found to reside in visceral adipose tissue of normal individuals and plays an important role in regulating adipose tissue inflammation and insulin sensitivity.<|other_cit|> A recent study demonstrated that the complete insulin-sensitizing effect of pioglitazone is dependent on the expression of PPARγ in visceral adipose T regulatory cells.<|cit|> A recent study demonstrated that the complete insulin-sensitizing effect of pioglitazone is dependent on the expression of PPARγ in visceral adipose T regulatory cells.167", "evidence": {"53004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53004]}
{"id": 211, "claim": "Moreover Cipolletta et al. identified peroxisome proliferator-activated receptor (PPAR)-γ, the “master regulator” of adipocyte differentiation, as a crucial molecular orchestrator of VAT Treg cell accumulation, phenotype, and function (<|cit|>).", "evidence": {"53005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53005]}
{"id": 213, "claim": "An equally novel approach might be to utilize features of tissue-resident Tregs that have recently been shown to contribute to tissue protection (<|cit|>) and the repair of damaged tissue (<|other_cit|>) via distinct transcription factors (Figure <|other_cit|>).", "evidence": {"53006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53006]}
{"id": 214, "claim": "Importantly, PPAR-γ, the master regulator of adipocyte differentiation, has been shown to be a crucial molecular driver for Treg cell accumulation and function in visceral adipose tissue (<|cit|>).", "evidence": {"53007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53007]}
{"id": 215, "claim": "Indeed, PPARγ is essential for the maintenance and accumulation of T  cells in adipose tissue (<|cit|>).", "evidence": {"53008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53008]}
{"id": 216, "claim": "Recent findings show that in local tissues such as adipose tissues, Treg cells, either induced locally or migrating from the lymphoid organs, exhibit unique characteristics, allowing specialized immune regulation (<|cit|>).", "evidence": {"53009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53009]}
{"id": 217, "claim": "VAT Tregs are a unique subset of Tregs that uniquely express PPARγ and are specifically recruited to adipose tissue to suppress the inflammatory process [<|cit|>].", "evidence": {"53010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53010]}
{"id": 218, "claim": "Along the same line, we found that X-box binding protein 1 (Xbp1, a bZIP domain transcription factor) (<|other_cit|>), Gata-binding factor 1 (Gata1, a transcription factor) (<|other_cit|>), microRNA processing enzyme Dicer (<|other_cit|>), cytotoxic T-lymphocyte-associated protein 4 (Ctla4) (<|other_cit|>), and peroxisome proliferator-activated receptor gamma (PPARγ) (<|cit|>) can also inhibit the expression of other Th subset regulators in Treg, and maintain Treg identity.", "evidence": {"53011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53011]}
{"id": 219, "claim": "PPARγ is mostly expressed in the adipose tissue [<|cit|>] and immune system, and is an important regulator of their differentiation and metabolism.", "evidence": {"53012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53012]}
{"id": 221, "claim": "Recently, peroxisome proliferator-activated receptor γ (PPARγ) activity in T  cells has been shown to be important to reduce chronic inflammation in adipose tissue (<|cit|>).", "evidence": {"53013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53013]}
{"id": 225, "claim": "Moreover, the expression of PPAR-γ in visceral adipose tissue (VAT) Tregs was essential for restoration of insulin sensitivity in obese mice (<|cit|>).", "evidence": {"53014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53014]}
{"id": 226, "claim": "However, there is mounting evidence that perturbations of lipid metabolic pathways may also be associated with T cell fate and function [<|other_cit|>], particularly in T  cells [<|cit|>].", "evidence": {"53015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53015]}
{"id": 228, "claim": "Pioneering work by the group of Diane Mathis demonstrated the existence of a unique subset of GATA-3+ PPARγ+ regulatory T cells in adipose tissue important for preventing insulin resistance (<|multi_cit|>).", "evidence": {"53016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53016]}
{"id": 229, "claim": "One of the current drugs for T2D, pioglitazone, can improve insulin sensitivity by stimulating PPARγ signaling in Tregs, leading to increased AT Treg cell frequency (<|cit|>).", "evidence": {"53017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53017]}
{"id": 231, "claim": "Treg cells do not accumulate in the VAT of mice with Foxp3-specifically deleted of PPARγ,<|cit|> indicating that PPARγ is a crucial mediator of Treg cell accumulation, phenotype and function by regulating the expression of chemokine receptors necessary for the migration of Treg cells.", "evidence": {"53018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53018]}
{"id": 232, "claim": "Tregs in tissues exhibit a unique phenotype that is reminiscent of the tissue microenvironment, as exemplified by PPARγ expression in Tregs in the adipose tissue (<|cit|>).", "evidence": {"53019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [53019]}
{"id": 234, "claim": "The relation between alcohol consumption and cardiovascular disease is both complex and controversial.<|other_cit|> There have been multiple systematic reviews and meta-analyses of the association between consumption and aggregated cardiovascular disease,<|multi_cit|> as well as cardiovascular traits.<|other_cit|> Most have shown that, compared with non-drinking, moderate levels of alcohol intake are associated with a lower risk of morbidity and mortality from cardiovascular disease, as well as more favourable cardiovascular health profiles in general.", "evidence": {"91000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91000]}
{"id": 235, "claim": "However, there seems to be a compelling argument for causation <|cit|>, yet the implications for public health strategies remain uncertain.", "evidence": {"91001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91001]}
{"id": 236, "claim": "We also reported a J-shaped association with mortality from all causes, cancer, heart disease, and cerebrovascular disease in women, which corroborates previous reports.<|multi_cit|>,10", "evidence": {"91002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91002]}
{"id": 237, "claim": "The relationship between alcohol consumption and CVD, particularly CHD, is controversial<|multi_cit|>,23.", "evidence": {"91003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91003]}
{"id": 239, "claim": "It has also been reported that light to moderate alcohol consumption has beneficial effects on many aspects of health, particularly on cardiovascular outcomes (<|multi_cit|>).", "evidence": {"91004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91004]}
{"id": 240, "claim": "Alcohol use, more specifically alcohol abuse, is frequently mentioned as a risk factor for several chronic diseases.<|other_cit|> However, evidence of a beneficial effect of moderate alcohol consumption for CVDs has been described in the literature.<|cit|> However, evidence of a beneficial effect of moderate alcohol consumption for CVDs has been described in the literature.24", "evidence": {"91005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91005]}
{"id": 241, "claim": "It is possible that the J-shaped association between alcohol consumption and all cause mortality may be in part a product of a similarly protective relation between alcohol and vascular diseases,<|multi_cit|> with circulatory conditions representing 29% (124 442/427 170) of deaths in 2013 among people aged 65 years or more and living in England and Wales—the largest proportion of any reported group of conditions.<|other_cit|>", "evidence": {"91006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91006]}
{"id": 242, "claim": "This reduced risk is ascribed to a reduced risk of cardiovascular diseases with moderate alcohol consumption [<|multi_cit|>], but remains disputed [<|other_cit|>].", "evidence": {"91007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91007]}
{"id": 243, "claim": "Extensive literature has documented the J shaped associations between alcohol intake and a variety of diseases, including multiple cardiovascular outcomes<|cit|> (such as congestive heart failure,<|other_cit|> and stroke<|other_cit|>) as well as diabetes<|other_cit|> and all cause mortality,<|other_cit|> and possibly coronary heart disease.<|other_cit|> Light to moderate drinkers have a lower risk of these disorders than abstainers, and heavy drinkers are at the highest risk.", "evidence": {"91008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91008]}
{"id": 244, "claim": "Studies have shown a direct relation between alcohol consumption and breast cancer,<|other_cit|> whereas the observed risk for coronary heart disease is lower among light to moderate drinkers than among abstainers.<|multi_cit|> Plausible biological mechanisms have been suggested for breast cancer<|other_cit|> and coronary heart disease,<|other_cit|> which speak in favour of the causality of these findings.", "evidence": {"91009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91009]}
{"id": 245, "claim": "However, the cardioprotective effects of alcohol consumption were found to be dose-dependent, with 2.5 g–14 g/day of alcohol being beneficial, and >60 g/day significantly increasing the risk of stroke [<|cit|>].", "evidence": {"91010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91010]}
{"id": 246, "claim": "The possible health benefits accentuated at older ages include lowering the risk of dementia [<|other_cit|>] and offering some protection against cardiovascular disease [<|multi_cit|>] and asthma [<|other_cit|>].", "evidence": {"91011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91011]}
{"id": 247, "claim": "Alcohol intake has been associated with an increased risk of death from a large list of morbid conditions, including digestive tract conditions, liver cirrhosis, chronic pancreatitis, hypertension, injuries and violence.<|other_cit|> In contrast, moderate alcohol drinking was suggested to be associated with a reduction in cardiovascular disease (CVD) mortality.<|multi_cit|> As for cancer, the International Agency for Research on Cancer and the World Cancer Research Fund/American Institute for Cancer Research concluded that alcohol use is associated with an increased risk to develop cancers of the upper aerodigestive tract, liver, colorectal and female breast.<|other_cit|> It has been estimated that alcohol accounted for about 2.7 million annual deaths and 3.8% of all deaths worldwide,<|other_cit|> but the impact of alcohol on mortality is differential with respect to specific causes of diseases.<|other_cit|>", "evidence": {"91012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91012]}
{"id": 248, "claim": "Where ORs were reported they were transformed into RRs using this this formula: RR = OR/[(1 – P ) + (P  × OR)], in which P  is the incidence of the outcome of interest in the non-exposed group (<|other_cit|>), standard errors (SEs) of the corrected RRs were calculated from this formula: SElog (relative risk) = SElog (odds ratio) × log(relative risk)/log(odds ratio) (<|cit|>).", "evidence": {"91013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91013]}
{"id": 249, "claim": "While past studies have reported a reduced risk of total mortality,<|other_cit|> cardiovascular diseases,<|other_cit|> and cancer<|other_cit|> in light-to-moderate drinkers, heavy alcohol consumption has been positively associated with mortality from the same causes of death.<|multi_cit|>,10 This means that light-to-moderate drinkers may receive health benefits from alcohol intake, although the optimal range varies across studies and by population.", "evidence": {"91014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91014]}
{"id": 251, "claim": "A systematic review that investigated the relationship between alcohol consumption and some CVD endpoints performed with more than 4,000 studies has described a dose-response effect, demonstrated by the lowest risk of CHD mortality occurring with one to two drinks per day<|cit|>.", "evidence": {"91015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91015]}
{"id": 252, "claim": "For instance, lifestyle behaviors (e.g., smoking, drinking, exercise, and sleeping) have been reported to be associated with a variety of diseases, such as obesity [<|other_cit|>], stroke [<|other_cit|>], type II diabetes [<|other_cit|>], and cardiovascular diseases [<|cit|>].", "evidence": {"91016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91016]}
{"id": 253, "claim": "Our companion systematic review assessing alcohol associations with clinically relevant cardiovascular end points offers parallel evidence of the protective effect of alcohol consumption.<|cit|> These combined reviews provide a foundation of knowledge on which clinical and public health messaging can be discussed.", "evidence": {"91017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91017]}
{"id": 254, "claim": "Merits and demerits of alcoholic beverage intake have been long explored because of its benefit for cardiovascular disease (<|multi_cit|>) or carcinogenic effect (<|other_cit|>).", "evidence": {"91018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [91018]}
{"id": 256, "claim": "Incidence density ratios and RRs were considered as HRs in meta-analyses (<|multi_cit|>; Zeng et al., <|other_cit|>).", "evidence": {"91019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [91019]}
{"id": 259, "claim": "The modification of the microbiota from the intestinal tract or from other parts of the human body can influence the development of a variety of diseases, such as multiple sclerosis, intestinal bowel disease, rheumatoid arthritis and autoimmune diseases (<|multi_cit|>).", "evidence": {"83000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83000]}
{"id": 261, "claim": "This genus appears to have effects on intestinal T helper 17 cells,<|other_cit|> and it has been found to be increased in faecal samples from patients with CD,<|other_cit|> and new-onset rheumatoid arthritis.<|cit|> and new-onset rheumatoid arthritis.29", "evidence": {"83001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83001]}
{"id": 262, "claim": "The relationships between microorganisms and some other diseases have also been investigated, such as oral diseases (Belda-Ferre et al. <|other_cit|>), neurological diseases (Hsiao et al. <|other_cit|>), rheumatoid arthritis (<|cit|>), and Crohn’s disease (Gevers et al. <|other_cit|>).", "evidence": {"83002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83002]}
{"id": 263, "claim": "Although in some particular cases complex diseases have been linked with the presence of specific bacteria (e.g. Prevotella in reactive arthritis; <|cit|>), it seems likely that bacterial communities and not specific bacteria determine susceptibility towards complex diseases, a concept that has been introduced as the ‘the pathobiome’ (Vayssier-Taussat et al.<|other_cit|>).", "evidence": {"83003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83003]}
{"id": 264, "claim": "The bacteria that live normally in our intestinal tract, or the gut microbiota, contribute to the pathogenesis of extraintestinal autoimmune disease via their ability to dynamically educate the <|other_cit|> For example, in a mouse model of relapsing, remitting multiple sclerosis (MS), experimental autoimmune encephalomyelitis or EAE, several studies demonstrated that commensal microorganisms are essential in causing clinical disease activity.<|other_cit|> Interestingly, MS patients have a distinct gut microbiota to healthy controls.<|other_cit|> Several studies have also illustrated the importance of the gut microbiome in the development of other diseases, including type 1 diabetes, metabolic syndrome, rheumatoid arthritis, and ankylosing spondylitis.<|multi_cit|> HLA-B27 transgenic rats, which develop spontaneous spondyloarthropathy analogous to patients who have ankylosing spondylitis, associated with uveitis in humans, do not develop intestinal or peripheral joint inflammation when raised in a germ-free environment.<|other_cit|> Our group has shown that HLA-B27 transgenic rats have an altered intestinal microbiota compared with healthy control rats.<|other_cit|>", "evidence": {"83004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83004]}
{"id": 265, "claim": "Recently, we summarized the evidence for a significant involvement of lipopolysaccharide shed by dormant and resuscitating bacteria as underpinning the chronic inflammation characteristic of a variety of diseases, and suggested that LPS may play a role in the pathogenesis of RA.<|other_cit|> The presence and role of LPS may be supported by a recent review that provided evidence for the involvement of a microbiome in inflammatory arthritis and rheumatic diseases.<|other_cit|> Recently, Scher et al.<|cit|> Recently, Scher et al.317", "evidence": {"83005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83005]}
{"id": 266, "claim": "This is the case for type 1 diabetes (<|other_cit|>), multiple sclerosis (<|other_cit|>), rheumatoid arthritis (<|cit|>), SLE (<|other_cit|>), Behcet’s syndrome (<|other_cit|>), autoimmune gastritis (<|other_cit|>), and ankylosing spondylitis (<|other_cit|>).", "evidence": {"83006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83006]}
{"id": 268, "claim": "Indeed, many such examples have been found, including graft-versus-host disease [<|other_cit|>], kidney transplantation [<|other_cit|>], hepatitis [<|other_cit|>], cirrhosis [<|other_cit|>], psoriasis [<|other_cit|>], IBD [<|other_cit|>], and arthritis [<|cit|>].", "evidence": {"83007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83007]}
{"id": 272, "claim": "<|multi_cit|>–8 For example, in a mouse model of relapsing, remitting multiple sclerosis (MS), experimental autoimmune encephalomyelitis or EAE, several studies demonstrated that commensal microorganisms are essential in causing clinical disease activity.1,6", "evidence": {"83008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83008]}
{"id": 273, "claim": "The Prevotella enterotype has been shown to be clinically relevant in (<|cit|>).", "evidence": {"83009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83009]}
{"id": 276, "claim": "These later changes in the intestinal microbiote are starting to be identified, possibly leading to disease initiation through changes in the T-cell phenotype toward a more inflammatory Th17 pathway [<|cit|>].", "evidence": {"83010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83010]}
{"id": 277, "claim": "A recent study in humans examined fecal microbiota in new-onset RA by sequencing microbial 16S ribosomal RNA genes [<|cit|>].", "evidence": {"83011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83011]}
{"id": 278, "claim": "Furthermore, it is becoming increasingly evident that alterations in abundance and diversity of these bacterial constituents are associated with inflammation and disease (<|multi_cit|>).", "evidence": {"83012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83012]}
{"id": 279, "claim": "Of note, altered intestinal bacterial diversity and dissemination of specific species have been postulated as a mucosal origin for arthritis (<|multi_cit|>).", "evidence": {"83013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83013]}
{"id": 280, "claim": "Taxa within the family Prevotellaceae have been associated with inflammation (particularly in the context of autoinflammatory disease [<|multi_cit|>]) and activation of gut dendritic cells [<|other_cit|>▪▪], but a greater abundance of Prevotellaceae is also characteristic of the baseline enteric microbial community of healthy individuals in developing world countries such as Burkina Faso, Venezuela, Malawi, or Papu<|other_cit|>].", "evidence": {"83014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83014]}
{"id": 281, "claim": "Nevertheless, several bacteria have been associated with many diseases [<|multi_cit|>–109] and fecal transplantation is already an emerging method to treat certain conditions.", "evidence": {"83015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83015]}
{"id": 282, "claim": "Changes of gut microbiota composition have been found in several diseases such as colon cancer (<|other_cit|>), rheumatoid arthritis (<|cit|>), cardiovascular diseases (<|other_cit|>) and diabetes (<|other_cit|>), obesity (<|other_cit|>).", "evidence": {"83016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [83016]}
{"id": 284, "claim": "Animal models also support the theory that both BED and SUD follow from dysregulation of the same dopaminergic pathways [<|multi_cit|>] and have likewise been able to produce somatic withdrawal symptoms with sucrose cessation [<|other_cit|>].", "evidence": {"67000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [67000]}
{"id": 285, "claim": "Recently, it was demonstrated that obese rats have dysregulated dopamine D2 receptors, which induces uncontrolled and compulsive feeding behaviors to palatable fat-rich diets <|cit|>.", "evidence": {"67001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67001]}
{"id": 286, "claim": "During eating, however, obese individuals, like drug addicts, present attenuated reward responses, probably promoting compensatory overconsumption (<|multi_cit|>).", "evidence": {"67002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67002]}
{"id": 287, "claim": "These include activation of the mesolimbic dopaminergic system (Blackburn et al., <|other_cit|>; Hernandez and Hoebel, <|other_cit|>), the activation of similar brain structures (Robinson et al., <|other_cit|>), as well as an overlapping symptomatology such as the appearance of tolerance, compulsive behaviors (<|multi_cit|>; Rossetti et al., <|other_cit|>) and withdrawal symptoms in relation to PHc food that has been consistently observed in obese individuals (Iemolo et al., <|other_cit|>; García-García et al., <|other_cit|>).", "evidence": {"67003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67003]}
{"id": 288, "claim": "The authors propose that obesity and drug addiction are related to common hedonic mechanisms [<|cit|>].", "evidence": {"67004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67004]}
{"id": 290, "claim": "For example, Johnson and Kenny (<|cit|>) showed that highly palatable and processed foods may trigger biological changes in the mesolimbic pathways (part of the reward system) of obese rats.", "evidence": {"67005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67005]}
{"id": 291, "claim": "Emerging evidence suggests that overweight and obesity represents a special case of addictive behavior, which involves underlying neural mechanisms similar to other addictions (Kelley and Berridge, <|other_cit|>; Rolls, <|other_cit|>; Trinko et al., <|other_cit|>; Volkow et al., <|multi_cit|>).", "evidence": {"67006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67006]}
{"id": 294, "claim": "Most of convincing evidences of FA in animal model was that rodents showed addiction-like behaviors such as binging, withdrawal, and craving and neuronal changes similar to previous reports in human drug addicts such as downregulated striatal dopamine D2 receptors dopamine release in the mesolimbic dopamine system after a few weeks of intermittent access to sugar or high-fat food (<|multi_cit|>).", "evidence": {"67007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67007]}
{"id": 295, "claim": "Like drug addicts, obese individuals present increased craving as well as attenuated reward responses to high-calorie foods, probably supporting compensatory overeating (Wang et al., <|other_cit|>; Stice et al., <|multi_cit|>).", "evidence": {"67008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67008]}
{"id": 296, "claim": "Thus, there appear to be very specific alterations in response to extremes or food intake in taste and subcortical dopamine related reward circuits (<|cit|>).", "evidence": {"67009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67009]}
{"id": 297, "claim": "This was further evidenced by a study reporting that a cafeteria diet of sweet and savoury human foods led to weight gain and obesity in male Wistar rats (fed for 18-23 h per day over a 40-day period), and these metabolic effects were accompanied by compulsive-like feeding behaviour and downregulation of striatal D2 dopamine receptors (<|cit|>).", "evidence": {"67010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67010]}
{"id": 298, "claim": "In recent years there has been an increased focus on the role of dopamine in obesity with several high profile papers likening overeating to a food addiction (Volkow and Wise, <|other_cit|>; Trinko et al., <|other_cit|>; Avena et al., <|other_cit|>; Corwin and Grigson, <|other_cit|>; Dagher, <|other_cit|>; Davis and Carter, <|other_cit|>; Ifland et al., <|other_cit|>; Pelchat, <|multi_cit|>; Volkow et al., <|other_cit|>).", "evidence": {"67011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67011]}
{"id": 299, "claim": "Obese mice have reduced striatal D2 receptors (<|cit|>), a deficit which has been shown to impair the ability to inhibit previously rewarded responses to natural rewards in mice (Kruzich et al., <|other_cit|>).", "evidence": {"67012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67012]}
{"id": 301, "claim": "Animal studies have more consistently linked impairments in D2Rs to obesity, via analysis of mRNA (Mathes et al., <|other_cit|>; Zhang et al., <|other_cit|>), protein (<|multi_cit|>; Adams et al., <|other_cit|>), and receptor binding (Huang et al., <|other_cit|>; Hajnal et al., <|other_cit|>; Thanos et al., <|other_cit|>; Michaelides et al., <|other_cit|>; van de Giessen et al., <|other_cit|>; Narayanaswami et al., <|other_cit|>).", "evidence": {"67013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67013]}
{"id": 302, "claim": "Decreases in striatal D2 receptors have been linked to compulsive food intake in obese rodents (<|cit|>) and with decreased metabolic activity in OFC and ACC in obese humans (Tremblay and Schultz, <|other_cit|>).", "evidence": {"67014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67014]}
{"id": 303, "claim": "Nevertheless, it is important to consider the results of a study by Johnson and Kenny (<|cit|>); they can sense and respond to both, the sensory and energy signals elicited by foods, but are more likely to select foods that will match their metabolic status and fulfill their energetic demands.", "evidence": {"67015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67015]}
{"id": 305, "claim": "Food craving and the anticipation of food reward in preclinical models are associated with changes in D2 striatal receptors [<|cit|>].", "evidence": {"67016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67016]}
{"id": 307, "claim": "Reduced inhibition of the indirect pathway, through low stimulation of D2R, can lead to loss of inhibitory control, resulting in behavioral deficits such as compulsivity, impulsivity, or excessive habit formation (Yin et al., <|multi_cit|>; Seger and Spiering, <|other_cit|>; Bock et al., <|other_cit|>).", "evidence": {"67017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67017]}
{"id": 308, "claim": "Altered dopamine signaling has been heavily implicated in obesity as both obese humans and rodents have lower levels of striatal dopamine D2 receptor (D2R) availability compared with lean people and animals (Wang et al., <|multi_cit|>).", "evidence": {"67018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67018]}
{"id": 310, "claim": "For example, reduced dopamine function, particularly DRD2 signaling, is associated with obesity development in rodents (<|multi_cit|>) and humans (<|other_cit|>).", "evidence": {"67019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [67019]}
{"id": 312, "claim": "This randomized trial recruited 1062 patients, and 541 received remdesivir while 521 received placebo (clinical trial no. NCT04280705 from ClinicalTrials.gov) (<|cit|>).", "evidence": {"15000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15000]}
{"id": 314, "claim": "There are 4 published randomized controlled trials (RCTs) that evaluated remdesivir for treatment of COVID-19.<|multi_cit|> The 2 largest were the Adaptive Covid-19 Treatment Trial (ACTT-1), a placebo-controlled RCT involving 1062 patients,1 and Solidarity, an open-label RCT that compared treatment with remdesivir to standard of care in 6838 patients.<|other_cit|>", "evidence": {"15001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15001]}
{"id": 315, "claim": "The evidence of good tolerance<|multi_cit|> and the efficacy data deriving from the adult population suggest using remdesivir instead of other antivirals.", "evidence": {"15002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15002]}
{"id": 316, "claim": "Interestingly, we observed greater improvements in CRP, ALT, AST and creatinine in the second wave in patients with longer hospitalisations; while this may be reflective of a sicker patient population, this could be due to time-dependent (ie, survivor) bias.<|other_cit|> Alternatively, there may have been increased corticosteroid use in patients with severe COVID-19 in the second wave following preliminary results of the controlled, open-label Randomized Evaluation of COVID-Therapy (RECOVERY) Trial, which may have improved inflammatory markers and mortality.<|other_cit|> In addition, there may have been increased remdesivir in combination with dexamethasone between the first and second waves that may confound these associations.<|multi_cit|> Further studies are warranted to investigate the alteration of biochemical trajectories of dexamethasone with remdesivir in contrast to dexamethasone or remdesivir monotherapy.<|other_cit|> It is also unclear why we observed between-country differences in the between-wave CRP trajectories, whereupon Spain and France had blunted improvement rates; this could certainly be due to differential clinical management across countries.", "evidence": {"15003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15003]}
{"id": 318, "claim": "There are 4 published randomized controlled trials (RCTs) that evaluated remdesivir for treatment of COVID-19.1,<|other_cit|> The 2 largest were the Adaptive Covid-19 Treatment Trial (ACTT-1), a placebo-controlled RCT involving 1062 patients,<|cit|> and Solidarity, an open-label RCT that compared treatment with remdesivir to standard of care in 6838 patients.<|other_cit|>", "evidence": {"15004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15004]}
{"id": 319, "claim": "However, remdesivir has been shown to reduce recovery time in hospitalized patients with COVID-19 and supplemental oxygen with respect to placebo patients (rate ratio [RR] 1.45; 95% confidence interval [CI] 1.18–1.79) [<|cit|>].", "evidence": {"15005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15005]}
{"id": 320, "claim": "These anti-viral agents, such as RNA polymerase and protease enzymes, functioned by blocking viral genomic replication; however, they showed limited benefit in the severely ill population [<|multi_cit|>].", "evidence": {"15006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15006]}
{"id": 321, "claim": "The study concluded that remdesivir administered for 10 days had a benefit in hospitalised patients with COVID-19, especially in patients receiving low-flow oxygen at baseline [<|cit|>] (Table <|other_cit|>).", "evidence": {"15007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15007]}
{"id": 322, "claim": "Patients receiving remdesivir had a shorter time to recovery (defined as meeting the criteria for the top 3 categories on an 8-point ordinal scale) compared with those receiving placebo (median time to recovery, 10 [95% CI, 9–11] vs 15 [95% CI, 13–18] days; rate ratio for recovery, 1.29 [95% CI, 1.12–1.49]; P < .001) [<|cit|>].", "evidence": {"15008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15008]}
{"id": 323, "claim": "One subgroup analysis from a randomized, placebo-controlled trial did find a mortality benefit with remdesivir for patients who required non-high-flow oxygen, however after methodological assessment there was no statistical significance found, reducing the reliabili<|other_cit|> Remdesivir does reduce time to clinical improvement when given early in the course of illness and/or in patients with less severe disease, defined as requiring non-invasive oxygen supplementation.<|multi_cit|>", "evidence": {"15009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15009]}
{"id": 324, "claim": "In the ACTT-1 trial, remdesivir reduced mortality by 70% (RR: 0.30; 95% CI 0.14–0.64) in hospitalized patients with COVID-19 and supplemental oxygen [<|cit|>].", "evidence": {"15010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15010]}
{"id": 325, "claim": "The trial did not find a difference in mortality (hazard ratio 0.73, 95% confidence interval [CI] 0.52–1.03), although it was not powered to do so.<|cit|> Solidarity failed to show a mortality benefit (rate ratio 0.95, 95% CI 0.81–1.11) and also did not show a benefit in the prespecified secondary outcomes of ventilation or time to discharge.<|other_cit|>", "evidence": {"15011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15011]}
{"id": 326, "claim": "Since emerging in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global health crisis.(<|other_cit|>) The disease caused by SARS-CoV-2 infection, coronavirus disease 19 (COVID-19), has caused over 2.1 million deaths worldwide through January 2021.(<|other_cit|>) Despite vast ongoing efforts to identify potential treatments for patients with acute COVID-19, few therapies have demonstrated benefit, and these drugs appear to only be effective for certain subgroups of patients with COVID-19.(<|multi_cit|>) The recent approval of two vaccines offers promise for preventing new infections in the future.(<|other_cit|>) However, logistics of manufacturing and deploying the vaccine worldwide appear challenging, especially in resource-poor and developing nations.(<|other_cit|>) Additionally, many people appear reluctant to receive SARS-CoV-2 vaccines even when they do become widely available.(<|other_cit|>) Furthermore, vaccines are unlikely to completely eliminate COVID-19 in vaccinated populations.(<|other_cit|>) Thus, COVID-19 may be a major cause of morbidity and mortality for the foreseeable future and effective therapies to treat patients moderately and severely ill with COVID-19 are urgently needed.", "evidence": {"15012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15012]}
{"id": 327, "claim": "Among the candidate drugs, RDV was developed as a broad-spectrum antiviral drug, but cannot meet the clinical needs of COVID-19 treatment due to the unsatisfactory therapeutic outcome and high mortality (<|cit|>).", "evidence": {"15013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15013]}
{"id": 329, "claim": "1,2,<|other_cit|> Drug-induced liver injuries have been reported,<|other_cit|> and anaphylaxis and infusion-related reactions can occur.<|cit|> and anaphylaxis and infusion-related reactions can occur.1", "evidence": {"15014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15014]}
{"id": 330, "claim": "For instance, remdesivir, an inhibitor of the viral RNA-dependent RNA polymerase, shortened the time to recovery in adults with COVID-19 (10 vs. 15 days for placebo) [<|cit|>].", "evidence": {"15015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15015]}
{"id": 332, "claim": "Since remdesivir has been shown to reduce hospitalization [<|cit|>] and may reduce mortality in patients with severe COVID-19 infection [<|other_cit|>], we hypothesized that suppression of viral entry into cells through inhibition of ACE2 and TMPRSS2 would reduce the spread of SARS-CoV-2 infection in a given COVID-19-(+) patient and this would allow the innate immune system and antivirals such as remdesivir to more effectively suppress early infection.", "evidence": {"15016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15016]}
{"id": 333, "claim": "The mean length of hospital stay was 15 days, which is a similar figure to that reported in the pivotal study of RDV [<|cit|>], and there were no differences in this variable between the severe patients who received RDV associated with corticosteroid boluses ± biological treatment and those severe patients who received RDV in monotherapy or associated with low-dose corticosteroid therapy.", "evidence": {"15017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15017]}
{"id": 334, "claim": "Regardless of nomenclature, the composite endpoint is appropriate for an event-based clinical trial of this size to predict a clinically meaningful outcome that equates ventilation with mortality.<|other_cit|> It is not confounded by mechanisms that may preferentially affect either ventilation or death.<|other_cit|> Lenzilumab’s ability to improve SWOV was more pronounced in combination with current treatments including remdesivir which has demonstrated a 5 day improvement in time to recovery<|cit|> and dexamethasone which improved survival in subjects needing respiratory support<|other_cit|> which may indicate a synergistic mechanism of action with the triple combination.", "evidence": {"15018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15018]}
{"id": 335, "claim": "Nevertheless, aspects such as the fact that the overall mortality, significant in the total study population of the ACTT-1 trial, reflects the huge COVID-19 heterogeneity in behavior in different patient subgroups and the difficulty of randomizing benefits coming from the highest sample size subgroup (n = 232 in remdesivir group and n = 203 in placebo group) should be taken into account [<|cit|>].", "evidence": {"15019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15019]}
{"id": 336, "claim": "On the other hand, a large, phase 3, double-blinded, placebo-controlled trial—the Adaptive COVID-19 Treatment Trial (ACTT-1)—showed that remdesivir was superior to a placebo in shortening the time to recovery in adults who were hospitalized with COVID-19 and produced evidence of lower respiratory tract infection; moreover, this study showed the larger benefit of remdesivir when given earlier, i.e., 10 days within the onset of symptoms than in those treated later [<|cit|>].", "evidence": {"15020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15020]}
{"id": 337, "claim": "Remdesivir is an antiviral drug which was proven in preclinical trials to block SARS-CoV-2 replication (<|cit|>) but there are still no data on its benefits for neurological complications (<|other_cit|>).", "evidence": {"15021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15021]}
{"id": 338, "claim": "Health outcomes represented in the model were based on the ordinal scale (OS) used to measure efficacy in the ACTT-2 trial [<|cit|>].", "evidence": {"15022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15022]}
{"id": 339, "claim": "Subgroup analyses from ACTT-1 and Solidarity showed that remdesivir conferred no benefit in patients who were intubated or on extracorporeal membrane oxygenation.<|multi_cit|> Although less certain, there did not appear to be significant benefit for patients on high-flow oxygen.1,<|other_cit|>", "evidence": {"15023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15023]}
{"id": 340, "claim": "The probability of needing mechanical ventilation, high-flow oxygen devices, or extracorporeal membrane oxygenation (ECMO) at 15 days, was lower in patients treated with remdesivir compared to those in the placebo group (7.76% vs. 13.79%) [<|cit|>].", "evidence": {"15024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15024]}
{"id": 341, "claim": "The ACTT-1 study compared remdesivir (200 mg loading dose followed by 100 mg daily for up to 9 additional days) with placebo in adults hospitalized with COVID-19 with evidence of lower respiratory tract infection [<|cit|>].", "evidence": {"15025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15025]}
{"id": 342, "claim": "However, the mentioned studies [<|multi_cit|>] did not clarify response to remdesivir when the disease severity categories or duration of symptoms before the treatment were stratification criteria.", "evidence": {"15026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15026]}
{"id": 343, "claim": "This scale was developed by the World Health Organization (<|other_cit|>) (WHO) early in the pandemic as a patient-centered clinical outcome for COVID-19 and has been successfully used in multiple clinical trials.(<|multi_cit|>) Secondary and safety outcomes are shown in <|other_cit|>.", "evidence": {"15027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15027]}
{"id": 344, "claim": "The modeled population consisted of 35.6% female patients with an average age of 58.9 years at hospital admission [<|cit|>].", "evidence": {"15028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15028]}
{"id": 345, "claim": "Subgroup analyses from ACTT-1 and Solidarity showed that remdesivir conferred no benefit in patients who were intubated or on extracorporeal membrane oxygenation.1,<|other_cit|> Although less certain, there did not appear to be significant benefit for patients on high-flow oxygen.<|multi_cit|>", "evidence": {"15029": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15029]}
{"id": 347, "claim": "Data from a double-blind, randomized controlled trial indicated a reduced time to recovery in patients hospitalized with SARS-CoV-2 infection receiving intravenous remdesivir for 10 days compared with placebo (median time to recovery 10 days [95% confidence interval {CI}, 9–11 days] vs 15 days [95% CI, 13–18 days]) [<|cit|>].", "evidence": {"15030": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15030]}
{"id": 348, "claim": "The sample size estimate was based on the event rates in similar patient populations from other published studies.<|multi_cit|> The event rate of subjects who required IMV or died by Day 28 in the placebo group was estimated to be approximately 25%, and the event rate in the lenzilumab treatment group was approximated as 15% resulting in a HR of 0.565.<|other_cit|> Using a Cox proportional hazard model to test for inequality of the HR, a total of 100 events were calculated as needed to provide 81.47% power to detect a difference using a two-sided alpha of 5.0% at the final analysis and assuming a fixed follow-up of 28 days.", "evidence": {"15031": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15031]}
{"id": 349, "claim": "In fact, the final report of the abovementioned pivotal clinical trial highlights the benefits associated with the use of RDV in patients requiring oxygen therapy but not IMV [<|cit|>], concluding that RDV does not reduce mortality in patients requiring IMV, while corticosteroids do have a beneficial effect in this type of patient.", "evidence": {"15032": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15032]}
{"id": 350, "claim": "Based on these preliminary results, the US Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) of remdesivir on 1 May 2020 [<|cit|>].", "evidence": {"15033": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15033]}
{"id": 352, "claim": "Remdesivir (RDV), an adenine nucleotide analog when inserted into viral RNA chains results in their premature termination (<|other_cit|>), has shown a broad spectrum of antiviral activity against severe acute respiratory syndrome coronavirus (SARS–CoV) (<|other_cit|>), Nipah virus (<|other_cit|>), Middle East respiratory syndrome coronavirus (MERS–CoV) (<|other_cit|>), Ebola virus (<|other_cit|>), and SARS-CoV-2 (<|multi_cit|>).", "evidence": {"15034": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15034]}
{"id": 353, "claim": "In parallel to the development and introduction of vaccines, significant progress has been achieved in the field of specific COVID-19 therapy [<|multi_cit|>].", "evidence": {"15035": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15035]}
{"id": 354, "claim": "The next most globally cited article was the paper published by Beigel JH et al. [<|cit|>], titled ‘Remdesivir for the treatment of COVID-19—Final Report’, published in 2020 by the New England Journal of Medicine, which also appeared to be the most frequently globally cited article; the article was cited 2458 times.", "evidence": {"15036": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15036]}
{"id": 355, "claim": "The final report of the Adaptive COVID-19 Treatment Trial 1 (ACTT-1) study described shorter recovery times in patients hospitalized for COVID-19 pneumonia who were treated with RDV compared with those who received a placebo [<|cit|>].", "evidence": {"15037": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15037]}
{"id": 356, "claim": "Because of data that the anti-viral agent remdesivir could reduce hospitalization of COVID-19 infected patients [<|cit|>], we investigated the effects of combining remdesivir on ACE2 expression.", "evidence": {"15038": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15038]}
{"id": 357, "claim": "<|cit|>  The clinical benefit of remdesivir is mixed, resulting in a lack of consensus among society and organizational guidelines.", "evidence": {"15039": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15039]}
{"id": 360, "claim": "In this regard, the mentioned comparative analysis of remdesivir vs. SOC treatment in adults with severe COVID-19 showed that remdesivir was associated with significantly greater recovery and a 62% reduction in the odds of death [<|cit|>].", "evidence": {"15040": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15040]}
{"id": 361, "claim": "This is consistent with previous analyses showing higher fatality rates in the earliest epidemic period which was characterized by substantial transmission in congregate care settings and no available clinical interventions (e.g. corticosteroids [<|other_cit|>], prone positioning [<|other_cit|>], antivirals [<|cit|>], antivirals [4]) that would improve survival odds for a hospitalized patients.", "evidence": {"15041": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15041]}
{"id": 362, "claim": "Following this, Beigel et al. conducted the Adaptive COVID-19 Treatment Trial (ACTT-1) trial [<|cit|>].", "evidence": {"15042": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15042]}
{"id": 363, "claim": "Randomised controlled trials provide proof on the efficacy and safety of remdesivir in hospitalised COVID-19 patients requiring supplemental oxygen therapy [<|multi_cit|>].", "evidence": {"15043": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15043]}
{"id": 364, "claim": "The pivotal study (ACTT-1) showed that remdesivir improves the time to recovery, reducing the length of hospital stay in patients with COVID-19 and pneumonia who require supplemental oxygen [<|cit|>], becoming the first drug indicated for the treatment of COVID-19.", "evidence": {"15044": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15044]}
{"id": 365, "claim": "Remdesivir is an intravenous inhibitor of the viral RNA-dependent RNA polymerase with in vitro and in vivo activity against Middle East respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and SARS-CoV-2.<|multi_cit|> In Canada, it is authorized and available through Health Canada for patients (≥ 12 yr of age and weighing ≥ 40 kg) with coronavirus disease 2019 (COVID-19) who require oxygen.<|other_cit|>", "evidence": {"15045": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15045]}
{"id": 366, "claim": "Some trials orient the ordinal outcomes scale in the reverse direction, with an odds ratio greater than 1.0 indicating benefit from the intervention.(<|multi_cit|>) With reversal of the ordinal outcomes scale, enrollment of 1000 patients would provide 80% power to detect an adjusted odds ratio ≥1.37.", "evidence": {"15046": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15046]}
{"id": 367, "claim": "Specifically, the ACTT-1 trial supports the use of remdesivir in COVID-19 patients receiving low-flow oxygen therapy as it expressed superiority in the time of recovery in comparison to the control [<|cit|>].", "evidence": {"15047": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [15047]}
{"id": 368, "claim": "Assessment of clinical status on day 29, using an eight-point ordinal scale, showed a significantly shorter time to recovery in the remdesivir group compared with the placebo group (rate ratio 1.29 [95% CI: 1.12 to 1.49]), p < 0.001) [<|cit|>].", "evidence": {"15048": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15048]}
{"id": 370, "claim": "The ACCORD-MIND trial was designed to assess whether strict control of glycemia (target glycated hemoglobin lower than 6%) offers benefits over conventional levels (7 to 7.9%) for preventing cognitive decline.<|other_cit|> However, the ACCORD study showed that strict control of glycemia increased mortality and is contra-indicated in diabetic patients at high risk.<|cit|> However, the ACCORD study showed that strict control of glycemia increased mortality and is contra-indicated in diabetic patients at high risk.45", "evidence": {"77000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [77000]}
{"id": 371, "claim": "That hypoglycemia is associated with an increased risk of death is not necessarily news; it is a consistent finding in different populations, including patients treated in ICUs [<|other_cit|>] and type II diabetes patients recruited to large randomized controlled trials [<|multi_cit|>,5].", "evidence": {"77001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77001]}
{"id": 373, "claim": "Further analyses from ACCORD have failed to establish that differences in the rate of reduction of A1C to near-normal levels, severe hypoglycemia, or weight gain explain the increased death rate among intensively treated subjects (<|multi_cit|>).", "evidence": {"77002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [77002]}
{"id": 374, "claim": "We included 20 randomised trials, of which 14 exclusively dealt with glycaemic control in the usual care setting in patients without acute events at entry.<|multi_cit|> Thirteen of the trials were published in English and one in Russian.<|other_cit|> The 14 included trials were described in 51 publications.", "evidence": {"77003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77003]}
{"id": 376, "claim": "Several studies have suggested that hypoglycemia in patients with diabetes is associated with increased cardiovascular events and death [<|multi_cit|>].", "evidence": {"77004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [77004]}
{"id": 377, "claim": "In the ACCORD study, which investigated the effect of intensive versus standard glycemic control on cardiovascular (CV) events in patients with T2DM at high CV risk, symptomatic severe hypoglycemia was associated with increased all-cause mortality [<|cit|>].", "evidence": {"77005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77005]}
{"id": 378, "claim": "The high frequency of severe hypoglycaemia in these studies was related to the percentage of participants using insulin in the intervention arms [<|other_cit|>] and was associated with higher mortality rates [<|multi_cit|>].", "evidence": {"77006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77006]}
{"id": 379, "claim": "That trial was prematurely stopped owing to increased mortality possibly related to the unfavourable effect of hypoglycaemia in susceptible participants, such as those with underlying coronary diseases.<|multi_cit|>", "evidence": {"77007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77007]}
{"id": 380, "claim": "While reduction of hyperglycemia is clearly beneficial, avoidance of hypoglycemia is also a critical concern, as severe hypoglycemia was associated with an increased risk of death during the ACCORD study [<|cit|>].", "evidence": {"77008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77008]}
{"id": 381, "claim": "Sub-analysis of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study showed that participants who had experienced symptomatic severe hypoglycemia were at greater risk of death than those who had experienced no hypoglycemia [<|cit|>].", "evidence": {"77009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77009]}
{"id": 382, "claim": "In ACCORD, intensive glycemia was associated with increased frequency of hypoglycemic episodes (16.2 vs. 5.1%) (<|multi_cit|>).", "evidence": {"77010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77010]}
{"id": 383, "claim": "These results are important given that the Action to Control Cardiovascular Risk in Diabetes (ACCORD)<|other_cit|> and Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE)<|other_cit|> trials showed an association between hypoglycemia (glucose < 50 mg/dL) and age, and ACCORD<|cit|> linked hypoglycemia to an increased risk of death, prompting the American Diabetes Association and the European Association for the Study of Diabetes to note that it is especially important to avoid treatment-related hypoglycemia in elderly patients.<|other_cit|> Hypoglycemia can impair judgment, behavior, and performance of physical tasks;<|other_cit|> such adverse effects can interfere with treatment adherence, especially in elderly patients.", "evidence": {"77011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77011]}
{"id": 385, "claim": "Daily glucose fluctuations may also increase the risk of microvascular and macrovascular complications associated with T2DM [<|other_cit|>] while severe hypoglycemia is associated with increased mortality [<|multi_cit|>].", "evidence": {"77012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77012]}
{"id": 387, "claim": "In a recent epidemiological analysis of the Action to Control Cardiovascular Risk in Diabetes trial, participants with severe hypoglycemic episodes had an increased risk of all-cause mortality (<|cit|>).", "evidence": {"77013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77013]}
{"id": 388, "claim": "The association between overtesting and potential overtreatment is concerning, particularly considering clinical trial data linking intensive glucose lowing treatment to adverse health outcomes, including hypoglycemia, cardiovascular events, and mortality.<|multi_cit|> Because all study patients had index HbA  levels lower than 7.0% at study entry, none was eligible for treatment intensification, and some were eligible for treatment deintensification (particularly if they are overwhelmed by treatment burden or hypoglycemia).", "evidence": {"77014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [77014]}
{"id": 389, "claim": "It remains unclear whether a high frequency of severe hypoglycemic events is a marker of poor health in patients with existing high CV risk or whether the hypoglycemia itself is a causal factor for adverse CV events [<|multi_cit|>].", "evidence": {"77015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77015]}
{"id": 391, "claim": "Also, rates of severe hypoglycemia were elevated at higher levels of A1C during treatment in both the intensively treated and standard treatment groups (<|cit|>) found that the excess mortality in ACCORD occurred among participants who were randomized to intensive treatment but were unable to reduce their average A1C levels during the initial year of follow-up to <7.0% (53 mmol/mol).", "evidence": {"77016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [77016]}
{"id": 393, "claim": "Hypoglycaemia occurs more frequently in insulin-deficient states (type 1) and in advanced insulin-resistant states (severe type 2).<|other_cit|> Severe hypoglycaemia in any type of diabetes is associated with increased risks of morbidity and mortality, especially in patients with comorbid cardiovascular risks, and in the elderly.<|other_cit|> Although direct causality was not demonstrated, a strong association between severe hypoglycaemia and an increased risk of death was shown in the Action to Control Cardiovascular Risk in Diabetes study.<|cit|> Moreover, quality of life decreases as the frequency of hypoglycaemic episodes increases.<|other_cit|> Consequently, prevention and control of hypoglycaemia is one of the major considerations for the primary care physicians when adopting a patient-centred approach to the management of DM.<|other_cit|>", "evidence": {"77017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [77017]}
{"id": 394, "claim": "In particular, upon mitophagy induction, such as during carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP)-mediated mitochondrial depolarization, parkin ubiquitinates and thus triggers the degradation of both MFNs, with a consequent mitochondrial fragmentation that favors mitochondria elimination<|multi_cit|>.", "evidence": {"81000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81000]}
{"id": 395, "claim": "PINK1 senses damaged mitochondria, and recruits and activates Parkin to ubiquitinate mitochondrial outer membrane proteins including mitofusins (<|multi_cit|>) and Miro (<|other_cit|>).", "evidence": {"81001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81001]}
{"id": 396, "claim": "The ubiquitin/proteasome system is known to degrade MOM proteins, such as mitofusins (<|cit|>), in damaged mitochondria.", "evidence": {"81002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81002]}
{"id": 397, "claim": "Recently, p97 was implicated in the execution of mitophagy (<|cit|>).", "evidence": {"81003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81003]}
{"id": 398, "claim": "Moreover, ubiquitination of Mfn by Parkin may account for its rapid removal from the mitochondria, therefore preventing damaged mitochondrial fragments to fuse back and corrupt healthy mitochondria.<|multi_cit|> However, in our study, silencing Mfn failed to ameliorate the survival of HD flies and abolished the beneficial effect of PINK1 on neuronal survival.", "evidence": {"81004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81004]}
{"id": 399, "claim": "This modification inhibits mitochondrial fusion and is key to the process of removing damaged mitochondria by mitophagy (Gegg et al., <|multi_cit|>).", "evidence": {"81005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [81005]}
{"id": 401, "claim": "Parkin recruitment promotes fission by ubiquitinating and targeting a mitochondrial fusion component for degradation [<|cit|>].", "evidence": {"81006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81006]}
{"id": 402, "claim": "Since OMM proteins such as MFN1 and MFN2 could also be degraded via Parkin-mediated ubiquitination and proteasome,<|multi_cit|> we validated the inhibitory effects of PTEN-L on mitophagy by examining changes of IMM proteins such as Tim23 and mitochondrial DNA (mtDNA)-encoded COX II.<|other_cit|> Moreover, we also examined the degradation of mtDNA nucleoids, a well-established indicator of mitophagy,<|other_cit|> and found that PTEN-L significantly blocked the degradation of mtDNA (Fig. <|other_cit|>).", "evidence": {"81007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81007]}
{"id": 404, "claim": "Mitophagy, a term originally coined over a decade ago (<|other_cit|>), is the selective autophagic removal of damaged mitochondria within a cell, although the UPS is also a critical component of this pathway (<|multi_cit|>).", "evidence": {"81008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81008]}
{"id": 406, "claim": "VCP is also involved in a wide variety of cellular processes, such as DNA repair [<|other_cit|>], myofibril biogenesis [<|other_cit|>], membrane fusion [<|other_cit|>], autophagosome maturation [<|other_cit|>] and mitophagy [<|cit|>].", "evidence": {"81009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81009]}
{"id": 407, "claim": "It is also known that mitofusins (Mfn1 and Mfn2) can be targeted for degradation in response to IMM depolarization [<|cit|>].", "evidence": {"81010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81010]}
{"id": 408, "claim": "Interestingly, Dnm1 activity in yeast (<|other_cit|>), and Drp1 activity in mammalian cells is required for mitophagy (<|multi_cit|>) suggesting a link with Fis1 in mitophagy.", "evidence": {"81011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81011]}
{"id": 409, "claim": "Recently, the extraction of mitochondrial proteins from the MOM has been demonstrated by cytosolic p97/Cdc48 (Heo et al., <|multi_cit|>).", "evidence": {"81012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81012]}
{"id": 410, "claim": "In addition p97, an AAA+ATPase, also accumulates on mitochondria in a Parkin-dependent manner to promote the degradation of OMM proteins and then mitophagy (<|cit|>).", "evidence": {"81013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81013]}
{"id": 411, "claim": "In addition, regulators of the mitophagy pathway (e.g., mitofusin), which turns over damaged mitochondria can also be subject to degradation by MAD (<|cit|>).", "evidence": {"81014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81014]}
{"id": 412, "claim": "Indeed, we examined the synaptic mitochondria >4 months after appearance of the characteristic swollen mitochondria with Drp1 loss at the cell body, a time interval that far exceeds estimates of mitochondrial lifespan.<|other_cit|> Nonetheless, we cannot exclude this possibility, as very little is known about mitochondrial lifespan in neurons and their axons, and Drp1KO could prolong their lifespan by impairing mitochondrial turnover.<|cit|> Nonetheless, we cannot exclude this possibility, as very little is known about mitochondrial lifespan in neurons and their axons, and Drp1KO could prolong their lifespan by impairing mitochondrial turnover.40", "evidence": {"81015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81015]}
{"id": 413, "claim": "Mitochondrial fission has been reported to be involved in mitophagy (<|multi_cit|>).", "evidence": {"81016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81016]}
{"id": 414, "claim": "First, disrupted fission may compromise the intrinsic function of axonal mitochondria, possibly by changing their normal turnover,<|cit|> which could cause dysfunctional mitochondria to accumulate.", "evidence": {"81017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81017]}
{"id": 415, "claim": "Some MOM proteins, including MIRO, MFN and TOM20, can also be extracted from the membrane and subsequently targeted for degradation by the proteasome <|multi_cit|>.", "evidence": {"81018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [81018]}
{"id": 416, "claim": "UPS dysfunction is associated with multifactorial toxicity including aberrant mitochondrial quality control [<|multi_cit|>], loss of synaptic plasticity [<|other_cit|>], amino acid shortage [<|other_cit|>] and ER stress [<|other_cit|>].", "evidence": {"81019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81019]}
{"id": 417, "claim": "The ubiquitinylated mitofusin proteins would next be targeted to proteosomal degradation [<|cit|>], a process that could explain why we observe a difference in the abundance of mitofusin proteins in LINCL cells without any change in the abundance of their transcripts.", "evidence": {"81020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81020]}
{"id": 418, "claim": "This gene codes for a chaperone protein involved in mitophagy through autophagosome maturation (<|multi_cit|>; Meyer et al., <|other_cit|>; Yamanaka et al., <|other_cit|>).", "evidence": {"81021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [81021]}
{"id": 419, "claim": "Upon mitochondrial damage, activated parkin ubiquitinates a wide variety of OMM proteins, many of which are then extracted from the OMM and degraded by the proteasome before engulfment of the mitochondrion into an autophagosome (<|multi_cit|>).", "evidence": {"81022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81022]}
{"id": 420, "claim": "This is exemplified with the ER protein Ubc6, and was also shown for mitochondrial OM proteins (<|other_cit|>), including mitofusins under damaging conditions (<|cit|>), including mitofusins under damaging conditions (Tanaka et al., 2010).", "evidence": {"81023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81023]}
{"id": 421, "claim": "During PARKIN recruitment, mitochondrial dynamics are shifted towards fission rather than fusion, partly due to the degradation of mitofusins (MFNs; Gegg et al., <|multi_cit|>; Ziviani et al., <|other_cit|>) Moreover, many mutations in mitochondrial fission/fusion genes, such as MFN2, OPA1 and DRP1, are associated with neurodegenerative diseases (Alexander et al., <|other_cit|>; Zuchner et al., <|other_cit|>).", "evidence": {"81024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81024]}
{"id": 423, "claim": "In addition, Mfn1 and Mfn2, the GTPase in charge of OM fusion, are degraded by the UPS (<|cit|>) and OPA1 isoforms are processed by OMA1, which results in an increase of the shorter isoforms and a decrease of the fusion rate (Baker et al. <|other_cit|>).", "evidence": {"81025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [81025]}
{"id": 425, "claim": "The conversion of LC3-I into LC3-II is an essential step in autophagosome formation, and the abundance of LC3-II correlates with the number of autophagosomes [<|multi_cit|>].", "evidence": {"78000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78000]}
{"id": 426, "claim": "Being the hub for aerobic respiration, it is also a major site of ROS generation (<|other_cit|>) [<|multi_cit|>].", "evidence": {"78001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78001]}
{"id": 427, "claim": "Therefore, uncontrolled ROS and defective proteins were removed by mitochondrial autophagy to regulate autophagy process (<|cit|>).", "evidence": {"78002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78002]}
{"id": 429, "claim": "One key role for autophagy is the removal of damaged mitochondria (<|cit|>), termed mitophagy, which in turn can modulate inflammatory processes by dampening activation of the nucleotide binding domain and leucine-rich repeat (NLR) pyrin domain containing 3 (NLRP3) inflammasome (<|other_cit|>).", "evidence": {"78003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78003]}
{"id": 430, "claim": "The AMPK/mTOR pathway has been well-established as a critical regulator of autophagy<|multi_cit|>.", "evidence": {"78004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78004]}
{"id": 432, "claim": "Several reports (<|cit|>) have highlighted the close relationship between oxidative stress and the autophagy process.", "evidence": {"78005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78005]}
{"id": 433, "claim": "Reactive nitrogen species (RNS), such as nitric oxide (NO) and peroxynitrite (ONOO), also act as signaling agents regulating numerous physiological and pathological conditions (<|multi_cit|>;  Lee et al., 2012); however, in this XO, xanthine oxidase.", "evidence": {"78006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78006]}
{"id": 435, "claim": "Oxidative stress is inseparably linked to mitochondrial dysfunction, as mitochondria are both generators of and targets for reactive species (<|cit|>).", "evidence": {"78007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78007]}
{"id": 436, "claim": "We showed that flow increased ROS production in EC, which was consistent with previous results.<|other_cit|> In addition, antioxidant treatment prevented flow-induced autophagy, and exogenous H O  mimicked the effects of flow, consistent with previous studies in neurons.<|other_cit|> It is clear that autophagy is regulated by intracellular redox status;<|other_cit|> however, the mechanistic links between ROS and autophagy are still poorly understood.<|multi_cit|> Our data have shed a light on this question.", "evidence": {"78008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78008]}
{"id": 439, "claim": "As the sole known mechanism for mitochondrial turnover, autophagy serves to preserve the balance between organelle biogenesis and their clearance, and engages in cross-talk with mitochondria and oxidative stress [<|cit|>].", "evidence": {"78009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78009]}
{"id": 440, "claim": "The mTOR kinase-mediated phosphorylation of ATG13 prevents its association to Unc-51 like kinase (ULK), and recruitment of focal adhesion kinase family interacting protein of 200 kD (FIP200) inhibits autophagy, whereas inhibition of mTOR activates phosphatases that cause dephosphorylation of ATG13 (Kundu, <|multi_cit|>), thereby promotes autophagy.", "evidence": {"78010": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78010]}
{"id": 441, "claim": "Mechanistically, autophagy has often been linked with mitochondrial dysfunctions and localized inside mitochondria (i.e., also named as mitophagy).<|cit|> However, through detailed dynamic cellular energetic analysis we have identified that upon challenge by the different drugs tested, at least until 8 h after treatment, mitochondrial functions of tooth pulp cells were not diminished.", "evidence": {"78011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78011]}
{"id": 443, "claim": "For example hydrogen peroxide (H O )<|other_cit|> and oxy-radicals (O −) are 2 major forms of ROS, both of which mediate the induction of autophagy.<|cit|> and oxy-radicals (O −) are 2 major forms of ROS, both of which mediate the induction of autophagy.9", "evidence": {"78012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78012]}
{"id": 444, "claim": "Oxidative stress has been shown to be an initiator and major contributor to both endoplasmic reticulum (ER) stress (Hotamisligil <|other_cit|>; Kaneto et al. <|other_cit|>) and lysosome-mediated autophagy (<|cit|>) and lysosome-mediated autophagy (Lee et al. 2012); however, the research on molecular pathways linking atmospheric PM  and skin damage is limited.", "evidence": {"78013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78013]}
{"id": 445, "claim": "Multiple lines of evidence suggest that mitochondrial-derived ROS are the early inducers of autophagy upon nutrient starvation.<|multi_cit|> Accumulation of ROS induces mitochondrial destabilization, thereby promoting apoptosis.", "evidence": {"78014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [78014]}
{"id": 446, "claim": "These changes appear to be underpinned by activation of the mitochondrial-based apoptotic pathway including caspase activation (Broyl et al., <|multi_cit|>) as well as dysregulation of calcium homeostasis (Landowski et al., <|other_cit|>).", "evidence": {"78015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78015]}
{"id": 447, "claim": "Other groups of kinases included in the cluster are ToR (TOR1B) that participates in signaling pathways of autophagy [<|cit|>] and tribbles (TRIB3) that regulate MAPKs [<|other_cit|>].", "evidence": {"78016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78016]}
{"id": 448, "claim": "In turn this might allow the slugs to store their kleptoplasts for longer periods of time, as their degradation through ROS-induced autophagy<|cit|> is postponed.", "evidence": {"78017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78017]}
{"id": 451, "claim": "Moreover, dysregulated activation of the NLRP3 inflammasome seems to be implicated in the pathogenesis of other chronic inflammatory diseases, including Alzheimer disease [<|cit|>], atherosclerosis [<|other_cit|>], and age-related macular degeneration [<|other_cit|>].", "evidence": {"89000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89000]}
{"id": 453, "claim": "Recently, an alternative pathway has been described for intracellular signaling produced by the binding of Aβ to microglial cells, activating NLRP3 inflammasome (<|multi_cit|>; Sheedy et al., <|other_cit|>).", "evidence": {"89001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89001]}
{"id": 454, "claim": "We carried out an ultra-sensitive RNAscope ISH assay to study the altered NRXN3 expression at cellular levels in control and AD postmortem brain samples that were co-hybridized and co-stained with inflammasome component NLRP3 [<|cit|>] and neuron marker NEUN/RBFOX3.", "evidence": {"89002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89002]}
{"id": 455, "claim": "Upon activation, microglia can migrate to the site of injury<|other_cit|>, shift from normal self-renewal to clonal expansion<|other_cit|> and secrete pro-inflammatory cytokines like interleukin-1β (IL-1β)<|cit|> as well as other immunomodulatory factors (Fig. <|other_cit|>).", "evidence": {"89003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [89003]}
{"id": 456, "claim": "In another study, Heneka and colleagues showed that NLRP3 inflammasome inhibition in the APP/PS1 model of AD skews microglial cells to an M2 phenotype and results in enhanced spatial memory and decreased deposition of Aβ [<|cit|>].", "evidence": {"89004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89004]}
{"id": 457, "claim": "NLRP3 inflammasome, one of the most widely studied members of the NLR family, can be activated by Aβ and enhances AD progression by mediating a detrimental chronic inflammatory tissue response (<|cit|>).", "evidence": {"89005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89005]}
{"id": 461, "claim": "In fact, Heneka et al. (<|cit|>) reported that chronic neuroinflammation emerged in the brain before the deposition of Aβ.", "evidence": {"89006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [89006]}
{"id": 462, "claim": "A compelling study shows that NLRP3 deficiency switches microglial cell from M1 to the M2 phenotype and thereby increases Aβ clearance [<|cit|>].", "evidence": {"89007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89007]}
{"id": 463, "claim": "While it is obviously not a trivial task to assign a certain reactive phenotype as a dominat as well as persisting response pattern of macrophages and microglia to a given pathology, in some cases a major orientation and the respective molecular and cellular mechanisms can be successfully linked to a disease (<|cit|>).", "evidence": {"89008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89008]}
{"id": 465, "claim": "Indeed, there is a highly upregulated expression of caspase-1 in human MCI and AD brains and mice carrying Nlrp3(-/-) or Casp1(-/-) mutations were largely protected from the neural deficits associated with early-onset AD (<|cit|>).", "evidence": {"89009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89009]}
{"id": 466, "claim": "This is in line with our previous work demonstrating an important role for the NLRP3 and caspase-1 pathway in the progression of AD pathology, both in AD patients and APP/PS1 mice [<|cit|>].", "evidence": {"89010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89010]}
{"id": 467, "claim": "The conversion of microglia from detrimental (M1) to beneficial (M2) phenotype may contribute to an anti-inflammatory microenvironment in the brain (<|cit|>).", "evidence": {"89011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89011]}
{"id": 468, "claim": "Microglial accumulation near Aβ plaques may thus not only shift the molecular and cellular milieu to one that can enhance neurotoxicity (Varvel et al., <|multi_cit|>), but also cause a progressive decrease in microglial process complexity that may impair the clearance of Aβ oligomers, modulation of the synaptic network, and/or neuronal repair processes.", "evidence": {"89012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89012]}
{"id": 471, "claim": "However, excessive activation of the NLRP3 inflammasome is responsible for progression of several inflammation-associated diseases, including cryopyrin-associated periodic syndrome<|other_cit|>, septic shock<|other_cit|>, rheumatoid arthritis<|other_cit|>, Alzheimer’s disease<|cit|>, and type 2 diabetes<|other_cit|>.", "evidence": {"89013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [89013]}
{"id": 472, "claim": "SARS-CoV-2 pseudoviruses were generated essentially as described previously (<|multi_cit|>).", "evidence": {"19000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19000]}
{"id": 473, "claim": "All controls had detectable virus in the upper and lower airways at comparable peak levels as in the previous studies<|multi_cit|>.", "evidence": {"19001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19001]}
{"id": 474, "claim": "Adoptive transfer (<|other_cit|>) and vaccine studies (<|cit|>) and vaccine studies (10) in rhesus macaques suggest that neutralizing antibody (NAb) responses are a critical correlate of protection against SARS-CoV-2 infection.", "evidence": {"19002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19002]}
{"id": 475, "claim": "The intact S glycoprotein rather than the shorter S or RBD proteins was shown to be the most effective antigen eliciting protective immunity against SARS-CoV-2 infection in DNA vaccines and Ad26 vectored vaccines [<|multi_cit|>].", "evidence": {"19003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19003]}
{"id": 476, "claim": "An sgRNA-specific assay enabled quantifying a replicating virus in several important NHP vaccine/challenge studies ([<|multi_cit|>]; testing the efficacy of mRNA-1273, ChAdOx1 nCoV-19, and Ad26 vaccines, respectively), and evaluating the protective efficacy of natural immunity and mAbs in NHP models [82,<|other_cit|>].", "evidence": {"19004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19004]}
{"id": 477, "claim": "Pre-clinical<|multi_cit|> and clinical studies<|other_cit|> of the Ad26.COV2.S vaccine demonstrated strong immunogenicity, as well as robust protection from severe clinical disease and hospitalization in large-scale efficacy trials<|other_cit|>.", "evidence": {"19005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19005]}
{"id": 478, "claim": "Many SARS-CoV-2 vaccine candidates are based on the whole S protein and limited testing in NHPs has been reported with RBD-based vaccines (<|multi_cit|>).", "evidence": {"19006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19006]}
{"id": 479, "claim": "Of note, the S.PP insert previously proved optimal in nonhuman primates [<|cit|>] and was advanced into clinical trials [<|other_cit|>].", "evidence": {"19007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19007]}
{"id": 480, "claim": "The Ad26.COV2.S (hAd26) vaccine (Janssen Vaccines & Prevention B.V.), also known as JNJ-78436735 has been found to be the most divergent vaccine against all sorts of S-mutations so far achieved as evaluated through the clinical trial NCT04505722 (Heinz and Stiasny <|multi_cit|>; Coughlan <|other_cit|>).", "evidence": {"19008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19008]}
{"id": 482, "claim": "While previous studies have revealed that antibody titers, particularly neutralizing antibody titers, are statistical correlates of protection<|multi_cit|>, study of the function of vaccine-elicited antibodies from humans remains an underexplored question.", "evidence": {"19009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19009]}
{"id": 484, "claim": "Binding antibodies were quantified by ELISA essentially as previously described (<|cit|>).", "evidence": {"19010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19010]}
{"id": 485, "claim": "The Ad26.COV2.S vaccine<|multi_cit|> has demonstrated clinical efficacy against symptomatic COVID-19, including against the B.1.351 variant that is partially resistant to neutralizing antibodies<|other_cit|>.", "evidence": {"19011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19011]}
{"id": 486, "claim": "Although several SARS-CoV-2 vaccines, developed using mRNA technology [<|other_cit|>] and adenovirus vectors [<|multi_cit|>], are currently in use; however, additional vaccines that are cost effective and could be transported without cold chain will still be worthwhile to develop.", "evidence": {"19012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19012]}
{"id": 487, "claim": "Data of SARS-CoV-2 Spike (S) protein immunogenicity as assessed by pseudotyped virus-neutralization assay (psVNA) and enzyme-linked immunospot assay (ELISpot) at four weeks after vaccination were previously reported<|cit|>.", "evidence": {"19013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19013]}
{"id": 488, "claim": "ELISPOT assays were performed essentially as described previously (<|cit|>).", "evidence": {"19014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19014]}
{"id": 489, "claim": "Rhesus macaque anti-SARS-CoV-2 serum was obtained after an adenoviral vector-based vaccination (<|cit|>).", "evidence": {"19015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19015]}
{"id": 490, "claim": "Delineating the contribution of “lingering” sgRNA to total sgRNA signal will bear significantly on the interpretation of the clinical significance (i.e., duration of infectivity) of several reports indicating prolonged sgRNA detection in patients [<|other_cit|>] and on the efficacy results from the NHP animal vaccine/challenge studies as described above [<|multi_cit|>].", "evidence": {"19016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19016]}
{"id": 491, "claim": "A SARS-CoV-2 pseudovirus, incorporating a luciferase reporter gene, was generated similar to previously described approaches<|multi_cit|>.", "evidence": {"19017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19017]}
{"id": 492, "claim": "In particular, the expansion of neutralizing antibody responses, as measured by both pseudovirus and live virus assays, in mice is encouraging, as this metric has emerged as a potential correlate of protection in hamster and non-human primate challenge models [<|multi_cit|>].", "evidence": {"19018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19018]}
{"id": 493, "claim": "This is attributed to the lack of vaccine-induced secretory IgA (sIgA) mucosal immune responses in the respiratory airways that could prevent person-to-person transmission (<|multi_cit|>).", "evidence": {"19019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19019]}
{"id": 494, "claim": "ChAdOx1 nCoV-19 [<|other_cit|>], Gam-COVID-Vac [<|other_cit|>], Ad5-nCoV [<|other_cit|>], Ad26.COV2.S [<|cit|>], and ChAd-SARS-CoV-2-S [<|other_cit|>] all express full-length S protein of SARS-CoV-2.", "evidence": {"19020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19020]}
{"id": 495, "claim": "Mercado et al. previously showed the importance of different effector functions of antibodies in protection against SARS-CoV-2 in rhesus macaques<|cit|>.", "evidence": {"19021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19021]}
{"id": 496, "claim": "SARS-CoV-2 E gene subgenomic RNA (sgRNA) was assessed by RT-PCR using primers and probes essentially as previously described (<|cit|>).", "evidence": {"19022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19022]}
{"id": 497, "claim": "Immunogenicity and candidate characteristics are described elsewhere<|cit|>.", "evidence": {"19023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19023]}
{"id": 498, "claim": "Early animal studies showed promising efficacy with low-dose single-shot vaccination [<|multi_cit|>].", "evidence": {"19024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19024]}
{"id": 499, "claim": "Several Adenovirus-based vaccines (such as ChAdOx) were demonstrated as quite effective following two dosages [19, <|other_cit|>], though single immunization is sufficient for the Ad26.COV2.S vaccine [<|cit|>], though single immunization is sufficient for the Ad26.COV2.S vaccine [19].", "evidence": {"19025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19025]}
{"id": 500, "claim": "The final candidates for mRNA vaccines of Moderna/National Institutes of Health (<|other_cit|>) and Pfizer/BioNTech (<|other_cit|>), a DNA vaccine of Inovio (<|other_cit|>), and adenoviral-vectored vaccines of AstraZeneca/Oxford University (<|other_cit|>), Janssen (<|cit|>) and Gamaleya Research Institute (<|other_cit|>) contain full-length S as an antigenic component.", "evidence": {"19026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19026]}
{"id": 501, "claim": "Correlation of SARS-CoV-2-neutralizing serum antibodies with protective efficacy was described in an earlier report<|cit|>.", "evidence": {"19027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19027]}
{"id": 502, "claim": "A total of 7 Ad26-based vaccines were tested in a rhesus macaque challenge model of SARS-CoV-2<|multi_cit|>.", "evidence": {"19028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19028]}
{"id": 503, "claim": "Ad26.COV2.S express full-length S protein with four mutations (R682S, R685G, K986P, and V987P) to stabilize the pre-fusion conformation of S protein, which induced higher neutralizing antibodies and confer better protection than recombinant Ad26 expressing wild-type S [<|cit|>].", "evidence": {"19029": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19029]}
{"id": 504, "claim": "Our previous and others’ studies investigating efficacy of COVID-19 vaccines in NHPs showed complete or near complete protection of the lower respiratory tract, but nasal shedding was still observed<|multi_cit|>.", "evidence": {"19030": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19030]}
{"id": 505, "claim": "Similar to our recent reports in hamsters [<|other_cit|>], non-human primates [<|multi_cit|>], and humans [<|other_cit|>], a robust correlation was observed between binding and neutralizing antibody responses.", "evidence": {"19031": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19031]}
{"id": 508, "claim": "SARS-CoV-2 E gene sgRNA was assessed by reverse transcription polymerase chain reaction (RT-PCR) using primers and probes essentially as previously described (<|cit|>).", "evidence": {"19032": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19032]}
{"id": 509, "claim": "It is thought the S-2P design could improve protein stability and elicit high titers of neutralizing antibodies [<|multi_cit|>].", "evidence": {"19033": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19033]}
{"id": 510, "claim": "In many preclinical studies, prefusion-stabilized S provided increased neutralizing Ab responses and protective efficacy against SARS-CoV-2 and MERS-CoV, compared to wild-type S (<|multi_cit|>).", "evidence": {"19034": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19034]}
{"id": 511, "claim": "We previously characterized the immunogenicity and protective efficacy of various Ad26-based vaccine candidates in a rhesus macaque (Macaca mulatta) challenge model of SARS-CoV-2<|multi_cit|> that resulted in the selection of Ad26.COV2.S as the lead vaccine candidate that has recently shown an early indication of efficacy of 85% against severe/critical disease in humans with a median follow-up of participants of two months<|other_cit|>.", "evidence": {"19035": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19035]}
{"id": 512, "claim": "The S-2P protein is the form used in most of the SARS-CoV-2 vaccines in human use<|other_cit|> or in development<|other_cit|> and was shown to induce a higher level of neutralizing antibodies than the WT S<|cit|>.", "evidence": {"19036": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19036]}
{"id": 513, "claim": "However, subgenomic and genomic viral RNA was detected in nasal samples of all NHP experiments, dependent on vaccine dose<|multi_cit|>–13.", "evidence": {"19037": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19037]}
{"id": 514, "claim": "So far, four adenovirus-vectored vaccines against COVID-19 have been approved for emergency use, including ChAdOx1 nCoV-19 (chimpanzee adenovirus type Y25 vector, University of Oxford and AstraZeneca) [<|other_cit|>], Ad5-nCoV (human adenovirus type 5 vector, Beijing Institute of Biotechnology and CanSino Biological Inc.) [<|other_cit|>], Gam-COVID-Vac (human adenovirus type 26 and human adenovirus type 5 vectors, Gamaleya Research Institute) [<|other_cit|>], and Ad26.COV2.S (human adenovirus type 26 vector, Janssen Pharmaceutical Companies) [<|cit|>], and Ad26.COV2.S (human adenovirus type 26 vector, Janssen Pharmaceutical Companies) [17].", "evidence": {"19038": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19038]}
{"id": 515, "claim": "A single immunization with rAd26.CoV.S was sufficient to inhibit viral replication in the lungs and nasal region of non-human primates (NHPs), and this was well-correlated with the increased neutralizing Ab titer (<|cit|>).", "evidence": {"19039": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19039]}
{"id": 516, "claim": "Several Adenovirus-based vaccines (such as ChAdOx) were demonstrated as quite effective following two dosages [<|multi_cit|>], though single immunization is sufficient for the Ad26.COV2.S vaccine [19].", "evidence": {"19040": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19040]}
{"id": 517, "claim": "In addition, compared with BAb (102.73 S-BAb or 102.24 RBD-BAb) and NAb (101.59 sNAb or 101.70 pNAb) from a panel of convalescent serum samples from COVID-19 patients (<|other_cit|>), the level of BAb (103.16 S-BAb or 102.75 RBD-BAb) and NAb (102.01 sNAb or 102.38 pNAb) from vaccinated macaques observed in this study was favorable and in line with other published data from adenovirus vectored COVID-19 vaccines [<|multi_cit|>], indicating the sufficient protection against SARS-CoV-2 infection.", "evidence": {"19041": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19041]}
{"id": 522, "claim": "Neutralizing antibody responses may represent key immune correlates of protection for SARS-CoV-2 (<|multi_cit|>, 3).", "evidence": {"19042": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19042]}
{"id": 524, "claim": "This was also evidenced by close correlation between ELISA and pVNT or cVNT by other studies using adenovirus vectored COVID-19 vaccines in rhesus macaques (P < 0.0001, R = 0.8314–0.8427) [<|cit|>], hamsters (P < 0.0001; R = 0.7849) [<|other_cit|>] and human clinical phase II trial (P < 0.0001, R = 0.72–0.75) [<|other_cit|>].", "evidence": {"19043": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19043]}
{"id": 525, "claim": "SARS-CoV-2 pseudoviruses were generated essentially as described previously (<|multi_cit|>).", "evidence": {"19044": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19044]}
{"id": 526, "claim": "Enzyme-linked immune absorbent spot (ELISPOT) assays were performed essentially as described previously (<|cit|>).", "evidence": {"19045": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19045]}
{"id": 527, "claim": "However, the pre-existing anti-Ad5 immunity might partly limit vaccine effectiveness, especially for populations aged over 50 [<|other_cit|>], while the low seroprevalence of antibodies to novel adenoviral vectors such as ChAdox1 [<|other_cit|>], Ad26 [<|multi_cit|>], and Sad23L and Ad49L used in this study might avoid a negative impact on vaccine efficacy [<|other_cit|>].", "evidence": {"19046": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19046]}
{"id": 529, "claim": "Pre-clinical studies of candidate SARS-CoV-2 vaccines support spike-specific binding and neutralizing antibody titers as a strong immune correlate of protection<|multi_cit|>.", "evidence": {"19047": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19047]}
{"id": 530, "claim": ") viral vectored vaccines in NHPs (<|cit|>), nAbs were observed after two vaccinations in our study.", "evidence": {"19048": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19048]}
{"id": 532, "claim": "Despite the challenge in comparing neutralizing antibody assays from laboratory to laboratory, these results appear competitive with published SARS-CoV-2 vaccine responses in NHPs (<|cit|>, <|other_cit|>), including a nanoparticle subunit vaccine (<|other_cit|>).", "evidence": {"19049": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19049]}
{"id": 533, "claim": "Binding antibodies were quantified by ELISA essentially as previously described (<|cit|>).", "evidence": {"19050": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19050]}
{"id": 534, "claim": ",   Sigmoid-Emax models of the correlation between the level of SARS-CoV-2-neutralizing antibodies (psVNA at four weeks after vaccination, IC , log ) and fractional reduction of the virus basic reproductive ratio in lung ( ) and nose ( ), were constructed based on data of 81 NHP obtained in three independent experiments<|multi_cit|>.", "evidence": {"19051": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19051]}
{"id": 535, "claim": "A lentiviral pseudovirus expressing a luciferase reporter gene was generated as previously described (<|cit|>).", "evidence": {"19052": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19052]}
{"id": 536, "claim": "SARS-CoV-2 vaccines developed by Moderna, Pfizer/BioNTech, Novavax and Janssen Pharmaceutical companies expressed a designed SARS-CoV-2 spike protein, S-2P, which contain two proline substitutions at K986 and V987 to stabilize the prefusion conformation of spike protein [<|multi_cit|>].", "evidence": {"19053": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19053]}
{"id": 537, "claim": "Using a luciferase-based pseudovirus neutralizing antibody (psVNA) assay<|multi_cit|>, the median psVNA titres were 169, 142, 102, 80, 60 and 51 against the WA1/2020, D614G, B.1.1.7, CAL.20", "evidence": {"19054": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [19054]}
{"id": 539, "claim": "Recent reports by Fisher et al. [<|cit|>] and Zheng et al. [<|other_cit|>] questioned the role of EMT in cancer metastasis but provided in vivo evidence that EMT cells are resistant to chemotherapy.", "evidence": {"97000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97000]}
{"id": 540, "claim": "Moreover, as EMT has also been associated with chemotherapy resistance [<|multi_cit|>], the reduction of lamin A expression, through miR-9 regulation, could represent a predictive factor of therapy efficacy.", "evidence": {"97001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97001]}
{"id": 542, "claim": "The ability of epithelioid mesothelioma to metastasize, presumably without requiring EMT, may represent a common behaviour of epithelial cancers<|multi_cit|>.", "evidence": {"97002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97002]}
{"id": 544, "claim": "Similarly, Fischer et al. recently reported that EMT program is not required for breast-to-lung metastasis (<|cit|>).", "evidence": {"97003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97003]}
{"id": 545, "claim": "In fact, recent works have questioned the importance of EMT in metastasis formation [<|cit|>], also proposing a negligible role of Snai2 in cancer cell metastatic properties [<|other_cit|>].", "evidence": {"97004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97004]}
{"id": 547, "claim": "EMT in other organs is an important pre-requisite for metastatic progression and/or chemoresistance [<|multi_cit|>].", "evidence": {"97005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97005]}
{"id": 549, "claim": "However, two recent studies show that EMT can be dispensable for metastasis, but nevertheless contributed substantially to chemoresistance [<|multi_cit|>].", "evidence": {"97006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97006]}
{"id": 550, "claim": "For instance, insights into the biological complexity of EMT has been provided by genetic and biochemical studies, that associated this program to the different phases of the metastatic cascade, including tumor formation (<|other_cit|>), early dissemination of tumor cells from the primary mass (<|other_cit|>), and the acquisition of a chemoresistance phenotype (<|multi_cit|>).", "evidence": {"97007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97007]}
{"id": 552, "claim": "Primary steps of metastases formation include cell detachment from the original primary tumor which in many cases involves EMT although previous work has demonstrated that EMT is not necessarily required for all kinds of metastatic behavior [<|multi_cit|>].", "evidence": {"97008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97008]}
{"id": 553, "claim": "Using mammary tumor models driven by MMTV-PyMT or human epidermal growth factor receptor 2 (HER2) oncogenes, Fischer and colleagues also established that EMT and metastasis might not be as intricately linked as first thought (<|cit|>).", "evidence": {"97009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97009]}
{"id": 554, "claim": "Thus EMT may not be essential for the spreading of the primary tumor, but still be involved in the acquisition of chemo-resistance [<|multi_cit|>].", "evidence": {"97010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97010]}
{"id": 555, "claim": "In fact, recent studies have challenged the current dogma by demonstrating that EMT may not be a prerequisite for metastasis [<|multi_cit|>].", "evidence": {"97011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97011]}
{"id": 556, "claim": "Also, in accordance with the work by Zheng et al. (<|other_cit|>), the tumors presented increased sensitivity to cyclophosphamide (<|cit|>).", "evidence": {"97012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97012]}
{"id": 560, "claim": "For example, knocking down TWIST or SNAIL sensitized tumors to gemcitabine in pancreatic cancer mouse models [<|other_cit|>], and miR-200 overexpression abrogated resistance to cyclophosphamide, a drug commonly used in breast cancer [<|cit|>].", "evidence": {"97013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97013]}
{"id": 561, "claim": "Independent of platelet activity, EMT has been shown to impart chemotherapy resistance in lung [<|cit|>], pancreatic [<|other_cit|>], breast [<|other_cit|>] and ovarian cancers [<|other_cit|>].", "evidence": {"97014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [97014]}
{"id": 562, "claim": "Some of these enhancers have been previously shown to form with the MYC gene by capturing Hi-C and regulating promoter activity by luciferase assays [<|multi_cit|>].", "evidence": {"86000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [86000]}
{"id": 563, "claim": "Long noncoding RNAs (lncRNAs), ncRNAs larger than 200 nucleotides, play a crucial role in diverse cellular processes such as cell growth [<|other_cit|>], differentiation [<|other_cit|>], the immune response [<|other_cit|>], and cancer metastasis [<|multi_cit|>–12].", "evidence": {"86001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86001]}
{"id": 564, "claim": "The lncRNA CCAT2 is highly overexpressed in CRC, and this lncRNA promotes tumor growth, metastasis, and chromosomal instability through TCF7 L2-mediated transcriptional regulation [<|cit|>].", "evidence": {"86002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86002]}
{"id": 567, "claim": "Moreover, physical interaction between CCAT2 and TCF7L2 contributes to the activation of the Wnt signaling pathway<|cit|>.", "evidence": {"86003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86003]}
{"id": 568, "claim": "Similarly to coding transcripts, lncRNA have epigenetic markers<|other_cit|> and may contain polymorphisms<|cit|> and may contain polymorphisms27.", "evidence": {"86004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86004]}
{"id": 569, "claim": "This positive feedback loop supports the function of highly expressed CCAT2 in CRC growth<|cit|>.", "evidence": {"86005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86005]}
{"id": 570, "claim": "Among them, for example, Colon Cancer Associated Transcript 2 (CCAT2) is overexpressed in microsatellite stable CRC samples (<|cit|>).", "evidence": {"86006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86006]}
{"id": 571, "claim": "CCAT2, a 340 nt ncRNA transcribed from the MYC-335 region, appeared to enhance invasion and metastasis through MYC-regulated miRNAs miR-17-5p and miR-20a<|cit|>.", "evidence": {"86007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [86007]}
{"id": 572, "claim": "Colon cancer-associated transcript 2 (CCAT2) represents a novel lncRNA located at the highly conserved 8q24.21 region [<|cit|>].", "evidence": {"86008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86008]}
{"id": 573, "claim": "Microsatellite instability is a sign of DNA mismatch repair deficiency that can be inherited, which is involved in regulation of lncRNA gene function, e.g. CCAT2 in colorectal cancer [<|cit|>].", "evidence": {"86009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [86009]}
{"id": 574, "claim": "The human 8q24 gene desert region has recently been shown to express distinct lncRNAs in different human tumors<|multi_cit|>).", "evidence": {"86010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86010]}
{"id": 575, "claim": "Colon cancer-associated transcripts (CCATs), 1 (<|other_cit|>) and 2 (<|cit|>), are lncRNAs transcribed from the highly conserved 8q24 region that has been shown to enhance the transcription of MYC oncogene and promote cancer progression, invasion, and metastasis.", "evidence": {"86011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86011]}
{"id": 577, "claim": "Very recently, Ling et al. [<|cit|>] reported the novel lncRNA colon cancer associated transcript 2 (CCAT2) encompassing the rs6983267 SNP (single nucleotide polymorphism) which is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "evidence": {"86012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86012]}
{"id": 578, "claim": "Moreover, CCAT2 was shown to promote cancer growth, metastasis, and induce chromosomal instability, and CCAT2 upregulated MYC expression through the activation of the Wnt signaling pathway by promoting TCF7L2 transcriptional activity rather than by increasing the quantity of TCF7L2 [<|cit|>].", "evidence": {"86013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86013]}
{"id": 579, "claim": "LncRNA gene variations are associated with disease outcomes, and molecular mechanisms have been delineated for a few in cancer (<|cit|>) and autoimmune disease (<|other_cit|>).", "evidence": {"86014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86014]}
{"id": 580, "claim": "Many lines of evidence point to an implication of lncRNAs originating from this region in MYC driven cancers [<|multi_cit|>].", "evidence": {"86015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86015]}
{"id": 581, "claim": "It is reported that the dysregulation of lncRNAs seems to be the primary cause of many complex human disease processes [<|other_cit|>], including the development and progression of many types of cancer [<|other_cit|>], such as colon cancer [<|cit|>], prostate cancer [<|other_cit|>], breast cancer [<|other_cit|>], liver cancer [<|other_cit|>], gastrointestinal cancer [<|other_cit|>] and other cancers [<|other_cit|>].", "evidence": {"86016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86016]}
{"id": 583, "claim": "The two previously studied cancer-associated ncRNAs in this region, the 2,613 bp-long CCAT1 [<|other_cit|>] and the 340 bp-long CCAT2 [<|cit|>] and the 340 bp-long CCAT2 [34], represent only a tiny fraction of its transcriptional complexity.", "evidence": {"86017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86017]}
{"id": 584, "claim": "Increased CCAT2 was associated with tumor metastasis, growth, and chromosomal instability [<|cit|>].", "evidence": {"86018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86018]}
{"id": 585, "claim": "Two more non-coding transcripts have been identified in the region upstream of MYC: CCAT2 [<|cit|>] and PCAT1 [<|other_cit|>].", "evidence": {"86019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86019]}
{"id": 586, "claim": "For example, in colorectal carcinoma, expression of the lncRNA CCAT2 correlated with a higher incidence of liver metastasis (<|cit|>).", "evidence": {"86020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [86020]}
{"id": 587, "claim": "Concerning environmental factors, lifetime number of ovulations was one of the first to be described,<|other_cit|> and rodent models of repeated superovulation confirmed the insurgence of modifications resembling early transformation.<|other_cit|> The explanation of the association between lifetime number of ovulations and HGSOC incidence may reside in cell damage by ovulation-induced oxidative stress.<|other_cit|> Concerning genetic risk factors, which have the greatest impact, less than half of the excess of risk is due to BRCA1/2 high penetrance mutations, whereas the remaining risk is probably because of low- to moderate-penetrance risk alleles.<|other_cit|> Low- to moderate-penetrance risk alleles (e.g. single-nucleotide polymorphism (SNP)) can be identified by genome-wide association studies (GWAS)<|other_cit|> and ultimately give novel molecular insights on tumor biology.<|multi_cit|>, 18", "evidence": {"86021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [86021]}
{"id": 588, "claim": "MSM continued to account for a large percentage (61%) of new HIV infections in the United States in 2009 [<|cit|>].", "evidence": {"94000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94000]}
{"id": 589, "claim": "From 2006 to 2009, overall HIV incidence did not change significantly in the general population or among specific racial/ethnic groups, but there was a 21% increase in incidence among people aged 13–29 years, driven primarily by a 34% increase among young MSM and 48% increase among young, black MSM [<|cit|>].", "evidence": {"94001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94001]}
{"id": 590, "claim": "<|other_cit|> It is therefore not surprising that overall HIV infection rates have been relatively stable in the U.S., though men who have sex with men (MSM) remain disproportionately affected by the transmission of HIV. <|cit|> New HIV infections in MSM have been attributed in part to increased access to sex partners via online meeting websites, <|other_cit|> thereby increasing the potential for transmission of HIV and other sexually transmitted infections (STIs).", "evidence": {"94002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94002]}
{"id": 592, "claim": "More recently, increases in incidence have been concentrated among young MSM of color [<|cit|>].", "evidence": {"94003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94003]}
{"id": 593, "claim": "In the US, HIV incidence is rising among young MSM, especially Blacks <|cit|>.", "evidence": {"94004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94004]}
{"id": 596, "claim": "From 2006–2009, HIV incidence among younger Black men who have sex with men (MSM) aged 13–29 increased by 48%; with HIV incidence unchanged among other young MSM [<|cit|>].", "evidence": {"94005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94005]}
{"id": 597, "claim": "The greater recruitment of African American MSM in Atlanta is reflective of Atlanta’s population [<|other_cit|>], but more direct targeting for young African American MSM may have been useful to ensure the inclusion of the population most at risk for HIV [<|multi_cit|>].", "evidence": {"94006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94006]}
{"id": 599, "claim": "Men who have sex with men (MSM) continue to represent the majority of all new HIV diagnoses in the United States (US); developing and testing interventions to serve MSM is a high priority for HIV prevention [<|multi_cit|>].", "evidence": {"94007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94007]}
{"id": 600, "claim": "Rates of new infections in Blacks/African Americans and Hispanics/Latinos is three times higher than in Whites [<|cit|>].", "evidence": {"94008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [94008]}
{"id": 601, "claim": "Each year, approximately another 50 000 individuals become infected with HIV-1 in the United States [<|multi_cit|>].", "evidence": {"94009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94009]}
{"id": 602, "claim": "Annual rates during that period were 48,600 (95% CI: 42,400–54,700) in 2006, 56,000 (95% CI: 49,100–62,900) in 2007, 47,800 (95% CI: 41,800–53,800) in 2008 and 48,100 (95% CI: 42,200–54,000) in 2009 <|cit|>.", "evidence": {"94010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94010]}
{"id": 604, "claim": "The STARHS window period defining a recent infection (non-reactive) is approximately 153 to 162 days from infection [<|multi_cit|>, 20].", "evidence": {"94011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94011]}
{"id": 605, "claim": "From 2006-2009, black MSM under age 30 experienced a 47% increase in the estimated annual number of new infections and in 2009, there were more new infections in black MSM under age 30 than in white MSM under age 39 and more than all Hispanic MSM [<|cit|>] found that black non-Hispanic MSM were significantly more likely to be living with HIV than were white non-Hispanic MSM (28% vs 18%), and among those living with HIV, blacks were also significantly more likely to be unaware of their HIV infection (59% vs 26%).", "evidence": {"94012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [94012]}
{"id": 606, "claim": "Among new cases, 27% were attributed to heterosexual contact with a person with known HIV infection or high risk for infection [<|cit|>].", "evidence": {"94013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94013]}
{"id": 607, "claim": "Men who have sex with men (MSM) continue to account for the largest risk group in the US for HIV incidence, accounting for 61% of new HIV infections in 2009 <|cit|>.", "evidence": {"94014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94014]}
{"id": 608, "claim": "The Centers for Disease Control and Prevention (CDC) estimates that 34% of new HIV infections occurred in individuals aged 15–29 in 2009 [<|cit|>].", "evidence": {"94015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [94015]}
{"id": 609, "claim": "Globally there continue to be rising rates of HIV incidence among men who have sex with men (i.e., gay and bisexual men) (<|multi_cit|>; Phillips et al., <|other_cit|>; Reback and Fletcher, <|other_cit|>; Newsum et al., <|other_cit|>), with the highest HIV incidence rates observed among MSM in countries such as China, Kenya, Thailand, and among young and minority MSM in the US (Beyrer et al., <|other_cit|>).", "evidence": {"94016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [94016]}
{"id": 611, "claim": "This concern was echoed by providers working with particularly hard-hit populations, such as African American MSM <|cit|>, who saw PrEP as an essential ingredient to breaking the cycle of HIV infection.", "evidence": {"94017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94017]}
{"id": 612, "claim": "Incidence estimates of 19.0 per 100,000 were obtained for the US [<|cit|>] and of 17 per 100,000 for France, both in 2008 [<|other_cit|>]; these estimates are similar to those obtained in the region of Lazio in the period 2004-2008.", "evidence": {"94018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94018]}
{"id": 613, "claim": "To our knowledge, no report is available regarding the functional significance of 354C>T. Also, it does not appear that the SNP is in high LD with any other SNP in TLR8, or with any SNP in TLR7.<|other_cit|> Given that 354C>T had a protective effect in African Americans, and that HIV/AIDS continues to disproportionately affect this population,<|cit|> Given that 354C>T had a protective effect in African Americans, and that HIV/AIDS continues to disproportionately affect this population,71 evaluating the functional and clinical effects of this SNP in further studies is important and highly relevant.", "evidence": {"94019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94019]}
{"id": 615, "claim": "Men who have sex with men (MSM) account for nearly two-thirds of all new HIV infections in the United States and young MSM (YMSM) are the only risk group experiencing an increase in HIV incidence [<|multi_cit|>].", "evidence": {"94020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [94020]}
{"id": 616, "claim": "In additional to atypical visual scan patterns while looking at faces and during social interactions [<|multi_cit|>], individuals with ASD show abnormalities in their the sensorimotor control of eye movements when viewing simple visual stimuli (illuminated dots on a blackened screen) [<|other_cit|>] and human faces [<|other_cit|>].", "evidence": {"48000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48000]}
{"id": 617, "claim": "Interestingly, in developmental disorders, such as autism spectrum disorders (ASD), this behavior seems to be disrupted and deficits in eye contact are a hallmark of autism (<|cit|>).", "evidence": {"48001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48001]}
{"id": 618, "claim": "Infant behaviors such as decreased eye contact, atypical preverbal vocalizations and atypical development of other behaviors are prognostic of ASD even before formal ASD diagnosis<|multi_cit|>.", "evidence": {"48002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [48002]}
{"id": 619, "claim": "For example, in autism, eye tracking has been used to identify abnormalities in infants between the ages of 2–6 months, substantially earlier than the diagnosis is typically made currently [<|cit|>].", "evidence": {"48003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48003]}
{"id": 620, "claim": "Specific attention to the eye-gaze is present too in infants at risk of ASD, but starts to decrease earlier, between 2 and 6 months of life, in infants that later develop the condition (<|cit|>).", "evidence": {"48004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48004]}
{"id": 621, "claim": "Further, eye tracking devices have yielded important information relevant to both early detection [<|cit|>] and toward understanding the nature of the social deficits in autism [<|other_cit|>].", "evidence": {"48005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48005]}
{"id": 622, "claim": "The biological mechanisms that underlie the neuropathology of the “growing deviant development in autistic disorders” are now thought to produce an individual deviation from normative developmental processes (<|cit|>).", "evidence": {"48006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48006]}
{"id": 623, "claim": "Similarly, early abnormalities in visual social engagement predict ASD among high-risk infant siblings [<|multi_cit|>].", "evidence": {"48007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48007]}
{"id": 624, "claim": "This may represent a marker of the unique developmental process underlying CDD, thereby suggesting a target for studies utilizing eye tracking for early identification and stratification of behaviorally and biologically heterogeneous forms of ASD [<|multi_cit|>, 41].", "evidence": {"48008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [48008]}
{"id": 625, "claim": "The eyes contain critical information about face identity and emotional state (<|other_cit|>), attention to the eyes may predict later social development (<|multi_cit|>), and eye size may affect both aesthetic ratings of and visual preference for human faces (<|other_cit|>).", "evidence": {"48009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48009]}
{"id": 627, "claim": "Indeed there are studies that report that eye looking is present but in decline within the first 2–6 months of life (<|cit|>), while others report consistent gaze to the eye region and typical affective behavior in 6 month-olds subsequently diagnosed with ASD (Young et al., <|other_cit|>).", "evidence": {"48010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48010]}
{"id": 628, "claim": "Moreover, atypical development of behavioral features serve as markers of later diagnosis of ASD in infants (<|other_cit|>), including a reduced attention to eyes (<|multi_cit|>), poor postural control (<|other_cit|>), early motor asymmetry (<|other_cit|>), increased perceptual sensitivity (Clifford et al., 2013), and atypical preverbal vocalizations (<|other_cit|>).", "evidence": {"48011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48011]}
{"id": 629, "claim": "Individuals with ASD show a reduced interest in socially relevant stimuli (McPartland et al., <|other_cit|>; Pelphrey et al., <|other_cit|>; Chevallier et al., <|other_cit|>; Kohls et al., <|other_cit|>), tend to avoid eye-contact with their immediate surrounding (Senju and Johnson, <|other_cit|>; Elsabbagh et al., <|multi_cit|>), and show repetitive behaviors and restricted interests (Turner, <|other_cit|>; Watt et al., <|other_cit|>; Arnott et al., <|other_cit|>).", "evidence": {"48012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48012]}
{"id": 630, "claim": "Jones and Klin (<|cit|>) reported that physiological responses of the brain (electroencephalography; EEG) to direct gazes were different between the high-risk group group and the control group.", "evidence": {"48013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48013]}
{"id": 631, "claim": "<|cit|> measured calibration accuracy for typically developing infants and infants later diagnosed with autism from 2 to 24 months.", "evidence": {"48014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48014]}
{"id": 632, "claim": "Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by restricted and repetitive behaviors and deficits in social communication.<|other_cit|> Evidence suggests that both genetic and environmental factors are involved in its etiology.<|other_cit|> While many studies have been conducted to examine possible environmental risk factors for ASD, much of the research focus has been on prenatal or perinatal factors.<|other_cit|> Yet other studies have found that some infants with seemingly normal or near-normal development in early infancy later regress into ASD.<|multi_cit|>,7 This suggests that postnatal factors may be of some importance as well.", "evidence": {"48015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48015]}
{"id": 633, "claim": "Reversal of group differences as a function of time has been reported by at least two recent studies comparing autistic infants with controls [<|multi_cit|>,27].", "evidence": {"48016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48016]}
{"id": 635, "claim": "A recent Nature article provided preliminary evidence that infants age 2–6 months old, who were later diagnosed with Autism Spectrum Disorder (ASD), fixated more on the mouth than eyes and more at objects than people when viewing videos of typical childhood social scenes (<|cit|>).", "evidence": {"48017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [48017]}
{"id": 636, "claim": "In contrast, social communication appears relatively typical in the first 6 months [<|other_cit|>], although neurocognitive measures reveal subtle vulnerabilities in social engagement [<|other_cit|>], response to eye gaze [<|other_cit|>], and declining interest in eyes [<|cit|>].", "evidence": {"48018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48018]}
{"id": 637, "claim": "Second, across the previously published studies of eye-tracking in ASD a uniform finding has been atypicalities in attentional parameters associated with social stimuli and this has been found for both static (Pelphrey et al., <|other_cit|>; Anderson et al., <|other_cit|>; Sasson et al., <|other_cit|>; McPartland et al., <|other_cit|>; Elison et al., <|other_cit|>; Sasson and Touchstone, <|other_cit|>) and dynamic stimuli (Klin et al., <|other_cit|>; Klin and Jones, <|other_cit|>; Pierce et al., <|multi_cit|>; Chevallier et al., <|other_cit|>).", "evidence": {"48019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48019]}
{"id": 638, "claim": "For example, an eye-tracking study reported that infants later diagnosed with ASD showed a decline in fixation to the eye region of the face from 2 to 6 months and were distinguishable from their typically developing peers by change over time; however, cross-sectional group differences in eye fixation emerged only later in the first year [<|cit|>].", "evidence": {"48020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [48020]}
{"id": 639, "claim": "While investigating only boys will increase prediction [<|cit|>], studying girls is crucial not only for tailoring diagnosis and intervention to this smaller but by no means negligible group but also for unveiling potential important protection that could be used to improve outcomes for both boys and girls.", "evidence": {"48021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [48021]}
{"id": 640, "claim": "Reduced ability to consistently modulate saccadic eye movement amplitudes could negatively impact early social experiences, which could have downstream effects on social and cognitive developments [<|multi_cit|>].", "evidence": {"48022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [48022]}
{"id": 641, "claim": "High-throughput sequencing of RNA (RNA-seq) quantifies transcripts expressed from known genes with an enormous dynamic range and discovers transcriptional units that are biologically novel yet previously unannotated, or not fully characterized in available databases or gene expression arrays [<|multi_cit|>].", "evidence": {"92000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92000]}
{"id": 642, "claim": "Analysis of gene expression experiments typically yields long lists of differentially expressed genes (DEGs) [<|cit|>].", "evidence": {"92001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [92001]}
{"id": 643, "claim": "Microarrays first make the large-scale analysis of the transcriptome possible and have produced much more important information about transcriptome deployment and gene expression [<|multi_cit|>].", "evidence": {"92002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92002]}
{"id": 644, "claim": "Distribution of spike-in measurement fits to straight linear line in RNA-Seq and a monotonic sigmoidal pattern against actual abundance in microarrays or bead-arrays <|other_cit|>, consistent with data compression in hybridization-based techniques <|cit|>, consistent with data compression in hybridization-based techniques 7.", "evidence": {"92003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92003]}
{"id": 645, "claim": "But in general, when the two methods are directly compared, they give comparable answers [<|multi_cit|>].", "evidence": {"92004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92004]}
{"id": 646, "claim": "The use of deep sequencing methodologies allows for determination of transcriptome differences between naïve and trained flies with greater resolution and sensitivity than previous techniques (<|cit|>), including the identification of differentially expressed genes and their isoforms.", "evidence": {"92005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92005]}
{"id": 647, "claim": "Therefore, NGS paves the way to studying the expression of different isoforms of a gene, and to measuring and comparing isoform diversity and abundance [<|cit|>].", "evidence": {"92006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92006]}
{"id": 649, "claim": "Although RNA-seq has demonstrated itself as a superior approach [<|cit|>], there is not much data available for PD, although there is likely going to be further applications in the future.", "evidence": {"92007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92007]}
{"id": 650, "claim": "The same with previous researches as it is evident from Table 2, networks derived by RNA-Seq data allowed to predict the higher percentage of true positive rates subsequently the more accurate regulatory relationships where one reason might be the capability of RNA-Seq technology in accurate measurement of the dynamic range of low and highly expressed genes [<|cit|>] and giving a better resolution of relationship between genes.", "evidence": {"92008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [92008]}
{"id": 652, "claim": "Examples are single nucleotide polymorphisms (SNPs) [<|other_cit|>], transcription factor binding affinities and probabilities [<|other_cit|>], and RNAseq data [<|multi_cit|>].", "evidence": {"92009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92009]}
{"id": 653, "claim": "Arrays still provide a cost effective way of assessing transcription for the whole genome (<|cit|>).", "evidence": {"92010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92010]}
{"id": 655, "claim": "In addition, the removal of genes expressed at very low levels is normally performed to minimise stochastic background expression at the lower ends of the dynamic ranges for both RNA-seq and microarray technologies [<|multi_cit|>].", "evidence": {"92011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92011]}
{"id": 656, "claim": "They have shown associated results for the same biological samples that have been analyzed using both technologies after normalizing the RNA-seq data into read counts per millions (CPM) (<|cit|>).", "evidence": {"92012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92012]}
{"id": 657, "claim": "RNA-Seq also avoids technical limitations inherent to the microarray platform related to probe performance, such as cross-hybridization, limited detection range of individual probes, as well as non-specific hybridization [<|multi_cit|>-8].", "evidence": {"92013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92013]}
{"id": 658, "claim": "The major advantages of RNAseq are more accurate measurement of the dynamic range of low and highly expressed genes [<|cit|>).", "evidence": {"92014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [92014]}
{"id": 661, "claim": "This issue was later overcome with the introduction of the MicroArray Quality Control consortium, which led to the development of quality control standards to establish a framework for the use of microarrays in both clinical and experimental settings [<|cit|>].", "evidence": {"92015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92015]}
{"id": 662, "claim": "But, another study also indicated that RNA-seq density generated by about 6 M (36 bp) reads showed a strong congruence with expression metrics from array intensities (Pearson’s r = 0.90–0.91) [<|cit|>].", "evidence": {"92016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92016]}
{"id": 664, "claim": "Several studies have compared exon microarrays and next generation technologies [<|multi_cit|>-16].", "evidence": {"92017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [92017]}
{"id": 665, "claim": "Independent HCV isolates of a given subtype typically differ by 6% to 10%, and genetic variation between viral genomes within an individual is usually 1% to 3% because of the replication of HCV as a quasispecies (that is, a collection of genetic variants that clusters around a master sequence and that evolves as a unit [<|cit|>].", "evidence": {"84000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [84000]}
{"id": 666, "claim": "The human immunodeficiency virus (HIV) replicates with an extremely high mutation rate and exhibits significant genetic diversity within an infected host, often referred to as a “mutant cloud” or “quasispecies” [<|multi_cit|>].", "evidence": {"84001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84001]}
{"id": 667, "claim": "Genetic interactions between mutant viruses within a quasispecies have been proposed to affect the overall fitness of the population through a combination of cooperative and antagonistic effects [<|multi_cit|>].", "evidence": {"84002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84002]}
{"id": 668, "claim": "Therefore, influenza viruses exist in an infected host as a dynamic viral population of genetically diverse variants, the composition of which is determined by selective pressures [<|cit|>].", "evidence": {"84003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84003]}
{"id": 669, "claim": "Besides this, the propensity of eukaryotic RNA viruses to a very high mutation rate is generally known and recognized as ambivalent (<|multi_cit|>).", "evidence": {"84004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [84004]}
{"id": 670, "claim": "Each population of RNA virus is composed of a collection of different, yet related genomes often referred to as mutant spectra or quasispecies (<|cit|>).", "evidence": {"84005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84005]}
{"id": 671, "claim": "RNA viruses are present within hosts as a cloud of closely related non-identical genomes, often referred to as the viral quasispecies (<|multi_cit|>; Domingo et al., <|other_cit|>).", "evidence": {"84006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84006]}
{"id": 673, "claim": "Pathogenesis, epidemiology and evolution of RNA viruses are influenced by the composition of the viral population.<|other_cit|> Genetic diversity is achieved by high mutation rates and as a consequence, quasi-species populations are generated which may allow adaptation to antiviral drugs, potentially inducing resistance or enhanced viral fitness.<|cit|> In addition, viral diversity represents a potential mechanism to escape a successful immune response while in turn immune pressure may drive viral evolution.<|other_cit|> For HEV, greater intrahost heterogeneity has been linked with evolution to chronicity.<|other_cit|> The immune pressure on HEV maybe weak in chronic hepatitis E where HEV-specific T-cell responses are barely detectable, but various cytokines and chemokines are elevated in acute and chronic hepatitis E correlating with disease activity and progression of liver disease.<|other_cit|> However, the mode and tempo of HEV evolution in persistently infected patients undergoing therapy is currently unknown.", "evidence": {"84007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84007]}
{"id": 674, "claim": "As well as a randomly generated swarm of mutants around one variant, quasispecies can also exist as a number of master variants, each with their own swarm of random mutations (<|multi_cit|>; Lauring and Andino, 2010).", "evidence": {"84008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [84008]}
{"id": 675, "claim": "Acting either individually or in concert, these processes can create novel combinations of new and pre-existing genetic polymorphisms, generating substantial genetic diversity within a single, closely-related group of viruses (such as those within the same species [<|multi_cit|>]), or among viruses belonging to more distantly-related species, genera, or even families.", "evidence": {"84009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84009]}
{"id": 676, "claim": "The resulting population of closely related yet non-identical viral genomes is known as a viral quasispecies (<|cit|>).", "evidence": {"84010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84010]}
{"id": 677, "claim": "Because of the high possibility of re-assortment and mutation, evolution of RNA viruses like influenza is quite different from other species <|cit|>.", "evidence": {"84011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84011]}
{"id": 679, "claim": "The quasispecies theory has presented remarkable insights into viral evolution and suggested new strategies of intervention <|multi_cit|>.", "evidence": {"84012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84012]}
{"id": 680, "claim": "Accordingly, the ExoN acquisition could have provided the ancestral virus with improved control over the fidelity of its replication and the mutation spectrum (quasispecies structure) of its progeny <|other_cit|>, which may have facilitated virus adaptation to the environment <|multi_cit|>, [73].", "evidence": {"84013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84013]}
{"id": 681, "claim": "Such ambiguity between sequencing errors vs. true polymorphisms is especially relevant to viruses with RNA genomes, whose genomes rapidly accumulate polymorphisms and exist as a population of diverse quasi-species, even in the context of single infections (<|cit|>).", "evidence": {"84014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84014]}
{"id": 682, "claim": "Stocks of viruses typically contain an array of biologically active viral particles, some of which are defective for replication owing to mutations or deletions in essential viral genes (<|multi_cit|>).", "evidence": {"84015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84015]}
{"id": 683, "claim": "This has for many years been enshrined in the concept of the viral quasispecies, whereby many RNA viruses are believed to exist at the sample level, not as a single sequence but as a collection of closely related variants (<|cit|>).", "evidence": {"84016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84016]}
{"id": 684, "claim": "High mutation rates resulting in quasispecies dynamics lead to interactions on a functional level and may be the major contributing factor in the adaptability of RNA viruses to changing environments <|multi_cit|>.", "evidence": {"84017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84017]}
{"id": 685, "claim": "The notion of quasispecies refers to the fact that RNA viruses exist as heterogeneous populations of closely related genetic variants (<|multi_cit|>), because their polymerase lacks fidelity and introduces point mutations during replication (<|other_cit|>).", "evidence": {"84018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84018]}
{"id": 686, "claim": "With this information in hand and based on the quasi-species theory principles [<|cit|>], such as its average copy number in the blood.", "evidence": {"84019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84019]}
{"id": 687, "claim": "This one-to-one sequence and structure relationship is also not true in many RNA viruses because they may exist in a quasispecies state where sequence space is sampled by high levels of replication error (Holmes, <|multi_cit|>; Marz et al., <|other_cit|>).", "evidence": {"84020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84020]}
{"id": 688, "claim": "In effect, the natural tendency to errors of the reverse transcriptase, combined with the high viral replication activity, result in the generation of genetically related viral variations called quasispecies with important implications on the dynamics of the infection [<|cit|>].", "evidence": {"84021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [84021]}
{"id": 689, "claim": "The high adaptive capacity of RNA viruses lies on their elevated error rates that promote the generation of populations composed by a mutant spectrum with a very wide phenotypic and genetic heterogeneity <|multi_cit|>.", "evidence": {"84022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84022]}
{"id": 690, "claim": "This effect is termed ‘survival of the flattest’ (<|multi_cit|>) and was demonstrated with two different viroids: the more slowly replicating viroid—with a lower influence of mutations on the replication rate—outcompeted a faster replicating viroid, if the mutation rate was raised by UV radiation (<|other_cit|>).", "evidence": {"84023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84023]}
{"id": 691, "claim": "However, if coupled to high fitness genotypes, low fitness virus variants can be maintained at higher levels than expected <|cit|>.", "evidence": {"84024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84024]}
{"id": 692, "claim": "This extremely high mutation rate leads to significant genetic and antigenic diversity that allows the EBOV population to evolve resistance to antiviral medications and vaccines [<|multi_cit|>].", "evidence": {"84025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84025]}
{"id": 693, "claim": "Thus, as with other RNA viruses, influenza viruses exist as a population of genetic variants, and such diversity cannot be assessed by the consensus sequence <|multi_cit|>.", "evidence": {"84026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [84026]}
{"id": 694, "claim": "Despite controversies surrounding the immunogenicity of hiPSC derivatives, almost all studies that involve transplantation of hiPSC-CMs induce immunosuppression in their animal models<|multi_cit|>.", "evidence": {"56000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56000]}
{"id": 695, "claim": "Stem cell “therapies” have shown promises in the animal studies (Orlic et al., <|other_cit|>; Miyahara et al., <|multi_cit|>; Noseda et al., <|other_cit|>).", "evidence": {"56001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56001]}
{"id": 696, "claim": "Stem cells once showed great potential in regenerative medicine because of their unparalleled proliferation/differentiation potential <|cit|>.", "evidence": {"56002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56002]}
{"id": 697, "claim": "Large animal models such as pigs and non-human primates are more valuable due to the greater resemblance of their heart rates with the beating frequency of transplanted cardiomyocytes (<|cit|>).", "evidence": {"56003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56003]}
{"id": 698, "claim": "However, non-fatal ventricular arrhythmias have been noted in non-human primates engrafted with hPSC-derived cardiomyocytes (<|cit|>).", "evidence": {"56004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56004]}
{"id": 699, "claim": "Secondly, in vitro (Chang et al., <|other_cit|>; Askar et al., <|other_cit|>; Ten Sande et al., <|other_cit|>), and in vivo (<|multi_cit|>; Shiba et al., <|other_cit|>) studies have shown that there is an inherent risk for the formation of a pro-arrhythmic substrate or the occurrence of arrhythmias after application (Menasche et al., <|other_cit|>; Makkar et al., <|other_cit|>).", "evidence": {"56005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56005]}
{"id": 700, "claim": "More recent studies using larger animal models have delivered human pluripotent stem cell derived cardiomyocytes (hPS-CM) to guinea pig (<|other_cit|>) and macaque monkey (<|cit|>) models of infarction and have demonstrated the ability to electrically couple to the host myocardium and remuscularize portions of the ischemic tissue.", "evidence": {"56006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56006]}
{"id": 702, "claim": "Furthermore, GEIs are being increasingly used to perform high-throughput evaluation of functional characteristics in stem-cell or somatic-cell reprogramming techniques for generating cardiomyocytes [<|multi_cit|>], in which staining procedures and dye toxicity are major limitations.", "evidence": {"56007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56007]}
{"id": 704, "claim": "In non-human primate preclinical studies, transplantation of ESC-derived cardiomyocytes improved heart function after a myocardial infarct with no ventricular arrhythmia- related problems<|cit|>.", "evidence": {"56008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [56008]}
{"id": 705, "claim": "For example, in heart regeneration, 1×109 cardiomyocytes are predicted to be needed for engraftments that recover function in large non-human primates (<|cit|>).", "evidence": {"56009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56009]}
{"id": 706, "claim": "In recent years, considerable advances have been made with this strategy,<|other_cit|> which has proven to be effective in primates.<|multi_cit|> However, although the complex mechanisms underlying in vitro differentiation and maturation have limited its application in clinical practice, a first-in-man clinical trial is already assessing the feasibility and the safety of the transplantation of human embryonic stem cell-derived cardiovascular progenitors.<|other_cit|>", "evidence": {"56010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56010]}
{"id": 707, "claim": "Myocardial infarction is confirmed by ST segment elevation on ECG and by subsequent serum assays for cardiac troponin and creatine kinase [<|cit|>].", "evidence": {"56011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56011]}
{"id": 708, "claim": "Human embryonic stem cell-derived cardiomyocytes have been successfully engrafted in a non-human primate model of myocardial infarction [<|cit|>].", "evidence": {"56012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56012]}
{"id": 710, "claim": "Our experience to date indicates that this approach, combined with careful screening, results in stable lines that can be routinely used as a unique tool to probe complex systems at a molecular scale (Ji et al., <|other_cit|>; Tallini et al., <|other_cit|>; Roell et al., <|other_cit|>; Ledoux et al., <|other_cit|>; Krasteva et al., <|other_cit|>; Nausch et al., <|other_cit|>; Shiba et al., <|other_cit|>; Sonkusare et al., <|multi_cit|>; Sonkusare et al., <|other_cit|>).", "evidence": {"56013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56013]}
{"id": 711, "claim": "For example, preclinical demonstration studies were successfully performed in non-human primates in heart [<|cit|>] and Parkinson’s disease treatment [<|other_cit|>], and in heart disease treatment in post-infarcted swine models [<|other_cit|>].", "evidence": {"56014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56014]}
{"id": 712, "claim": "Now, the generation of human pluripotent stem cell (hPSC)-derived cardiovascular cells is of growing interest for multiple applications [<|multi_cit|>].", "evidence": {"56015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56015]}
{"id": 713, "claim": "For example, when used in the regenerative context, a transgenic GCaMP3 knock-in to the AAVS1 locus that worked in human embryonic stem cell (ESC)-derived cardiomyocytes delivered to the guinea pig [<|other_cit|>] and the pigtail Macaque [<|cit|>] did not produce a dynamic calcium transient in a macaque iPSc cardiomyocyte cardiac graft, and a separate probe was developed to overcome this (GCaMP7.09, M153K, T203V, N205S, N105Y, E124V, L36M, N60D, D78Y compared to the original GCaMP, K  212 nM, range 1900%) [<|other_cit|>].", "evidence": {"56016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56016]}
{"id": 714, "claim": "Several studies have broadly observed ESC-derived cardiomyocytes could improve cardiac regeneration and enhance function in experimental animal models (Laflamme et al., <|multi_cit|>).", "evidence": {"56017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56017]}
{"id": 716, "claim": "The differentiation setup was initiated by plating undifferentiated human ESCs as single cells as described previously [<|multi_cit|>–52].", "evidence": {"56018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [56018]}
{"id": 717, "claim": "Recent studies have shown that hESC-derived cardiomyocytes and cardiovascular progenitors are able to halt the deterioration of cardiac function and improve experimentally induced diminished heart function in rodent and monkey models [<|multi_cit|>,96].", "evidence": {"56019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56019]}
{"id": 718, "claim": "In principle, the damaged heart could be regenerated by transplanting cardiomyocytes differentiated in vitro from a variety of cellular sources such as endogenous cardiac stem/progenitor cells [<|other_cit|>], embryonic stem cells [<|multi_cit|>], and induced pluripotent stem cells [<|other_cit|>].", "evidence": {"56020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [56020]}
{"id": 719, "claim": "Life expectancy has increased greatly for ART-treated PLHIV, and may even be approaching life expectancy in the general population [<|multi_cit|>].", "evidence": {"47000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47000]}
{"id": 720, "claim": "The tolerability, dosing schedules, and efficacy of antiretroviral therapy (ART) for HIV infection have improved substantially in recent years, allowing persons living with HIV (PLWH) to live longer lives, and experience a higher quality of life, than in the earlier phases of the epidemic (<|cit|>).", "evidence": {"47001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47001]}
{"id": 721, "claim": "North American publications evaluating mortality in HIV-positive cohorts accessing ART have demonstrated comparable sex-related differences to those shown in our study [<|multi_cit|>].", "evidence": {"47002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47002]}
{"id": 724, "claim": "In large cohort studies, people who inject drugs have been demonstrated to have inferior virologic outcomes and higher mortality than other patients receiving ART [<|cit|>] are less likely to achieve HIV viral suppression.", "evidence": {"47003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47003]}
{"id": 725, "claim": "This finding has been consistently reported in the published literature [<|multi_cit|>].", "evidence": {"47004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47004]}
{"id": 726, "claim": "The increased risk of mortality after 3 and 4 years in this study (HR = 3) contrasts with one other study conducted in North America, where PLHIV on ART with a baseline CD4 > 350 had mortality rates comparable with the general population.<|cit|> It also contrasts with the COHERE 2012 study that followed PLHIV on ART (CD4 ≥ 500) over a median period of 3.5 years and found mortality rates similar to that of the general population.<|other_cit|> However, the COHERE study had also found that mortality was 4.2 times higher than in the general population when all PLHIV (regardless of CD4 and mode of transmission) were considered.", "evidence": {"47005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47005]}
{"id": 728, "claim": "In the era of modern combination anti-retroviral therapy (cART), life expectancy of human immunodeficiency virus (HIV)-infected patients approaches that of the general population if cART is initiated at high CD4 cell counts.<|cit|> Therefore, non-AIDS defining events are increasingly responsible for morbidity and mortality among aging HIV-infected individuals.<|other_cit|> In particular, liver-related deaths occur 10 times higher than in the general population,<|other_cit|> ranging between 7% and 14% in different cohorts<|other_cit|> and rendering liver diseases an important non-AIDS condition in HIV patients.", "evidence": {"47006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47006]}
{"id": 729, "claim": "A 20-year-old HIV-positive patient on antiretroviral therapy in the U.S. and Canada can expect to live into his or her 70s with proper treatment<|cit|>.", "evidence": {"47007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47007]}
{"id": 730, "claim": "This finding is consistent with previous mortality studies [<|multi_cit|>], and reinforces the long-term health benefits of ART initiation earlier in the course of HIV infection.", "evidence": {"47008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47008]}
{"id": 731, "claim": "The increase in life expectancy of HIV-infected patients [<|multi_cit|>] has also driven increased costs due to life-long HIV treatment and concurrent age-related comorbidities [<|other_cit|>].", "evidence": {"47009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47009]}
{"id": 732, "claim": "Combination antiretroviral therapy (cART) for HIV-1 infection and AIDS available at this time potently suppresses the replication of HIV-1 and significantly extends the life expectancy of HIV-1-infected individuals (<|multi_cit|>).", "evidence": {"47010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47010]}
{"id": 733, "claim": "People living in such settings now have similar life expectancies as those observed in the general population [<|multi_cit|>].", "evidence": {"47011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47011]}
{"id": 734, "claim": "These differences were consistent with the changing HIV epidemic over these time periods, notably as earlier initiation of effective ART results in better control of the infection [<|other_cit|>] and longer life expectancy [<|cit|>].", "evidence": {"47012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47012]}
{"id": 735, "claim": "The current antiretroviral classes include the nucleoside and nucleotide reverse-transcriptase inhibitors (NRTIs), non-nucleoside reverse-transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), entry inhibitors, and integrase strand transfer inhibitors (INSTIs).<|other_cit|> Increasingly, co-formulations are constructed with the goal of enhancing adherence, thereby ensuring the continual HIV suppression necessary to avoid the development of resistance.<|other_cit|> Antiretroviral therapy has lengthened the average life span of HIV-infected individuals to approach that of the general population while concurrently increasing the burden of comorbidities.<|multi_cit|> Accordingly, there is an increasing need for agents with few drug–drug interactions, reduced toxicity, high genetic barrier to resistance, low pill burden, and decreased cost.", "evidence": {"47013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47013]}
{"id": 736, "claim": "The introduction of combination antiretroviral therapy (cART) has changed HIV-1 infection from a life-threatening disease to a manageable chronic condition, and life expectancy of people living with HIV (PLWH) is approaching that of non-infected individuals [<|cit|>].", "evidence": {"47014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47014]}
{"id": 739, "claim": "With the benefit of combination antiretroviral therapy (cART), persons living with human immunodeficiency virus (PLWH) have survived to older ages [<|multi_cit|>] with fewer opportunistic infections and AIDS-defining cancers [<|other_cit|>].", "evidence": {"47015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47015]}
{"id": 740, "claim": "One other study had similar findings, although with ART-treated PLHIV with a baseline CD4 > 350.<|cit|> These studies are some of many that have found CD4 to be strongly predictive of mortality.", "evidence": {"47016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47016]}
{"id": 742, "claim": "Medical advancements in antiretroviral therapy regimens enable HIV-infected individuals to lead long, healthy, and productive lives.<|multi_cit|> However, despite the availability of effective therapy for people living with HIV/AIDS (PLWHA), and the availability of biomedical and other HIV/AIDS prevention methods, there are still a substantial number of new HIV infections reported in the United States each year.<|other_cit|> Gaps in retention in care alone, a key metric along the HIV care continuum, may be responsible for as many as 60% of new HIV transmissions.<|other_cit|>", "evidence": {"47017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47017]}
{"id": 743, "claim": "Patients on cART are among these, benefitting from the improvement in survival and wellbeing offered by effective therapy [<|cit|>].", "evidence": {"47018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47018]}
{"id": 744, "claim": "The life expectancy for North Americans with HIV is approximately 71 years, near the life expectancy of the general population (<|cit|>).", "evidence": {"47019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47019]}
{"id": 745, "claim": "The North American AIDS Cohort Collaboration on Research and Design observed that life expectancy of HIV-infected (HIV+) adults increased from 36 to 51 years between 2000 and 2007,<|cit|> accompanied by multiple morbidities and rising healthcare costs.", "evidence": {"47020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [47020]}
{"id": 748, "claim": "In recent decades, most research has been conducted in the context of cardiovascular disease, with growing evidence implicating the psychological factors of psychosocial stress,<|cit|> cognitive function,<|other_cit|> and selected personality types (particularly neuroticism and conscientiousness)<|other_cit|> as potentially having roles at various stages of the disease process, including acting as predictive factors, markers of undiagnosed pathology, triggers of clinical events in individuals with subclinical disease, or a consequence of diagnosed somatic disease.<|other_cit|>", "evidence": {"73000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73000]}
{"id": 749, "claim": "In several reviews and meta-analyses, these dimensions have been related to health outcomes such as cardiovascular diseases [<|multi_cit|>], musculoskeletal diseases [<|other_cit|>] and mental disorders [<|other_cit|>].", "evidence": {"73001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73001]}
{"id": 750, "claim": "The IPD-Work Consortium had already published a meta-analysis on perceived work stress and CHD in 2012 [<|cit|>].", "evidence": {"73002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73002]}
{"id": 751, "claim": "Increasing attention is being directed to work-related psychosocial factors, such as job strain,<|multi_cit|>–5 effort–reward imbalance,<|other_cit|> organisational justice<|other_cit|> and workplace social capital<|other_cit|>; there is a major focus on work stress.<|other_cit|> These factors may affect cardiovascular disease (CVD), metabolic diseases and psychotic and neurodegenerative disorders through such mechanisms as prolonged overactivation and dysregulation of the autonomic nervous system and the hypothalamic–pituitary–adrenal cortex axis.<|other_cit|>", "evidence": {"73003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73003]}
{"id": 752, "claim": "We drew individual-level data from eight prospective cohort studies participating in the Individual–Participant–Data meta-analysis in Working Populations (“IPD-Work”) Consortium.<|cit|> We excluded people not in full-time employment and those with extant disease at study baseline.", "evidence": {"73004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73004]}
{"id": 753, "claim": "Within Germany, work stress is currently reported by employees at least as often as adverse physical work exposure.<|other_cit|> Earlier investigations have shown associations between work stress and certain physical and mental health indicators, such as symptoms and risk factors for coronary heart disease<|multi_cit|> and depression.<|other_cit|> In Germany, depression is a leading reason for disability-related early retirement.<|other_cit|> Thus far, the association between work stress as measured using the effort-reward imbalance (ERI) model<|other_cit|> and depression has been shown mainly for health professionals.<|other_cit|> In contrast, lidA allows investigation of ERI and depression (Beck Depression Inventory-V, BDI-V) in a general working population and in relation to age.<|other_cit|>ble 3.", "evidence": {"73005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73005]}
{"id": 754, "claim": "In the present pooled dataset, however, we found an association between job strain and an increased risk of coronary heart disease, which suggests that a single validated measure of job strain exposure is capable of showing an association with chronic disease.<|cit|>", "evidence": {"73006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73006]}
{"id": 755, "claim": "Even after completion of a study, authors sometimes choose not to submit their work for publication because they are not satisfied with the results (i.e., the “file drawer” problem) (<|other_cit|>), or they encounter difficulties with getting results published because of reviewer or editorial bias (“publication bias”) (<|multi_cit|>–4).", "evidence": {"73007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73007]}
{"id": 756, "claim": "In a recent meta-analysis (<|cit|>), some authors choose age- and gender-adjusted risk estimates, and some multiple-adjusted risk estimates, respectively.", "evidence": {"73008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73008]}
{"id": 757, "claim": "In addition, an in-depth meta-analysis using individual participant data from almost 200,000 employees in eight European countries, the individual-participant data meta-analysis in working populations (IPD)-Work consortium, suggests that the association between job strain and incident coronary heart disease is similar in men and women, among younger and old, as well as across all levels of socioeconomic position [<|cit|>].", "evidence": {"73009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73009]}
{"id": 758, "claim": "This estimate replicates the findings of recent meta-analyses, extending their results to a Southern European country with low CHD incidence rates.<|multi_cit|> The novelty of our paper relates to results of the stratified analysis, which showed an excess risk of 78% (HR=1.78; 95% CI 1.20 to 2.66) among high-strain non-manual and manual workers.", "evidence": {"73010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73010]}
{"id": 760, "claim": "Our evidence base of up to 44 000 individuals mainly consists of European studies and is much smaller than those reported in meta-analyses of job strain, coronary heart disease<|cit|> and type 2 diabetes.<|other_cit|> The generalizability of our findings should therefore be interpreted with caution, particularly as the statistical power was insufficient to detect small effects.", "evidence": {"73011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73011]}
{"id": 761, "claim": "The remaining three JS categories, that is, active, passive and low strain were also defined according to the standard criteria.<|other_cit|> These three last strain categories were collapsed in a unique category, called non-high JS, to allow direct comparisons with the results reported by the recent pooled-cohort meta-analysis.<|cit|> These three last strain categories were collapsed in a unique category, called non-high JS, to allow direct comparisons with the results reported by the recent pooled-cohort meta-analysis.6", "evidence": {"73012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73012]}
{"id": 762, "claim": "Research has established solid evidence on the impact of work stress on health, mostly based on theoretical models, such as the demand–control and the effort–reward imbalance models, and their empirical tests in the frame of occupational cohort studies.<|other_cit|> Yet, despite this important progress, one critique of this line of research maintains that these are static models, failing to grasp the dynamic aspects of current work and employment arrangements characterized by increased flexibility, insecurity, differentiation and fragmentation.<|other_cit|> Similarly, in most studies, work stress was assessed only once and linked to future health risks without taking into account its chronicity.<|multi_cit|> Other studies using repeated assessment of stressful work, though, document an increased effect on health.<|other_cit|>", "evidence": {"73013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73013]}
{"id": 763, "claim": "Recently The IPD Work Consortium published a study<|multi_cit|> based upon nearly 200 000 Europeans showing that working men and women who report the combination of high psychological demands and low decision latitude (job strain) have an elevated risk of developing IHD during a follow-up period of on average 7 years.", "evidence": {"73014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73014]}
{"id": 764, "claim": "Stress at work is an important public health issue, as it contributes to the development of several widespread forms of physical and mental illness, such as coronary heart disease (<|cit|>) and depression (Madsen et al. <|other_cit|>), burdening companies and society with high costs (European Agency for Safety and Health at Work <|other_cit|>).", "evidence": {"73015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73015]}
{"id": 765, "claim": "Work stress has been reported to increase the risk of coronary heart disease<|cit|>) and stroke<|other_cit|>).", "evidence": {"73016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73016]}
{"id": 768, "claim": "Occupational stress is no different and also increases the incidence of coronary events<|multi_cit|>.", "evidence": {"73017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [73017]}
{"id": 769, "claim": "Based on this low excess risk and an arguable estimate of the high JS prevalence, the authors calculated a small population-attributable risk of 3–4%.<|cit|> and injustice at work too.", "evidence": {"73018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73018]}
{"id": 771, "claim": "Exposure to workplace stress is often evaluated according to the job demand-control model.<|other_cit|> Throughout the literature, high strain, the combination of high demands and low control, has been linked to ill-health, primarily coronary heart disease.<|other_cit|> A recent meta-analysis of 13 studies concluded that the association with coronary heart disease was rather small but consistent (HR 1.23).<|cit|> However, there seems to be an interaction between job strain and occupational noise.<|other_cit|>", "evidence": {"73019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73019]}
{"id": 772, "claim": "2012; 380: 1491–7) [<|cit|>••]", "evidence": {"73020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73020]}
{"id": 773, "claim": "Our present conclusion is consistent with the large IPD study published more recently.<|multi_cit|> In the IPD study exposure and outcome data were standardized in a number of European cohort studies.", "evidence": {"73021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73021]}
{"id": 774, "claim": "Changes in the workplace and in the working population lead to a continuous steep increase in the literature on the association of psychosocial stress experienced at the workplace and disease in particular cardiovascular diseases (CVD) (reviewed by Kivimäki et al. <|multi_cit|>; Backé et al. <|other_cit|>; Eller et al. <|other_cit|>; Belkic et al. <|other_cit|>).", "evidence": {"73022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73022]}
{"id": 775, "claim": "Both stress at work and job strain, a related construct where employees have high work demands and low control, have been found to be associated with coronary heart disease [<|multi_cit|>], metabolic syndrome [<|other_cit|>], and elevated blood pressure [<|other_cit|>].", "evidence": {"73023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73023]}
{"id": 777, "claim": "The study exposures (adverse psychosocial factors at work) will include a range of task and organisational characteristics and work conditions,<|other_cit|> such as job strain,<|multi_cit|>–5 low social support, effort–reward imbalance,<|other_cit|> organisational injustice<|other_cit|> and low workplace social capital.<|other_cit|> Long working hours and shift work will also be included as target exposures.", "evidence": {"73024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73024]}
{"id": 778, "claim": "All studies were a part of the IPD-Work (individual-participant-data meta-analysis in working populations) consortium.<|multi_cit|> 29 The consortium used a predefined two stage data acquisition protocol: in the first stage, baseline data on work stress and sociodemographic and lifestyle factors were acquired and harmonised; in the second stage, these data were linked to register data on disease outcomes, including cancer.", "evidence": {"73025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73025]}
{"id": 780, "claim": "The last decades have seen increasing efforts in research on associations between psychosocial working conditions and different health outcomes: Poor working conditions have been shown to be related to incident heart disease [<|multi_cit|>], development of depressive symptoms [<|other_cit|>], new cases of long term sickness absence [<|other_cit|>] and disability pensioning [<|other_cit|>].", "evidence": {"73026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [73026]}
{"id": 781, "claim": "In the Individual-Participant-Data Meta-analysis in Working Populations (IPD-Work) Consortium [<|multi_cit|>••], these limitations were addressed by collecting both published and unpublished data from prospective cohort studies and by carefully harmonizing the exposure (long working hours) and cardiovascular outcomes to be as consistent across studies as possible.", "evidence": {"73027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [73027]}
{"id": 783, "claim": "In comparison to previous studies which are aligned to the concept that suppressing microglial function may be beneficial in the setting of AD [49], the data described here, together with studies on TREM2 and other AD-associated variants, suggest that a different directionality may be therapeutically useful [<|multi_cit|>, 50].", "evidence": {"44000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44000]}
{"id": 784, "claim": "More recently, it has been demonstrated that TREM2 is able to specifically sense fibrillar Aβ, activating microglial clustering around plaques, thereby limiting Aβ diffusion and subsequent toxicity (<|cit|>, <|other_cit|>).", "evidence": {"44001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44001]}
{"id": 785, "claim": "Most recently, it was shown that R47H impairs detection of lipid ligands known to associate with fibrillar β-amyloid [<|cit|>].", "evidence": {"44002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44002]}
{"id": 786, "claim": "However, <|other_cit|>, reported that the TREM2 response could be age-dependent, resulting in decreased number of plaques at early age (4 months) and increasing number of plaques in late stages of the pathology (8 months) (<|cit|>).", "evidence": {"44003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [44003]}
{"id": 787, "claim": "In AD condition, TREM2-deficient microglia demonstrated a reduced uptake of Aβ-lipoprotein complexes in vitro (<|other_cit|>) and a less effective Aβ internalization in vivo (<|multi_cit|>).", "evidence": {"44004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44004]}
{"id": 789, "claim": "These mutations in TREM2 are proposed to confer loss of TREM2 protein function, which causes decreased microglial phagocytosis and altered inflammatory responses (Kleinberger et al., <|multi_cit|>).", "evidence": {"44006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44006]}
{"id": 790, "claim": "TREM2 detects damage associated with lipids, which enables microglia to sense Aβ accumulation and cell damage and supports microglia survival and Aβ-mediated reactive microgliosis (<|cit|>).", "evidence": {"44007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44007]}
{"id": 794, "claim": "Given that TREM2 signaling is also involved in the production of inflammatory cytokines,<|multi_cit|> it may be of interest to further determine whether PS1 has a γ-secretase-independent role in mediating neuroinflammation.", "evidence": {"44008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44008]}
{"id": 795, "claim": "Signal transduction induced by ligand engagement, for example, ApoE,<|other_cit|> with the TREM2 extracellular domain is mediated through its association with DNAX-activating protein of 12 kDa (DAP12), which triggers intracellular signals through an immunoreceptor tyrosine-based activation motif.<|other_cit|> TREM2 expression is primarily found in microglia, and mounting evidence indicates that TREM2 signaling is important in the regulation of microglial phagocytosis and inflammatory cytokine production.<|multi_cit|> Several disease-associated TREM2 mutations have been reported to reduce cell surface TREM2 distribution and impair microglial phagocytic function.<|other_cit|> Therefore, the presence of TREM2 at the cell surface is important in mediating microglial functions such as phagocytosis.", "evidence": {"44009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44009]}
{"id": 798, "claim": "TREM2 is upregulated on activated microglia and involved in microglial phagocytosis [<|other_cit|>], survival [<|cit|>] and chemotaxis and response to neuronal injury [<|other_cit|>].", "evidence": {"44010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44010]}
{"id": 799, "claim": "In addition, since the well-known, AD-associated variant R47H has been proposed to impair TREM2’s ability to bind extracellular ligands [<|multi_cit|>], it will be interesting to determine in the future whether the variants identified here similarly affect ligand binding.", "evidence": {"44011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44011]}
{"id": 801, "claim": "Most attractively, heterozygous rare variants in TREM2 have been associated with a significant increase in the risk of AD emergence (Guerreiro et al., <|other_cit|>), while TREM2 deficiency in an AD animal model, the 5xFAD, increased cerebral Aβ accumulation (<|cit|>).", "evidence": {"44012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44012]}
{"id": 802, "claim": "Although the natural ligands of TREM2 are unknown, TREM2 activation was verified to regulate the activity of microglia, including cytokine secretion and autophagy [<|other_cit|>], and to maintain microglial survival [<|cit|>].", "evidence": {"44013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44013]}
{"id": 804, "claim": "Genome-wide transcriptional profiling in microglia has revealed widespread changes in gene expression in mouse models of AD (<|multi_cit|>; Wang et al., 2015).", "evidence": {"44014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [44014]}
{"id": 805, "claim": "The chemokine receptor CXCR6 was originally identified as a co-receptor for the human immunodeficiency virus (HIV) [<|other_cit|>] and is expressed on subsets of CD4+ and CD8+ T-cells [<|other_cit|>], plasma cells [<|other_cit|>] and NK-cells [<|cit|>].", "evidence": {"65000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65000]}
{"id": 807, "claim": "Interestingly, hepatic NK mice cells were shown to develop a specific adaptive immunity to HIV-1 antigens through a mechanism requiring the expression of CXCR6 (<|cit|>).", "evidence": {"65001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65001]}
{"id": 808, "claim": "It has been shown for example in mice that infection with viruses and other pathogens determines the expansion of specific NK cell subsets (<|multi_cit|>) which maintain for prolonged periods of time the ability to produce increased amounts of TNFα and IFNγ.", "evidence": {"65002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65002]}
{"id": 809, "claim": "While there is some evidence in murine systems, and more recently in rhesus macaques (<|other_cit|>), that these “memory” NK cell responses may be antigen specific, this has only been shown definitively for liver-resident NK cells (<|multi_cit|>) and the only well-characterized receptor–ligand interaction is the mouse Ly49 receptor family binding murine cytomegalovirus (MCMV) ligands (<|other_cit|>).", "evidence": {"65003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65003]}
{"id": 810, "claim": "The first demonstration of antigen-specific recall responses by NK cells was in the setting of hapten-induced contact hypersensitivity, where CXCR6+ liver-derived murine NK cells could mediate antigen-specific contact hypersensitivity independently from B and T cells [<|multi_cit|>, 14].", "evidence": {"65004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65004]}
{"id": 811, "claim": "These hyper-reactive and long-lived NK cells have been described after certain, mostly viral antigen encounters and are able to mount stronger protective responses upon re-encounter of the same pathogen and sometimes even antigen <|multi_cit|>.", "evidence": {"65005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65005]}
{"id": 812, "claim": "As memory NK cells are long-lived and have relatively higher responses compared with naïve NK cells (<|multi_cit|>), developing memory NK cells for clinical therapy is an attractive approach.", "evidence": {"65006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65006]}
{"id": 814, "claim": "Murine liver-resident NK cells confer hapten- and virus-specific memory responses (<|multi_cit|>).", "evidence": {"65007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65007]}
{"id": 815, "claim": "In studies that utilized murine models, it was shown that a persistent and transferable NK cell memory response is generated to haptens and viruses and that the retention of this memory population requires CXCR6 expression (<|cit|>).", "evidence": {"65008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65008]}
{"id": 816, "claim": "NK cell memory response has been reported in three circumstances—antigen-specific memory NK cells in the liver, CMV-specific NK cells and cytokine-induced memory-like NK cells (<|cit|>).", "evidence": {"65009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [65009]}
{"id": 817, "claim": "Interestingly, a hepatic NK cell population has been reported that can display adaptive-like immune memory against haptens or viral antigens (<|cit|>).", "evidence": {"65010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65010]}
{"id": 818, "claim": "Moreover, hepatic CXCR6+ NK cells of T and B cell-deficient mice develop nonspecific memory upon vaccination with structurally diverse antigens [<|cit|>].", "evidence": {"65011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65011]}
{"id": 819, "claim": "The authors were able to show that the phenotype observed is not due to altered trafficking, but is likely due to the absence of CXCR6-mediated NK cell localization/survival in sinusoidal endothelium, which constitutively presents CXCL16 (<|cit|>).", "evidence": {"65012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65012]}
{"id": 820, "claim": "NK cells have also been recently described as having memory potential (<|multi_cit|>).", "evidence": {"65013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65013]}
{"id": 821, "claim": "Work in this model demonstrated that these memory–NK cells are confined to the liver, since hapten-specific memory is conferred to naïve mice by adoptive transfer only of liver NK cells from sensitized donors (<|multi_cit|>).", "evidence": {"65014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65014]}
{"id": 822, "claim": "Thus, the lifespan of NK cells, their mechanism of recognition, and in addition, recent evidence for memory in NK cell responses (<|multi_cit|>) suggest that they play a truly intermediate role between innate and adaptive responses (Figure <|other_cit|>).", "evidence": {"65015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65015]}
{"id": 824, "claim": "A vaccination study using antigens from viruses including, influenza, vesicular stomatitis virus, and human immunodeficiency virus type 1 also showed memory-like NK cell responses in mice (<|cit|>) and NK cells exhibited enhanced protection against secondary infections with vaccinia virus and herpes simplex virus type 2 (<|other_cit|>).", "evidence": {"65016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65016]}
{"id": 825, "claim": "However, recent studies using mouse models have shown that NK cells can exhibit features of adaptive immune responses, including antigen-specific and -dependent clonal expansion and the ability to differentiate into long-lived memory cells that display anamnestic responses to secondary antigen exposure (<|multi_cit|>).", "evidence": {"65017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65017]}
{"id": 826, "claim": "NK cells are innate lymphocytes, though recent studies have revealed “adaptive” features of these cells (<|multi_cit|>).", "evidence": {"65018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [65018]}
{"id": 829, "claim": "Furthermore, the burden of diseases among people with diabetes is heavier [<|multi_cit|>].", "evidence": {"45000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45000]}
{"id": 830, "claim": "As also emphasized by the recent consensus report of the ADA for diabetes in older adults (<|cit|>), some considerations should be done when comparing the ADA/EASD general algorithm of treatment (<|other_cit|>) to the one proposed for older adults.", "evidence": {"45001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45001]}
{"id": 831, "claim": "Once diagnosed, many older adults with diabetes may remain under the care of a primary care provider who should customize treatment on the basis of the clinical and functional heterogeneity of this population [<|multi_cit|>].", "evidence": {"45002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45002]}
{"id": 832, "claim": "Notably, although glucose control was overall good in all age-groups (mean HbA1c 7.2%), a larger percentage of subjects in the youngest group showed out-of-target HbA1c values (> 8.5%), compared to subjects > 65 years, whereas the higher prevalence of HbA1c between 7.5–8.5% at older age in our cohort could be interpreted in the light of current guidelines that suggest to mitigate glucose targets in the elderly [<|multi_cit|>, 38].", "evidence": {"45003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45003]}
{"id": 833, "claim": "In 2012, participants in a consensus development conference convened by the American Diabetes Association provided a report recommending higher targets for older persons with diabetes and those in poorer health.<|cit|> In addition, a position statement was published by the American Diabetes Association and the European Association for the Study of Diabetes supporting a similarly individualized approach.<|other_cit|> The most recent American and Canadian Diabetes Association guidelines emphasized less stringent targets (HbA1c ≤8.0% (64 mmol/mol) in the USA and ≤8.5% (69 mmol/mol) in Canada) for older individuals with diabetes living with multiple comorbidities, individuals with extensive cardiovascular disease or patients with a limited life expectancy; more stringent targets (≤6.5%) could be considered for young patients with recently diagnosed diabetes to further reduce the risk of nephropathy and retinopathy.<|other_cit|> In the USA, about half of the patients with diabetes would have a recommended target of ≥7% (53 mmol/mol).<|other_cit|>", "evidence": {"45004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45004]}
{"id": 834, "claim": "Information was not available on diabetes type for the current analyses, but the majority of cases in this age group will be of type II diabetes (<|cit|>).", "evidence": {"45005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45005]}
{"id": 835, "claim": "About 33% of adults aged at least 65 years in the United States have diabetes and older adults with diabetes are at an elevated risk for mortality than those without diabetes [<|cit|>].", "evidence": {"45006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [45006]}
{"id": 836, "claim": "Updated consensus statements have been put forth by both the ADA and AGS based on new evidence between 2002 and 2012 (13,<|multi_cit|>).", "evidence": {"45007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45007]}
{"id": 837, "claim": "Prevalence of postural hypotension in diabetes is associated with complications and duration of disease<|other_cit|>; in this cohort, diabetes was present in only 6% of participants, whereas recent data suggest that 25% of adults over the age of 65 in the USA have it.<|cit|>; in this cohort, diabetes was present in only 6% of participants, whereas recent data suggest that 25% of adults over the age of 65 in the USA have it.59", "evidence": {"45008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45008]}
{"id": 838, "claim": "The prevalence of type 2 diabetes in adults aged 65 years or older in the U.S. is ∼20–25% (<|multi_cit|>).", "evidence": {"45009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45009]}
{"id": 839, "claim": "In more frail patients, treatment targets might reasonably be relaxed, while symptomatic hyperglycemia or the risk of DKA should still be avoided (<|cit|>).", "evidence": {"45010": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [45010]}
{"id": 840, "claim": "This is in general agreement with a number of disease management guidelines [<|multi_cit|>].", "evidence": {"45011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45011]}
{"id": 841, "claim": "This is especially problematic in older patients with dementia who are at much greater risk of hypoglycaemia compared with those without dementia [<|other_cit|>] and may be at an added risk of drug interactions due to polypharmacy [<|cit|>] and may be at an added risk of drug interactions due to polypharmacy [35].", "evidence": {"45012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [45012]}
{"id": 842, "claim": "However, older adults may have issues particular to their age, such as advanced disease, cognitive dysfunction, complex treatment regimens, comorbid health conditions, functional impairment, limited social and financial resources, and depression (<|cit|>).", "evidence": {"45013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45013]}
{"id": 843, "claim": "Diabetes disproportionally affects the elderly, as more than 25% of the U.S. population older than 65 years of age has diabetes (<|cit|>).", "evidence": {"45014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45014]}
{"id": 844, "claim": "Their guidelines recommend that the same glycemic targets be applied to otherwise healthy older people as to younger people with diabetes; and a less ambitious target be applied to patients with more complicated conditions that include multiple comorbidities, a high level of functional dependency, and limited life expectancy [<|multi_cit|>, 70].", "evidence": {"45015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45015]}
{"id": 845, "claim": "The high pill burden seen among older patients is presumably because of multiple morbidities and higher age, and it also entails the risk of drug interactions (<|cit|>), as also seen in this study, with one-fourth of patients aged >65 years of age reporting a pill burden of more than eight tablets per day.", "evidence": {"45016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45016]}
{"id": 846, "claim": "Patients with elderly-onset type 2 diabetes have better glycemic control and lower rates of microvascular complications than elderly subjects with adult-onset diabetes.<|cit|> Furthermore, hypoglycemic complications have the potential to be more dangerous because adrenergic symptoms of hypoglycemia are more silent in elderly diabetics.<|other_cit|> Thus, consideration of the adverse effects of hypoglycemia is crucial, especially in frail elderly subjects.", "evidence": {"45017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [45017]}
{"id": 847, "claim": "The nation’s elderly (<|multi_cit|>), minority, and economically challenged populations, who are at highest risk for diabetes, are growing (<|other_cit|>) and rates of overweight and obesity are escalating (<|other_cit|>), while health care disparities remain pervasive (<|other_cit|>), and issues associated with costs and access to quality care persist.", "evidence": {"45018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45018]}
{"id": 848, "claim": "We refer the reader to the ADA consensus report “Diabetes in Older Adults” (<|cit|>).", "evidence": {"45019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45019]}
{"id": 850, "claim": "Diabetes in older adults is also linked to reduced functional status, increased risk of institutionalization and higher mortality [<|cit|>].", "evidence": {"45020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45020]}
{"id": 851, "claim": "It has been estimated that the number of people over 65 with diabetes will increase by 4.5-fold by 2050 [<|other_cit|>]; and diabetes is linked to higher mortality, reduced functional status, impaired quality of life, increased risk of institutionalization [<|cit|>]; and diabetes is linked to higher mortality, reduced functional status, impaired quality of life, increased risk of institutionalization [4], and mortality.", "evidence": {"45021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45021]}
{"id": 852, "claim": "Both inadequate treatment and treatment complications (e.g. hypoglycemia) are major concerns that are frequently encountered among older patients [<|cit|>].", "evidence": {"45022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45022]}
{"id": 853, "claim": "Indeed, current guidelines suggest that patient characteristics such as older age, frailty, or multiple comorbidities may be legitimate reasons for delaying therapy intensification.<|multi_cit|> In addition, clinician beliefs about the importance of glycemic control, especially in the context of these patient characteristics, may help explain why apparent clinical inertia is, in fact, clinical decisiveness.", "evidence": {"45023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45023]}
{"id": 855, "claim": "The American Geriatrics Society and the American Diabetes Association recommendations for care of the older adult with diabetes continue to recommend personalized HbA1c goals based on co-morbidities with appropriate goals being 7.5–8 % (58–64 mmol/mol) [<|multi_cit|>].", "evidence": {"45024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [45024]}
{"id": 856, "claim": "A consensus report on diabetes and older adults (<|cit|>) influenced the following discussion and recommendations.", "evidence": {"45025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45025]}
{"id": 857, "claim": "The increasing incidence and prevalence of diabetes will inevitably result in accumulation of diabetes in older people [<|cit|>].", "evidence": {"45026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45026]}
{"id": 858, "claim": "Indeed, in patients above the age of 80 years, in agreement with the consensus report for diabetes in older adults (<|cit|>), we suggest not using it unless normal renal function is present.", "evidence": {"45027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45027]}
{"id": 859, "claim": "Furthermore, some studies suggest that strict metabolic control may not be advisable for older and frail people, because the benefits may not outweigh the risks of the treatment [<|cit|>].", "evidence": {"45028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45028]}
{"id": 860, "claim": "Considering this study’s limitation, it is important to remember, as experts and professional organizations recommend, that health care providers need to customize treatment on the basis of a patient’s lifestyle, health status, risk factors, cognitive function, medical history, and social support [<|multi_cit|>].", "evidence": {"45029": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [45029]}
{"id": 862, "claim": "A power analysis was performed a priori based on a previous unpublished pilot study, and we determined that nine subjects were required to demonstrate that a weight reduction of 5–10%, accompanied by lower blood glucose, lower blood pressure, and improved lipid levels, would lead to clinically significant differences in metabolic parameters to reduce cardiovascular risk factors with 80% power at 5% significance level, as postulated in a previous study (<|cit|>).", "evidence": {"82000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82000]}
{"id": 863, "claim": "A study by Wing et al <|cit|> found that modest weight losses of 5%–10% have been associated with significant improvements in cardiovascular disease risk factors (ie, decreased HbA1C levels, reduced blood pressure, increase in HDL cholesterol, decreased plasma triglycerides) in patients with T2D.", "evidence": {"82001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82001]}
{"id": 864, "claim": "Often, successful patients most responsive to intervention (ie, greatest weight loss) are left disappointed.<|other_cit|> Also, patients with the highest pretreatment weights are the most likely to have unrealistic expectations for success.<|other_cit|> The dramatic disparity between patient expectations and professional recommendations highlight the need for patient education concerning realistic outcomes that encourage acceptance of modest weight loss, as slight reductions in body weight yield substantial health benefits.<|multi_cit|> Here, the concept of “best weight” rather than “ideal weight” is likely a more realistic and feasible option to highlight for long-term success by shifting the focus away from BMI.<|other_cit|> In brief, best weight is whatever weight a patient can achieve while living the healthiest lifestyle they can enjoy, acknowledging that there comes a point when a person cannot eat less and exercise more and still like their life.", "evidence": {"82002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82002]}
{"id": 866, "claim": "The existing studies suggest that modest, sustained weight loss can have long-term benefits on biochemical disease risk indicators [<|multi_cit|>].", "evidence": {"82003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [82003]}
{"id": 868, "claim": "We defined improvement of systolic BP (SBP) as mean reduction by more than ≥5 mmHg after PTRA compared to baseline, which is clinically and statistically meaningful, as done before [<|cit|>].", "evidence": {"82004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82004]}
{"id": 869, "claim": "Although energy balance on its own may not prevent CVD, reducing portion sizes and weight loss in overweight and obese individuals with diabetes is recommended in order to reduce CVD risk [<|multi_cit|>].", "evidence": {"82005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82005]}
{"id": 870, "claim": "Weight control is important for patients with type 2 diabetes to help improve glycemic control (<|other_cit|>) and improve cardiovascular risk factors (<|multi_cit|>), and is particularly pertinent for patients taking a sulfonylurea.", "evidence": {"82006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82006]}
{"id": 871, "claim": "Modest weight loss—5 –10% of initial body weight has been shown to have a beneficial effect on cardiovascular risk factors associated with obesity and to improve risk factor clustering, such as improvements in blood pressure, and cholesterol [<|cit|>].", "evidence": {"82007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82007]}
{"id": 872, "claim": "This level of weight loss has been shown to be associated with improved cardiovascular disease risk factors [<|cit|>].", "evidence": {"82008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82008]}
{"id": 873, "claim": "Although lifestyle changes (ie, diet and exercise) can improve glycemic control and cardiovascular (CV) risk factors in T2D,<|cit|> most patients do not adhere to such changes over the long term and subsequently require pharmacotherapy to achieve glycemic goals.<|other_cit|> Furthermore, despite a wide range of available treatment options, only ~50% of patients with diabetes in the United States have glycated hemoglobin (A ) <7%.<|other_cit|>", "evidence": {"82009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [82009]}
{"id": 874, "claim": "Marked loss of bodyweight following surgery is one of the most important factors in diabetes remission.<|other_cit|> The Look AHEAD study has clearly demonstrated the linear association between the degree of weight loss and HbA1c reduction in the study participants.<|cit|> The Look AHEAD study has clearly demonstrated the linear association between the degree of weight loss and HbA1c reduction in the study participants.69", "evidence": {"82010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82010]}
{"id": 875, "claim": "Also, the magnitude of the reduction of TGs has been shown to be directly related to the amount of weight lost.<|multi_cit|>,33 The greater degree of weight loss alone, in the RYGB group, may explain the greater reducing of hypertriglyceridemia versus SG.", "evidence": {"82011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82011]}
{"id": 876, "claim": "Our results are consistent with the Look AHEAD cohort, which showed that a modest weight loss of 2%–5% was associated with significant improvement in A1c (1.80% (95% CI 1.44–2.24)), and other CVD risk factors [<|cit|>].", "evidence": {"82012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82012]}
{"id": 878, "claim": "Moreover, small reductions in body weight alone can have beneficial effects on blood pressure as well as glucose and cholesterol metabolism (Klein et al., <|multi_cit|>; Wing et al., 2011).", "evidence": {"82013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82013]}
{"id": 879, "claim": "However, even just a 10% weight loss can significantly improve obesity-related comorbidities.<|multi_cit|>, 17 In addition, patients must realize that it often took years to gain the excess weight, and thus it is reasonable and realistic to expect that it is likely to require years and significant investment to lose the weight.", "evidence": {"82014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82014]}
{"id": 880, "claim": "Other intervention studies have not been able to adjust for these factors <|multi_cit|>.", "evidence": {"82015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [82015]}
{"id": 881, "claim": "Two recent randomized controlled trials reported that obese T2DM participants in weight loss programs showed improved glycaemic status and lowered triglycerides level, which was associated with a decreased risk of cardiovascular disease [<|multi_cit|>].", "evidence": {"82016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82016]}
{"id": 883, "claim": "Although the weight relapse seems to be common for long-term WL studies, Wing et al. concluded that large or modest WL at 1 year is still clinically beneficial for diabetic patients with obesity (<|cit|>), and it has been reported that acute weight loss affects long-term cardiovascular function (Corbi et al., <|other_cit|>).", "evidence": {"82017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82017]}
{"id": 884, "claim": "Although medical intervention can lead to modest weight loss in select patients <|other_cit|>, 5–10% weight loss in a morbidly obese individual still leaves that patient with significant cardiometabolic risk <|multi_cit|>, 3.", "evidence": {"82018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [82018]}
{"id": 885, "claim": "Weight reduction in T2DM patients can be a challenge (<|other_cit|>), but even a modest weight reduction of <5% is of clinical importance, since glycemic metabolism and cardiovascular disease risk factors improved with net weight loss of as little as 2–5% in persons with T2DM (<|cit|>).", "evidence": {"82019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [82019]}
{"id": 886, "claim": "In parallel, mesenchymal markers, such as vimentin or fibronectin [<|other_cit|>], are upregulated [<|cit|>], are upregulated [13], as is N-cadherin.", "evidence": {"95000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95000]}
{"id": 888, "claim": "Epithelial-mesenchymal transition, characterized by loss of cell-cell junctions, polarity and epithelial markers, and acquisition of mesenchymal features and motility, has been suggested to be involved in cancer progression and metastasis [<|cit|>].", "evidence": {"95001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95001]}
{"id": 889, "claim": "During the EMT process, the cell–cell junction disassembled and cancer cells lose their apico-basal polarity and gain the ability to migrate from the primary tumor into the surrounding tissue, which is the first step toward metastasis<|multi_cit|>.", "evidence": {"95002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95002]}
{"id": 890, "claim": "In human breast cancer, however, there is little agreement about exactly what constitutes EMT tumorigenesis [<|multi_cit|>,35].", "evidence": {"95003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [95003]}
{"id": 891, "claim": "Molecular changes intrinsic to a cancer cell and resulting from signaling cascades activated by exogenous cytokines arising from the tumor microenvironment (TME), drive EMT and metastasis [<|multi_cit|>].", "evidence": {"95004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95004]}
{"id": 893, "claim": "Emerging evidence shows that in addition to epithelial (E) and mesenchymal (M) phenotypes, cells can acquire a hybrid epithelial/mesenchymal (E/M) phenotype (also referred to as ‘partial EMT’) that has combined traits of epithelial (cell-cell adhesion) and mesenchymal (invasion) phenotypes (Revenu & Gilmour, <|multi_cit|>; Friedl & Gilmour, <|other_cit|>; Yu et al., <|other_cit|>; Hou et al., <|other_cit|>; Jolly et al., <|other_cit|>; Bierie et al., <|other_cit|>).", "evidence": {"95005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95005]}
{"id": 894, "claim": "During embryonic development, TGFβ and Wnt signaling exhibit synergistic effects (Letamendia et al., <|other_cit|>; Lei et al., <|other_cit|>; Deng et al., <|other_cit|>; Owens et al., <|multi_cit|>), and both DAPPER1 and ANKRD1 are involved in both of these pathways (Waxman et al., <|other_cit|>; Labbe et al., <|other_cit|>; Su et al., <|other_cit|>).", "evidence": {"95006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [95006]}
{"id": 895, "claim": "There is increasing interest in regulators of the oncogenic epithelial-mesenchymal transition (EMT) and its reciprocal process, mesenchymal-epithelial transition (MET), for elucidation of the mechanisms underlying tumor progression and metastasis and the possible identification of new targets for cancer treatment [<|cit|>].", "evidence": {"95007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95007]}
{"id": 896, "claim": "EMT involves the dedifferentiation of cancer cells and is induced by upregulation of the mesenchymal transcription factors TWIST, SLUG and SNAIL in conjunction with downregulation of epithelial transcription factors FOXA1 and GATA3 [<|cit|>].", "evidence": {"95008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [95008]}
{"id": 897, "claim": "Epithelial cells are firmly anchored to the basement membrane, and gaining of mesenchymal cell markers coincides with the acquisition of cell mobility towards external mucosal layers and other organs [<|cit|>].", "evidence": {"95009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95009]}
{"id": 900, "claim": "Interestingly, the inappropriate reactivation of embryonic and developmental programs in adult tissues has been linked to the initiation and progression of human malignancies [<|multi_cit|>].", "evidence": {"95010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95010]}
{"id": 901, "claim": "EMT describes a situation that epithelial and mesenchymal cells can, under certain conditions, switch their phenotypes<|cit|> and emerging evidence suggests that EMT is an important mechanism contributing to airway remodeling in asthma,<|other_cit|> which can explain lower post-BD FEV1 and post-BD FEV1/FVC ratios in cluster 2 compared to those in cluster 1.", "evidence": {"95011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95011]}
{"id": 902, "claim": "In line with these findings, CSCs have been connected to a mesenchymal phenotype [<|cit|>], and it was shown that chemoresistant cells display not only CSC but also mesenchymal features [<|other_cit|>].", "evidence": {"95012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95012]}
{"id": 904, "claim": "It was initially described in the context of embryonic differentiation [<|cit|>].", "evidence": {"95013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95013]}
{"id": 905, "claim": "During the EMT, cells lose their origin markers, polarity, and cell-cell connections and gain mesenchymal-like pro-migratory phenotypes that enable them to cross anatomical boundaries such as the extracellular matrix (ECM) or the basement membrane [<|multi_cit|>].", "evidence": {"95014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95014]}
{"id": 906, "claim": "Many authors have drawn parallels between the branching morphogenesis processes underlying normal embryonic mammary gland development and the initiation of invasive events in breast cancer progression, based on the fact that, in the developing gland, epithelial cells proliferate, migrate and invade from a pre-existing epithelium into the adjacent fat pad [<|cit|>].", "evidence": {"95015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95015]}
{"id": 907, "claim": "It is well recognized that some cancer cells are capable of undergoing an EMT-like transformation and develop a migratory and invasive phenotype to detach from the primary tumor (<|multi_cit|>).", "evidence": {"95016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95016]}
{"id": 908, "claim": "TWIST has been considered as a critical EMT inducer which allows the acquisition of mesenchymal phenotype that permit the invasion and metastasis from the primary tumor site [<|multi_cit|>].", "evidence": {"95017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95017]}
{"id": 909, "claim": "While we are currently in the process of confirming the regional effects of sizzled loss of function in X. laevis, as well as the role of particular Sizzled-regulated target genes in axial patterning and mesodermal and neural crest differentiation, the broader significance of these observations involves the linkage between snail2/slug, a gene well known to be involved in tumor metastasis (<|multi_cit|>), and metastatic behavior (<|other_cit|>).", "evidence": {"95018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [95018]}
{"id": 912, "claim": "As with inflammatory bowel diseases, impaired mucin production is related to colorectal cancer (Weiss et al., <|multi_cit|>) that is also linked to the presence of bacterial biofilms (Dejea et al., <|other_cit|>).", "evidence": {"51000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51000]}
{"id": 913, "claim": "Intestinal trefoil factor (ITF) is a structural component of the mucus layer and a member of the trefoil peptide family, which is essential for maintaining and recovering of the intestinal mucosal barrier (<|cit|>).", "evidence": {"51001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51001]}
{"id": 914, "claim": "It is known that reduction in size and number of goblet cells is a characteristic feature of human ulcerative colitis (<|cit|>).", "evidence": {"51002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51002]}
{"id": 915, "claim": "In humans, the goblet cell-to-enterocyte ratio increases from the proximal to distal intestine, with an estimated 4, 6, 12, and 16% of goblet cells in the epithelium of the duodenum, jejunum, ileum, and distal colon, respectively (<|cit|>).", "evidence": {"51003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51003]}
{"id": 916, "claim": "Goblet cells can synthesize and secrete bioactive molecules that are components of mucus, such as mucins and trefoil factors [<|cit|>].", "evidence": {"51004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51004]}
{"id": 917, "claim": "The major structural component of mucus is mucin, a glycoprotein that has a protein backbone connected to hydrophilic and hygroscopic oligosaccharide side chains that form a gel-like tridimensional structure (<|cit|>).", "evidence": {"51005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51005]}
{"id": 918, "claim": "Elevated levels of MUC1 and MUC4 in UC have been demonstrated before.<|multi_cit|> Contrary to results reported by others who have shown that expression of MUC5B is increased in colorectal cancer [CRC] but not in UC,<|other_cit|> we here report increased expression of MUC5B in UC.", "evidence": {"51006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [51006]}
{"id": 920, "claim": "Mucins are an essential component of epithelial integrity, serving as a formidable barrier to microbial invasion and repository for secreted AMPs (<|multi_cit|>).", "evidence": {"51007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51007]}
{"id": 921, "claim": "FCGBP is highly expressed in mucous neck cells and involved in the formation of mucus that protects the gastric mucosa [<|cit|>].", "evidence": {"51008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [51008]}
{"id": 922, "claim": "An appropriate secretion of MUC2 requires extensive O-glycosylation of central mucin repeats and intra- and inter-chain disulfide bond formation in the cysteine-rich N and C-terminal domains within the ER (<|cit|>).", "evidence": {"51009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51009]}
{"id": 924, "claim": "Sometimes called the body’s second skin, the intestinal mucosal barrier is composed of specialized epithelial cells that help regulate nutrient absorption, gut permeability, and immune homeostasis—functions the immune system performs under steady-state conditions.<|other_cit|> Studies in germ-free mice, which are bred in a sterile environment and lack a microbiome, suggest that commensal bacteria can alter gene expression in intestinal epithelial cells.<|cit|> These findings support a role for the microbiome in regulating immune responses across the mucosal barrier.<|other_cit|>", "evidence": {"51010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51010]}
{"id": 925, "claim": "The epithelial cells are covered by the glycocalyx, a dense mesh of glycostructures [<|other_cit|>], and mucus, a lubricant and gel-like diffusion barrier, is constantly released by goblet cells [<|cit|>].", "evidence": {"51011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51011]}
{"id": 927, "claim": "Additionally, MUC2 glycosylations can be metabolized by intestinal commensal or pathogenic bacteria, serving as an energy source [<|multi_cit|>], suggesting a role in intestinal microbiota selection.", "evidence": {"51012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51012]}
{"id": 930, "claim": "However, only a several-fold increase of goblet cells may indicate an infection of the intestinal pathogens [<|cit|>].", "evidence": {"51013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [51013]}
{"id": 931, "claim": "These are also glycosylated and are released upon binding by microorganisms as a defense mechanism to prevent colonization [<|other_cit|>],[<|multi_cit|>],[30].", "evidence": {"51014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51014]}
{"id": 932, "claim": "The mRNA levels of the goblet cell products Mucin1 and Mucin2<|cit|> were decreased in K8−/− colon (<|other_cit|>), suggesting that also the terminal differentiation of goblet cells may be disrupted.", "evidence": {"51015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51015]}
{"id": 933, "claim": "Hence, the mucus layer is an important habitat and source of carbohydrates for bacterial communities that colonize mucosal surfaces, especially in the colon (<|cit|>).", "evidence": {"51016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51016]}
{"id": 934, "claim": "GCs are responsible for the production and maintenance of the mucus layer that protects the epithelium of the intestine (<|cit|>).", "evidence": {"51017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51017]}
{"id": 935, "claim": "This mucus traps and transports bacteria and is a rich source of nutrients used for bacterial metabolism and growth [<|cit|>].", "evidence": {"51018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51018]}
{"id": 936, "claim": "Mucus is continuously secreted into the GIT lumen by specialized epithelial cells, the goblet cells, and is mainly composed of heavily O-glycosylated proteins called mucins [<|cit|>].", "evidence": {"51019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51019]}
{"id": 937, "claim": "Alterations of the mucus layer as well as goblet cell pathology have been associated with IBD [<|cit|>].", "evidence": {"51020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [51020]}
{"id": 938, "claim": "Finally, when different markers related to the integrity of the intestinal epithelium were evaluated, the TNBS intestinal damage was characterized by reduced expression of the intestinal trefoil factor (TFF)-3, a bioactive peptide involved in epithelial protection and repair, and the mucin MUC-2, the primary constituent of the mucus layer in the colon (<|other_cit|>).<|cit|> Both treatments with SFNs (RGD functionalized and bare) increased the expression of TFF-3 and MUC-2 (<|other_cit|>), thus contributing to the restoration of the epithelial barrier and the preservation of the mucus layer that covers and protects the integrity of the epithelium and accelerating the recovery of the damaged intestinal mucosa.", "evidence": {"51021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [51021]}
{"id": 939, "claim": "It has been demonstrated in rodents that intestinal microorganisms are able to survive and even proliferate in the outer loose mucus layer since the glycans present in this layer are accessible as energy source for these microorganisms (<|multi_cit|>; Johansson et al. <|other_cit|>).", "evidence": {"51022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [51022]}
{"id": 940, "claim": "The HIV care continuum, sometimes referred to as the care cascade, is a paradigm for understanding the states in the health care system that HIV-infected individuals find themselves following HIV infection [<|cit|>].", "evidence": {"76000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [76000]}
{"id": 941, "claim": "However, significant loss to follow-up of people living with HIV occurs in the various steps between HIV testing and viral suppression [<|multi_cit|>], resulting in an undesirable cascade [<|other_cit|>].", "evidence": {"76001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76001]}
{"id": 942, "claim": "Early enrolment to pre-ART care is a gateway to appropriate timing of ART initiation, therefore pre-ART care coverage is an important indicator of the future success of national and regional ART program implementation [<|multi_cit|>].", "evidence": {"76002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76002]}
{"id": 943, "claim": "We have previously shown an even higher mortality rate, around 30 deaths per 100 person-years, during the pre-treatment screening period [<|other_cit|>] in this population and recent reviews show 32% loss to follow-up during this pre-treatment period despite eligibility for ART [<|cit|>], a 20% loss to follow-up among patients within the first year of antiretroviral therapy [<|other_cit|>], among whom mortality is very high [<|other_cit|>].", "evidence": {"76003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [76003]}
{"id": 944, "claim": "Moreover, a recent systematic review has highlighted the high rate of attrition in the pre-ART period [<|cit|>], with long delays and failures to complete eligibility assessments (CD4 counts and WHO clinical staging assessments) major contributors to sub-optimal retention before initiation [<|other_cit|>].", "evidence": {"76004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76004]}
{"id": 945, "claim": "In addition to a general call for enhanced data on losses to follow-up [<|cit|>], there has also been a push toward developing more evidence-based definitions [<|other_cit|>] that minimize the misclassification of patients as LTFU.", "evidence": {"76005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76005]}
{"id": 948, "claim": "The high percentage of those who delay to enter HIV care in our setting can be linked to the fact that in the early era of rapid antiretroviral treatment (ART) scale up, much attention was directed towards initiating eligible patients on ART while those who were HIV positive and not eligible (that is those in the pre-HAART period) were not given enough attention and follow up [<|cit|>].", "evidence": {"76006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76006]}
{"id": 949, "claim": "Another possibility is poor transition of care from the inpatient setting to self-management at home due to weak linkage to outpatient care [<|cit|>].", "evidence": {"76007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [76007]}
{"id": 951, "claim": "Lacking information system between facilities was found to be among the factors causing patient loss, followed by patients being asymptomatic, cost involved to access testing and fear of social stigma [<|cit|>].", "evidence": {"76008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76008]}
{"id": 952, "claim": "Attrition is high in the Lusaka ART programme,<|other_cit|> as in other ART programmes in sub-Saharan Africa.<|multi_cit|>–32 As mathematical models show, when many patients are lost to follow-up – and, therefore, discontinue therapy prematurely – the public health benefits of ART programme expansion are substantially reduced.", "evidence": {"76009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76009]}
{"id": 954, "claim": "Studies from other settings have also demonstrated poor linkage rates following testing [<|multi_cit|>].", "evidence": {"76010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76010]}
{"id": 957, "claim": "Attrition rates are often reported as proportions of patients who meet a specific outcome at various time points since ART initiation (e.g., 6 months, 12 months) [<|other_cit|>], although definitions of outcome measures over a specified period of follow-up are generally unclear [<|cit|>].", "evidence": {"76012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76012]}
{"id": 958, "claim": "Rosen and colleagues carried out a systematic review between testing and treatment initiation in sub Saharan Africa and demonstrated that the rate of delay entry between HIV diagnosis and receipt of first CD4 measurement varies between 12 % and 65 % [<|cit|>].", "evidence": {"76013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [76013]}
{"id": 959, "claim": "Many studies reported significant attrition from the process [<|cit|>-<|other_cit|>].", "evidence": {"76014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76014]}
{"id": 960, "claim": "Improving HIV/AIDS care and treatment program outcomes is dependent on successful linkage of patients to pre-ART care and retention in care until ART initiation [<|cit|>].", "evidence": {"76015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76015]}
{"id": 961, "claim": "Mortality rates of people on ART remain four to five times higher in Africa than in developed countries <|other_cit|> and retention in HIV care is a major concern <|cit|> and retention in HIV care is a major concern [17].", "evidence": {"76016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76016]}
{"id": 962, "claim": "Despite active follow-up through personal calls to participants and their relatives the LTFU was high, but comparable to several other African HIV-cohort studies [<|cit|>].", "evidence": {"76017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [76017]}
{"id": 964, "claim": "Metabolic dysfunction, including impaired insulin action, hyperlipidemia, hypertension, and other components of the metabolic syndrome, comprise well-established features of aging in humans (<|cit|>).", "evidence": {"93000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93000]}
{"id": 966, "claim": "Later Barzilai et al suggested that insulin-resistance might serve as an adaptive mechanism in some tissues by preventing excess uptake of nutrients by cells [<|cit|>].", "evidence": {"93001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93001]}
{"id": 968, "claim": "Under favorable environmental conditions, these signaling cascades control energy balance, cellular plasticity, and the mechanisms supporting homeostasis, growth, and reproduction.<|cit|> However, under harsh conditions, the hormonal stimulation of growth is blocked, while stress-resistance proteins are activated.", "evidence": {"93002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93002]}
{"id": 969, "claim": "Caloric restriction also promotes build-up of sirtuins and FOXO and inhibition of TOR, ultimately improving mitochondrial function and promoting longevity.[<|cit|>]", "evidence": {"93003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93003]}
{"id": 970, "claim": "Despite all the beneficial effects of IGF-I described up to now and the following ones reporting its role in aging-related pathologies as musculoskeletal, neurodegenerative, cardiovascular diseases, IGF-I has been paradoxically negatively related to lifespan [<|other_cit|>], probably due, at least in part, to its downstream molecule Akt and its interactions with FOXO, mTOR and SIRT-1, among others [<|multi_cit|>].", "evidence": {"93004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93004]}
{"id": 971, "claim": "An alternative hypothesis regarding the non-cell-autonomous importance of insulin action for health and survivorship posits that insulin resistance may be viewed in certain circumstances as a protective, or even beneficial, adaptation to aging- or diet-related increases in insulin levels (<|cit|>).", "evidence": {"93005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93005]}
{"id": 972, "claim": "It has previously been suggested that metabolism-related pathways play roles in aging and aging-related diseases (<|cit|>).", "evidence": {"93006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93006]}
{"id": 974, "claim": "Aging has been observed to have tentative hallmarks such as genomic instability <|other_cit|>, telomere shortening <|other_cit|>, improper epigenetic alterations <|other_cit|>, imbalance of protein homeostasis <|other_cit|>, mitochondrial dysfunction <|other_cit|>, replicative senescence <|other_cit|>, stem cell exhaustion <|other_cit|>, deregulated inter-cellular and intra-cellular communications <|other_cit|>, and impaired nutrient signaling <|multi_cit|>.", "evidence": {"93007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93007]}
{"id": 975, "claim": "Inflammation plays important roles in the progression of obesity and diabetes, which are correlated with human aging (<|cit|>).", "evidence": {"93008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93008]}
{"id": 978, "claim": "Pharmacologic and/or genetic manipulation of these pathways increases longevity to varying degrees, suggesting the feasibility of drugs that increase lifespan in the absence of caloric restriction (<|multi_cit|>; Barzilai et al., 2012).", "evidence": {"93009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93009]}
{"id": 979, "claim": "Therefore, profound metabolic abnormality represents a hallmark of aging [<|cit|>].", "evidence": {"93010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93010]}
{"id": 980, "claim": "Most hypotheses on the underlying mechanisms of the ageing process involve deterioration of the maintenance of homeostatic metabolic, inflammatory, and/or redox processes in cells and tissues [<|multi_cit|>].", "evidence": {"93011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93011]}
{"id": 981, "claim": "SIRT1 has been reported that it plays a cardinal role in glucose metabolism and insulin signaling activation (Guarente, <|multi_cit|>; Wang et al., <|other_cit|>; Mortuza et al., <|other_cit|>; Silvestre et al., <|other_cit|>).", "evidence": {"93012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93012]}
{"id": 982, "claim": "Corroborating with this hypothesis, caloric restriction, one of the most robust preventers or delayers of age-related processes and responsible for significantly extended lifespan (<|cit|>), has been previously associated with sleep.", "evidence": {"93013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93013]}
{"id": 983, "claim": "Further, genetic studies of exceptionally long-lived individuals suggest that they may possess genetically mediated factors that modulate fundamental biological processes underlying aging and protect them from developing many age-related diseases (Andersen et al. <|multi_cit|>; Milman and Barzilai <|other_cit|>).", "evidence": {"93014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [93014]}
{"id": 986, "claim": "These common modules were supported by our current knowledge of the role of immune system in tumorigenesis [<|multi_cit|>,42].", "evidence": {"57000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57000]}
{"id": 987, "claim": "A change in its composition can be indicative of disease, such as cancer [<|multi_cit|>], but is also associated with major physiological events, such as embryo fertilisation and development [<|other_cit|>].", "evidence": {"57001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57001]}
{"id": 989, "claim": "The molecular signals derived from stromal cells and/or the extracellular matrix (ECM) play an important role in the progression of an indolent tumor to a malignant state [<|multi_cit|>].", "evidence": {"57002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57002]}
{"id": 990, "claim": "Not surprisingly, altered extracellular protease activity in cancer is common and is increasingly linked to significant changes in patient outcomes.<|cit|> Considering the many structural and functional roles played by the ECM, it is evident that its cleavage and remodeling must be highly regulated.", "evidence": {"57003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [57003]}
{"id": 991, "claim": "Moreover, altered expression of ECM molecules also deregulates the behavior of stromal cells and promotes tumor-associated angiogenesis and inflammation, leading to the generation of a tumorigenic microenvironment [<|multi_cit|>].", "evidence": {"57004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57004]}
{"id": 992, "claim": "It has been suggested that hyperplastic growth of ductal tissue is the result of stromal changes and that the epithelium is influenced to become malignant because its environment has provided a permissive niche [<|cit|>].", "evidence": {"57005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [57005]}
{"id": 993, "claim": "Extracellular matrix (ECM) provides mechanical and chemical support to cells and orchestrates the structural framework and homeostasis of connective tissues where the local components and composition of ECM collectively determine the biochemical properties of the connective tissue [<|multi_cit|>].", "evidence": {"57006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57006]}
{"id": 994, "claim": "Although oncology researches regarding tumor microenvironment have intensively focused on the intricate networks of extracellular matrix molecules and hypoxia [<|multi_cit|>], the cellular metabolism in tumor microenvironment is beginning to receive significant attention only recently.", "evidence": {"57007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57007]}
{"id": 997, "claim": "The extracellular matrix is a complex dense network consisting of multiple proteins, glycoproteins and polysaccharides including collagens, laminins, fibronectins, proteoglycans and hyaluronic acid [<|cit|>].", "evidence": {"57008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57008]}
{"id": 998, "claim": "In pre-clinical models, collagens increase multiple tumor properties including growth, tumorigenicity, invasion [<|other_cit|>], the drug resistance, and the mesenchymal state [<|multi_cit|>, 33].", "evidence": {"57009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57009]}
{"id": 999, "claim": "Alterations of dermal connective tissue collagen impair skin structural integrity and are associated with age-related disorders such as delayed wound healing (Uitto, <|other_cit|>) and cancer (Bissell et al., <|other_cit|>; Bissell & Hines, <|multi_cit|>; Lu et al., 2012).", "evidence": {"57010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57010]}
{"id": 1002, "claim": "During tumor formation and progression, cancer cells participate in dense crosstalk with all of the cell types that form the surrounding tissue and with the ECM that provides structural support [<|cit|>].", "evidence": {"57011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [57011]}
{"id": 1003, "claim": "The neovascularisation is influenced by some ECM proteins of the tumour environment [<|multi_cit|>, 71].", "evidence": {"57012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57012]}
{"id": 1004, "claim": "First, since cells are able to actively remodel the surrounding micro-environment, the tissue mechanical properties do not stay constant [<|multi_cit|>].", "evidence": {"57013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57013]}
{"id": 1005, "claim": "For example, during the invasion, the stiffness of the interstitial matrix increases and microtracks with oriented collagen fibers are formed (Blackmon et al. <|other_cit|>; Cukierman and Bassi <|multi_cit|>).", "evidence": {"57014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57014]}
{"id": 1006, "claim": "Extracellular matrix plays an important role in cancer progression as a dynamic niche [<|cit|>].", "evidence": {"57015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [57015]}
{"id": 1007, "claim": "Deposition of collagen IV, a common characteristic of cancer cells, [<|cit|>] was increased overall in TE-11 (Fig. <|other_cit|>) [<|other_cit|>].", "evidence": {"57016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [57016]}
{"id": 1009, "claim": "SARS-CoV-2 glycosylation of S trimer was characterized by 14 N-linked complex, 6 N-linked hybrid-type, 2 high-mannose glycosylation sites, and O-linked serine-attached and O-linked threonine glycosylation sites (<|multi_cit|>).", "evidence": {"13000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13000]}
{"id": 1010, "claim": "Further, both the viral Spike and host receptor ACE2 are densely glycosylated with asparagine linked N-glycans [<|multi_cit|>].", "evidence": {"13001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13001]}
{"id": 1012, "claim": "The disproportionate number of non-RBD S1 and S2 nanobodies reveals the highly antigenic nature of the RBD and highlights likely occlusion of non-RBD S1 regions and S2 due to the glycan shield of SARS-CoV2 Spike (<|multi_cit|>).", "evidence": {"13002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13002]}
{"id": 1013, "claim": "An important feature of SARS-CoV-2 S protein is its extensive glycosylation, comprising 18 N-glycosylation sequons [<|cit|>] per monomer and two O-glycosylation [<|other_cit|>] sites.", "evidence": {"13003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13003]}
{"id": 1014, "claim": "Given the exposure in the virion surface and its essential role for cell infection, extensive work has been performed in the structural characterization of S (<|multi_cit|>).", "evidence": {"13004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13004]}
{"id": 1015, "claim": "In addition, the trimeric S protein is highly glycosylated with 22 N-glycosites and 2 O-glycosites per monomer (<|multi_cit|>); the 2 O-glycosites and 2 N-glycosites are located in the receptor binding domain (RBD) region, while some other N-glycosites are fully conserved (e.g., N122, N343).", "evidence": {"13005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13005]}
{"id": 1016, "claim": "For example, while many post-translational modifications (glycans) have been identified (13 and 9 on each S1 and S2 monomer)(<|multi_cit|>), there has not been an investigation into their role during the fusion step of infection.", "evidence": {"13006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13006]}
{"id": 1017, "claim": "The mutation Ser323Thr does not affect the low occurrence of O-glycosylation observed at this site (<|cit|>).", "evidence": {"13007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13007]}
{"id": 1018, "claim": "Each monomer in the trimeric S protein has 22 N-glycosylation sites, which have been characterized by mass spectrometry experiments [<|multi_cit|>].", "evidence": {"13008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13008]}
{"id": 1020, "claim": "The glycosylation of the SARS-CoV-2 spike has been studied using soluble or detergent-solubilized versions of the uncleaved S glycoprotein trimer, modified to retain a pretriggered conformation (<|multi_cit|>).", "evidence": {"13009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13009]}
{"id": 1021, "claim": "The S protein of SARS-CoV-2 is extensively glycosylated with each protomer of the transmembrane homotrimeric protein displaying 22 N-glycosylation sites and several O-glycosylation sites [<|cit|>].", "evidence": {"13010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13010]}
{"id": 1022, "claim": "(D) Heatmap showing amino acid positions that are glycosylated [<|cit|>]) MHC-II alleles (x-axis) versus across all MHC-II alleles (y-axis).", "evidence": {"13011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13011]}
{"id": 1023, "claim": "Binding of CVN-E41A to SARS-CoV-2 S protein, bearing complex-type N-linked glycosylation and O-glycosylation, was achieved in the SPR at micromolar concentrations (<|other_cit|>) through the rather small number of high-mannose containing oligosaccharides via SARS-CoV-2 RBD (<|cit|>; <|other_cit|>).", "evidence": {"13012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13012]}
{"id": 1024, "claim": "This is consistent with previous analyses of the SARS-CoV-2 spike glycoprotein (<|multi_cit|>).", "evidence": {"13013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13013]}
{"id": 1025, "claim": "Furthermore, glycans N165 and N234 interact with each other, corroborating the notion of glycans forming an extensive interaction network that leads to higher order structuring of the glycan shield.<|cit|>), thus forming contacts with mostly charged and polar residues.", "evidence": {"13014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13014]}
{"id": 1026, "claim": "Glycosylation modulates accessibility to host proteases and facilitates immune evasion by shielding epitopes from neutralizing antibodies [<|cit|>].", "evidence": {"13015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13015]}
{"id": 1027, "claim": "They mainly include N-glycans of the oligomannose, hybrid and complex types that broadly cover the protein surface (<|multi_cit|>).", "evidence": {"13016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13016]}
{"id": 1028, "claim": "Targeting glycosylation sites can also help in the early and rapid immune response to neutralize the virion (<|cit|>).", "evidence": {"13017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13017]}
{"id": 1029, "claim": "The glycosylation profile of virion S glycoproteins and several of these modified S glycoproteins has been characterized (<|multi_cit|>).", "evidence": {"13018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13018]}
{"id": 1030, "claim": "They are mainly oligomannosides and complex fucoside-derived sugars localized in 22 different sites on the spike protein (<|cit|>).", "evidence": {"13019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13019]}
{"id": 1031, "claim": "In this work, we present the results of a set of multi-microsecond MD simulations of different SARS-CoV-2 S glycoforms aimed at characterizing the effect of changes in the type of glycosylation at positions N234, N165 and N343, see <|other_cit|>, while the rest of the glycan shield is represented consistently with a stable recombinant S prefusion trimer (S ).<|multi_cit|>,17 More specifically, we investigated if shorter oligomannoses structures at N234, such as Man5 and paucimannose (Man3), see <|other_cit|>, could occupy the empty cleft in the open SARS-CoV-2 S as effectively as larger oligomannoses such as Man9, characteristic of a highly stable prefusion S .10", "evidence": {"13020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13020]}
{"id": 1032, "claim": "We have previously determined the glycosylation of several coronaviruses, including SARS-CoV-1, MERS-CoV, HKU1 and SARS-CoV-2 (<|cit|>, <|other_cit|>) and we employed a similar analytical approach involving in-line liquid chromatography-mass spectrometry (LC-MS).", "evidence": {"13021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13021]}
{"id": 1033, "claim": "Thus, we aim to compare our previously tested chemically mannosylated HA peptides in binding affinity and specificity with short peptide sequences from SARS-related 2019 novel coronavirus (nCoV) spikes and SARS-CoV-2, which are naturally modified by different N-linked glycosylation sites (<|multi_cit|>) and O-linked glycosylation (Watanabe et al., 2020, <|other_cit|>).", "evidence": {"13022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13022]}
{"id": 1034, "claim": "In many viral infections (influenza, Ebola, SARSCoV, among others), glycan-mediated interactions are essential for the initial contact between the virus and the host [<|multi_cit|>].", "evidence": {"13023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13023]}
{"id": 1036, "claim": "The field of glycoproteomics is undergoing exciting developments and expansions, to the point that many researchers are reporting site-specific glycosylation for complex glycoproteins, including the spike protein of SARS-CoV-2 [<|multi_cit|>].", "evidence": {"13024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13024]}
{"id": 1037, "claim": "These include wild-type S glycoproteins purified from SARS-CoV-2 virions, as well as soluble and full-length S glycoprotein trimers modified to inhibit furin cleavage and to stabilize a prefusion conformation (<|multi_cit|>).", "evidence": {"13025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13025]}
{"id": 1038, "claim": "Taking a hybrid approach combining homology modeling, protein–protein docking and MD, and the available experimental data (37<|multi_cit|>–40), a full-length, palmitoylated, and fully glycosylated spike is modeled.", "evidence": {"13026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13026]}
{"id": 1039, "claim": "Thus, we aim to compare our previously tested chemically mannosylated HA peptides in binding affinity and specificity with short peptide sequences from SARS-related 2019 novel coronavirus (nCoV) spikes and SARS-CoV-2, which are naturally modified by different N-linked glycosylation sites (<|other_cit|>; Watanabe et al., 2020) and O-linked glycosylation (<|cit|>, <|other_cit|>).", "evidence": {"13027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13027]}
{"id": 1040, "claim": "This is most pronounced on the HIV-1 Envelope glycoprotein (<|other_cit|>); however they have been observed on Influenza HA (<|other_cit|>), Lassa virus glycoprotein complex (<|other_cit|>), Ebola glycoprotein (<|other_cit|>), SARS-CoV-1 (<|other_cit|>), MERS-CoV (<|other_cit|>) and importantly SARS-CoV-2 (<|multi_cit|>).", "evidence": {"13028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13028]}
{"id": 1041, "claim": "Since spike carries a glycan coat, in which each asparagine glycosylation site can host a variety of glycan types, ranging from oligomannose to higher order glycans,<|cit|> we took a conservative stance and used doGlycans<|other_cit|> to build an M3 glycan at each of the 16/22 solvent accessible N-linked glycosylation sites of the spike structure,<|other_cit|> namely at residues (N61, N122, N165, N234, N282, N331, N343, N603, N616, N657, N709, N717, N801, N1074, N1098, N1134).", "evidence": {"13029": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13029]}
{"id": 1042, "claim": "It is known that glycosylation has crucial roles in viral pathobiology, such as protein proper folding and viral tropism [<|cit|>].", "evidence": {"13030": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13030]}
{"id": 1043, "claim": "Specifically, we determined the effects of site-specific glycan structure on the SARS-CoV-2 S ectodomain's structure and dynamics by systematically reducing the size of the oligomannose at N234; from Man9 (N234-Man9), found in highly stable prefusion SARS-CoV-2 S constructs,<|multi_cit|>,12,30 and also studied in previous work,<|other_cit|> we progressed to a shorter Man5 (N234-Man5), found on the virus and on other SARS-CoV-2 S constructs,<|other_cit|> and to paucimannose (N234-Man3) as a hypothetical size limit.", "evidence": {"13031": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13031]}
{"id": 1044, "claim": "An asymmetric glycosylation of the three monomers of each protein has been performed and the structure of glycans has been derived by glycoanalytic data for the N-glycans [<|cit|>] and O-glycans [<|other_cit|>] and according to the work of Casalino et al. [<|other_cit|>].", "evidence": {"13032": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13032]}
{"id": 1045, "claim": "Viral glycoproteins often display a large number of oligomannosidic N-glycans that are not further processed to complex N-glycans [<|cit|>].", "evidence": {"13033": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13033]}
{"id": 1046, "claim": "In “Site-specific glycan analysis of the SARS-CoV-2 spike” [<|cit|>], Watanabe et al. used long liquid chromatography gradients (over four hours) compared to most quantitative glycoproteomics experiments (1.5–2 h) and three different proteases in separate experiments, each with a single replicate.", "evidence": {"13034": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13034]}
{"id": 1047, "claim": "However, the extent of N-linked glycan processing in our study is greater than that seen for either soluble S glycoprotein trimers or for modified (cleavage-defective, proline-substituted) S glycoprotein variants (<|multi_cit|>).", "evidence": {"13035": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13035]}
{"id": 1049, "claim": "The above-described modeling procedure was combined with the biochemical data on the palmitoylation sites (<|other_cit|>) and the recently reported glycomics data to determine the glycosylation compositions of specific Asn residues (<|multi_cit|>) (<|other_cit|> and SI Appendix, Table S2) to develop the full-length, palmitoylated, and fully glycosylated spike structure (<|other_cit|>).", "evidence": {"13036": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13036]}
{"id": 1051, "claim": "Based on mass spectrometry data (<|multi_cit|>), we then added a total of 22 N-glycans and 1 O-glycan (39) to each spike monomer (SI Appendix, Table S2) using Glycan Reader & Modeler (<|other_cit|>) in CHARMM-GUI (<|other_cit|>).", "evidence": {"13037": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13037]}
{"id": 1052, "claim": "Although we cannot precisely assign a glycan composition at either site, our result is consistent with observations on soluble/modified S glycoproteins suggesting that one or both of these sites is occupied by a significant percentage of high-mannose glycans (<|multi_cit|>).", "evidence": {"13038": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13038]}
{"id": 1053, "claim": "For the two published data sets [<|multi_cit|>], we find that it is not possible to distinguish biological from computational sources for observed differences in glycoproteomics search results.", "evidence": {"13039": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13039]}
{"id": 1054, "claim": "The glycoforms of 21 out of the 29 predicated N-glycosylation sites on the PEDV HC070225 S were quantitatively determined, including that of Asn325, which is equivalent to that of Asn324 of PEDV PT52 S. The major glycoform of Asn325 of PEDV PT52 S is a high mannose type with eight mannose residues (M8), which could be attributed to the spatial occlusion by the D0 and the neighboring protein structures that prevent further processing into complex type glycoforms<|cit|>).", "evidence": {"13040": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13040]}
{"id": 1055, "claim": "The latter hypothesis corroborates a recent study supporting the glycosylation of these residues with more complex mannose glycans.<|cit|>).", "evidence": {"13041": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13041]}
{"id": 1056, "claim": "The resulting protein structure of spike glycoprotein WT and UK mutant (residues 27–1147) contains 18 N-glycosylation sites and two O-glycosylation sites per monomer [<|multi_cit|>], detailed in <|other_cit|>.", "evidence": {"13042": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13042]}
{"id": 1057, "claim": "Some recent reports have shown a small correlation with ABO blood type and susceptibility to COVID-19, and this effect may involve pre-existing serum antibodies to the blood group A (BG-A) and/or blood group B (BG-B) carbohydrates.<|other_cit|> Another recent study reported an inverse relationship between COVID-19 disease severity and serum anti-α-Gal antibodies.<|other_cit|> α-Gal is a non-human glycan, and natural antibodies to this glycan epitope can be part of the protective response to pathogenic viruses, bacteria, and parasites that contain this glycan.<|other_cit|> In addition to these studies on serum anti-carbohydrate antibodies, several studies have demonstrated that the SARS-CoV-2 spike protein is heavily glycosylated.<|other_cit|> Glycosylation mapping of the spike protein subunits revealed a variety of O-linked and N-linked glycans, including high-mannose.<|cit|> These glycans can be recognized by 2G12, an antibody that targets high mannose glycans on gp120 of HIV.<|other_cit|> Collectively, these studies suggest that glycans and anti-glycan antibodies may play an important role in the prevention, treatment, and severity of COVID-19.", "evidence": {"13043": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13043]}
{"id": 1058, "claim": "Viral envelope proteins, including those of the severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 are extensively glycosylated (<|cit|>).", "evidence": {"13044": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13044]}
{"id": 1059, "claim": "Targeting glycosylation sites can aid in the primary and rapid immune response to neutralize the virus (<|cit|>).", "evidence": {"13045": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13045]}
{"id": 1060, "claim": "A recent site-specific mass spectrometry analysis (<|cit|>).", "evidence": {"13046": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13046]}
{"id": 1061, "claim": "More specifically, we investigated if shorter oligomannoses structures at N234, such as Man5 and paucimannose (Man3), see <|other_cit|>, could occupy the empty cleft in the open SARS-CoV-2 S as effectively as larger oligomannoses such as Man9, characteristic of a highly stable prefusion S .<|cit|> As an important note, Man5, rather than Man7/8/9 is found to be present, or even to be the dominant glycosylation type at N234 in the virus, vaccine epitopes and in some recombinant S constructs.<|other_cit|> We also explored how the role of oligomannose structures at N234 is supplemented by the complex N-glycans at N165 and N343, which can form a tight network of glycan–glycan and glycan–protein interactions that stabilize the orientation and dynamics of the open RBD across different possible orientations.", "evidence": {"13047": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13047]}
{"id": 1062, "claim": "Viral glycoproteins undergo incomplete maturation, which results in higher levels of high-mannose N-glycans than those found in most mammalian glycoproteins [<|cit|>].", "evidence": {"13048": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13048]}
{"id": 1063, "claim": "Based on mass spectrometry data (<|other_cit|>, 39), we then added a total of 22 N-glycans and 1 O-glycan (<|cit|>) to each spike monomer (SI Appendix, Table S2) using Glycan Reader & Modeler (<|other_cit|>) in CHARMM-GUI (<|other_cit|>).", "evidence": {"13049": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13049]}
{"id": 1064, "claim": "Glycan data were obtained from [<|cit|>] and true-positive sites were aggregated across 3 replicates.", "evidence": {"13050": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13050]}
{"id": 1065, "claim": "More recently, a detailed picture of glycosylation in the SARS-CoV-2 S glycoprotein was elucidated, offering a basis for the investigation of novel vaccine targets [<|cit|>].", "evidence": {"13051": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13051]}
{"id": 1066, "claim": "This is especially true in highly stable prefusion SARS-CoV-2 S trimer glycoforms,<|multi_cit|>,30 which bear the 2P mutation.<|other_cit|> Meanwhile, a shorter Man5 appears to be present or even the dominant structure at N234 in the virus<|other_cit|> and in the secreted ChAdOx1 nCoV-19 (AZD1222) vaccine epitope,<|other_cit|> suggesting a higher degree of accessibility to that site by alpha-mannosidases in the ER.", "evidence": {"13052": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13052]}
{"id": 1067, "claim": "However, the proteomic analysis reported recently was only focused on the S protein and the detailed functions of glycosylation remained unclear (<|cit|>).", "evidence": {"13053": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13053]}
{"id": 1068, "claim": "This unprecedented redirection of scientific inquiry has rapidly provided atomic-resolution structures of SARS-CoV-2 proteins at various stages of infection (<|multi_cit|>), as well as computational analysis of specific conformational states (<|other_cit|>).", "evidence": {"13054": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13054]}
{"id": 1069, "claim": "Another critical feature of the S protein is its extensive glycosylation, which mediates protein folding and stability and promotes immune evasion by shielding epitopes from neutralizing antibodies [<|multi_cit|>].", "evidence": {"13055": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13055]}
{"id": 1070, "claim": "Mapping of SARS-CoV-2 S glycosylation reveals amino acid substitutions that determine its specific glycan signatures and exposed epitopes for antibody neutralization (<|multi_cit|>).", "evidence": {"13056": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13056]}
{"id": 1071, "claim": "In all of these models the glycosylation at all sites other than the ones listed above is consistent and the same as the profile experimentally determined for the stable prefusion S ,<|cit|> see Table S1.<|other_cit|> Results are based on the analysis of multiple uncorrelated MD trajectories (replicas) run in parallel for each model (see details in the Computational methods section in ESI<|other_cit|>).", "evidence": {"13057": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13057]}
{"id": 1072, "claim": "Glycans found on the SARS-CoV-2 S trimer (<|cit|>) revealed few, but invariant interactions with human neutralizing antibodies to SARS-CoV-2 WT, the Alpha, Delta, Lambda, and Omicron variants (<|other_cit|>), from which many were isolated, investigated during the current pandemics (<|other_cit|>) and classified according to their binding capacities for epitopes on S trimer.", "evidence": {"13058": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13058]}
{"id": 1073, "claim": "In the present study, we modeled the RBD glycan at Asn343 as a complex FA2 glycoform, in accordance with previous experimental studies [<|multi_cit|>].", "evidence": {"13059": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13059]}
{"id": 1074, "claim": "Site-specific mass spectrometric analysis of the homotrimer after mutation of the furin cleavage site and expression in HEK293F cells revealed that all 22 N-glycosylation sites were occupied with oligomannose-type, hybrid-type or complex-type N-glycans [<|multi_cit|>].", "evidence": {"13060": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13060]}
{"id": 1075, "claim": "Each of the three SARS-CoV-2 S glycoprotein protomers possesses 22 canonical sequons for N-linked glycosylation (<|multi_cit|>).", "evidence": {"13061": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13061]}
{"id": 1076, "claim": "Spike is highly dynamic and is composed of two domains: S1, which contains the host receptor binding domain (RBD); and S2, which undergoes large conformational changes that enable fusion of the viral membrane with that of its host (<|multi_cit|>).", "evidence": {"13062": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [13062]}
{"id": 1077, "claim": "We therefore hypothesized that tetherin, like the retroviral restriction factor TRIM5α, might act as a sensor for the presence of viral infection coupled to its antiviral activity (<|cit|>).", "evidence": {"46000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46000]}
{"id": 1078, "claim": "An emerging theme is that antiviral TRIM proteins both inhibit viral infection and initiate innate immune signaling cascades that lead to inflammatory cytokine production and an antiviral state (<|multi_cit|>; McEwan et al, <|other_cit|>; Uchil et al, <|other_cit|>; Versteeg et al, <|other_cit|>).", "evidence": {"46001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46001]}
{"id": 1079, "claim": "When human TRIM5α recognizes an invasive pathogen (dotted arrow in black), human TRIM5α catalyzes the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 complex (<|cit|>).", "evidence": {"46002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46002]}
{"id": 1080, "claim": "Also, additional activities linked to viral restriction have been described, including a role in signal transduction, the promotion of innate immune signaling and recognition of the retroviral capsid lattice [<|multi_cit|>].", "evidence": {"46003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46003]}
{"id": 1081, "claim": "In addition to a role in viral restriction, E3 ligase activity of TRIM5α has been implicated in establishing NF-κB-dependent pro-inflammatory cell signaling upon viral capsid recognition and formation of the above-described TRIM5α multi-hexameric net on the viral capsid lattice (<|cit|>).", "evidence": {"46004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46004]}
{"id": 1082, "claim": "Although its effect in the coronary arteries has not been investigated, Ccm2 knockdown in the mouse brain endothelial cells leads to increased monolayer permeability, decreased tubule formation, and reduced cell migration after wound healing.<|other_cit|> TRIM5 has been suggested to promote innate immune signaling, and its activity is amplified by retroviral infections.<|cit|> TRIM5 has been suggested to promote innate immune signaling, and its activity is amplified by retroviral infections.26", "evidence": {"46005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46005]}
{"id": 1083, "claim": "As a positive control, we compared its activity to that of TRIM5α, a related antiviral TRIM protein whose over-expression is sufficient to drive spontaneous NFκB signalling (<|cit|>).", "evidence": {"46006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [46006]}
{"id": 1084, "claim": "Subsequently, Pertel et al. (<|cit|>) reported similar upregulation of NF-κB and AP-1 activation in human TRIM5α-transfected HEK-293 cells and further confirmed interaction with TAB2, TAB3, and TAK1 complex by immunoprecipitation; however, they did not mention TAB2 degradation reported by Tareen and Emerman (<|other_cit|>).", "evidence": {"46007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46007]}
{"id": 1085, "claim": "The expression of cellular restriction factors and cytokine genes that affect HIV-1 infection in macrophages have been previously described (<|multi_cit|>).", "evidence": {"46008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46008]}
{"id": 1086, "claim": "In addition, TRIM5α is a potent modulator of antiviral innate immunity (<|cit|>).", "evidence": {"46009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46009]}
{"id": 1087, "claim": "TRIM5α binding to a susceptible retroviral capsid increases its E3 ubiquitin ligase activity, which catalyzes the synthesis of unanchored K63-linked poly-ubiquitin chains that activate the TAK1 kinase protein leading to downstream activation of AP-1- and NF-κB-dependent cascades (<|multi_cit|>), which may lead to the modulation of innate and adaptive immune responses.", "evidence": {"46010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46010]}
{"id": 1088, "claim": "Although this is insufficient to induce IFN production alone, these cascades synergize with other pathways, thus enhancing the IFN response <|cit|>.", "evidence": {"46011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46011]}
{"id": 1089, "claim": "An additional role of TRIM5α as a pattern recognition receptor was recently identified (<|cit|>).", "evidence": {"46012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46012]}
{"id": 1090, "claim": "For instance, TRIM5 has been reported as a pattern recognition receptor, specific for retrovirus capsid lattice (<|cit|>).", "evidence": {"46013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46013]}
{"id": 1091, "claim": "TRIM5 is a retrovirus restriction factor, which mediates the innate immune defense against retroviruses infection [<|cit|>].", "evidence": {"46014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46014]}
{"id": 1092, "claim": "Human TRIM5α has also recently been shown to be involved in this innate immunity (<|cit|>).", "evidence": {"46015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46015]}
{"id": 1093, "claim": "For efficient elimination of T5a activity, the presence of an unmodified capsid lattice was reported to be required (<|cit|>).", "evidence": {"46016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [46016]}
{"id": 1094, "claim": "However, human TRIM5α does not exert a similar function in human cells and recent studies suggest that, upon recognition of the capsid lattice, it may act as a trigger of innate immunity via activation of NF-kB and AP-1 transcription factors (<|cit|>).", "evidence": {"46017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46017]}
{"id": 1096, "claim": "Although TRIMCypA lacks the PRYSPRY domain, it also activates the TAK1 pathway (<|cit|>), suggesting that the E3 ubiquitin ligase activity (RING domain) is crucial for TRIM5α-mediated immune signaling.", "evidence": {"46018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [46018]}
{"id": 1097, "claim": "In DCs, TRIM5α binding to the capsid lattice also triggers signal transduction cascades resulting in the activation of the transcription factors AP-1 and NF-κB <|cit|>.", "evidence": {"46019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46019]}
{"id": 1098, "claim": "More recently, Pertel et al. (<|cit|>) reported that the interaction of CypA and newly synthesized Gag proteins induces the type I interferon response to activate T-cells.", "evidence": {"46020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46020]}
{"id": 1099, "claim": "Overexpression of human TRIM5 activates signalling pathways that lead to the activation of both NF-κB and AP-1, and conversely, TRIM5 knockdown decreases the expression of NF-κB- and AP1-dependent genes involved in inflammatory responses (<|cit|>).", "evidence": {"46021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46021]}
{"id": 1100, "claim": "Antiviral activity of TRIM5 has also been attributed to the induction of an inflammatory response (<|multi_cit|>).", "evidence": {"46022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46022]}
{"id": 1101, "claim": "Pertel et al (<|cit|>) have postulated that the role of TRIM5α Ub ligase activity is to stimulate an innate immune response through the synthesis of unanchored K63-Ub and that this activity is necessary for TRIM5α to restrict viral infection.", "evidence": {"46023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46023]}
{"id": 1102, "claim": "HIV-1 capsid interaction with TRIM5α generates ubiquitin chains that activate the TAK1 kinase complex and subsequenlty activate transcription factors NFκB and AP-1 (<|cit|>).", "evidence": {"46024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46024]}
{"id": 1103, "claim": "For instance, TAK1 was found to be constitutively activated in HTLV-1-infected T lymphoma cell lines in a viral Tax oncoprotein-dependent manner.<|other_cit|> EB virus-encoded latent membrane protein 1 can also activate TAK1.<|other_cit|> Interestingly, it was recently demonstrated that the HIV-1 glycoprotein gp41 activated NF-κB pathway in a TAK1-dependent manner to potentiate viral replication in CD4+ T cells.<|other_cit|> It was also recently demonstrated that BST2 (also known as tetherin), a cellular protein that inhibits HIV-1 virion release by physically tethering virions to the cell surface, was able to induce pro-inflammatory signaling in CD4+ T cells in a TAK1-dependent manner, when it restricted virion release.<|other_cit|> Another cellular HIV-1 restriction protein, TRIM5, was also reported to activate TAK1 when it interacted with the viral capsid lattice.<|cit|> Another cellular HIV-1 restriction protein, TRIM5, was also reported to activate TAK1 when it interacted with the viral capsid lattice.51", "evidence": {"46025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46025]}
{"id": 1104, "claim": "The retroviral restriction factor TRIM5 has been reported as an innate immune sensor for the retrovirus capsid lattice [<|cit|>].", "evidence": {"46026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46026]}
{"id": 1105, "claim": "There have been several reports that TRIM5α has additional activities that are uncoupled from retroviral capsid recognition (<|multi_cit|>; Tareen and Emerman, <|other_cit|>).", "evidence": {"46027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46027]}
{"id": 1106, "claim": "These chains are currently thought to recruit the kinase TAK1, ultimately resulting in TAK1 transactivation (<|cit|>).", "evidence": {"46028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46028]}
{"id": 1108, "claim": "This observation agrees well with a previous report that Ube2N/Ube2V1 and TRIM5α  synthesize unanchored K63-Ub (<|cit|>).", "evidence": {"46029": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46029]}
{"id": 1109, "claim": "These unanchored polyUb chains are postulated to activate transforming growth factor-β-activated kinase 1 (TAK1), which in turn stimulates NF-κB nuclear translocation and induces antiviral gene expression (Shi et al, <|multi_cit|>; Pertel et al, 2011).", "evidence": {"46030": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46030]}
{"id": 1110, "claim": "Pertel et al.[<|cit|>] reported that TRIM5α makes a major contribution to lipopolysaccharide signalling through Toll-like receptor 4.", "evidence": {"46031": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [46031]}
{"id": 1112, "claim": "PINK1 then phosphorylates various proteins and recruits the E3 ubiquitin ligase PARK2,<|multi_cit|> However, damaged mitochondria that no longer can import proteins into the inner membrane accumulate PINK1 on the outer membrane.", "evidence": {"55000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [55000]}
{"id": 1114, "claim": "This activates PINK1's kinase activity, and activated PINK1 then phosphorylates ubiquitin (<|multi_cit|>) and parkin (<|other_cit|>) at a conserved residue (Ser65).", "evidence": {"55001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55001]}
{"id": 1115, "claim": "The same phosphorylation also generates a type of phospo-ubiquitin (pUb) [<|multi_cit|>] that triggers morphologic changes leading to the release of the UbI domain.", "evidence": {"55002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55002]}
{"id": 1118, "claim": "PINK1 is critical for a number of post-translational modifications to Parkin (<|other_cit|>), MOM proteins (<|other_cit|>), and ubiquitin (<|multi_cit|>), as well as promoting fission to isolate damaged mitochondria for degradation (<|other_cit|>).", "evidence": {"55003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55003]}
{"id": 1119, "claim": "PINK1 activates Parkin by a twofold mechanism: (1) direct phosphorylation of Parkin at S65 [<|other_cit|>] and (2) trans-activation by phosphorylation of ubiquitin at S65 and subsequent binding to Parkin [<|other_cit|>•, <|other_cit|>•, <|multi_cit|>•].", "evidence": {"55004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55004]}
{"id": 1120, "claim": "In particular, PINK1 directly phosphorylates and ubiquitinates Parkin at serine 65 (Ser65) [<|other_cit|>] and these modifications are necessary to ensure maximal recruitment and activation of Parkin at mitochondria [<|multi_cit|>].", "evidence": {"55005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [55005]}
{"id": 1121, "claim": "This alteration may cause cytotoxicity at two levels—on one side, it may reduce PINK1 interaction with its normal mitochondrial substrates such as NdufA10<|other_cit|>, leading to mitochondrial dysfunction; on the other side, the cytosolic accumulation of PINK1 may cause gain of toxicity due to ectopic or increased phosphorylation of cytosolic substrates such as Parkin, ubiquintin, and others yet to identify<|multi_cit|>.", "evidence": {"55006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [55006]}
{"id": 1122, "claim": "Loss of the membrane potential leads to its accumulation on the mitochondrial outer membrane where it promotes recruitment and activation of Parkin by phosphorylating the Parkin UBL-domain as well as ubiquitin itself on a positionally equivalent serine <|multi_cit|>.", "evidence": {"55007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55007]}
{"id": 1123, "claim": "During stress, dissipation of mitochondrial membrane potential results in accumulation of PINK1 on the mitochondrial surface, which phosphorylates/activates the E3 ubiquitin ligase Parkin (<|cit|>).", "evidence": {"55008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55008]}
{"id": 1124, "claim": "Additionally, ubiquitin itself can be phosphorylated on serine 65 by PINK1 <|multi_cit|>.", "evidence": {"55009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55009]}
{"id": 1126, "claim": "However, S65-mutated or UBD-depleted Parkin is still recruited to mitochondria with a PINK1 kinase-dependent mechanism suggesting that a cytosolic substrate of PINK1 is involved in Parkin activation and recruitment (<|cit|>).", "evidence": {"55010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55010]}
{"id": 1127, "claim": "Dysfunction of Parkin/PINK1-dependent mitophagy contributes to the pathogenesis of PD.<|other_cit|> In mitophagy, PINK1 phosphorylates and activates Parkin<|other_cit|> and ubiquitin.<|multi_cit|> Phosphorylated ubiquitin further activates Parkin and recruits it to impaired mitochondria.<|other_cit|> Subsequently, Parkin ubiquitinates outer mitochondrial membrane (OMM) proteins and triggers their degradation by proteasome,<|other_cit|> leading to the clearance of mitochondria via autophagy.<|other_cit|> Mitogen-activated protein kinase (MAPK) signaling pathways have been identified to play a role in mitophagy.", "evidence": {"55011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55011]}
{"id": 1128, "claim": "In addition to phosphorylating Parkin, PINK1 also phosphorylates ubiquitin at Ser65, which enhances Parkin-induced ubiquitination of substrate proteins on the outer mitochondrial membrane [<|multi_cit|>].", "evidence": {"55012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [55012]}
{"id": 1129, "claim": "Lung cancer is the most commonly diagnosed cancer as well as the leading cause of cancer-related death globally and in China.<|other_cit|> The prevalence of diabetes has increased substantially in China, with the age-standardised rates from 2.4% in 1994<|other_cit|> to 9.7% in 2007–2008,<|other_cit|> which may parallel a marked lifestyle transition.<|cit|> which may parallel a marked lifestyle transition.4", "evidence": {"69000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69000]}
{"id": 1130, "claim": "Type 2 diabetes is a worldwide epidemic associated with obesity and a sedentary lifestyle.<|cit|> The estimated lifetime risk of developing diabetes for a person born in the United States in 2000 is 32.8% for males and 38.5% for females.<|other_cit|> Diabetes increases morbidity and mortality due to heart disease, stroke, blindness, kidney failure, foot problems, and periodontal disease,<|other_cit|> and has a significant impact on quality of life.<|other_cit|> In 2010 it accounted for US$376 billion or 12% of the global health expenditure.", "evidence": {"69001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69001]}
{"id": 1131, "claim": "Over past decades, a continuous increase in prevalence of type 2 diabetes, which parallels a marked lifestyle transition and a worldwide epidemic of obesity, has been observed in both developed and developing countries (<|cit|>).", "evidence": {"69002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69002]}
{"id": 1133, "claim": "Instances of diabetes have increased and it is expected that there will be over 472 million people with diabetes worldwide by the year 2030.[<|cit|>] India has more than 40 million diabetic people that represent nearly 20% of total diabetic population worldwide.", "evidence": {"69003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [69003]}
{"id": 1134, "claim": "Diabetes mellitus (DM) is a chronic disease and a growing epidemic that has become a global public health concern.<|cit|> Approximately 366 million people worldwide have DM, and this number is expected to increase to 552 million adults by 2030.<|other_cit|> According to the National Diabetes Information Clearing house and the World Health Organization, up to 90% of diabetics have type 2 diabetes mellitus (T2DM).", "evidence": {"69004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69004]}
{"id": 1135, "claim": "It has become a global alarming disease not sparing any country thus posing a serious threat to its economy [<|cit|>].", "evidence": {"69005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69005]}
{"id": 1137, "claim": "Factors responsible for DM include increased deskbound lifestyle, nutrition changeover and rapid urbanization leading to widespread, parallel to rise in obesity (<|cit|>).", "evidence": {"69006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69006]}
{"id": 1138, "claim": "Despite the apparent phenotypic and possible pathophysiologic differences in type 2 diabetes among races/ethnicities,<|multi_cit|> few insulin clinical trials have examined the effect of race/ethnicity with regard to both Asian and non-Asian populations on treatment outcomes within one study.", "evidence": {"69007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [69007]}
{"id": 1139, "claim": "Nutritional factors may play a role in the development of diabetes (<|multi_cit|>).", "evidence": {"69008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69008]}
{"id": 1140, "claim": "Type 2 diabetes is a growing problem worldwide.<|other_cit|> Alongside this increased prevalence comes an increased burden of disease from complications, which are potentially preventable.<|cit|> The importance of patient education and promoting self-care has long been recognised as a key component in chronic disease management and improving patient outcomes.<|other_cit|> One component of self-care is adherence to often complicated medication regimes.", "evidence": {"69009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69009]}
{"id": 1141, "claim": "Globally, there is evidence of a marked increase in the prevalence of type 2 diabetes mellitus (T2DM) in the developing world in the past two decades.[<|multi_cit|>] This trend has been supported by a systematic review and meta-analysis of diabetes studies in Nigeria which indicated that the age-adjusted prevalence rates of T2DM in Nigeria among persons aged 20–79 years increased from 2% (95% CI 1.9%–2.1%) in 1990 to 5.7% (95% CI 5.5–5.8%) in 2015, accounting for over 874,000 and 4.7 million cases, respectively.[<|other_cit|>]", "evidence": {"69010": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [69010]}
{"id": 1142, "claim": "In low- and middle-income countries – areas with a higher prevalence of the disease – the nutritional quality of food may be low, food with a very high glycemic index is consumed [<|cit|>], and very little physical activity is done, because of technological advances and the lack of time.", "evidence": {"69011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [69011]}
{"id": 1143, "claim": "The concomitant prevalence of obesity and T2DM in Korea is increasing, and the prevalence of T2DM in Asian countries including Korea is rapidly increasing because of lifestyle changes, such as a shift toward a Westernized diet and reduced physical activities, migration to urban areas, and genetic-environmental factors [<|multi_cit|>].", "evidence": {"69012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69012]}
{"id": 1144, "claim": "Excessive caloric intake and high-energy diet quality are major driving forces behind escalating diabetes and the appearance of epidemics worldwide [<|cit|>].", "evidence": {"69013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69013]}
{"id": 1145, "claim": "Although elements such as physical inactivity and hypercaloric diets are regarded as largely ubiquitous westernized lifestyles propagated by mass globalization [<|cit|>], drinking patterns tend to be dictated by population-specific geographic, sociodemographic, and cultural factors [<|other_cit|>].", "evidence": {"69014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [69014]}
{"id": 1146, "claim": "However, obesity appears to exert its effect primarily on insulin resistance rather than on β-cell function, and only a minority of obese individuals will develop T2D [<|other_cit|>], while many non-obese individuals will do so [<|cit|>].", "evidence": {"69015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69015]}
{"id": 1148, "claim": "These early life risk factors may also be enhanced or modified by later life environmental influences [<|cit|>].", "evidence": {"69016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69016]}
{"id": 1149, "claim": "In the context of the worldwide epidemic of obesity and diabetes [<|cit|>], the increase in sugar consumption in our contemporary western diets [<|other_cit|>], and the increase in sedentary lifestyles [<|other_cit|>], we conducted studies in mice to evaluate the effects of 24 h access to fructose as well as the influence of the timing of consumption (fructose access provided only in the light or dark period).", "evidence": {"69017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69017]}
{"id": 1150, "claim": "Asia, being the epicenter for the epidemics of diabetes, is responsible for more than 60% of the global burden of diabetes mellitus [<|multi_cit|>].", "evidence": {"69018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69018]}
{"id": 1151, "claim": "The prevalence of type 2 diabetes (T2D) has increased dramatically in China during the past few decades (<|cit|>), and currently >92 million Chinese adults are estimated to have T2D (<|other_cit|>).", "evidence": {"69019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69019]}
{"id": 1153, "claim": "Additionally, differences between Asians and Caucasians in, for example, genetic susceptibility to diabetes and underlying pathophysiology, body mass index, diet, insulin dose requirements, and postprandial hyperglycemia, have been suggested/reported [<|multi_cit|>].", "evidence": {"69020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69020]}
{"id": 1154, "claim": "Both vegetable and animal ghee are used for cooking in Iran and consists of saturated fats [<|cit|>].", "evidence": {"69021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [69021]}
{"id": 1155, "claim": "Dysregulated activity of the founding father of mammalian caspases, interleukin (IL)-1β-converting enzyme and later renamed caspase-1, has been linked to inflammatory bowel diseases (Villani et al., <|multi_cit|>; Dupaul-Chicoine et al., <|other_cit|>; Zaki et al., <|other_cit|>), gouty arthritis (Martinon et al., <|other_cit|>), type II diabetes (Larsen et al., <|other_cit|>), and less common autoinflammatory disorders that are collectively referred to as cryopyrinopathies (Lamkanfi and Kanneganti, <|other_cit|>).", "evidence": {"88000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88000]}
{"id": 1156, "claim": "Using the same DSS model, mice deficient in the adapter protein inflammasome component ASC experienced increased disease, morbidity, and precancerous lesions compared to wild-type mice exposed to DSS (<|cit|>).", "evidence": {"88001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88001]}
{"id": 1157, "claim": "In addition, upon tissue damage, Nlrp3 inflammasome-dependent production of IL-18 was shown to be required for tissue repair and protection from colitis and colitis-associated colorectal cancer (<|multi_cit|>; Dupaul-Chicoine et al., <|other_cit|>; Saleh and Trinchieri, <|other_cit|>; Zaki et al., <|other_cit|>).", "evidence": {"88002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88002]}
{"id": 1158, "claim": "A protective role for IL-1β is reported in models of colon cancer associated to colitis, possibly due to the concomitant production of IL-18, relevant for intestine healing (<|cit|>), or in a model of epithelial skin carcinogenesis, where the inflammasome adapter ASC may play a protective role in keratinocytes.", "evidence": {"88003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88003]}
{"id": 1160, "claim": "Utilizing azoxymethane (AOM)/dextran sodium sulfate (DSS) model, it was shown that NLRC4 knockout mice developed increased tumor volume (<|cit|>).", "evidence": {"88004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88004]}
{"id": 1161, "claim": "Consistently, Nlrp3−/− mice or mice deficient in inflammasome components were found to be significantly more susceptible to experimental models of colitis compared to wild-type mice (<|multi_cit|>).", "evidence": {"88005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88005]}
{"id": 1162, "claim": "While in colitis-associated cancer, Allen et al. demonstrated that NLRP3 inflammasome in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, functioned as a negative tumorigenesis regulator [<|cit|>].", "evidence": {"88006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88006]}
{"id": 1164, "claim": "Several studies showed that mice deficient for inflammasome components including NLRP3, ASC, and caspase-1 were highly susceptible to acute colitis induced by DSS, indicating the protective role of inflammasome in acute colitis (<|multi_cit|>).", "evidence": {"88007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88007]}
{"id": 1166, "claim": "While earlier studies indicated that IL-1β and IL-18, together with other components of the inflammasome, exacerbate colitis and promote colitis-associated cancer (<|other_cit|>), more recent evidence suggests that these molecules play a protective role by impeding colitis and progression to cancer (<|multi_cit|>).", "evidence": {"88008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88008]}
{"id": 1167, "claim": "These studies, as well as those of Zaki et al. (<|other_cit|>) and Allen et al. (<|cit|>) (the latter discussed below) insofar as they explored the effect of caspase-1 deficiency as a surrogate for a NLRP3 defect are challenged by the recent discovery that the caspase-1-deficient mice used in these studies were generated using ES cells from the 129 mouse strain that bears a natural mutation in the caspase-11 gene that is not easily separated from a mutated caspase-1 gene by recombination because these gene are too close together; thus the caspase-1-deficient mice were, in reality, carrying a “passenger mutation” and were deficient in both Caspase-1 and Caspase-11 (<|other_cit|>).", "evidence": {"88009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88009]}
{"id": 1168, "claim": "A clinical score based on body condition, stool consistency, rectal bleeding, and the presence of blood in the stool (<|cit|>) was significantly higher in Nlrx1−/− animals compared to WT controls (<|other_cit|>).", "evidence": {"88010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88010]}
{"id": 1170, "claim": "In one of these studies, Allen et al. showed that mice lacking ASC and caspase-1 manifested increased DSS-colitis severity as well as AOM tumorigenesis (<|cit|>); this was also seen in mice lacking NLRP3 albeit to a lesser degree.", "evidence": {"88011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88011]}
{"id": 1171, "claim": "A study by <|cit|> showed that NLRP3-deficient mice were more sensitive to colorectal tumorigenesis.", "evidence": {"88012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88012]}
{"id": 1173, "claim": "However, lack of consensus in the susceptibility of Nlrc4−/− mice to DSS as well as AOM–DSS treatment makes it difficult to gage the protective effect of NLRC4 in these models (<|multi_cit|>).", "evidence": {"88013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88013]}
{"id": 1174, "claim": "Initially, NLRP3 was reported to have a key role in protecting intestinal homeostasis, as NLRP3-deficient mice were shown to have an altered microbiota and displayed increased susceptibility to DSS-colitis (<|other_cit|>) and tumorigenesis (<|cit|>).", "evidence": {"88014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88014]}
{"id": 1175, "claim": "The same lack of inflammatory regulation was found to render Nlrp3−/− and Casp1−/− mice more susceptible to AOM–DSS carcinogenesis (<|multi_cit|>).", "evidence": {"88015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88015]}
{"id": 1177, "claim": "Further studies are required to determine if the difference is related to a regulatory function of the NLRP3 inflammasome in controlling cancer development caused by chronic inflammation or if it is possibly due to a decrease in apoptosis via reduced caspase-1 activity (<|cit|>).", "evidence": {"88016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88016]}
{"id": 1179, "claim": "Nevertheless, the above DSS studies using gut microbiota normalized Nlrp6−/−, caspase-1−/− or IL-18IEC-KO mice (by embryo transfer or by littermate-controlled experiments) are all in contrast with multiple prior studies suggesting that mice lacking inflammasomes or IL-18 develop more severe DSS colitis when compared to non-littermate controls.<|multi_cit|> Thus, these DSS colitis studies highlight the importance of eliminating non-genetic impacts on the gut microbiota - such as by using littermate controls – when studying host genetic effects on physiological processes that can be affected by the microbiota.<|other_cit|>", "evidence": {"88017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88017]}
{"id": 1180, "claim": "In a study by Allen et al., already discussed above, it was shown that deletion of the NLRC4 inflammasome had no effect on the severity of DSS-colitis, at least in mice harboring commensal organisms as in studies of the NLRP3 inflammasome (<|cit|>).", "evidence": {"88018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88018]}
{"id": 1183, "claim": "However, in another study, yet with the same model system, no difference in tumor growth was found between NLRC4-deficient and wild-type mice (<|multi_cit|>).", "evidence": {"88019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88019]}
{"id": 1184, "claim": "Although IL-1β has a protumourigenic effect [<|other_cit|> in this study; and (Apte & Voronov, <|other_cit|>)], inflammasome and IL-1β-mediated antitumour activity have been reported recently by two other studies in gene-deficient mice, which described the effect of the NLRP3 and IL-1β produced by hematopoietic cells against cancer (<|multi_cit|>; Ghiringhelli et al, <|other_cit|>).", "evidence": {"88020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88020]}
{"id": 1185, "claim": "Allen et al. showed that NLRP3-deficient mice are more susceptible to develop colitis (<|cit|>).", "evidence": {"88021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [88021]}
{"id": 1186, "claim": "In contrast, others studies have demonstrated an anti-tumor effect of IL-18 (<|multi_cit|>) in part through the generation of “helper” NK cells producing CCL3 and CCL4, which results to the local recruitment of DCs and effector CD8 T cells (<|other_cit|>).", "evidence": {"88022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88022]}
{"id": 1187, "claim": "However there are findings that do not support the protective role of inflammasome activation in IECs or immune cells [<|cit|>] and induce mucosal damage.", "evidence": {"88023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88023]}
{"id": 1188, "claim": "Interestingly, multiple earlier experimental and simulation studies have collectively demonstrated that the SARS-CoV-2 RBD (RBD ) has a higher ACE2-binding affinity than the SARS-CoV RBD (RBD ) [<|multi_cit|>,29].", "evidence": {"17000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17000]}
{"id": 1189, "claim": "RBD mutant expression and ACE2 binding scores were calculated according to the equations in [<|cit|>].", "evidence": {"17001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17001]}
{"id": 1190, "claim": "Deep mutational scanning of SARS-CoV-2 RBD revealed protein stability patterns and constraints on folding and ACE2 binding [<|cit|>].", "evidence": {"17002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17002]}
{"id": 1192, "claim": "The highly immunogenic receptor-binding domain (RBD) of this protein is the main target for the neutralizing activity of antibodies and serves as a basis for the development of vaccines [<|multi_cit|>,18].", "evidence": {"17003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17003]}
{"id": 1194, "claim": "In particular, mutations of several important interface positions can enhance ACE2 binding affinity (N501F, N501T, and Q498Y) [<|cit|>] suggesting dynamic and energetic plasticity of the SARS-CoV-2 interaction network in which mutations that attenuate the polar nature of these residues may enhance binding affinity.", "evidence": {"17004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17004]}
{"id": 1195, "claim": "These results are consistent with deep mutagenesis studies and suggest that N501Y is optimally positioned for interactions with ACE2 [<|multi_cit|>].", "evidence": {"17005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17005]}
{"id": 1196, "claim": "Many sites are highly tolerant of mutations with respect to ACE2 binding as well as their expression<|cit|>.", "evidence": {"17006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17006]}
{"id": 1198, "claim": "The 16-nucleotide barcode sequences identifying each RBD variant were amplified by polymerase chain reaction (PCR) and prepared for Illumina sequencing as described in [<|cit|>].", "evidence": {"17007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17007]}
{"id": 1199, "claim": "The affinity scores from Starr et al<|cit|> were developed for hACE2 (not mACE2), so we expected a greater correlation than what has been observed in situ in human populations, but perhaps it is still early in the pandemic to assess this definitively.", "evidence": {"17008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17008]}
{"id": 1200, "claim": "variants, enhances transmissibility (<|multi_cit|>; Tegally et al., <|other_cit|>), and the E484K and K417N/K417T, found in B.1.351 or P.1", "evidence": {"17009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17009]}
{"id": 1201, "claim": "Several experimental studies made effort to investigate the mutational escape from neutralizing and convalescent antibodies (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [17010]}
{"id": 1202, "claim": "This mutation is located in the tip of the receptor binding domain and can increase the binding affinity for ACE2 (<|multi_cit|>), thus contributing to an increase in SARS-CoV-2 infectivity as shown in a murine model (<|other_cit|>).", "evidence": {"17011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17011]}
{"id": 1203, "claim": "K417N, E484K, and N501Y are located in the RBD.<|other_cit|> These changes confer enhanced affinity for ACE2<|cit|> and help to escape from neutralization and reduce neutralization sensitivity to convalescent plasma.<|other_cit|> Gamma variant, also known as lineage P.1, harbors ten mutations in the S protein.", "evidence": {"17012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17012]}
{"id": 1204, "claim": "It is unsurprising that the latter variants requiring 2 or more changes were rarely observed in situ regardless of their high in vitro affinity scores from Starr et al.<|cit|>)—compared with F501, V501, and W501, which require 2, 2, and 3 nucleotide changes, respectively.", "evidence": {"17013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17013]}
{"id": 1205, "claim": "However, although many spike variants have been reported so far, there seems to be a limitation in terms of the ‘freedom’ possibilities to which and how many non-synonymous mutations are emerging in the S gene and particularly in the RBD coding region (<|cit|>).", "evidence": {"17014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17014]}
{"id": 1206, "claim": "The mechanism through which S371 mutations mediate this perturbation of RBD dynamics might include modulation of 1) RBD -RBD  interface interactions<|other_cit|>, 2) the N343 glycan<|other_cit|>, or 3) folding/stability<|cit|>, or 3) folding/stability14 of the RBD which only produces an escape effect in the trimeric context.", "evidence": {"17015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17015]}
{"id": 1207, "claim": "A second round of PCR was performed using the same forward primer (5’-tctgcaggctagtggtggag-3’) and the reverse primer 5’-ccagtgaattgtaatacgactcactatagggcgaattggagctcgcggccgcnnnnnnnnnnnnnnnnagatcggaagagcgtcgtgtag-3’ to append the Nx16 barcodes and add the overlapping sequences to clone into the recipient vector backbone as described in [<|multi_cit|>].", "evidence": {"17016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17016]}
{"id": 1209, "claim": "Changes at this position directly affect receptor binding and can affect the binding of multiple classes of neutralizing antibodies [<|multi_cit|>].", "evidence": {"17017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17017]}
{"id": 1210, "claim": "Furthermore, we compared the predicted stability effects of target SARS-CoV-2 S RBD mutations with the current deep mutational scanning approach (<|cit|>).", "evidence": {"17018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17018]}
{"id": 1211, "claim": "The Bloom research group used deep mutational scanning for the quantitative assessment of the sequence dependence of S RBD on ACE2 binding affinity.<|cit|> This same platform was also used to map epitopes and escape mutants for several monoclonal antibodies,<|other_cit|> predicting in advance the N501Y mutation observed in several VoC.", "evidence": {"17019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17019]}
{"id": 1212, "claim": "Changes at this position directly affect receptor binding [<|multi_cit|>].", "evidence": {"17020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17020]}
{"id": 1213, "claim": "A previous study performed deep mutation scanning on SARS-CoV-2 identified N501T as a binding affinity enhancer (<|cit|>).", "evidence": {"17021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17021]}
{"id": 1214, "claim": "Unlike the allosteric disruption of RBD structure observed in the case of the E406W mutation<|other_cit|> that also lead to broad antibody escape, the S371 mutations did not impact ACE-2 binding and only slightly reduced monomeric RBD expression when assayed via yeast display<|cit|> that also lead to broad antibody escape, the S371 mutations did not impact ACE-2 binding and only slightly reduced monomeric RBD expression when assayed via yeast display14.", "evidence": {"17022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17022]}
{"id": 1215, "claim": "The barcoded variant gene fragments were cloned in bulk into the NotI/SacI-digested unmutated wildtype plasmid, as described in [<|multi_cit|>].", "evidence": {"17023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17023]}
{"id": 1216, "claim": "The N501Y mutation will also lead to favorable π-stacking with the highly conserved Y41 residue in mammalian ACE2, as suggested by Starr et al<|cit|> with deep scanning of RBD mutations and hACE2 affinity assays.", "evidence": {"17024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17024]}
{"id": 1217, "claim": "In the case of the N439K mutation, studies have shown enhanced binding to the ACE2 receptor [<|multi_cit|>].", "evidence": {"17025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17025]}
{"id": 1218, "claim": "As described by Starr et al. [<|cit|>], PacBio sequencing was used to generate long sequence reads spanning the Nx16 barcode and RBD coding sequence.", "evidence": {"17026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17026]}
{"id": 1219, "claim": "<|cit|> systematically changed every amino acid in the RBD of the SARS-CoV-2 spike protein and determined the effects of the substitutions on RBD expression, folding, and ACE2 binding.", "evidence": {"17027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17027]}
{"id": 1221, "claim": "These mutations of interest and concern can also serve to facilitate and focus research using infectious clones<|other_cit|>, pseudoviruses<|other_cit|>, and deep mutational scanning<|multi_cit|> to determine the functional characteristics and clinical therapeutic consequences.", "evidence": {"17028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17028]}
{"id": 1222, "claim": "In general, mutation effects on RBD binding and expression are correlated with residues that deviated from this trend clustering at the ACE2 interface<|cit|>, two patterns of binding free energies were observed and separated in (i) high ΔG  form (≥ 10 kcal mol−1), and (ii) low ΔG  form (< 10 kcal mol−1).", "evidence": {"17029": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17029]}
{"id": 1223, "claim": "The effects of each mutation on RBD expression on the surface of yeast and on ACE2 binding were measured essentially as described previously for the Wuhan-Hu-1 RBD [<|cit|>].", "evidence": {"17030": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17030]}
{"id": 1224, "claim": "It also looks likely that there are factors other than enhancement of ACE2 binding that determine susceptibility—as seen from Starr et al<|cit|> and <|other_cit|>, from our own inconclusive attempts at correlating free energy binding affinities using in silico methods (not shown), and from a more detailed in silico model by Piplani et al<|other_cit|> that counter-intuitively predicts lower binding free energy for dogs compared with more susceptible animals such as monkeys, hamsters, ferrets, cats, and tigers.<|other_cit|>", "evidence": {"17031": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17031]}
{"id": 1226, "claim": "The newly generated Delta libraries (like the Beta RBD mutant libraries described in [<|other_cit|>]) were ordered from Twist Bioscience to have one amino-acid mutation per variant, whereas the Wuhan-Hu-1 libraries were generated in-house with a PCR-based approach, with an average of 2.7 mutations per variant [<|cit|>].", "evidence": {"17032": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17032]}
{"id": 1229, "claim": "Consistent with deep mutagenesis experiments [<|multi_cit|>], the strongest stability and binding energy hotspots correspond to the Y453, F456, Y489 and Y505 residues (<|other_cit|>A,B).", "evidence": {"17033": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17033]}
{"id": 1230, "claim": "Importantly, because the Delta libraries were generated using a different method than the Wuhan-Hu-1 RBD libraries, which is fully described in [<|cit|>], the analysis of deep sequencing data to compute each mutation’s escape fraction is also different.", "evidence": {"17034": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17034]}
{"id": 1231, "claim": "Specifically, we removed variants that had ACE2 binding scores < −1.86 or expression scores < −0.75, after calculating mutation-level deep mutational scanning scores for this library as in [<|cit|>,53].", "evidence": {"17035": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17035]}
{"id": 1232, "claim": "Although the ranges of the ΔG  values of the two complexes are overlapping when taking the SDs into account, the p-value of 2.1 × 10−19 by the one-sided t-test indicates that the BFE of RBD  -ACE2 is statistically significantly lower than that of RBD  -ACE2, which is consistent with previous experimental observations demonstrating that the RBD  has a higher ACE2-binding affinity than RBD  [<|multi_cit|>,29].", "evidence": {"17036": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17036]}
{"id": 1233, "claim": "The effects of each mutation on RBD expression and ACE2 binding were determined as described in [<|cit|>].", "evidence": {"17037": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [17037]}
{"id": 1234, "claim": "Diabetic macular edema (DME), a common cause of vision loss, is estimated to affect 21 million individuals worldwide [<|cit|>].", "evidence": {"85000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85000]}
{"id": 1235, "claim": "Globally, it has been estimated that approximately 30% of diabetes have DR, and one-third of DR is sight-threatening diabetic retinopathy (STDR) [<|cit|>].", "evidence": {"85001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85001]}
{"id": 1236, "claim": "Worldwide, 17 million people are affected with proliferative diabetic retinopathy [<|cit|>].", "evidence": {"85002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85002]}
{"id": 1237, "claim": "However, DMO can be far more common in certain populations, with age-standardised prevalence approaching 15% in patients with type 1 diabetes and 20% in those who have had diabetes for ≥20 years [<|cit|>].", "evidence": {"85003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85003]}
{"id": 1240, "claim": "The global pooled prevalence estimates derived from population-based studies for age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) were 8.69% of people aged 30–97 years [<|other_cit|>], 7.48% of diabetic patients aged 20–79 years [<|cit|>], and 0.52% of people worldwide [<|other_cit|>], respectively.", "evidence": {"85004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85004]}
{"id": 1241, "claim": "As one of the most prominent pathological microvascular complications in diabetes, the prevalence of DR in diabetes patients has been estimated at 34.6% and that of proliferative diabetic retinopathy (PDR) has been estimated at 7.0% [<|cit|>].", "evidence": {"85005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85005]}
{"id": 1242, "claim": "The results of a recent meta-analysis of 22,896 individuals with diabetes (META-EYE Study) found that the prevalence of DME was 6.81% which was comparable to that of proliferative diabetic retinopathy (6.96%) [<|cit|>].", "evidence": {"85006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85006]}
{"id": 1243, "claim": "In a pooled analysis performed by Yau et al. (2012) a total 93 million people are suffering from different types of DR [<|cit|>].", "evidence": {"85007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85007]}
{"id": 1244, "claim": "Longer duration of disease, poorer glycemic control, and blood pressure control have all been shown to be associated with diabetic retinopathy.<|cit|> The aim of this study was to investigate whether social deprivation is as an independent risk factor for the development of R3 diabetic retinopathy.", "evidence": {"85008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85008]}
{"id": 1245, "claim": "Population-based studies have highlighted the global prevalence of these diseases, with the pooled prevalence of AMD and late AMD at 8.69 and 0.37%, respectively [<|other_cit|>], DME prevalence at 7% [<|multi_cit|>], and age- and sex-standardised RVO prevalence at 0.5%.", "evidence": {"85009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85009]}
{"id": 1246, "claim": "Age-standardised prevalence of ERMs in each study was calculated by projecting its crude prevalence rates to the WHO world standard age structure.<|other_cit|> This method has been adopted to estimate the regional and global prevalence and burden of several major eye diseases, such as AMD,<|other_cit|> diabetic retinopathy<|cit|> and retinal vein occlusion.<|other_cit|> The I2 statistic was used to estimate heterogeneity between studies with a value greater than 50% as significantly heterogeneous.", "evidence": {"85010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85010]}
{"id": 1247, "claim": "Diabetic Macular Oedema (DMO) is one of the leading causes of blindness in the working-age population [<|multi_cit|>] In the UK, 17.7 % of severe sight impairment certifications in adults aged 16–64 has been attributed to diabetes [<|other_cit|>].", "evidence": {"85011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85011]}
{"id": 1248, "claim": "It was notable that none of the records reviewed in this feasibility study recorded ethnicity, a common risk factor for many eye conditions including glaucoma<|other_cit|> and diabetic retinopathy.<|cit|> and diabetic retinopathy.30", "evidence": {"85012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85012]}
{"id": 1249, "claim": "Until recently, studies on the prevalence of diabetic retinopathy have used photographic assessment (‘CSME’) which may underestimate the prevalence by threefold or more.<|other_cit|> A 2014 cross-sectional analysis of 1038 participants aged 40 or older with diabetes in the US National Health and Nutrition Examination Survey (NHANES) found weighted prevalence of CSME was 3.8% based on NHANES digital grading protocol of fundus photography.<|other_cit|> This contrasts with a UK study of electronic medical records from 76 127 diabetic patients managed by the UK hospital eye service which found CSME present in 15.8%–18.1% of eyes, involving the central macula in 8.7%–10.0% of eyes.<|other_cit|> This finding is more in line with those found in the Veteran Affairs Diabetes Trial that observed CSME prevalence of 10.0% based on 7-field stereo fundus photographs in 1268 type 2 diabetic patients.<|other_cit|> Furthermore, a 2012 meta-analysis of 35 population-based studies in the USA, Australia, Europe and Asia from 1980 to 2008 found prevalence of CSME of 7.48% among individuals with both type 1 and type 2 diabetes.<|cit|> Furthermore, a 2012 meta-analysis of 35 population-based studies in the USA, Australia, Europe and Asia from 1980 to 2008 found prevalence of CSME of 7.48% among individuals with both type 1 and type 2 diabetes.27", "evidence": {"85013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85013]}
{"id": 1250, "claim": "A study in Liverpool reported prevalences of any DR and PDR to be 46% and 4% in type 1 diabetes, and 25% and 0.5% in type 2 diabetes, respectively, although the prevalence will vary with mean duration of diabetes, with higher proportions of those with long duration having DR.<|other_cit|> However, a more recent study by Yau et al found that prevalence for PDR was much higher at 7%.<|cit|> However, a more recent study by Yau et al found that prevalence for PDR was much higher at 7%.4", "evidence": {"85014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85014]}
{"id": 1251, "claim": "This estimate is higher than a previous hospital-based study based on patients with type 2 diabetes (14.8 %) [<|other_cit|>] and primary care data from the UK (19.6 %) [<|other_cit|>] but lower than global prevalence estimates (34.6 %) [<|cit|>].", "evidence": {"85015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85015]}
{"id": 1253, "claim": "Depending on the country, the prevalence rate of direct ophthalmological screening ranges from 40.3% in the study by Kempen et al;<|other_cit|> 34.6% in the meta-analysis by Yau et al;<|cit|> 33.2% in the study by Wong et al;<|other_cit|> to 27.9% in the work from Ruta et al.<|other_cit|> DR prevalence in Spain also differs according to the authors.", "evidence": {"85016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85016]}
{"id": 1255, "claim": "For example, diabetic retinopathy, which is the leading cause of blindness in adults world-wide [<|cit|>], can be treated effectively via laser surgery if diagnosed at an early stage.", "evidence": {"85017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85017]}
{"id": 1257, "claim": "Considering the risk factors for developing DR, our results corroborate: male gender, long duration of DM, arterial hypertension and bad metabolic glycaemia control evaluated by HbA1c levels, and insulin treatment.<|cit|> It is difficult to compare the present study with other studies because the methods and the follow-up times vary.<|other_cit|> Screening by non-mydriatic fundus camera is the same as that used by the National Health Service in the UK.", "evidence": {"85018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85018]}
{"id": 1258, "claim": "Globally, 35.4% of people with diabetes mellitus were estimated to have diabetic retinopathy in 2012 and 11.7% had sight-threatening disease.<|cit|> In 2017, 73 of the 451 million people with diabetes worldwide (16.2%) lived in India.<|other_cit|> Studies carried out in the country over the last decade reported that diabetic retinopathy prevalence were approximately 9.6% in rural areas<|other_cit|> and 18.0% (255/1414) in urban areas;<|other_cit|> the rates of sight-threatening retinopathy in the two areas were 3.8% (45/1190) and 6.6% (39/592), respectively.<|other_cit|> Risk factors for diabetic retinopathy include longer duration of diabetes, poor diabetes control and hypertension.", "evidence": {"85019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85019]}
{"id": 1259, "claim": "In this framework, it is well acknowledged that DR appear more frequently in T1DM than in T2DM patients and that DR prevalence end points positively correlate with the length of time afflicted by DM, as well as by the glycosilated hemoglobin (HbA1c), and hypertension blood pressure (HBP) levels [<|multi_cit|>].", "evidence": {"85020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85020]}
{"id": 1260, "claim": "There are limitations to the use of HbA  as a diagnostic measure, particularly early in T2D disease progression, as some studies have found evidence of diabetic complications such as proliferative retinopathy at HbA  levels <6.5% [<|multi_cit|>].", "evidence": {"85021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85021]}
{"id": 1261, "claim": "The major risk factors for DR are long duration of diabetes, poor glycaemic control and hypertension [<|cit|>], and there is evidence from clinical trials that early treatment of PDR and DME can preserve visual acuity [<|other_cit|>].", "evidence": {"85022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85022]}
{"id": 1262, "claim": "DMO is the most common cause of moderate visual loss from diabetic retinopathy [<|other_cit|>], with an estimated age-standardised prevalence of 6.81% amongst patients with diabetes [<|cit|>].", "evidence": {"85023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [85023]}
{"id": 1263, "claim": "Importantly, these studies should also address differential individual patient sensitivity and de novo or acquired resistance to cisplatin using assays that reflect relative genetic instability (low or high copy number alteration, expression of other DNA repair genes, RAD51 nuclear foci as surrogate markers for HR and BRCA1/2-genetic reversion; <|multi_cit|>).", "evidence": {"54000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54000]}
{"id": 1265, "claim": "Other reported mechanisms of function recovery include post-treatment restorative acquired mutations in previously dysfunctional repair genes (<|multi_cit|>, 40).", "evidence": {"54001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54001]}
{"id": 1266, "claim": "A striking example of this antagonism is provided by cells that have impaired BRCA1 activity: inhibition of 53BP1 in this background is able to restore viability and suppress genomic instability associated with defective BRCA1, by allowing resection of DSBs and repair via the HR pathway to occur (<|multi_cit|>).", "evidence": {"54002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54002]}
{"id": 1267, "claim": "Importantly, the interplay between BRCA1 and 53BP1 determines effective DSB repair by one of the two major DSB repair pathways, with BRCA1 promoting the error-free homologous recombination (HR) process while 53BP1 committing to non-homologous end joining (NHEJ; <|multi_cit|>).", "evidence": {"54003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54003]}
{"id": 1268, "claim": "Depletion of 53BP1 abrogates the ATM-dependent checkpoint response and G2 cell-cycle arrest triggered by the accumulation of DNA breaks in BRCA1-deleted cells.<|cit|> Studies have shown that loss of 53BP1 leads to resistance to cis-platinum and PARP inhibitors in BRCA1-difficient cells.<|other_cit|> Importantly, when both BRCA1 and 53BP1 are lost, sensitivity to DNA damage is reduced and homology-mediated repair is restored.<|other_cit|> The MRE11, RAD50 and NBS1 genes encode proteins of the MRE11-RAD50-NBS1 (MRN) complex (<|other_cit|> and <|other_cit|>) which is critical for proper maintenance of genomic integrity and tumor suppression.<|other_cit|> Interestingly, mutations in two SNP-containing genes ATM and CHEK2 whose products are functionally intimately linked with MRN complex (<|other_cit|> and <|other_cit|>) are associated with subtypes of breast cancer.", "evidence": {"54004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54004]}
{"id": 1269, "claim": "Notably, the latter has been shown to interfere with HR in the absence of BRCA1, thereby accounting for genomic instability observed in BRCA1 mutant tumors (<|multi_cit|>).", "evidence": {"54005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54005]}
{"id": 1270, "claim": "It was demonstrated that TP53BP1 is downregulated in most cases of triple-negative breast cancer [<|cit|>].", "evidence": {"54006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54006]}
{"id": 1272, "claim": "In vitro and in vivo experiments showed that mutations causing loss of 53BP1 are able to restore the HR in BRCA1/2 mutated cells, at least partially [<|multi_cit|>]: this “DNA damage repair rewiring” ultimately leads to reduced sensitivity to PARPi [<|other_cit|>].", "evidence": {"54007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54007]}
{"id": 1273, "claim": "Previously, we found that 53BP1 loss could rescue BRCA1 deficiency and was associated with triple-negative and BRCA-mutated breast cancers.<|cit|> Low 53BP1 expression was reported to be associated with increased local recurrence in breast cancer patients treated with breast-conserving surgery and radiotherapy.<|other_cit|> In 2012, we formally presented that 53BP1 functions as a tumor suppressor gene in breast cancer.<|other_cit|> 53BP1 could significantly inhibit cell proliferation and the invasiveness and metastasis in breast cancer both in vitro and in vivo by the inhibition of nuclear factor-κB through miR-146a.<|other_cit|> However, the mechanism of metastasis in breast cancer is complex.", "evidence": {"54008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54008]}
{"id": 1274, "claim": "These studies showed that 53BP1 inhibits HR in BRCA1-deficient cells via a blocking resection of DNA breaks [<|multi_cit|>].", "evidence": {"54009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54009]}
{"id": 1275, "claim": "In fact, even in such HR-defective backgrounds, damaged cells exhibit normal checkpoint responses [<|cit|>], allowing them to induce apoptosis when they sense DNA damage.", "evidence": {"54010": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54010]}
{"id": 1277, "claim": "Therefore, ES cells containing Brca1 deletion are not viable [<|multi_cit|>] (Figure <|other_cit|>).", "evidence": {"54011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54011]}
{"id": 1278, "claim": "In human cells, Rev7 appears to act in concert with another inhibitor of resection, 53BP1(<|other_cit|>), loss of which is also sufficient to drive PARPi resistance (<|multi_cit|>).", "evidence": {"54012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54012]}
{"id": 1280, "claim": "Loss of the NHEJ factor TP53BP1 has been shown to cause resistance to PARP inhibitors in several models (<|multi_cit|>).", "evidence": {"54013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54013]}
{"id": 1283, "claim": "While cells with defect in BRCA1 alone were susceptible to PARPi, an additional loss of 53BP1 allowed a partial ATM-dependent HR repair (Aly and Ganesan, <|other_cit|>), making these cells resistant to PARPi (Cao et al., <|multi_cit|>; Bunting et al., <|other_cit|>; Brandsma and Gent, <|other_cit|>; Oplustilova et al., <|other_cit|>).", "evidence": {"54014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54014]}
{"id": 1285, "claim": "Two groups independently described the deletion of a previously identified BRCA2 mutation in PARP inhibitor-resistant cancer cells that led to restoration of the open reading frame, and hence HR proficiency.<|other_cit|> Furthermore, in BRCA1-deleted cells, loss of expression of the HR protein 53BP1 appears to partially restore HR competency and abrogate the ATM-dependent checkpoint response, limiting the resultant cell cycle arrest triggered by DSB accumulation after DNA damaging agent exposure.<|cit|> Furthermore, in BRCA1-deleted cells, loss of expression of the HR protein 53BP1 appears to partially restore HR competency and abrogate the ATM-dependent checkpoint response, limiting the resultant cell cycle arrest triggered by DSB accumulation after DNA damaging agent exposure.118", "evidence": {"54015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54015]}
{"id": 1286, "claim": "In HR-deficient cells, DSBs can only be repaired by illegitimate (toxic) NHEJ—joining one-ended DSBs from different locations—leading to cell death [<|multi_cit|>].", "evidence": {"54016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54016]}
{"id": 1287, "claim": "If both of these deficits occur in concert, then partial ATM-dependent HR repair proceeds in BRCA1- but not BRCA2-deficient cells [<|multi_cit|>].", "evidence": {"54017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54017]}
{"id": 1288, "claim": "Interestingly loss of 53BP1 on top of BRCA1 deficiency restores a resistant phenotype in these radiosensitive cells (“synthetic viability”) (<|multi_cit|>; Bunting et al., <|other_cit|>).", "evidence": {"54018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54018]}
{"id": 1290, "claim": "HRR and A-NHEJ are actively suppressed in the initial phase of DSB repair by ATM (<|other_cit|>), which inhibits the resection of the DNA ends at the DSB by phosphorylating KU70 and KU86 (<|other_cit|>), DNA-PKcs (<|other_cit|>), 53BP1 (<|multi_cit|>), the MRN complex (<|other_cit|>), and histone H2AX (<|other_cit|>).", "evidence": {"54019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54019]}
{"id": 1292, "claim": "One week later, cells were seeded in triplicate at 1000 cells per well in 96-well plates for drug sensitivity testing as described.<|cit|> Mouse Brca1 was deleted by incubating overnight with 0.5 μM 4-OHT (Sigma, St. Louis, MO, USA).", "evidence": {"54020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [54020]}
{"id": 1295, "claim": "Thus, it has been proposed that the elevated level of FGF21 (a condition termed “hyper-FGF21-nemia”) in obese subjects is due to a decrease in the number of responsive FGF21 receptors on target cells, a phenomenon known as FGF21 resistance [<|cit|>].", "evidence": {"100000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [100000]}
{"id": 1298, "claim": "Shen Y et al. also showed that FGF21 concentrations increased in coronary heart disease [17] and “FGF21 resistance”, a phenomenon reminiscent of hyperinsulinemia and insulin resistance might be one of the reasons for the increase of elevated FGF21 [<|cit|>].", "evidence": {"100001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100001]}
{"id": 1299, "claim": "However, as FGF21 is already increased in animal models of obesity and type 2 diabetes [<|cit|>] it is unknown how treatment with metformin will affect hepatic FGF21 expression and FGF21 plasma level and a careful evaluation of the time course is needed.", "evidence": {"100002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100002]}
{"id": 1300, "claim": "The elevated levels of circulating FGF21 in diet-induced obesity, ob/ob, and db/db mice may be associated with increased liver and adipose FGF21 mRNA expression <|multi_cit|>-43.", "evidence": {"100003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100003]}
{"id": 1301, "claim": "FGF21 functions as an endocrine hormone with antidiabetic and antiobesity effects and is produced in peripheral tissues (e.g., the liver, white and brown adipose tissues, skeletal muscle, and the pancreas) (<|cit|>).", "evidence": {"100004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [100004]}
{"id": 1302, "claim": "This scenario, which is reminiscent of “FGF21 resistance,” is analogous to the situation found in obesity and type 2 diabetes (<|multi_cit|>, 15).", "evidence": {"100005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100005]}
{"id": 1305, "claim": "Comparable to insulin resistance, a significant FGF-21 resistance may exist in obesity (<|cit|>).", "evidence": {"100006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100006]}
{"id": 1306, "claim": "This notion is in line with the finding that Fgf21 serum levels are often elevated in obesity-associated IR (Fisher and Maratos-Flier, 2016; Morrice et al., 2017), possibly reflecting resistance to Fgf21 (<|cit|>).", "evidence": {"100007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100007]}
{"id": 1307, "claim": "Indeed, obesity is characterized by resistance to FGF21<|cit|> and there is notable interest in the administration of FGF21 as a therapy for obesity.16", "evidence": {"100008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100008]}
{"id": 1308, "claim": "Diet-induced obese mice also have increased serum (endogenous) FGF21 levels and respond poorly to exogenous FGF21, indicating that obesity is an FGF21-resistant state [<|cit|>].", "evidence": {"100009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100009]}
{"id": 1309, "claim": "The higher FGF-21 levels suggest the possibility of an FGF-21–resistant state in obesity (<|cit|>).", "evidence": {"100010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100010]}
{"id": 1312, "claim": "A similar elevation in obesity has also been reported in fibroblast growth factor-21, which is also thought to be a result of hormone resistance (<|cit|>).", "evidence": {"100011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100011]}
{"id": 1313, "claim": "Although there are few studies to demonstrate the physiologic role of FGF21 in the human body, a recent study showing that diet-induced obese mice had increased expression of FGF21 in liver and white adipose tissue with a significantly attenuated signaling response to exogenous FGF21 suggests FGF21 resistance in obesity [<|cit|>].", "evidence": {"100012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [100012]}
{"id": 1314, "claim": "Although it is a completely preventable disease, tetanus remains responsible for around 60,000 deaths per year worldwide [<|cit|>].", "evidence": {"60000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60000]}
{"id": 1315, "claim": "At present, 40 million deaths per year, which accounts for nearly 70% of total deaths globally, are attributable to non-communicable diseases.<|multi_cit|> 2 Moreover, the number of deaths due to non-communicable diseases, such as cardiovascular disease (CVD),<|other_cit|> hypertension,<|other_cit|> diabetes<|other_cit|> and cancer,<|other_cit|> has increased dramatically over the past few decades, although age-standardised CVD and cancer rates as well as systolic blood pressure levels<|other_cit|> have declined.<|other_cit|> However, trends in these disease traits have varied across different populations, particularly with less favourable changes observed in East Asian populations compared with Western populations.", "evidence": {"60001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60001]}
{"id": 1317, "claim": "Adjustment by this technique ensures that the sum of the estimated number of deaths per each cause does not exceed 100% of the estimated deaths in a certain year.<|cit|>", "evidence": {"60002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60002]}
{"id": 1319, "claim": "This has been accompanied by public health concerns about the declining quality and quantity of sleep in modern society.<|other_cit|> Both short and long sleep duration are consistently associated with mortality and serious chronic diseases, such as diabetes and cardiovascular disease (CVD).<|other_cit|> Similarly, poor sleep quality has been associated with mortality and CVD.<|other_cit|> CVD is the leading cause of non-communicable disease deaths globally and deaths by CVD have risen by 12.5% between 2005 and 2015.<|cit|> There is still debate about whether the association between sleep and CVD is causal or whether sleep disturbances are merely symptoms or risk markers of disease.<|other_cit|> Understanding the possible mechanisms through which sleep affects CVD can provide important supportive evidence for a causative link.", "evidence": {"60003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60003]}
{"id": 1320, "claim": "According to the recent Global Burden of Disease Study 2015, diabetes mellitus has become one of the most common causes for disability and premature death [<|multi_cit|>].", "evidence": {"60004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60004]}
{"id": 1321, "claim": "In 2015, it was estimated that 1.3 million deaths were caused by diarrheal diseases, of which 499,000 were underfive children [<|cit|>].", "evidence": {"60005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60005]}
{"id": 1322, "claim": "For example, diarrhoeal diseases have been listed as one of four leading causes of early death in all sub-Saharan African countries [<|cit|>].", "evidence": {"60006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60006]}
{"id": 1323, "claim": "Cardiovascular diseases (CVD) are a major global cause of premature death, chronic disability [<|other_cit|>], and ischaemic heart disease, including coronary artery disease (CAD), which is the leading cause of death from CVD [<|cit|>].", "evidence": {"60007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60007]}
{"id": 1325, "claim": "The Global Burden of Disease (GBD) uses a similar approach, estimating burden based on one cause of death.<|cit|> The most recently published GBD-injury study reports that drowning decreased worldwide by 27% from 1990 to 2013.<|other_cit|> Deciding which ICD codes are included in these calculations and which is used as the primary code can impact the estimated number of deaths.", "evidence": {"60008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60008]}
{"id": 1326, "claim": "As the most common cause of death, CAD caused approximately 15.9% of all mortalities globally [<|cit|>].", "evidence": {"60009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60009]}
{"id": 1327, "claim": "Respiratory and gastrointestinal infections are the major causes of morbidity and mortality worldwide in children under the age of five [<|multi_cit|>].", "evidence": {"60010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60010]}
{"id": 1330, "claim": "Cancer is one of the most important causes of morbidity and mortality, especially in high-income countries.<|cit|> A substantial part of cancer cases can be detected earlier and undergo treatment with curative intent.<|other_cit|> Improvements in early detection of cancer may be achieved through increases in population awareness, enabling early consultation with health professionals, and screening programmes.<|other_cit|> Cervical cancer screening is one of the oldest and most effective screening programmes, with relevant decreases in mortality since its implementation.<|other_cit|> Although the increasing coverage of vaccination against high-risk human papillomavirus strains is expected to play a major role in the prevention of cervical cancer,<|other_cit|> screening will still be needed, at least for non-vaccinated women and high-risk groups.", "evidence": {"60011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60011]}
{"id": 1331, "claim": "The life expectancy at birth in the GBD 2016 reference life table is 86 years for both sexes [<|cit|>].", "evidence": {"60012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60012]}
{"id": 1332, "claim": "CLD is a major cause of morbidity and mortality, and was responsible for an estimated 1.3 million deaths worldwide in 2015 [<|cit|>].", "evidence": {"60013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60013]}
{"id": 1333, "claim": "Stroke is the second-leading cause of death worldwide [<|cit|>].", "evidence": {"60014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [60014]}
{"id": 1334, "claim": "COPD is the leading cause of mortality worldwide, as it afflicts approximately 174.5 million adults [<|other_cit|>] and leads to 3.2 million deaths [<|cit|>] in 2015.", "evidence": {"60015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60015]}
{"id": 1336, "claim": "Although the phase 3 trial of mRNA-1273 included patients from several risk groups for developing severe COVID-19, such as diabetics, hypertensive individuals, individuals with chronic lung disease, liver disease, significant heart disease, people with HIV, and people with severe obesity, other conditions, such as patients with chronic kidney disease, were not evaluated [<|cit|>].", "evidence": {"20000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20000]}
{"id": 1337, "claim": "In early 2021, state and local authorities in the USA vaccinated millions of people weekly against coronavirus disease 2019 (COVID-19).[<|other_cit|>] Vaccination curbed viral infection and transmission and reduced illness, hospitalization, and death from COVID-19.[<|multi_cit|>] Vaccines were free countrywide regardless of health insurance coverage.", "evidence": {"20001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20001]}
{"id": 1338, "claim": "In two large randomized controlled trials (RCTs), the Pfizer vaccine exhibited an efficacy of 95% (95% confidence interval [CI], 90.3%–97.6%)<|other_cit|> in preventing COVID-19, and the Moderna vaccine showed an efficacy of 94.1% (95% CI, 89.3%–96.8%)<|cit|>.", "evidence": {"20002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20002]}
{"id": 1339, "claim": "Authorization trials were powered to detect differences in COVID-19 cases yet studied primarily young, healthy adults [<|multi_cit|>].", "evidence": {"20003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20003]}
{"id": 1340, "claim": "The vaccines are designed to induce an immune response against the SARS-CoV-2 spike protein<|multi_cit|>, which is required for viral entry to host cells<|other_cit|>.", "evidence": {"20004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20004]}
{"id": 1342, "claim": "In randomized clinical trials, their rates of effectiveness against symptomatic COVID-19 were 95% for the BNT162b2 vaccine (Pfizer BioNTech), 70.4% for the ChAdOx1 nCoV-19 vaccine (AZD1222, Astra Zeneca) and 94.1% for the mRNA-1273 SARS-CoV-2 vaccine (Moderna) [<|multi_cit|>].", "evidence": {"20005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20005]}
{"id": 1344, "claim": "In the abovementioned clinical trials, the incidence of lymphadenopathy after the administration of the BNT162b2 vaccine was 0.3% (<|other_cit|>), while the incidence of lymphadenopathy after the administration of the mRNA-1273 vaccine was 6.1–11.6% (<|cit|>).", "evidence": {"20006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20006]}
{"id": 1345, "claim": "In the next few months, trials that were conducted to evaluate the safety and efficacy of the COVID-19 vaccines found the mRNA vaccines to be 94–95% effective in the general population [<|multi_cit|>].", "evidence": {"20007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20007]}
{"id": 1346, "claim": "The AEs evaluated were local (pain, redness or swelling on injection site) or systemic (fever, chills, fatigue, myalgia, arthralgia, headache, vomiting, diarrhea) in line with trials of mRNA vaccines [<|multi_cit|>].", "evidence": {"20008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20008]}
{"id": 1348, "claim": "mRNA COVID-19 vaccine-related lymphadenopathy was mostly identified on the injected side (<|multi_cit|>) and in the axial and/or supraclavicular regions (<|other_cit|>).", "evidence": {"20009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20009]}
{"id": 1349, "claim": "None of the more than 117,000 volunteers included in the phase III SARS-CoV-2 vaccination trials were recently diagnosed cancer patients or patients on active cancer treatment or any sort of immunomodulatory treatment [<|multi_cit|>].", "evidence": {"20010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20010]}
{"id": 1356, "claim": "Multiple COVID-19 vaccines across different platforms are under investigation; several are available via emergency use authorization (EUA), including two mRNA vaccines, BNT162b2 and mRNA-1273 (Table <|other_cit|>; [<|multi_cit|>]), which represent the first use of an mRNA vaccine platform outside of clinical trial settings [<|other_cit|>].", "evidence": {"20011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20011]}
{"id": 1357, "claim": "Vaccine effectiveness against symptomatic COVID-19 was estimated at 70.4% for the ChAdOx1 nCoV-19 vaccine (AZD1222, Astra Zeneca) [<|other_cit|>] and 94.1% for the mRNA-1273 SARS-CoV-2 vaccine (Moderna) [<|cit|>].", "evidence": {"20012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20012]}
{"id": 1358, "claim": "Efficacy was demonstrated for the modified RNA (mRNA) vaccine of the SARS-CoV-2 spike protein, to induce neutralising antibodies,<|other_cit|> as well as a recombinant, replication-incompetent adenovirus vector that encodes a full-length and stabilised SARS-CoV-2 spike protein (adenovirus-vectored (Ad-V)).<|other_cit|> Demonstrated vaccine efficacy shown from pooled data of randomised clinical trials is 95% (95% CI 94 to 95) and 80% (95% CI 56 to 93), respectively.<|other_cit|> Even within 14 days of receipt of a first dose, vaccine efficacy can reach 80%.<|multi_cit|> Even within 14 days of receipt of a first dose, vaccine efficacy can reach 80%.4 5", "evidence": {"20013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20013]}
{"id": 1359, "claim": "Both the BNT162b2 (Pfizer/BioNTech) vaccine and the mRNA-1273 (Moderna) vaccine require two doses<|cit|>.", "evidence": {"20014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20014]}
{"id": 1360, "claim": "Systemically, fatigue, headaches, muscle pains, and fevers are some of the most frequently reported adverse actions [<|multi_cit|>].", "evidence": {"20015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20015]}
{"id": 1361, "claim": "Though more subjects are needed to confirm the validity of this trend, such a difference could be a consequence of the higher dose of mRNA in the Moderna vaccine compared to Pfizer (100 μg and 30 μg respectively)<|multi_cit|>.", "evidence": {"20016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [20016]}
{"id": 1362, "claim": "However, results from the National Health and Nutrition Examination Survey from 1999 to 2010 and from 2007 to 2010 indicated that almost half of all adults with type 2 diabetes were not at the generally recommended A1C goal of <7.0% (<|multi_cit|>).", "evidence": {"90000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90000]}
{"id": 1363, "claim": "The T2C treatment programme in this complex high-risk cohort resulted in a higher prevalence of risk factors in control equal to what has been observed in the more general diabetes population in the National Health and Nutrition Examination Surveys (NHANES) from 2007 to 2010.<|cit|> Here, the relative proportion of patients achieving HbA <53 mmol/mol (7%) nearly doubled, BP<130/80 mm Hg increased by 42% and LDL<2.5 mmol/L by 25%.", "evidence": {"90001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90001]}
{"id": 1365, "claim": "Our analyses focused on HbA1c, blood pressure, and cholesterol testing and control for patients with diabetes, since these ‘ABCs’ for controlling CVD risk are widely considered to be the critical elements for reducing CVD-related mortality and morbidity.<|cit|> Risk factor control was calculated based on last measurement in 2011 using cut-off points of HbA1c >9% (>74.9 mmol/mol), LDL-C ≥100 mg/dL, and SBP ≥130 mm Hg.", "evidence": {"90002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90002]}
{"id": 1366, "claim": "Despite the availability of numerous glucose-lowering drugs, there remains an unmet need for effective diabetes treatment [<|cit|>], as a significant proportion of individuals with T2D are still not achieving recommended glycemic targets (e.g., HbA  < 7.0% [American Diabetes Association (ADA) and Japanese Diabetes Society] and ≤ 6.5% [American Association of Clinical Endocrinologists]) [<|other_cit|>].", "evidence": {"90003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90003]}
{"id": 1367, "claim": "Importantly, more than half the diabetic population is not under adequate glycemic control with current therapies.<|cit|> Metabolic studies indicate that introduction of nutrients more quickly and distally in the small intestine can improve glucose homeostasis.", "evidence": {"90004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90004]}
{"id": 1368, "claim": "Recent evidence from the National Health and Nutrition Evaluation Survey shows that even with medication therapy, only about half of patients with diabetes achieve a target A1c <7%.<|cit|> Barriers to achieving glucose control include factors beyond drug efficacy, such as adherence, cost, fear of hypoglycemia, weight gain, and clinical inertia.", "evidence": {"90005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90005]}
{"id": 1369, "claim": "From 2007 to 2010, a study of almost 5,000 patients with diabetes revealed that only 52.5% of patients met the goal A1C of <7.0%, 56.2% met the goal LDL cholesterol level of <100 mg/dL, 51.1% met goal blood pressure level of <130/80 mmHg, and 18.8% met all three goals (<|cit|>).", "evidence": {"90006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90006]}
{"id": 1370, "claim": "National surveys show that the large majority of individuals with T2D are not at recommended treatment goals for its underlying risk factors, namely, hyperglycemia, hypertension, and dyslipidemia (<|cit|>).", "evidence": {"90007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90007]}
{"id": 1371, "claim": "Despite the strong scientific evidence showing the benefits of the aggressive promotion of BP and lipid control in reducing CVD mortality among persons with diabetes [<|other_cit|>], many patients do not reach the treatment targets for BP and lipids [<|multi_cit|>].", "evidence": {"90008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90008]}
{"id": 1372, "claim": "Although lifestyle changes (ie, diet and exercise) can improve glycemic control and cardiovascular (CV) risk factors in T2D,<|other_cit|> most patients do not adhere to such changes over the long term and subsequently require pharmacotherapy to achieve glycemic goals.<|other_cit|> Furthermore, despite a wide range of available treatment options, only ~50% of patients with diabetes in the United States have glycated hemoglobin (A ) <7%.<|multi_cit|>,10", "evidence": {"90009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90009]}
{"id": 1373, "claim": "This includes, in addition to glucose lowering, the control of blood pressure (BP) and lipids, weight management, smoking cessation and, when indicated, anti-platelet therapy.<|other_cit|> Despite these recommendations, it is known to be difficult for most patients in clinical practice to reach their therapeutic goals.<|cit|> Despite these recommendations, it is known to be difficult for most patients in clinical practice to reach their therapeutic goals.7", "evidence": {"90010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90010]}
{"id": 1374, "claim": "Rising incidence of type 2 diabetes mellitus (T2DM) is associated with a substantial increase in the burden of cardiovascular diseases (CVD) among individuals in South Asian countries.<|other_cit|> Interventional studies have revealed that morbidity and mortality from CVD among individuals with and without diabetes could be significantly reduced by the interventions aimed at controlling modifiable risk factors for CVD such as elevated blood glucose, low-density lipoproteins (LDLs), systolic blood pressure (SBP) and diastolic blood pressure (DBP).<|multi_cit|> Based on the findings of these studies, professional organizations such as the American Diabetes Association (ADA) recommend control of four major modifiable CVD risk factors below an optimal level for both primary and secondary prevention of CVD in patients with diabetes.<|other_cit|>", "evidence": {"90011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90011]}
{"id": 1375, "claim": "These combine to promote serious and costly complications of the cardiovascular system, eyes, kidneys, and feet (<|cit|>).", "evidence": {"90012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [90012]}
{"id": 1377, "claim": "National data show that only 52.5% of people with diabetes achieved a goal A1C <7% in the 2007–2010 period, indicating the continued need for effective and durable treatment approaches (<|cit|>).", "evidence": {"90013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90013]}
{"id": 1380, "claim": "With National Health and Nutrition Examination Surveys data from 2007 to 2010 suggesting that almost half (47.5 %) of all US patients with T2DM fail to achieve the target goal of A1C <7.0 % [<|cit|>], less stringent targets of <8.0 % are likely to be more achievable [<|other_cit|>].", "evidence": {"90014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90014]}
{"id": 1381, "claim": "Type 2 diabetes is a progressive disease that requires ongoing treatment intensification to achieve and maintain glycemic control.<|other_cit|> Only 53% of people with diabetes in the USA between 2007 and 2010 had the American Diabetes Association's recommended glycated hemoglobin (HbA1c) levels of less than 7%.<|multi_cit|> Studies suggest that approximately 50–60% of patients with HbA1c levels above goal are not being prescribed a change in therapy or are actually having their therapy decreased,<|other_cit|> despite several therapeutic guidelines for managing hyperglycemia.<|other_cit|> One factor that has been cited for driving this lack of therapy intensification is ‘clinical inertia’, defined as a clinician recognizing a problem but failing to act.<|other_cit|>", "evidence": {"90015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90015]}
{"id": 1382, "claim": "Although recent statistics show that rates of diabetes-related complications have decreased (<|other_cit|>) and A1C, blood pressure, and LDL cholesterol levels have improved since the late 1980s, almost half the people with diabetes in the United States still are not achieving these targets (<|cit|>).", "evidence": {"90016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90016]}
{"id": 1383, "claim": "It is worth noting the advanced age of this cohort (mean age of 71 years in 2010), reflecting the rapid population ageing of Minamisoma City.<|other_cit|> While older age is generally linked with an increased risk of developing diabetes,<|other_cit|> it has been found in non-disaster settings that older adults are more likely to meet HbA1c goals than younger adults,<|cit|> and the results of this study indicate that they may also be less likely to experience HbA1c deterioration following disasters.", "evidence": {"90017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90017]}
{"id": 1384, "claim": "The developed world has experienced improved care and outcomes in patients with type 2 diabetes but quite a high proportion of treated patients have not achieved desired targets in glucose, blood pressure and cholesterol control [<|cit|>].", "evidence": {"90018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90018]}
{"id": 1385, "claim": "Clinical inertia has been widely recognised as a barrier in the management of diabetes for many years; however, the proportion of people with diabetes achieving blood pressure, lipid and glycaemic targets has not substantially improved [<|cit|>].", "evidence": {"90019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [90019]}
{"id": 1386, "claim": "Previous studies have indicated that the US health care system is doing a poor job of effectively managing T2D.<|multi_cit|> In the past 15 years, new knowledge has been generated; patients treated with a sulfonylurea were shown to have worse outcomes than those treated with metformin,<|other_cit|> and the results of the ACCORD,<|other_cit|> ADVANCE,<|other_cit|> and VADT<|other_cit|> failed to demonstrate an improvement in cardiovascular disease (CVD) outcomes with intensive glycemic control in high-risk patients.", "evidence": {"90020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90020]}
{"id": 1387, "claim": "However, Stark et al. reported that even with insulin treatment, approximately 70% of patients with diabetes fail to reach their glycemic goal [<|cit|>].", "evidence": {"90021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90021]}
{"id": 1388, "claim": "Despite clear evidence linking glycemic control and risk for complications (<|cit|>) ∼50% of adults with diabetes achieve glycemic control targets (A1C <7%) (<|other_cit|>).", "evidence": {"90022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [90022]}
{"id": 1389, "claim": "In animal models chronic corticosterone treatment reduces neurogenesis in the dentate gyrus that can be reversed by ECT.<|other_cit|> On the other hand, inhibition of neurogenesis in this region interferes with endocrinological recovery from stress and induces a depressive phenotype.<|cit|> Next to effects on neurogenesis the structural changes following electroconvulsive seizures could be attributed to increases in dendritic spine and synapse densities, as shown in the adult hippocampus of rats.<|other_cit|> In unmedicated major depression a reduced volume and number of granule neurons in the dentate gyrus is observed post-mortem, which is not found in patients treated with selective serotonin reuptake inhibitors.<|other_cit|> In line with observed changes of serotonin 1a receptors during ECT in patients with depression,<|other_cit|> the expression of this receptor in the dentate gyrus is essential for the behavioural and hypothalamic–pituitary–adrenal axis response to antidepressants.<|other_cit|> Altogether, this evidence highlights the association of phenotypical alterations in these hippocampal subfields with stressful experience and mental illness that may be plastically modified by antidepressant treatment in general and ECT specifically.", "evidence": {"43000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43000]}
{"id": 1390, "claim": "Increasing evidences have revealed that depressive- and anxiety-like behaviors have been linked to impairments of all major aspects of plasticity in the adult mammalian brain such as neurogenesis,<|multi_cit|> gliogenesis<|other_cit|> and angiogenesis.<|other_cit|> Our present study found that EE significantly increased angiogenesis around the peri-infarction region.", "evidence": {"43001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43001]}
{"id": 1391, "claim": "It has even been proposed that reduced neurogenesis was involved in the pathogenesis of anxiety related behavior (<|cit|>).", "evidence": {"43002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43002]}
{"id": 1392, "claim": "Indeed, reductions in hippocampal neurogenesis have been mechanistically linked to abnormalities in the HPA axis at least in male mice [<|cit|>].", "evidence": {"43003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43003]}
{"id": 1393, "claim": "In addition, a decrease in neuronal production in response to systemic inflammation is known to be associated with increased anxiety <|other_cit|> and depression-like behaviors <|multi_cit|>; Vollmayer et al., 2007.", "evidence": {"43004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [43004]}
{"id": 1394, "claim": "An agreement (license L-O 15-2015/0) between the NIH and the Université Paris-Sud provides CESP/UMRS 1178 laboratory with the use of transgenic mice that express herpes simplex virus (HSV) TK under control of the GFAP promoter (GFAP-TK mice), as previously described (<|multi_cit|>) and developed in the laboratory of Dr. Heather Cameron of the National Institute of Mental Health (NIMH).", "evidence": {"43005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43005]}
{"id": 1395, "claim": "For example, prolactin can enhance SVZ neurogenesis in pregnant mice (Shingo et al., <|other_cit|>), while increased levels of glucocorticoids associated with stress have the opposite effect (<|cit|>).", "evidence": {"43006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [43006]}
{"id": 1396, "claim": "Particularly, reduced hippocampal neurogenesis may be having a major role in the pathophysiology of depression in this model, as multiple previous studies have showed evidence that mood function depends on the extent of hippocampal neurogenesis (Santarelli et al., <|multi_cit|>; Eisch and Petrik, <|other_cit|>; Kheirbek et al., <|other_cit|>)", "evidence": {"43007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43007]}
{"id": 1399, "claim": "This process is essential for cognitive and emotional processes and its disruption may lead to learning deficits and symptoms of anxiety and depression [<|multi_cit|>].", "evidence": {"43008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43008]}
{"id": 1400, "claim": "A deficiency in neurogenesis in the SGZ was found to disrupt negative hippocampal control in the hypothalamic-pituitary-adrenal axis, thereby leading to depressive illnesses (<|cit|>), while that in the SVZ led to the lack of predator avoidance and sex-specific responses (Sakamoto et al., <|other_cit|>), indicating that neurogenesis is a region-specific function.", "evidence": {"43009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43009]}
{"id": 1401, "claim": "Previous studies suggested that adult neurogenesis can influence anxiety- and depression-like behaviors through regulation of the HPA axis (Surget et al., <|other_cit|>), and thus reduction of neurogenesis exacerbated hyponeophagia under stressful conditions (<|cit|>), and thus reduction of neurogenesis exacerbated hyponeophagia under stressful conditions (Snyder et al., 2011).", "evidence": {"43010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43010]}
{"id": 1402, "claim": "Neurogenesis in the SVZ is important for olfactory learning,<|other_cit|> whereas hippocampal neurogenesis is involved in memory and spatial learning.<|other_cit|> Numerous studies suggest that stress and MDD are associated with decreased hippocampal neurogenesis.<|other_cit|> Additionally, disturbed adult neurogenesis, possibly resulting in a malfunctioning of hippocampus, may contribute to cognitive deficits.<|other_cit|> Conversely, hippocampal neurogenesis buffers stress responses and depressive behavior.<|cit|> Enriched environment, exercise, electroconvulsive therapy, deep brain stimulation, and antidepressants increase hippocampal neurogenesis.<|other_cit|> The regulatory factors that control adult neurogenesis are currently under investigation; however, recent studies demonstrate that miRNAs play a role in both embryonic as well as adult neurogenesis.<|other_cit|> For example, Choi et al<|other_cit|> demonstrated that olfactory tissues express more than 100 distinct miRNAs, the most abundant being the miR-124a and let-7 variants and the family of miR-200.", "evidence": {"43011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43011]}
{"id": 1403, "claim": "Another exception was in the GFAP-TK model of neurogenesis inhibition (Snyder et al., <|cit|>), where loss of hippocampal neurogenesis (99%) was associated with increased immobility, but only during the first 2 min of the 6 min Forced Swim Test; there were no differences in the remainder.", "evidence": {"43012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43012]}
{"id": 1404, "claim": "However, neurogenesis in dentate gyrus, which is critical to hippocampal-mediated modulation in H-H-A axis also appears to be impaired by masticatory dysfunction causing cognitive deficits which are dependent on morphofunctional integrity of the hippocampus (<|cit|>).", "evidence": {"43013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [43013]}
{"id": 1405, "claim": "For example, neurogenesis seems to be important for buffering the stress response (<|cit|>) and mediating the effects of antidepressants (e.g., Santarelli et al., <|other_cit|>).", "evidence": {"43014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43014]}
{"id": 1406, "claim": "In fact, the GC response to stress is under restrictive regulation and newly generated neurons in the hippocampus can shut off the stress induced GC responses (<|multi_cit|>).", "evidence": {"43015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [43015]}
{"id": 1407, "claim": "The sucrose preference test was conducted as previously described (Strekalova et al., <|multi_cit|>; Wu et al., <|other_cit|>) with some modifications.", "evidence": {"43016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43016]}
{"id": 1408, "claim": "In consequence, stress-induced disruption of adult neurogenesis may play a role in the development of various psychiatric disorders, including depression, anxiety, and schizophrenia (<|multi_cit|>).", "evidence": {"43017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [43017]}
{"id": 1409, "claim": "Hippocampal neurogenesis is essential for regulation of the HPA axis (Schloesser et al., <|multi_cit|>; Surget et al., <|other_cit|>), and an increase in neurogenesis might facilitate recovery via normalization of HPA axis function.", "evidence": {"43018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43018]}
{"id": 1410, "claim": "In addition, there is now ample evidence that hippocampal neurogenesis is also associated with emotional control <|multi_cit|>.", "evidence": {"43019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43019]}
{"id": 1411, "claim": "For example, the contribution of hippocampal neurogenesis in the pathophysiology of depression and in the therapeutic efficacy of pharmacological treatments has been shown using rodent models [<|multi_cit|>], and then confirmed in human studies [<|other_cit|>].", "evidence": {"43020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43020]}
{"id": 1413, "claim": "Neurons generated in the dentate gyrus (DG) area of the hippocampus during adulthood mature into dentate granule cells (DGCs), which can integrate into existing hippocampal neural circuits (<|other_cit|>) and influence affective states or cognitive processes (<|multi_cit|>).", "evidence": {"43021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43021]}
{"id": 1414, "claim": "The hippocampus, as the advanced negative control centre of the HPAA, not only suppresses the stress response of the HPAA but also restores the excessive stress state of the HPAA to baseline levels through governing the negative regulation of the hypothalamus<|cit|>.", "evidence": {"43022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43022]}
{"id": 1415, "claim": "Adult neurogenesis has been suggested it can buffer stress response and depressive behaviors (<|cit|>).", "evidence": {"43023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43023]}
{"id": 1416, "claim": "Snyder et al. (<|cit|>) showed that neurogenesis-deficient mice presented a heightened stress-induced depressive-like behavior and impaired hypothalamus-pituitary-adrenal axis response to stress.", "evidence": {"43024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [43024]}
{"id": 1417, "claim": "Various Indian studies have reported prevalence rates of depression that vary from 9 – 83% in primary care practices.[<|multi_cit|>] There are few population-based studies from India.", "evidence": {"62000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [62000]}
{"id": 1418, "claim": "The worldwide occurrence of MDD varies by country, but epidemiologic data generally indicate that this disorder is both common and chronic.<|other_cit|> In the United States, the lifetime prevalence for MDD is estimated to be 16.2%,<|other_cit|> affecting all ethnic groups,<|other_cit|> – <|other_cit|> and with onset generally occurring during early adulthood.<|other_cit|> Most patients have a chronic or recurrent course of illness,<|cit|> which negatively affects patient quality of life even during periods of remission.<|other_cit|>", "evidence": {"62001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62001]}
{"id": 1419, "claim": "The relationship between depression and sociodemographic characteristics, such as gender, age, marital status, income level, and educational level has been investigated worldwide in various populations [<|cit|>].", "evidence": {"62002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62002]}
{"id": 1420, "claim": "Results of the World Health Organization World Mental Health survey, which analyzed data from 18 countries using the Composite International Diagnostic Interview<|other_cit|> for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition,<|other_cit|> estimated that the average lifetime and 12-month prevalence of major depressive disorder was 14.6% and 5.5% in ten high-income countries and 11.1% and 5.9% in eight low- to middle-income countries, respectively.<|cit|> Current therapies used to treat major depressive disorder include selective serotonin reuptake inhibitors, dopamine–norepinephrine reuptake inhibitors, and serotonin–norepinephrine reuptake inhibitors (SNRIs), among others.<|other_cit|>", "evidence": {"62003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62003]}
{"id": 1421, "claim": "In the case of primary-care samples, a selection bias occurs regarding help-seeking on the basis of distress or impairment (<|cit|>).", "evidence": {"62004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62004]}
{"id": 1422, "claim": "Despite the increasing prevalence of depression in China, compared to other countries, the rate of diagnosed depression is relatively low [<|multi_cit|>], suggesting a collective denial and under treatment of depression as a disease [<|other_cit|>].", "evidence": {"62005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62005]}
{"id": 1424, "claim": "Depression is the third leading source of years lived with disability worldwide and has a lifetime prevalence of 14.6% among people living in high-income countries (<|multi_cit|>).", "evidence": {"62006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62006]}
{"id": 1425, "claim": "Depression is a highly prevalent mental disorder in our society, with 10 to 20% of the population experiencing a major depressive disorder/depressive episode during their lives [<|multi_cit|>].", "evidence": {"62007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62007]}
{"id": 1426, "claim": "In general, the prevalence of depression is high (approximately 11-15%) worldwide [<|cit|>] and depression is associated with a high burden and social disability.", "evidence": {"62008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62008]}
{"id": 1427, "claim": "Unipolar depression is recognised as one of the leading causes of disability worldwide<|other_cit|> and is associated with medical morbidity, mortality and diminished quality of life.<|other_cit|> Depressive disorders have also been linked to substantial impairments across several important domains, with regard to overall educational, occupational and social functioning.<|other_cit|> Recent research points to the high cost of illness related to depression and other mental health disorders, further underscoring the societal challenge posed by these conditions.<|other_cit|> The 12-month prevalence of depression is estimated to be about 6% in the adult general population,<|cit|> with a strong female preponderance (about 2:1).<|other_cit|> Similar estimates have been reported for mid-to-late adolescence.<|other_cit|> A growing body of research from epidemiological investigations indicates that first onset of depression frequently occurs in adolescence, and evidence suggests an increasing cumulative probability rising from around 5% in early adolescence to 20% in late adolescence.<|other_cit|> In addition, a substantial proportion of adolescents present with subthreshold symptoms and go undiagnosed or untreated,<|other_cit|> despite an elevated risk for future adversity.<|other_cit|> This emphasises the need for efficacious prevention and early treatment for those affected.<|other_cit|>", "evidence": {"62009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62009]}
{"id": 1428, "claim": "Major depressive disorder is a chronic and recurring condition with an estimated lifetime prevalence of 14.6% and 11.1% in high- and lower- and middle-income countries, respectively [<|multi_cit|>].", "evidence": {"62010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62010]}
{"id": 1429, "claim": "Similarly, lifetime prevalence estimates were found to be significantly higher in high- than in low- to middle-income countries overall [<|cit|>], though there was wide variation within each income group.", "evidence": {"62011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62011]}
{"id": 1431, "claim": "Mental disorders constitute a major public health problem in India [<|multi_cit|>].", "evidence": {"62012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [62012]}
{"id": 1432, "claim": "A separated or divorced status increases the risk of greater depression.<|cit|>", "evidence": {"62013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62013]}
{"id": 1433, "claim": "Worldwide up to 15% of a given population, women more often than men, experience a major depressive episode at least once in a lifetime <|cit|>) and 50% of the patients who had one depressive episode will suffer from recurrent depressive episodes (Kupfer, <|other_cit|>).", "evidence": {"62014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62014]}
{"id": 1434, "claim": "Low- and middle-income countries (LMICs) bear most of the global burden of depression [<|multi_cit|>].", "evidence": {"62015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [62015]}
{"id": 1435, "claim": "The nation-wide prevalence rate of T2DM among young adults is 9.2%,[<|other_cit|>] whereas lifetime prevalence of depression is about 36%.[<|cit|>] So, it is to be noted that depression is more prevalent than diabetes.", "evidence": {"62016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62016]}
{"id": 1436, "claim": "The lifetime prevalence ranges from 11 to 15% and its 12 months prevalence is about 6% in the global setting [<|cit|>].", "evidence": {"62017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62017]}
{"id": 1437, "claim": "Furthermore, about 10 % of the study population met the criteria for depression, almost double that of the12-month prevalence (5.6 %) found in other low and middle income countries, based on data collected from a cross-national survey in 18 countries [<|cit|>].", "evidence": {"62018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [62018]}
{"id": 1438, "claim": "Within the World Mental Health Survey Initiative a 12-month prevalence of major depressive disorders of 5.5% in high-income countries and 5.9% in middle and low income countries was reported [<|cit|>].", "evidence": {"62019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62019]}
{"id": 1439, "claim": "According to a recent study by the World Health Organization (WHO), the average lifetime and 12-month prevalence estimates of DSM-IV major depressive disorder were 14.6% and 5.5% in ten high-income countries and 11.1% and 5.9% in eight low- to middle-income countries [<|cit|>].", "evidence": {"62020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [62020]}
{"id": 1440, "claim": "Depression is also very common in the general population with a lifetime prevalence of 8 to 12 percent.[<|cit|>] Pharmacotherapy of depression and anxiety is often unsatisfactory with more than one third of the depressed patients not responding properly to the currently available drugs.[<|other_cit|>] Even in those who respond, the cost and the associated adverse effects of prolonged therapy with the current medications, have been important limiting factors for proper compliance and effective management.", "evidence": {"62021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [62021]}
{"id": 1443, "claim": "Chen et al. [<|cit|>].", "evidence": {"63000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63000]}
{"id": 1444, "claim": "Recently XBP1 has been shown to be important in driving TNBC oncogenesis through the formation of transcriptional complexes with hypoxia inducing factor 1α (HIF1α) [<|cit|>].", "evidence": {"63001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63001]}
{"id": 1445, "claim": "The apparent discrepancy in these observations may reflect the differential reliance of distinct tumor types (or similar tumors at distinct stages of progression) on the ER stress response for survival in adverse microenvironment conditions (<|cit|>).", "evidence": {"63002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63002]}
{"id": 1446, "claim": "Additionally, natural antagonists or antisense strategies have been applied in mouse models, and therapeutic strategies have focused on developing new small-molecule HIF-1 ɑ inhibitors [<|cit|>].", "evidence": {"63003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63003]}
{"id": 1448, "claim": "IRE-XBP1’s signaling can sustain cancer growth in hypoxic condition, likely through interaction with HIF1α [<|cit|>].", "evidence": {"63004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63004]}
{"id": 1449, "claim": "Several lines of studies have shown that XBP1s is also implicated in various biological processes, such as lipid metabolism (<|other_cit|>), pro-inflammatory cytokines synthesis (<|other_cit|>), the hypoxia response signaling pathway (<|cit|>), cellular differentiation (<|other_cit|>), and the hexosamine biosynthetic pathway (<|other_cit|>), indicating a critical role for IRE1-XBP1 UPR signaling and cellular response.", "evidence": {"63005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63005]}
{"id": 1450, "claim": "The IRE1α/XBP1 pathway is largely activated in different types of cancer including breast cancer, multiple myeloma, colorectal cancer, and gliomas (<|cit|>).", "evidence": {"63006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63006]}
{"id": 1452, "claim": "The higher UPR in TNBC is shown by a dilated ER [<|cit|>] and increased sensitivity to hsp90 inhibitors that kill cells by hindering the UPR [<|other_cit|>].", "evidence": {"63007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63007]}
{"id": 1453, "claim": "Moreover, in triple negative breast cancer in which ERα is absent, the IRE1/XBP1 axis plays a central role in tumorigenicity and progression, and the extent of activation of an XBP1 gene index is correlated with reduced patient survival (<|multi_cit|>).", "evidence": {"63008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63008]}
{"id": 1454, "claim": "The active spliced isoform of X-box binding protein 1 (XBP-1), a downstream effector of IRE1α known to regulate the tumorigenicity and progression of triple-negative breast cancer, is enriched in tumor-initiating cells and cooperates in the transactivation of known hypoxia-inducible factor 1 (HIF1) targets <|cit|>.", "evidence": {"63009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63009]}
{"id": 1455, "claim": "In a recent letter to Nature, Chen and colleagues [<|cit|>] provided intriguing data to show that XBP1 acts as a tumor driver that is required for oncogenesis and cancer stem cell phenotypes associated with TNBC.", "evidence": {"63010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63010]}
{"id": 1456, "claim": "XBP1s is constitutively activated through the hypoxia-inducible factor-1α pathway in response to hypoxia, resulting in tumor development (<|cit|>).", "evidence": {"63011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63011]}
{"id": 1457, "claim": "It was found in classifying Luminal B versus TNBC [<|cit|>].", "evidence": {"63012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63012]}
{"id": 1458, "claim": "Research by Chen et al. indicated that XBP1 also plays a pivotal role in tumorigenesis and progression of a human breast cancer subtype and is activated in triple-negative breast cancer [<|cit|>].", "evidence": {"63013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63013]}
{"id": 1460, "claim": "These signaling pathways are partially overlapping<|multi_cit|> and are balanced to either mediate a pro-survival or a pro-apoptotic response, depending on the severity of stress received.<|other_cit|> Fluphenazine treatment or SM supplementation lead to an overinduction of the hypoxia response, including both HIF and ATF4 transcriptional overactivity, specifically in HIF-stabilized cells or hypoxic spheroids.", "evidence": {"63014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63014]}
{"id": 1461, "claim": "Other genes present in our MINT gene signature include XPB1 [<|cit|>], AGR3 [<|other_cit|>], CCDC170 [<|other_cit|>] and TFF3 [<|other_cit|>] that were reported as being associated with breast cancer.", "evidence": {"63015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63015]}
{"id": 1462, "claim": "XBP1, a well-characterized transcription factor, plays a key role in response to endoplasmic reticulum stress<|other_cit|> and tumorigenesis via regulating target genes related to cell proliferation and survival.<|multi_cit|> We further demonstrated that up-regulation of XBP1 could restore the inhibitory effects on proliferation, invasion, and EMT in MG63 and U20S cells caused by GNL3 knockdown.", "evidence": {"63016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63016]}
{"id": 1463, "claim": "Of note, the UPR has recently been associated with triple-negative breast cancer<|cit|>, aminoacyl-tRNA synthetases have been linked to tumorigenesis<|other_cit|>, and multiple cross-talks have been established between the Wnt and RANKL/RANK pathways, including molecular cross-talks that control mammary progenitor cells<|other_cit|>.", "evidence": {"63017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63017]}
{"id": 1466, "claim": "Within these pathways (as shown in Figures <|other_cit|> and <|other_cit|>), immune system process analysis showed that T cell differentiation, regulation of immune response, and macrophage activation interacted with each other through the key genes such as GATA Binding Protein 3 (GATA3) (regulates tumor microenvironment [<|other_cit|>]), XBP1 (promotes triple-negative breast cancer by regulating the HIF1α pathway [<|cit|>]), interleukin-33 (IL-33) (promotes breast cancer growth and progression [<|other_cit|>]), MYB protooncogene, transcription factor (MYB), kallikrein related peptidase 5 (KLK5), microtubule associated protein tau (MAPT), and solute carrier family 7 member 2 (SLC7A2).", "evidence": {"63018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [63018]}
{"id": 1467, "claim": "Taking advantage of the RNA-seq technique [<|other_cit|>], recent large-scale studies have reported pervasive transcription signals on genomes in diverse cell-types [<|multi_cit|>] and unprecedented complex transcription structures in genomes [<|other_cit|>].", "evidence": {"68000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68000]}
{"id": 1468, "claim": "Of the total genome that is transcribed, only 2% codes for proteins, whereas the vast majority of it is transcribed as non-coding RNAs which include long non-coding RNAs (lncRNAs), microRNAs, and others [<|cit|>].", "evidence": {"68001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68001]}
{"id": 1469, "claim": "At least 50,000 lncRNAs are expressed from intergenic regions of the human genome, more than twice the number of protein-coding genes [<|cit|>].", "evidence": {"68002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68002]}
{"id": 1470, "claim": "Compared to protein-coding transcripts, lncRNA demonstrate much less sequence conservation between species [<|cit|>], with conservation being allocated across several other perspectives, such as regulation, position or secondary structure.", "evidence": {"68003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [68003]}
{"id": 1471, "claim": "More extreme pervasive transcription is displayed by mammalian genomes (e.g. [<|multi_cit|>–55]), in which the difference between protein coding sequence (generally <5% of the genome) and total transcribed sequence (70-90%) far exceeds that seen in the more gene-dense fungi.", "evidence": {"68004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68004]}
{"id": 1472, "claim": "They are broadly classified based on their genomic loci and function (<|other_cit|>) (1)   are synthesized from exons of protein-coding genes utilizing the same promoter region of the gene (<|other_cit|>), (2)   are aberrant transcripts synthesized from the opposite strand of protein-coding region (<|other_cit|>), (3)   are generated from an intron of a protein-coding gene (<|other_cit|>), (4)  , also referred to as large intergenic (or intervening) non-coding RNAs (lincRNAs), are encoded between protein-coding genes and are transcribed independently (<|multi_cit|>), (5)  , also known as enhancer RNA (eRNA), are synthesized from the transcription binding regions i.e., activator/repressor elements of a protein-coding gene (<|other_cit|>), (6)   forms are RNAs where the 3′-5′ ends are covalently enclosed to create a circular loop derived from splicing of a protein-coding gene (<|other_cit|>), and (7)   transcripts are transcribed from the same promoter as coding genes, but in the opposite direction (<|other_cit|>).", "evidence": {"68005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68005]}
{"id": 1473, "claim": "Using a de novo transcriptome assembly method, Hangauer et al.<|cit|> identified tens of thousands more putative lincRNAs in the human transcriptome.", "evidence": {"68006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68006]}
{"id": 1474, "claim": "Furthermore, it is anticipated that analysis of non-coding RNAs will lead to a better understanding of the significance of intergenic loci identified by GWAS (<|cit|>).", "evidence": {"68007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68007]}
{"id": 1475, "claim": "In the human genome, only 1–2% of the entire genome encodes proteins, with evidence of at least 80% of the remaining genome being actively transcribed<|multi_cit|>.", "evidence": {"68008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68008]}
{"id": 1476, "claim": "Recent genome-wide surveys on lincRNAs allow us to draw some general observations about this particular RNA species [<|cit|>].", "evidence": {"68009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68009]}
{"id": 1477, "claim": "Many human annotation projects use cell lines [<|other_cit|>], however, some also use primary tissues [<|multi_cit|>].", "evidence": {"68010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68010]}
{"id": 1478, "claim": "Recent studies estimate that >85% of the genome is transcribed (<|cit|>) versus 128 Mbp here].", "evidence": {"68011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68011]}
{"id": 1479, "claim": "Nonetheless, debate persists as to the proportion of the transcriptome that could be defined as spurious ‘noise,’ resulting from the essentially stochastic nature of transcription and splicing (<|cit|>).", "evidence": {"68012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68012]}
{"id": 1481, "claim": "The similar expression level, expression width of relics compared with their orthologous counterparts and the specific regulation of expression suggest their expression is not likely just transcriptional noise [<|cit|>].", "evidence": {"68013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68013]}
{"id": 1482, "claim": "Gene annotations for 23 K coding genes and 67 K lncRNAs (including lincRNAs) were obtained from RefSeq [<|other_cit|>] and Hangauer et al.’s dataset S3 [<|cit|>], respectively.", "evidence": {"68014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [68014]}
{"id": 1484, "claim": "With the help of deep sequencing, numerous lncRNAs have been identified<|cit|>.", "evidence": {"68015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68015]}
{"id": 1485, "claim": "Only until recently, it was appreciated that 85% of the human genome can be transcribed, albeit only 3% of the genome encodes protein-coding genes.<|cit|> Thus, RNA-seq has been instrumental to catalog the diversity of novel transcript species including long non-coding RNA, miRNA, siRNA, and other small RNA classes (eg, snRNA and piRNA) involved in regulation of RNA stability, protein translation, or the modulation of chromatin states.<|other_cit|> For instance, RNA-seq has been used to discover enhancer RNA, a class of short transcript directly transcribed from the enhancer region, which contributes to our knowledge of epigenetic gene regulation.<|other_cit|> In addition, RNA-seq can give information about transcriptional start sites, revealing alternative promoter usage, information about mRNA isoforms derived from alternative splicing, and premature transcription termination at the 3′ end, which is critical from mRNA stability.<|other_cit|> Most recently, RNA-seq was used to study biological problems including precisely locating regulatory elements.<|other_cit|> RNA-seq information can also identify allele-specific expression, disease-associated single nucleotide polymorphisms (SNP), and gene fusions contributing to our understanding about disease causal variants in cancer.<|other_cit|> Furthermore, RNA-seq can provide information about the transcription of endogenous retrotransposons and other parasitic repeat elements that may influence the transcription of neighboring genes or may result in somatic mosaicism in the brain.<|other_cit|> Finally, single-cell RNA-seq analysis has been widely applied to study the cellular heterogeneity and diversity in stem cell biology and neuroscience.<|other_cit|>", "evidence": {"68016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68016]}
{"id": 1486, "claim": "Whilst the presence of R-loops has traditionally been linked to predisposition to DNA damage<|other_cit|>, given our expanding understanding of the pervasiveness of transcription throughout the genome<|cit|>, it is clear that complementary RNA will be co-localized with multiple genomic loci upon damage.", "evidence": {"68017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68017]}
{"id": 1487, "claim": "In fact, many lncRNAs are bi-morphic and can exist in both polyadenylated and non-polyadenylated states (<|cit|>).", "evidence": {"68018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68018]}
{"id": 1488, "claim": "Over the past decades, it has been estimated that only 2% of the mammalian genome encodes for proteins, whereas the vast majority of it is extensively transcribed to give rise to a large transcriptome of ncRNA species [<|cit|>].", "evidence": {"68019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68019]}
{"id": 1489, "claim": "Dataset S6, composed of those intergenic lncRNAs that had been found to be expressed at significantly higher levels than expected from random simulations, was retrieved from the supplementary information of <|cit|>.", "evidence": {"68020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68020]}
{"id": 1490, "claim": "Surprisingly, only 1–2 % of the whole genome encodes proteins, with evidence of at least 80 % of the remainder being actively transcribed [<|multi_cit|>].", "evidence": {"68021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68021]}
{"id": 1491, "claim": "One of the most unexpected recent developments in molecular biology is the finding that the genome is rather promiscuous in its transcription, producing a staggering number of transcripts that do not encode proteins [<|multi_cit|>–10].", "evidence": {"68022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [68022]}
{"id": 1493, "claim": "One earlier cohort study, for example, found that a Thr/Ala substitution in the CCL11 gene increases risk of myocardial infarction independently of BMI and DM.<|other_cit|> Blockade of CCL11 can suppress aspects of age-related cellular dysfunction,<|other_cit|> and it is possible that observed effects of metformin on mammalian longevity,<|other_cit|>,49 where suppression of NF-κB is also observed,<|cit|> may owe at least in part to suppression of this cytokine.", "evidence": {"99000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99000]}
{"id": 1495, "claim": "Metformin, a treatment for type 2 diabetes, is able to mimic CR through its activation of AMP kinase and has also been shown to extend lifespan and healthspan in several species including rodents (<|cit|>).", "evidence": {"99001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99001]}
{"id": 1497, "claim": "The life extension by intermittent treatment with rapamycin may be further potentiated with diet, the antidiabetic drug metformin (Anisimov et al., <|multi_cit|>; Martin-Montalvo et al., 2013) and, if possible, physical exercise.", "evidence": {"99002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99002]}
{"id": 1499, "claim": "While the example of metformin shows that it is possible to safely modulate insulin and/or general metabolism (<|multi_cit|>), we should note that the glucose lowering effects of metformin were discovered accidently through malaria research and not by a screen based on a validated target (<|other_cit|>)", "evidence": {"99003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99003]}
{"id": 1500, "claim": "It was shown almost 50 years ago that phenformin and metformin, anti-diabetic drugs that improve IR, also slow down aging and prevent cancer in rodents.<|multi_cit|> These effects were explained from the mTOR perspective, revealing a rationale to combine rapamycin and metformin.<|other_cit|> Two agents may even cancel each other side effects.", "evidence": {"99004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99004]}
{"id": 1501, "claim": "Notably, treatment of rats (Anisimov, <|other_cit|>) mice (<|cit|>) and nematodes (Cabreiro et al., <|other_cit|>) with metformin extends lifespan.", "evidence": {"99005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99005]}
{"id": 1506, "claim": "Although metformin was previously identified as a classic activator of AMPK (<|cit|>), it can also target mitochondria to inhibit NADH dehydrogenase and adenosine triphosphate (ATP) synthase, thereby triggering mitochondrial biogenesis (<|other_cit|>).", "evidence": {"99006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99006]}
{"id": 1507, "claim": "It is possible that recent observations, consistent with the ability of metformin to prolong mammalian lifespan [<|multi_cit|>], may, at least in part, be due to suppression of this cytokine.", "evidence": {"99007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99007]}
{"id": 1508, "claim": "Others, (e.g. [<|multi_cit|>]) quantify activity over shorter periods ranging from minutes to hours.", "evidence": {"99008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [99008]}
{"id": 1509, "claim": "Actually, metformin, an AMPK activator, extends lifespan in C. elegansand mice (Cabreiro et al. <|multi_cit|>).", "evidence": {"99009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99009]}
{"id": 1510, "claim": "Other of our reports describe results obtained for other treatment groups in these cohorts (Spindler et al. <|multi_cit|>).", "evidence": {"99010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99010]}
{"id": 1511, "claim": "A shorter but largely healthy lifespan (the healthy component is sometimes called the healthspan [<|cit|>]) with a rapid decline to death may offer better welfare than a longer but more ailed life with a slow and painful decline to death.", "evidence": {"99011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99011]}
{"id": 1512, "claim": "For example, metformin, an oral antidiabetic agent of the biguanide class, can prolong the life of C. elegans [<|other_cit|>], D. melanogaster [<|other_cit|>] and M. musculus [<|cit|>].", "evidence": {"99012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99012]}
{"id": 1513, "claim": "Moreover, oral supplementation with the antidiabetic drug metformin leads to healthier and longer life in male mice (<|cit|>).", "evidence": {"99013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99013]}
{"id": 1514, "claim": "This was recently shown in an animal model for metformin-dependent AMP-activated protein kinase activation that suppressed oxidative damage and chronic inflammation in old animals and increased their lifespan and healthspan [<|cit|>].", "evidence": {"99014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99014]}
{"id": 1515, "claim": "These findings, together with ground-breaking studies demonstrating its ability to prolong healthspan and lifespan in mice (<|cit|>), provided the basis for defining metformin as a potential antiaging molecule (<|other_cit|>).", "evidence": {"99015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99015]}
{"id": 1516, "claim": "One earlier cohort study, for example, found that a Thr/Ala substitution in the CCL11 gene increases risk of myocardial infarction independently of BMI and DM.<|other_cit|> Blockade of CCL11 can suppress aspects of age-related cellular dysfunction,<|other_cit|> and it is possible that observed effects of metformin on mammalian longevity,<|multi_cit|> where suppression of NF-κB is also observed,49 may owe at least in part to suppression of this cytokine.", "evidence": {"99016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [99016]}
{"id": 1517, "claim": "TNFR1 activation may also lead to apoptosis; however, the deficiency of caspase-8 [<|cit|>], a Fas-associated protein with death domain (FADD) [<|other_cit|>], FLICE-like inhibitory protein [<|other_cit|>] and cellular inhibitor of apoptosis proteins (CIAPs) 1 and 2 [<|other_cit|>] induce necroptosis.", "evidence": {"70000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70000]}
{"id": 1518, "claim": "Recent studies from other laboratories have also showed necroptosis in intestinal epithelial cells in models of chronic intestinal inflammation in gene-deficient mice.<|multi_cit|> Although there is no data on the timing of necrotic death caused by hypoxic stress in normal human epithelial cells, rapid villous necrosis in jejunum and colon was found in rats after 60 min of hemorrhagic shock or 40 min of mesenteric ischemia,<|other_cit|> showing that normal cells are more sensitive to oxygen and nutrient deprivation compared with cancer cells.", "evidence": {"70001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70001]}
{"id": 1522, "claim": "Markedly, genes associated with uncontrolled cell death seem to be involved.<|multi_cit|> Also, defects in mucus assembly and production can lead to spontaneous development of colitis in mice models.<|other_cit|>", "evidence": {"70002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70002]}
{"id": 1523, "claim": "A critical step is the activation of caspase-8 through a series of cleavages from pro-enzyme to active protease.<|other_cit|> The two activated protease domains of caspase-8, p18 and p10, cleave downstream substrates such as caspase-3 to propagate apoptosis.<|other_cit|> The active form of caspase-8 is composed of a heterotetramer consisting of p18 /p10 .<|other_cit|> Death receptor signaling can also drive a related, although mechanistically distinct, cell-death pathway called necroptosis.<|other_cit|> Activation of this pathway requires the caspase-8 protein to remain in its uncleaved pro-enzyme form.<|cit|> This leads to the formation of the necroptosome (RIP1, RIP3, trimeric MLKL) that ultimately kills cells through loss of mitochondria membrane potential.<|other_cit|>", "evidence": {"70003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70003]}
{"id": 1524, "claim": "Necroptosis is associated with inflammation and has been suggested to be involved in inflammatory conditions such as Crohn’s disease (<|cit|>).", "evidence": {"70004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70004]}
{"id": 1525, "claim": "Dysregulated necroptosis is an important driver of epithelial cell death in the gut and is an active principle in chronic inflammatory states including human IBD (<|multi_cit|>).", "evidence": {"70005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70005]}
{"id": 1526, "claim": "Clinically relevant examples of this cell death form include disorders with acute or chronic courses like ischemia reperfusion injuries [<|other_cit|>], brain trauma [<|other_cit|>], myocardial infarction [<|other_cit|>], inflammatory diseases [<|multi_cit|>], sepsis [<|other_cit|>], oxidative stress-related disorders [<|other_cit|>], neurodegenerative diseases [<|other_cit|>], transplantation [<|other_cit|>] and cancer [<|other_cit|>], in addition to a multiplicity of other pathophysiological settings.", "evidence": {"70006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70006]}
{"id": 1529, "claim": "Mice with a conditional deletion of caspase 8 (a protease involved in apoptosis regulation) in the IECs (Casp8deltaIEC mice) spontaneously develop chronic inflammation in the terminal ileum due to increased necroptosis (<|cit|>).", "evidence": {"70007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70007]}
{"id": 1530, "claim": "TNF-dependent survival signals are mediated primarily by canonical NF-κB signaling (<|other_cit|>), whereas the TNF-induced death signal is driven by caspase-8–dependent apoptosis or RIP1/3-dependent necroptosis (<|multi_cit|>).", "evidence": {"70008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70008]}
{"id": 1531, "claim": "Necroptosis, a newly recognized programmed cell death, of intestinal epithelial cells led to disruption of the intestinal barrier and resulted in spontaneous colitis or terminal ileitis in mice<|multi_cit|>.", "evidence": {"70009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70009]}
{"id": 1533, "claim": "Caspase-8 also suppresses necroptosis via CYLD cleavage.<|multi_cit|> Hence, administration of pan-caspase inhibitors can lead to necroptotic cell death during death receptor activation by enhancing the phosphorylation of receptor-interacting protein (RIP) 1 and RIP3.<|other_cit|> Even though cell death may not absolutely require Caspase-3 and Caspase-7, activation of these specific proteases is still of significant biological importance in the context of tissue homeostasis.", "evidence": {"70010": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70010]}
{"id": 1534, "claim": "When FADD-caspase-8-FLIP complex functions are inhibited, the pathway of cell death switches from apoptosis to typical necroptosis features [<|multi_cit|>].", "evidence": {"70011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70011]}
{"id": 1535, "claim": "Increasing evidence affirms the relevance of this mode of cell death in the pathogenesis of various diseases [<|multi_cit|>–42].", "evidence": {"70012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70012]}
{"id": 1538, "claim": "This culture model has proven to serve as a powerful system to investigate regulatory and pathological mechanisms of the intestinal epithelium on a molecular level.<|cit|> Of note, the supplemented growth factors in the culture medium are identical with the signals that regulate intestinal stem cell niches in vivo.<|other_cit|> Thus far, this system has been extensively used for studying the regulation of intestinal stem cell self-renewal, growth and differentiation.", "evidence": {"70013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70013]}
{"id": 1540, "claim": "In contrast it was hypothesized that K13/vFLIP may induce necroptosis in infected cells [<|other_cit|>] because insufficient caspase 8 activity has been identified as a key parameter in the induction of necroptosis [<|cit|>] because insufficient caspase 8 activity has been identified as a key parameter in the induction of necroptosis [8].", "evidence": {"70014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [70014]}
{"id": 1541, "claim": "In aged animals, predominantly proinflammatory immune cells (i.e. M1 macrophages) are recruited and reducing infiltration with these immune cells would, therefore, attenuate the development of insulin resistance [<|cit|>].", "evidence": {"98000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98000]}
{"id": 1542, "claim": "Aging cells undergo substantial cellular changes [<|cit|>].", "evidence": {"98001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98001]}
{"id": 1543, "claim": "The decline in subcutaneous fat depot storage and function is thought to occur through the decline in progenitor cell function and the accumulation of senescent adipose tissue cells (<|cit|>).", "evidence": {"98002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98002]}
{"id": 1545, "claim": "Age was forced into the model because aging is associated with alterations in the amount and distribution of body fat depots with a shift from subcutaneous to visceral fat accumulation [<|other_cit|>] and increases the risk for the progression of ectopic fat accumulation including fatty liver [<|cit|>] and increases the risk for the progression of ectopic fat accumulation including fatty liver [29].", "evidence": {"98003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98003]}
{"id": 1546, "claim": "The dynamic change found in the adipose tissue is considered “adipose tissue remodeling”, in which stromal cells change dramatically in number and cell type during the course of aging [<|multi_cit|>, 62].", "evidence": {"98004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [98004]}
{"id": 1547, "claim": "Also, an increasing body of evidence reveals accumulation of senescent preadipocytes and ECs in the fat tissue of obese and aging subjects, which generate increased amount of cytokines and chemokines which appear to be capable of activating immune responses.<|multi_cit|> Several rodent studies demonstrate that an increase in adipose tissue macrophages worsens insulin sensitivity.<|other_cit|>6 The most recent study has shown macrophageinduced apoptosis in both preadipocytes and adipocytes mediated in a paracrine manner by cytokine secretion during adipocyte inflammation in vitro.<|other_cit|> Our ultrastructural analysis of BAT of hyperinsulinaemic rats showed closely positioned macrophages to clusters of apoptotic cells, usually containing few brown adipocytes and ECs (adipoendothelial clusters).", "evidence": {"98005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98005]}
{"id": 1548, "claim": "In cellular senescence, proliferation becomes arrested and cells acquire a pro-inflammatory senescent secretory phenotype (SASP), with release of chemokines and cytokines [<|cit|>].", "evidence": {"98006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98006]}
{"id": 1549, "claim": "With aging, there is a decline in preadipocyte replication and an expansion of senescent cells in adipose tissue which enhance lipotoxicity and favor the generation of a pro-inflammatory status (<|cit|>).", "evidence": {"98007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98007]}
{"id": 1550, "claim": "In the past century, the incidence of chronic age-related diseases, particularly obesity and type 2 diabetes, has increased dramatically [<|other_cit|>] and it has been suggested that adipose tissue might have a central role in these pathologies [<|cit|>].", "evidence": {"98008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98008]}
{"id": 1551, "claim": "Alterations in adipose tissue are major contributors to age-associated metabolic dysfunctions and other health issues (<|multi_cit|>).There are two types of adipose tissue depots: (1) brown adipose tissue, composed of brown adipocytes, which contain numerous mitochondria and lipid droplets and function as the site of adaptive thermogenesis (<|other_cit|>); (2) white adipose tissue, which includes visceral adipose depots and subcutaneous adipose depots and acts as the prime location where metabolic energy is stored in the form of triglycerides during periods of nutritional excess (<|other_cit|>).", "evidence": {"98009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98009]}
{"id": 1552, "claim": "However, cellular stress and adipocyte overutilization with ageing led to metabolic dysfunction [<|cit|>].", "evidence": {"98010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98010]}
{"id": 1553, "claim": "This could explain how senescent cells might drive the aging process in vivo as proposed (<|multi_cit|>).", "evidence": {"98011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98011]}
{"id": 1554, "claim": "Several lines of evidence suggest that senescent cells could accumulate in fat tissue with chronological aging and that these cells might contribute to age-related fat tissue inflammation and dysfunction [<|cit|>].", "evidence": {"98012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98012]}
{"id": 1556, "claim": "The pre-adipocytes from which new fat cells develop switch into a pro-inflammatory, tissue-remodeling state in old age, instead of differentiating into fat cells [<|cit|>].", "evidence": {"98013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98013]}
{"id": 1557, "claim": "Importantly, a redistribution of fat stores is a hallmark of aging and is characterized by a depletion of subcutaneous fat stores in older rodents and humans, which contributes to a simultaneous expansion of visceral and ectopic fat stores in sites such as liver, pancreas, bone, and skeletal muscle (<|cit|>).", "evidence": {"98014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98014]}
{"id": 1558, "claim": "Autophagy is typically considered to decrease with age [<|other_cit|>], and aging alters energetic balance and body fat distribution [<|cit|>], in addition to affecting food intake [<|other_cit|>], although marked reduction in food intake is more commonly observed in advanced stages due to terminal conditions.", "evidence": {"98015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98015]}
{"id": 1559, "claim": "There are three main general theories of aging: genetic mutation, wear and tear (both proposed in the 1950s by Denham Harman [<|other_cit|>]), and accumulated functional impairments in multiple tissues in the body [<|multi_cit|>, 5].", "evidence": {"98016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98016]}
{"id": 1560, "claim": "However, macrophage induction by the types of chemokines released by senescent cells may decline with aging [<|multi_cit|>].", "evidence": {"98017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98017]}
{"id": 1561, "claim": "Given that this inflamm-aging is linked with various age-associated disorders [<|cit|>], targeting inflammatory pathways could prevent or alleviate the pathological consequences observed in the course of aging, obesity or both in parallel.", "evidence": {"98018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98018]}
{"id": 1562, "claim": "Proinflammatory cytokines also inhibit preadipocyte differentiation and maturation, and promote adipocyte senescence (<|multi_cit|>).", "evidence": {"98019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98019]}
{"id": 1563, "claim": "Aging is closely related to damaged adipogenesis in various fat depots in humans [<|multi_cit|>].", "evidence": {"98020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98020]}
{"id": 1565, "claim": "These preadipocytes secrete a proinflammatory profile similar to senescent cells, with factors such as PAI, IL-6 and proinflammatory cytokines and chemokines [<|multi_cit|>,144].", "evidence": {"98021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98021]}
{"id": 1566, "claim": "It is thus likely that obesity reduces life- and health span and plays a predominant role in the onset of age-related diseases [<|cit|>].", "evidence": {"98022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98022]}
{"id": 1567, "claim": "Also, the percent of ingested fat that is stored in subcutaneous depots is lower in older than young people, and the abdominal circumference increases in the old age [<|cit|>].", "evidence": {"98023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [98023]}
{"id": 1568, "claim": "<|multi_cit|>  Recent autopsy series of Covid-19 patients showed histologic pattern of diffuse alveolar damage, severe endothelial injury, widespread alveolar capillary thrombosis, micro angiopathy and angiogenesis.", "evidence": {"12000": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12000]}
{"id": 1571, "claim": "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), an enveloped single-stranded RNA virus, responsible for COVID-19, predisposes some patients to a proinflammatory and pro thrombotic state<|multi_cit|>.", "evidence": {"12001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12001]}
{"id": 1572, "claim": "Data suggests that rates of thrombotic complications may involve almost 1/3 of critically ill patients.[<|other_cit|>] Hypercoagulability in COVID-19 is primary the results of direct effects of the virus able to infect endothelial cells and cause perturbation of the cellular homeostasis,[<|other_cit|>] leading to plasminogen activator release, and high molecular size multimeric von Willebrand factor causing thrombotic microangiopathy.[<|other_cit|>] Furthermore, severe inflammatory response, critical illness, and underlying traditional risk factors may all predispose to thrombotic events, similar to prior coronavirus outbreaks.[<|cit|>] Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common complication in critically ill patients with COVID-19, especially when admitted to ICU (<|other_cit|>).", "evidence": {"12002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12002]}
{"id": 1573, "claim": "The incidence of macrovascular thrombotic events varies from 10% to 30% in COVID-19 hospitalised patients depending on the type of thrombosis, arterial or venous, and the severity of the illness.<|other_cit|> Based on observational data of patients receiving routine low-dose prophylactic anticoagulation (LD-PA), several institutions released guidance statements recommending escalated anticoagulant doses to prevent macrovascular thrombotic events.<|other_cit|> In these recommendations, high-dose PA (HD-PA) and therapeutic anticoagulation (TA) can be employed either empirically or based on various criteria like body mass index or D-dimer concentration.<|other_cit|> However, other conflicting recommendations challenge this approach.<|multi_cit|> However, other conflicting recommendations challenge this approach.6 8", "evidence": {"12003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12003]}
{"id": 1574, "claim": "These supportive therapies should be continued for at least 3 months if VTE is suspected or confirmed in COVID-19 patients (<|multi_cit|>).", "evidence": {"12004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12004]}
{"id": 1575, "claim": "Pathophysiological speaking, high-dose heparin in this setting may not only be ineffective, but it may also be harmful, possibly contributing to the described hemorrhagic component of microangiopathy [<|cit|>].", "evidence": {"12005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12005]}
{"id": 1576, "claim": "<|multi_cit|>–76 Then there was an urgent need for practical guidance regarding the prevention of VTE in hospitalized COVID-19 patients.74–79", "evidence": {"12006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12006]}
{"id": 1578, "claim": "Patients with COVID-19 exhibit elevated markers of hypercoagulation that correspond with negative outcomes, and deep vein thrombosis and pulmonary embolism are reported at unusually high rates (<|cit|>).", "evidence": {"12007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12007]}
{"id": 1579, "claim": "This complication is assumed to be secondary to uncontrolled inflammatory process, platelet activation, endothelial dysfunction, and marked stasis [<|cit|>].", "evidence": {"12008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12008]}
{"id": 1581, "claim": "This question was the subject of some debate during the development of a recent consensus on the prevention, antithrombotic therapy and follow-up of thrombotic or thromboembolic disease in COVID-19 patients [<|cit|>].", "evidence": {"12009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12009]}
{"id": 1582, "claim": "Excessive inflammation has been suggested as one of the main drivers of blood coagulation activation in severely ill patients [<|cit|>].", "evidence": {"12010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12010]}
{"id": 1584, "claim": "Coronavirus-2019 (COVID-19) has been notorious for the pulmonary and cardiovascular complications that it confers.<|other_cit|> However, more recently, this novel virus, responsible for an unprecedented pandemic disease and the world-wide turmoil that it has created, has also been demonstrated to predispose patients to arterial and venous thromboses attributable to the inflammatory state, platelet activation, endothelial dysfunction, and blood stasis.<|cit|> However, more recently, this novel virus, responsible for an unprecedented pandemic disease and the world-wide turmoil that it has created, has also been demonstrated to predispose patients to arterial and venous thromboses attributable to the inflammatory state, platelet activation, endothelial dysfunction, and blood stasis.5", "evidence": {"12011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12011]}
{"id": 1585, "claim": "Indeed, in this document, the authors were unable to reach consensus on the optimal dosing of anticoagulant therapy, stipulating that “the majority of panel members consider prophylactic anticoagulation, although a minority consider intermediate-dose or therapeutic dose to be reasonable” [<|cit|>].", "evidence": {"12012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12012]}
{"id": 1587, "claim": "Severe acute respiratory syndrome Coronavirus 2, which causes coronavirus disease (COVID-19), binds to the angiotensin converting enzyme 2 receptor, which is widely expressed in vascular endothelial cells and damages these cells.<|other_cit|> COVID-19 predisposes patients to venous and arterial thrombotic complications due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis.<|cit|> Multiple studies have strongly suggested that anticoagulant therapy improves the prognosis of patients with COVID-19, and thromboprophylaxis is currently recommended for patients requiring hospitalization in Europe and America.<|other_cit|> The risk of venous thromboembolism in Asians is lower than that in Caucasians and much lower than that in African Americans.<|other_cit|> The incidence of thrombotic events in hospitalized patients with COVID-19 has been reported to be 16% in New York<|other_cit|> but only 1.9% in Japan.<|other_cit|> Coagulative and fibrinolytic activities are markedly increased in COVID-19 patients, and this increase provides a big impact on their prognosis.<|other_cit|> Therefore, the International Society on Thrombosis and Haemostasis issued an interim guidance recommending the measurement of D-dimer, fibrinogen, prothrombin time, and platelet count in all COVID-19 patients.<|other_cit|> For the treatment of COVID-19-associated hypercoagulability, the interim guidance proposes the use of anticoagulation therapy for a wide range of patients, recommending prophylactic administration of low-molecular-weight heparin for hospitalized COVID-19 patients.", "evidence": {"12014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12014]}
{"id": 1588, "claim": "It is proposed that antifibrotics such as pirfenidone and nintedanib may reduce the severity of SARS-CoV-2 infection and might be an integral part of COVID-19 therapeutics (<|multi_cit|>).", "evidence": {"12015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12015]}
{"id": 1589, "claim": "The key features of COVID-19 associated thrombosis are the relatively increased incidence in younger patients, and propensity for multiterritory thrombotic events.<|other_cit|> In a series of 184 critically ill patients, 31% were found to have thrombotic complications.<|cit|> Both micro and macrovascular venous and arterial thrombosis have been described, resulting in stroke and myocardial infarction.<|other_cit|>", "evidence": {"12016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12016]}
{"id": 1591, "claim": "The antiviral therapies lopinavir/ritonavir and remdesivir interfere with common blood-clotting medications (<|cit|>).", "evidence": {"12017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12017]}
{"id": 1592, "claim": "Due to the observed abnormalities in coagulation profiles, plasma D-dimer, PT, aPTT, fibrinogen and platelet counts are recommended to be measured on admission.<|other_cit|> Although elevations of the D-dimer are common in COVID-19 and appear to be a prognostic marker, there remains a lack of robust clinical data to support the routine intervention with anticoagulation in patients with a rising D-dimer without clinical or radiological evidence of thrombosis.<|multi_cit|> Although elevations of the D-dimer are common in COVID-19 and appear to be a prognostic marker, there remains a lack of robust clinical data to support the routine intervention with anticoagulation in patients with a rising D-dimer without clinical or radiological evidence of thrombosis.38 40", "evidence": {"12018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12018]}
{"id": 1593, "claim": "These acute thromboembolic events were strongly associated with worsening outcomes, highlighting the necessity for thromboembolism risk management [<|cit|>].", "evidence": {"12019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12019]}
{"id": 1594, "claim": "When indicated, the guidelines recommend either enoxaparin or rivaroxaban for a duration of 14 to 45 days post-discharge [<|cit|>].", "evidence": {"12020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12020]}
{"id": 1595, "claim": "For cases of documented or highly suspected VTE, therapeutic anticoagulation is the mainstay of VTE management.<|cit|> When selecting the appropriate antithrombotic agent, one needs to take into account coexisting comorbidities such as renal or hepatic dysfunction, thrombocytopenia, and gastrointestinal function.", "evidence": {"12021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12021]}
{"id": 1596, "claim": "Furthermore, LMWH has also anti-inflammatory properties that might be beneficial in COVID-19 patients (<|multi_cit|>).", "evidence": {"12022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12022]}
{"id": 1597, "claim": "<|multi_cit|>–10 In recent autopsy studies, it has been found that the lungs of the infected patients are characterized by a widespread thrombosis with microangiopathy, whereas a high incidence of DVT has been recognized with PE being identified as a direct cause of death.69,70", "evidence": {"12023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12023]}
{"id": 1598, "claim": "<|multi_cit|>–10 Furthermore, important details such as the optimal dose-intensity of the anticoagulation therapy are lacking.", "evidence": {"12024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12024]}
{"id": 1599, "claim": "Thrombo-inflammation – occurs by overproduction of early response proinflammatory cytokines (TNFα, IL-6, and IL-1β) that create a “cytokine storm” [<|multi_cit|>].", "evidence": {"12025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12025]}
{"id": 1600, "claim": "Furthermore, the efficacy of VTE prophylaxis in patients with COVID-19 is poorly documented [<|cit|>].", "evidence": {"12026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12026]}
{"id": 1601, "claim": "Selective use of inferior vena cava filters is also recommended, especially in the setting of contraindications to anticoagulation.<|cit|> In cases of submassive PE, rescue systemic fibrinolysis should be considered, with catheter-directed options as an alternative option.<|other_cit|> For patients with hemodynamic instability, systemic fibrinolysis or catheter-based therapies are available.", "evidence": {"12027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12027]}
{"id": 1602, "claim": "This thrombotic risk assessment should also include biological markers such as DD and fibrinogen levels, the sudden increase of which is an indicator of the imminent worsening o<|other_cit|> Then there was an urgent need for practical guidance regarding the prevention of VTE in hospitalized COVID-19 patients.<|multi_cit|>", "evidence": {"12028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12028]}
{"id": 1603, "claim": "Therefore, COVID-19 patients with high VTE risk should receive pharmacologic thromboprophylaxis, unless there are absolute contraindications (<|multi_cit|>).", "evidence": {"12029": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12029]}
{"id": 1604, "claim": "Together, these processes can exacerbate the acute lung injury [epithelial cell death, local inflammation, endothelial and epithelial barrier impairment, and subsequent lung edema (<|other_cit|>)] beyond that directly caused by the viral infection itself and can lead to ARDS, as well as pulmonary embolism in some patients (<|cit|>).", "evidence": {"12030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12030]}
{"id": 1605, "claim": "The latter allows for platelet binding and TF expression which activates the coagulation system [<|multi_cit|>].", "evidence": {"12031": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12031]}
{"id": 1606, "claim": "Several societies have recently produced guidelines regarding the prophylactic and therapeutic management of VTE in patients with COVID-19 infection, which are outlined in <|multi_cit|> In addition, prior to the COVID-19 pandemic, the American Society of Hematology had issued guidelines (2018) for management of VTE for hospitalized and non-hospitalized medical patients.<|other_cit|> In that document, strong recommendations included use of VTE prophylaxis in acutely or critically ill inpatients at acceptable bleeding risk; use of mechanical prophylaxis in patients with high bleeding risk; advising against use of DOACs during hospitalization, and against extending pharmacological prophylaxis after hospital discharge.", "evidence": {"12032": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12032]}
{"id": 1607, "claim": "The reported prevalence of VTE is ∼25–30% in severe COVID-19 patients, which is considerably higher than that of other viral infections (<|multi_cit|>).", "evidence": {"12033": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12033]}
{"id": 1608, "claim": "We currently know that pulmonary thrombi in COVID-19 develop as a consequence of vascular damage associated with viral infection and severe inflammation as evidenced by their D-dimer levels and inflammatory markers and increase in multiple thrombolytic factors like IL-6 and antiphospholipid antibodies [<|multi_cit|>].", "evidence": {"12034": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12034]}
{"id": 1609, "claim": "Instead, the increased risk of thrombosis could be a consequence of the cascade triggered by the endothelial damage characteristic of the COVID-19 infection<|multi_cit|>.", "evidence": {"12035": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12035]}
{"id": 1610, "claim": "The most common laboratory test abnormalities found in COVID-19 patients are thrombocytopenia and increased D-dimer levels, which are associated with a higher risk of requiring mechanical ventilation, ICU admission, or death.[<|cit|>] In a multicenter retrospective cohort study from China, elevated D-dimer levels (> 1 g/L) were strongly associated with in-hospital death, even after multivariable adjustment.[<|other_cit|>] As assessed by Tang, et al.[<|other_cit|>] in a retrospective study of 183 COVID-19 patients, those who died presented levels of D-dimer and fibrin degradation products significantly increase (3.5- and ~1.9-fold increase, respectively) and PT prolongation.", "evidence": {"12036": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12036]}
{"id": 1611, "claim": "Deaths among individuals with COVID-19 have been partially attributed to venous thromboembolism and arterial thromboses.1,<|other_cit|> In intensive care settings, prevalence of venous thromboembolism among patients with COVID-19 has been reported to be over 40%.<|other_cit|> In response, several expert organizations including the American Society of Hematology, the International Society on Thrombosis and Haemostasis, and the CHEST Guideline and Expert Panel have recommended the use of prophylactic anticoagulation for patients admitted with COVID-19 who do not have a contraindication to this therapy.<|multi_cit|>", "evidence": {"12037": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12037]}
{"id": 1612, "claim": "<|multi_cit|>  Patients with CAC develop prothrombotic state with significant elevation of d-dimer, fibrinogen, fibrin and fibrin degradation products, modest prolongation of PT and aPTT, normal or small decrease in platelet count and increased clot strength by thrombo-elastography.", "evidence": {"12038": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [12038]}
{"id": 1614, "claim": "In many neurodegenerative disorders, neuropathology and atrophy are most marked in those brain regions that are densely connected, both at the structural (<|cit|>) and functional level (<|other_cit|>).", "evidence": {"87000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87000]}
{"id": 1615, "claim": "Descriptive graph metrics denote brain regions as nodes, and connections between them as edges, and have yielded many interesting findings (Bullmore and Sporns, <|other_cit|>; Rubinov and Sporns, <|other_cit|>; Biswal et al., <|other_cit|>; Achard et al., <|other_cit|>; Crossley et al., <|multi_cit|>; Fornito et al., <|other_cit|>; van den Heuvel and Sporns, <|other_cit|>; Stam, <|other_cit|>).", "evidence": {"87001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87001]}
{"id": 1617, "claim": "Previous research has shown that brain networks are vulnerable to a targeted attack on hub nodes—expressed in the significant reduction of connectivity and efficiency—regardless of whether the network is structural (He et al., <|other_cit|>) or functional (<|cit|>) or functional (Crossley et al., 2014).", "evidence": {"87002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87002]}
{"id": 1618, "claim": "Meanwhile, these hubs are more likely to be abnormal in a brain disorder like AD [<|cit|>].", "evidence": {"87003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [87003]}
{"id": 1620, "claim": "From the connectome, it can be inferred how intelligent someone is (<|other_cit|>), how vulnerable the brain is to traumatic stress or neurodegeneration (<|multi_cit|>), or how well the brain will recover from damage (<|other_cit|>).", "evidence": {"87004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87004]}
{"id": 1621, "claim": "With this approach, a large-scale functional organization of the brain has been proposed (Bota et al., <|other_cit|>) and many common mental health disorders linked to the vulnerability of particular topological elements of the connectome (<|cit|>) and many common mental health disorders linked to the vulnerability of particular topological elements of the connectome (Crossley et al., 2014).", "evidence": {"87005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87005]}
{"id": 1623, "claim": "While we did find selective vulnerability of highly connected hub or “rich club” brain regions, this finding is generalizable across a number of brain disorders (<|cit|>) and may be due to the high metabolic demands (<|other_cit|>) of hub brain regions, as opposed to a disease-specific mechanism such as prion-like spread.", "evidence": {"87006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87006]}
{"id": 1624, "claim": "This finding is in agreement with previous findings in human function based on functional network (Joyce et al., <|other_cit|>) and in brain disorder on structural brain networks (He et al., <|other_cit|>; Alstott et al., <|multi_cit|>; Crossley et al., 2014).", "evidence": {"87007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [87007]}
{"id": 1625, "claim": "These studies reported altered local and global graph properties, supporting the clinical relevance of brain networks, especially within group-wise association studies (<|multi_cit|>; Daianu et al., <|other_cit|>).", "evidence": {"87008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [87008]}
{"id": 1626, "claim": "Nodes with the highest strength values are termed hubs and their reorganization has been repeatedly linked to different brain pathologies (<|cit|>), such as coma (Achard et al., <|other_cit|>) or Alzheimer's disease (Buckner et al., <|other_cit|>).", "evidence": {"87009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87009]}
{"id": 1627, "claim": "Indeed, structural abnormalities in hubs has been found to be overrepresented across a range of brain disorders (<|cit|>).", "evidence": {"87010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87010]}
{"id": 1628, "claim": "Further studies show that the graph metrics and network structures of brain connectivity are altered in brain disorders (Collin et al., <|multi_cit|>; Deco and Kringelbach, <|other_cit|>; Hong et al., <|other_cit|>; Korgaonkar et al., <|other_cit|>; van den Heuvel and Fornito, <|other_cit|>; Fornito and Bullmore, <|other_cit|>; Fornito et al., <|other_cit|>; Gong and He, <|other_cit|>; Wheeler et al., <|other_cit|>).", "evidence": {"87011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87011]}
{"id": 1629, "claim": "Initial work has shown that inter-individual variations in topological properties of functional networks correlated with variability in cognitive performance (Li et al., <|other_cit|>; Bassett et al., <|other_cit|>; Zalesky et al., <|other_cit|>; Crossley et al., <|multi_cit|>, 2014).", "evidence": {"87012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87012]}
{"id": 1630, "claim": "As a whole structure however, a recent meta-analytic approach found the thalamus (as a whole) to be generally altered across a range of different brain disorders (<|cit|>).", "evidence": {"87013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87013]}
{"id": 1631, "claim": "Notably, Crossley et al. (<|cit|>) employed network-based statistic (NBS) method in the WM networks for OCD patients and revealed a single decreased structural sub-network in the patients comprising OFC, striatal, insula, and temporo-limbic regions.", "evidence": {"87014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87014]}
{"id": 1632, "claim": "Using statistical measures of correlation and coherence, they have shown that generalised epilepsies may be associated with dysfunction in similar brain networks, particularly resting state networks like the DMN, a network that underpins self-awareness.<|other_cit|> Causal models have also provided evidence of the existence of epileptogenic hubs in generalized epilepsies as well, illustrated by the precuneus in absence epilepsy.<|other_cit|> These findings have, therefore, challenged the traditional distinction between generalised and focal epilepsy and further emphasized the primary role of neuronal networks in epileptogenesis.<|multi_cit|>,53", "evidence": {"87015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87015]}
{"id": 1633, "claim": "A natural continuation of this work is to incorporate a translational outlook to, for example, investigate whether hubs of human brain networks are more likely to be anatomically abnormal than non-hubs in brain disorders (<|cit|>).", "evidence": {"87016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87016]}
{"id": 1634, "claim": "The application of graph theoretical techniques to these networks has shown that healthy brain networks demonstrate ‘small-world’ features (indicative of balanced integration and segregation), minimising total fibre length.<|other_cit|> Such organisational properties appear to be compromised in many disorders,<|other_cit|> exemplified by the burgeoning connectomic research elucidating network aberrations in schizophrenia.<|other_cit|> Disturbances appear to involve highly connected hub regions,<|multi_cit|> in particular those hub-regions with dense wiring among themselves, known as the ‘rich club’.<|other_cit|> Intriguingly, this core architectural feature may also be compromised in unaffected relatives of schizophrenia patients.<|other_cit|>", "evidence": {"87017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87017]}
{"id": 1635, "claim": "Indeed, it was shown by meta-analysis of case–control VBM studies representing primary data on more than 20,000 patients with one of 26 clinical brain disorders, that grey matter ‘lesions’ measured by VBM were significantly more likely to occur in brain regions that were high-degree hubs in the normal structural or functional connectome (<|cit|>).", "evidence": {"87018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87018]}
{"id": 1636, "claim": "Interestingly, recent studies suggest that the network hubs are the first set of structures susceptible to Alzheimer’s disease and psychiatric disorders (<|multi_cit|>).", "evidence": {"87019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87019]}
{"id": 1638, "claim": "Future studies examining whether and if so to what extent weak and strong pathways differ in their macroscale neuroarchitectonics might provide important insights into the hypothesized disproportionally high vulnerability of high degree regions and their connections in disease processes (van den Heuvel and Sporns <|other_cit|>; Crossley et al. <|multi_cit|>, 2014).", "evidence": {"87020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [87020]}
{"id": 1639, "claim": "Alzheimer’s disease has been widely described as a disconnection syndrome (<|multi_cit|>).", "evidence": {"87021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [87021]}
{"id": 1640, "claim": "So far, most reported SARS-CoV-2-specific mAbs have no or few somatic hypermutations [<|multi_cit|>].", "evidence": {"16000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16000]}
{"id": 1641, "claim": "In response to the urgent need for Ab-based therapy for COVID-19, several reports have demonstrated efficacy against SARS-CoV-2 infection by neutralizing Abs, primarily as prophylactic protection<|multi_cit|>–32.", "evidence": {"16001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16001]}
{"id": 1643, "claim": "Antibodies that target the RBD B epitope have been seen in other convalescent donor samples<|multi_cit|>, but to our knowledge, this is the first high-resolution structure reported.", "evidence": {"16002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16002]}
{"id": 1645, "claim": "Lentiviral based pseudo-viruses were produced similarly to a previous report (<|cit|>).", "evidence": {"16003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16003]}
{"id": 1646, "claim": "Many of the most potent neutralizing antibodies against SARS-2 block binding of ACE2 to the RBD (<|other_cit|>,  <|multi_cit|>), and RBD targeting has been suggested for COVID-19 vaccine development (<|other_cit|>).", "evidence": {"16004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16004]}
{"id": 1648, "claim": "Control antibodies RBD A, RBD B and RBD C were CC12.1, CC12.16 (ref. <|cit|>) and CR3022 (ref. <|other_cit|>), respectively.", "evidence": {"16005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16005]}
{"id": 1650, "claim": "Currently, most of the discovered nAbs target the RBD [<|multi_cit|>] and NTD [<|other_cit|>], in contrast to a small number of nAbs target the S2 subunit [<|other_cit|>].", "evidence": {"16006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16006]}
{"id": 1651, "claim": "Across several studies, the majority of the nAb polyclonal response (in some cases >90%) have been mapped to SARS-Cov-2 RBD, as has been the case with mAbs isolated from infected individuals<|multi_cit|>.", "evidence": {"16007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16007]}
{"id": 1652, "claim": "SARS-CoV-2 viruses were detected with a mixture of CC6.29, CC6.33, L25-dP06E11, CC12.23, and CC12.25 antibodies, previously derived from a cohort of convalescent SARS-CoV-2 donors (<|cit|>).", "evidence": {"16008": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16008]}
{"id": 1654, "claim": "Robust assays, particularly those linked to functional activity or correlated with immunologic protection as is true for RBD ELISAs (<|cit|>), are essential for assessing population level prevalence and incidence of SARS-CoV-2 infection, as well as for determining infection endpoints in intervention trials.", "evidence": {"16009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16009]}
{"id": 1655, "claim": "In addition, individuals with low antibody responses, far from the doses reported to be protective in animal models<|cit|>, seem to have been protected against severe infection.", "evidence": {"16010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16010]}
{"id": 1658, "claim": "Authentic SARS-CoV-2 virus was produced in Vero E6 cells as described previously (<|cit|>).", "evidence": {"16011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16011]}
{"id": 1659, "claim": "Furthermore, several ELISAs have been shown to correlate well with neutralizing antibody titers <|other_cit|>, and thus may be useful clinically and in vaccine development <|cit|>.", "evidence": {"16012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16012]}
{"id": 1660, "claim": "In this mini-review we will focus on the SARS-CoV-2 Spike protein (S) as it is a highly glycosylated surface exposed protein on the virus and the focus of the overwhelming majority of SARS-CoV-2 epitope studies published to date (<|multi_cit|> The S protein is a homotrimer in which each protomer is arranged as two subunits, S  and S .", "evidence": {"16013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16013]}
{"id": 1661, "claim": "The reason for this is unclear but may relate to glycan heterogeneity within the S309 epitope (<|other_cit|>) coupled with differences in receptor expression or protease cleavage efficiency between the two types of target cells (<|cit|>).", "evidence": {"16014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16014]}
{"id": 1662, "claim": "It has been reported that serum concentrations of ~22 and 12 μg/ml (pseudovirus neutralization IC ×1160 and 630, respectively) of CC12.1 nAb protect hamsters challenged with SARS-CoV-2 (USA-WA1/2020 strain, 1 × 106 plaque-forming units) from weight loss (100% or 50%, respectively) [<|cit|>].", "evidence": {"16015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16015]}
{"id": 1664, "claim": "Furthermore, because the labeled reagent does not have species specificity, the single assay kit could be used in pre-clinical vaccine development studies to measure antibody responses in experimental animals <|cit|>.", "evidence": {"16016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16016]}
{"id": 1665, "claim": "These antibodies, which are elicited in most infected individuals, are able to protect golden Syrian hamsters from acquisition of SARS-CoV-2 infection<|multi_cit|>, and are thought to play a relevant role in viral clearance after infection<|other_cit|>.", "evidence": {"16017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16017]}
{"id": 1667, "claim": "Recombinant receptor-binding domain (RBD) protein and the RBD-binding monoclonal antibody CR3022 were used according to previously described protocols (<|other_cit|>), as well as SARS-CoV-2 neutralizing monoclonal antibody CC12.1 (<|cit|>).", "evidence": {"16018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16018]}
{"id": 1668, "claim": "In assessing convalescent patients, the most potent mAbs were found to bind to RBD and determined to block the RBD–ACE2 interaction at two specific sites, RBD-A (site Ia) and RBD-B (site Ib)<|multi_cit|>.", "evidence": {"16019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16019]}
{"id": 1671, "claim": "Pseudotyped viral neutralization assays were performed similar to a previous report (<|cit|>).", "evidence": {"16020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16020]}
{"id": 1673, "claim": "Anti-RBD antibodies raised by infection and vaccination can potently neutralize SARS-2 through blocking S trimer binding to the ACE2 receptor required for viral entry (<|other_cit|>,  <|multi_cit|>).", "evidence": {"16021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16021]}
{"id": 1674, "claim": "This model shows severe disease manifestations with SARS-CoV-2 infection, including predictable weight loss, alveolar inflammation and bronchiolo-alveolar hyperplasia [<|other_cit|>]; and has been used for the evaluation of other COVID-19 antibody treatment candidates [<|multi_cit|>].", "evidence": {"16022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16022]}
{"id": 1675, "claim": "(A) The usage distribution of light-chain germline gene that paired with VH3-53 in 80 known RBD-targeted antibodies[<|multi_cit|>].", "evidence": {"16023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [16023]}
{"id": 1676, "claim": "While efficient therapeutic use of human mAbs has been previously succeeded<|multi_cit|>,32, the current report documents efficient protection by administration of therapeutic Abs at significant late time points post-infection.", "evidence": {"16024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16024]}
{"id": 1679, "claim": "In fact, several recent studies have shown therapeutic efficacy of infused bNAbs in humanized mice [<|other_cit|>], non-human primates [<|multi_cit|>] and humans [<|other_cit|>].", "evidence": {"72000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72000]}
{"id": 1680, "claim": "Only a subset of HIV-1–infected individuals produce potent and broadly neutralizing antibodies (bNAbs) (<|other_cit|>), which can protect against and suppress infection in animal models (<|multi_cit|>) and exhibit antiviral activity in human clinical trials (<|other_cit|>).", "evidence": {"72001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72001]}
{"id": 1682, "claim": "Similarly, several studies have demonstrated the potential antiviral activities of antibodies against HIV-1 [<|multi_cit|>] while most of them are yet to be approved by FDA.", "evidence": {"72002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72002]}
{"id": 1684, "claim": "Recent proof-of-concept studies with passively delivered bnAbs in HIV-infected humanized mice and simian–human immunodeficiency virus (SHIV)-infected macaques have generated encouraging therapeutic results, especially when combinations of bnAbs were used<|multi_cit|>.", "evidence": {"72003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72003]}
{"id": 1685, "claim": "With passive transfer of bNAbs, the studies demonstrated that prevention of viral acquisition among uninfected animals [<|other_cit|>] and suppression of viremia among infected animals [<|multi_cit|>].", "evidence": {"72004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72004]}
{"id": 1686, "claim": "Humoral immunity can completely suppress viremia in humanized mice (<|other_cit|>), SIV-infected Rhesus Macaques (<|cit|>) and, in combination with viral inducers, decrease rebound from latent reservoirs of HIV-1 in humanized mice (<|other_cit|>).", "evidence": {"72005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [72005]}
{"id": 1687, "claim": "Recent studies in SHIV-infected Rhesus macaques also yielded promising results.<|multi_cit|>", "evidence": {"72006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72006]}
{"id": 1688, "claim": "Recently, combination monoclonal antibody therapy has shown promise in suppressing viral infection in animal models<|multi_cit|>; however, it does not provide a mechanism for activating infected T cells from latency.", "evidence": {"72007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72007]}
{"id": 1689, "claim": "The combination of b12, PGT121 and 3BC117 was found to suppress viral rebound in SHIV-infected rhesus macaques [<|cit|>].", "evidence": {"72008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72008]}
{"id": 1690, "claim": "Several approaches involve the implementation of improved drugs on existing targets, new formulations and delivery systems [<|other_cit|>], new viral and cell targets [<|other_cit|>], the use of therapies based on neutralizing monoclonal antibodies [<|multi_cit|>], or chimeric proteins as eCD4-Ig (a fusion of CD4-Ig with a small CCR5-mimetic sulfopeptide) expressed in adeno-associated virus vectors [<|other_cit|>].", "evidence": {"72009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72009]}
{"id": 1692, "claim": "The new Abs also showed remarkable therapeutic effects in vivo: in rhesus monkeys chronically infected with pathogenic simian–human immunodeficiency virus SHIV-SF162P3, they were able to rapidly reduce plasma viremia to undetectable levels and keep it at bay for months (<|cit|>).", "evidence": {"72010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72010]}
{"id": 1693, "claim": "Apart from their use in the vaccine field, bNAbs are potentially interesting compounds in terms of other preventative strategies such as microbicides or as therapeutic agents [<|multi_cit|>,42].", "evidence": {"72011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72011]}
{"id": 1694, "claim": "The stimulation of the adaptive immune response was also observed following nAb therapy in infected macaques (<|multi_cit|>).", "evidence": {"72012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72012]}
{"id": 1695, "claim": "Proviral DNA was reduced in macaques treated with these antibodies [<|multi_cit|>,34]; however, the extent of the ability of antibodies to clear latently infected cells is not well understood.", "evidence": {"72013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72013]}
{"id": 1696, "claim": "As monotherapy, PGT121 (V3 glycan) was profoundly effective against established SHIV-SF162P3 infection<|cit|>, whereas 3BNC117 (CD4bs) and 10-1074 (V3 glycan) were profoundly effective against established SHIV-AD8EO infection<|other_cit|>, resulting in up to 3-log reductions in plasma viraemia in each case.", "evidence": {"72014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72014]}
{"id": 1697, "claim": "I4C is engaging in ongoing collaborations with Janssen and Gilead to determine the effects of therapeutic vaccination <|other_cit|>, or passive bNAb administration <|cit|>, or passive bNAb administration [14], combined with latency reversal on viral control and reservoir size after ART interruption.", "evidence": {"72015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72015]}
{"id": 1698, "claim": "Approximately 30%–50% of infected individuals eventually develop bNAbs (<|other_cit|>), and passive immunization studies have shown that various bNAbs can protect macaques from experimental challenge (<|multi_cit|>).", "evidence": {"72016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72016]}
{"id": 1700, "claim": "Individually, these bNAbs have clear therapeutic efficacy in rhesus macaques [<|other_cit|>▪▪,<|multi_cit|>].", "evidence": {"72017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72017]}
{"id": 1701, "claim": "More recently, species differences have been pushed further with nonhuman primates showing increased translational validity in, for instance, regenerative medicine utilizing induced pluripotent stem cells [<|other_cit|>] and antiviral antibody therapy development [<|multi_cit|>].", "evidence": {"72018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [72018]}
{"id": 1702, "claim": "For example, HOTAIR, has been determined as a negative prognostic indicator in breast, liver and pancreatic cancer, representing a close association especially with breast cancer metastasis [<|multi_cit|>].", "evidence": {"58000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58000]}
{"id": 1703, "claim": "These studies suggest several interferon- and cell cycle-related genes as targets of HOTAIR in pancreatic cancer cells<|cit|>.", "evidence": {"58001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58001]}
{"id": 1704, "claim": "In recent years, increasing studies have revealed that dysregulation of lncRNAs might affect epigenetic information and provide a cellular growth advantage, resulting in progressive and uncontrolled tumor growth.<|multi_cit|> However, for most of these lincRNAs, the detailed functions, mechanisms and signaling pathways through which they exert their biological functions have not been well understood.", "evidence": {"58002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58002]}
{"id": 1705, "claim": "The details are as described previously.<|cit|>.", "evidence": {"58003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58003]}
{"id": 1707, "claim": "As a novel regulator in tumorigenesis, the expression of HOTAIR negatively correlates with tumor progression in several cancers, such as breast cancer [<|other_cit|>], pancreatic cancer [<|cit|>], colorectal cancer [<|other_cit|>], gastric cancer [<|other_cit|>] and hepatocellular carcinoma [<|other_cit|>].", "evidence": {"58004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [58004]}
{"id": 1710, "claim": "In this regard, HOTAIR is deregulated in various cancers like pancreatic cancer (<|cit|>), lung cancer (Loewen et al., 2014[<|other_cit|>]), esophageal cancer (Lv et al., 2013[<|other_cit|>]), and HCC.", "evidence": {"58005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58005]}
{"id": 1711, "claim": "The involvement of lncRNAs during tumorigenesis is a recent emerging theme (<|multi_cit|>).", "evidence": {"58006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58006]}
{"id": 1713, "claim": "Consistent with the results of previous studies on HOTAIR (<|cit|>), when the KYSE510 and KYSE180 cells were transiently transfected with HOTAIR siRNA using Lipofectamine 2000 (Invitrogen), which effectively knocked down the expression of HOTAIR within 48 h, a significant increase in apoptosis was observed in the KYSE510 and KYSE180 cells compared with cells infected with the control shRNA vector (<|other_cit|>).", "evidence": {"58007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58007]}
{"id": 1715, "claim": "And one of the deepest and broadest studied PRC2 interacting lncRNA is HOTAIR, which is deregulated in diverse cancers and could be an independent and powerful predictor of eventual metastasis and death [<|multi_cit|>, 8].", "evidence": {"58008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58008]}
{"id": 1716, "claim": "Similar to classical oncogenes or tumor-suppressor genes such as eIF4F (eukaryotic translation initiation factor 4F, <|other_cit|>) and DLK1 (Delta-like 1 homolog, <|other_cit|>), lncRNAs may act as oncogenes or tumor-suppressor genes by altering gene expression (<|multi_cit|>).", "evidence": {"58009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58009]}
{"id": 1718, "claim": "HOTAIR, a 2.2-kb-long transcript localized to the boundaries of the HOXC gene cluster, is highly expressed and correlated with metastasis in a variety of cancer types, including breast (<|other_cit|>), colorectal (<|other_cit|>), lung (<|other_cit|>), and pancreatic (<|cit|>) cancers.", "evidence": {"58010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58010]}
{"id": 1719, "claim": "Clinically, the overexpression of HOTAIR is a powerful predictor of overall survival and progression for several cancers, including gastrointestinal stromal tumours (<|other_cit|>), colon cancer (<|other_cit|>), pancreatic cancer (<|cit|>), hepatocellular carcinoma (<|other_cit|>), nasopharyngeal carcinoma (<|other_cit|>), and laryngeal SCC (<|other_cit|>).", "evidence": {"58011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58011]}
{"id": 1720, "claim": "The qPCR results were analyzed and expressed relative to the CT (threshold cycle) values and then converted to fold changes; 2.0-fold change was considered significant.<|cit|>.", "evidence": {"58012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [58012]}
{"id": 1721, "claim": "HOTAIR is the first discovered tumor related lncRNA and is upregulated in breast, hepatocellular, colorectal, pancreatic, and other cancers in recent years [<|multi_cit|>–32].", "evidence": {"58013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58013]}
{"id": 1722, "claim": "Although it has been demonstrated that lncRNAs influence epigenetic gene regulation (<|other_cit|>), proliferation (<|other_cit|>), apoptosis (<|other_cit|>) and prognosis (<|cit|>) in solid tumors, few studies have identified their effects on AML.", "evidence": {"58014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58014]}
{"id": 1723, "claim": "The subcutaneous growth of tumor was examined every three days, and tumor volumes were calculated using the equation V = 0.5 × D × d2 (V, volume; D, longitudinal diameter; d, latitudinal diameter) [<|cit|>].", "evidence": {"58015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [58015]}
{"id": 1725, "claim": "A study from the United Kingdom published in The Lancet reported similar results; 46.9% (AZ) and 20.7% (PF) of people aged 55 years or younger reported at least one systemic effect after receiving their first dose, compared with 30.7% (AZ) and 10.6% (PF) of those older than 55 [<|multi_cit|>].", "evidence": {"21000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21000]}
{"id": 1726, "claim": "It was proved, both in clinical trials and in the real-world data, that side effects associated with the COVID-19 vaccine are mild to moderate [<|multi_cit|>].", "evidence": {"21001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21001]}
{"id": 1727, "claim": "The frequency of reporting of adverse events following immunization was more common in younger respondents and this reflects the results reported by other authors [<|multi_cit|>].", "evidence": {"21002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21002]}
{"id": 1728, "claim": "This is in line with results of previous studies, which stated that Pfizer-BioNTech was associated with lower side effects compared to Oxford-AstraZeneca and other vaccines.<|other_cit|> Consistently, the previous published results of phase III clinical trials and the fact sheets of the vaccines, which reported post-vaccination symptoms for those who received the second dose.<|other_cit|> Similar findings were also reported in a recent prospective observational study performed by Menni et al.<|cit|> Similar findings were also reported in a recent prospective observational study performed by Menni et al.8", "evidence": {"21003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21003]}
{"id": 1729, "claim": "The ChAdOx1/AZD1222 effectiveness was investigated in 4 out of 27 studies [<|multi_cit|>], while only one study estimated Ad26.COV2.S effectiveness [<|other_cit|>].", "evidence": {"21004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21004]}
{"id": 1730, "claim": "Similar results were reported in previous studies after administration of the second vaccine dose.<|multi_cit|> A limitation of our study was the different survey methods in different age groups, which might have resulted in differences in reported proportions of AEs.", "evidence": {"21005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21005]}
{"id": 1731, "claim": "The two mRNA vaccines were the first to be administered, and for these vaccines as well as for DNA vaccines, some cases of hypersensitivity adverse reactions have been reported [<|multi_cit|>].", "evidence": {"21006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21006]}
{"id": 1732, "claim": "These findings resemble the results of other studies, demonstrating that systemic SRAEs were more frequent among the groups of vaccine recipients aged ≤55 years of BNT162b2 in the United Kingdom [<|cit|>].", "evidence": {"21007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21007]}
{"id": 1733, "claim": "The largest post-marketing study to date of COVID-19 vaccines analyzed the side effects of BNT162b2 (mRNA-based vaccine) and ChAdOx1 nCoV-19 (viral vector-based vaccine) reported by UK inhabitants using the COVID-19 Symptom Study app (ZOE Global, London, UK) [<|multi_cit|>].", "evidence": {"21008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21008]}
{"id": 1734, "claim": "This finding also agrees with other findings and confirms that the development of post-vaccinal side effects were significantly higher in females than in males (<|multi_cit|>).", "evidence": {"21009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21009]}
{"id": 1735, "claim": "These results are in agreement with previous works that reported lower adverse effects in males and those aged over 55 years [<|multi_cit|>].", "evidence": {"21010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21010]}
{"id": 1736, "claim": "These cutaneous reactions close to the injection site are common just as in other vaccines,<|other_cit|> and our result concurs well with a study conducted in Jordanian and Polish health workers.<|other_cit|> But this finding is higher than another prospective observational study conducted in the United Kingdom, which has shown injection site symptoms among 58.7% of study participants.<|cit|> Among the reported injection site symptoms, the commonest being injection site pain (65.48%) followed by tenderness (57.89%).", "evidence": {"21011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21011]}
{"id": 1737, "claim": "However, there are concerns regarding adverse events following vaccination  <|cit|> .", "evidence": {"21012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21012]}
{"id": 1738, "claim": "Up to 15 May, only two studies evaluated ChAdOx1/AZD1222 [<|multi_cit|>], and only one Ad26.COV2.S effectiveness [<|other_cit|>].", "evidence": {"21013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21013]}
{"id": 1739, "claim": "In an observational study that was done in the United Kingdom to report side effects following vaccination with Pfizer and AstraZeneca vaccines among general population, Pain at the injection site was identified in less than half of the participants and it is more common among women.<|cit|> In a study conducted by Hoffman et al, reported that 72% of females have no pain while 78% of males indicated they have no pain.<|other_cit|> Some theories revealed that both endogenous opioids and genetics have a fundamental role in these variations, while lots of studies imply that sex hormones influence pain sensitivity.", "evidence": {"21014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21014]}
{"id": 1740, "claim": "We confirm the predisposition of females to develop adverse reactions to the vaccine more frequently than males [<|multi_cit|>].", "evidence": {"21015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21015]}
{"id": 1742, "claim": "In this observational study of immunocompetent HCWs who received a third (booster) vaccine dose BNT162b2, the local and systemic reactions within 1 week after vaccination were mild and were similar to those observed in previous studies that evaluated the safety of the BNT162b2 primary series [<|multi_cit|>].", "evidence": {"21016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21016]}
{"id": 1743, "claim": "Although individuals may worry about the adverse effects of vaccines (e.g., serious effects of anaphylaxis and minor effects of nausea),<|multi_cit|> such worry seems not to be associated with mental QoL after individuals get vaccinated.", "evidence": {"21017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21017]}
{"id": 1745, "claim": "Research carried out thus far around the world as well as this report has shown that participants who were vaccinated with an Oxford–AstraZeneca vaccine are at a greater risk of systemic side effects, including fatigue and fever, compared with those who received a Pfizer–BioNTech vaccine [<|multi_cit|>].", "evidence": {"21018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21018]}
{"id": 1746, "claim": "Younger adults may report more adverse effects, probably due to their robust immune systems, than older adults [<|cit|>].", "evidence": {"21019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21019]}
{"id": 1747, "claim": "Nonetheless, most participants recovered in less than seven days despite a longer duration of headache post-PF [<|cit|>].", "evidence": {"21020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21020]}
{"id": 1748, "claim": "Gender discrepancy was more apparent in Polish HWs compared to results obtained from other CoVaST studies ([<|other_cit|>], <|other_cit|>) and independent, non-commercial surveys [<|multi_cit|>].", "evidence": {"21021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21021]}
{"id": 1749, "claim": "The similar finding was reported by the UK study were the side effects prevalence among the app user being significantly lower than the manufacturers’ reports [<|cit|>].", "evidence": {"21022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21022]}
{"id": 1751, "claim": "Both this study and the studies by Alhazmi et al. [<|other_cit|>] and Menni et al. [<|cit|>] showed that the vast majority of subjects reported side effects regardless of the type of vaccine received.", "evidence": {"21023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21023]}
{"id": 1752, "claim": "<|cit|>  Although rare, there is still concern over neurological vaccine-related side effects <|other_cit|> ; however, only two patients to date have reportedly developed NA involving the brachial plexus after receiving the BNT-162b2 (Pfizer, New York, NY, USA) vaccination antigen.<|other_cit|> The vaccination is suspected to elicit an immune-mediated inflammatory response to the injected antigen,<|other_cit|> and this vaccine-triggered immune reaction may result in an NA attack involving the lumbosacral plexus.", "evidence": {"21024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21024]}
{"id": 1753, "claim": "Incidence of AEFI reported in our study is more than reported in phase 1/2 clinical trial of this vaccine and study conducted among Armed Forces Medical Services healthcare workers (HCWs) deployed in northern India.[<|other_cit|>] Although it is lesser than reported by Kamal et al.[<|other_cit|>] and Menni et al.,[<|cit|>] and Menni et al.,[23] this variation could be because of different periods of follow-up.", "evidence": {"21025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21025]}
{"id": 1755, "claim": "Moreover, more than 90% of individuals reported that adverse effects cleared within 48 hours after COVID-19 vaccinations [<|cit|>].", "evidence": {"21026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21026]}
{"id": 1756, "claim": "The same order was found in both vaccines, the UK, Jordan, Saudi Arabia, and the Czech Republic [<|multi_cit|>].", "evidence": {"21027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21027]}
{"id": 1757, "claim": "Given the strong bias that can be caused by reduced test specificity and a high frequency of testing, it would not be unreasonable for the true VE  to be closer to our upper uncertainty interval, especially considering that effectiveness studies have estimated greater protection against infection than the trial [<|multi_cit|>].", "evidence": {"21028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21028]}
{"id": 1758, "claim": "This observation is coherent with previous results of the Phase IV trials of COVID-19 vaccines from the UK and Saudi Arabia [<|multi_cit|>].", "evidence": {"21029": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21029]}
{"id": 1759, "claim": "In a British prospective observational study, 71.9% and 68.5% of vaccinated people developed local adverse events after the first and second dose, respectively, and 13.5% and 22% developed systemic adverse events after the first and the second dose, respectively [<|cit|>].", "evidence": {"21030": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21030]}
{"id": 1761, "claim": "While the phase III trials used the retirement age cut-offs, e.g., 55 years-old and 65 years-old, some phase IV studies were inclined to use the median age of their own surveyed samples in order to compare the prevalence of post-vaccination side effects [<|multi_cit|>].", "evidence": {"21031": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21031]}
{"id": 1763, "claim": "Individuals who had been previously diagnosed with COVID-19 were more likely to report more side-effects after the first dose of the COVID-19 vaccine [<|multi_cit|>].", "evidence": {"21032": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21032]}
{"id": 1764, "claim": "These findings are consistent with the results of other studies.[<|multi_cit|>]", "evidence": {"21033": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21033]}
{"id": 1765, "claim": "Strikingly, in our study participants with past COVID-19 infection experienced the same trend of side effects of other studies, as well as a significantly higher rate of some systemic side effects including body pain, fatigue, and weakness in comparison with participants without past COVID-19 infection, however, some systemic side effect such as fever, headache, and joint pain were significantly less common in the participants with past COVID-19 infection<|multi_cit|>.", "evidence": {"21034": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21034]}
{"id": 1766, "claim": "These observations are in line with the results reported in phase three clinical trials and vaccine fact sheets [<|multi_cit|>].", "evidence": {"21035": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21035]}
{"id": 1767, "claim": "The effect of vaccination on the immunogenicity of individuals who encountered laboratory-confirmed COVID-19 is worth researching [<|cit|>].", "evidence": {"21036": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21036]}
{"id": 1768, "claim": "Still, they were more common with AZ, with at least one symptom reported by 33.7% after the first dose, compared to 13.5% and 22% after the first and second respective PF doses [<|cit|>].", "evidence": {"21037": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21037]}
{"id": 1769, "claim": "Most studies have assessed post-vaccination AEs of Pfizer–BioNTech, Moderna, and AstraZeneca vaccines,<|multi_cit|> but limited data are available on Sinopharm vaccine<|other_cit|> knowledge no comprehensive published studies are available in subjects with hemoglobinopathies.", "evidence": {"21038": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21038]}
{"id": 1770, "claim": "This study is one of the few studies that aims to enhance our emerging knowledge about the risk factors of COVID-19 vaccines side effects by inquiring and analyzing the self-reported side effects across various demographic and medical parameters [<|multi_cit|>].", "evidence": {"21039": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21039]}
{"id": 1771, "claim": "<|cit|>  However, the follow-up periods for monitoring vaccine-related complications have so far been short.", "evidence": {"21040": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21040]}
{"id": 1772, "claim": "However, the finding is inconsistent with that of other reports from Saudi Arabia [<|other_cit|>] and elsewhere [<|multi_cit|>], which suggested that female gender was a significant factor for the development of more severe and a higher number of COVID-19 post-vaccination adverse events.", "evidence": {"21041": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21041]}
{"id": 1774, "claim": "Menni et al., 2021 found that the British individuals aged 55 years or below had significantly higher prevalence of side effects following both mRNA-based and viral vector-based vaccines [<|cit|>].", "evidence": {"21042": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21042]}
{"id": 1775, "claim": "Younger adults may report more adverse events probably due to their robust immune system, than older adults [<|multi_cit|>].", "evidence": {"21043": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21043]}
{"id": 1776, "claim": "In contrary to our results, Menin et al. in a large prospective observational study in the UK found that systemic side effects after receiving Pfizer-BioNTech vaccine increased in the second dose<|cit|>.", "evidence": {"21044": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21044]}
{"id": 1777, "claim": "For example, Menni et al. [<|cit|>] recruited participants at the mean age of 50 y, and most of them were above 55 y.", "evidence": {"21045": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21045]}
{"id": 1778, "claim": "In this respect, our findings agree with other studies that reported similar findings (<|multi_cit|>).", "evidence": {"21046": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21046]}
{"id": 1779, "claim": "Other factors such as type of COVID-19 vaccine and dose received might also play an important role [<|multi_cit|>].", "evidence": {"21047": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21047]}
{"id": 1782, "claim": "Minor side effects after vaccination are fairly common; however, there have been some concerns regarding rare but serious adverse events of some vaccines  <|cit|> .", "evidence": {"21048": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21048]}
{"id": 1783, "claim": "Unlike other reports [<|multi_cit|>], in our study the history of a previous diagnosis of SARS-CoV-2 was not a predictor for adverse effects after vaccination.", "evidence": {"21049": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21049]}
{"id": 1784, "claim": "The proportion of self-reported AEs that occurred in our study was similar or lower than that after the administration of the second vaccine dose in several previous studies.<|multi_cit|>,4 A study by Menni et al4 found a similar proportion of systemic reactions among older individuals after the second vaccine dose as after the third dose in our study (16.4% vs 16.6%).", "evidence": {"21050": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21050]}
{"id": 1785, "claim": "Headache was also more common among females according to a study done by Menni et al in United Kingdom.<|cit|> In a study done in Germany, to report the incidence of adverse effects following vaccination with one of COVID-19 vaccines among HCWs, headache, chills and fever were also more common in women.<|other_cit|>", "evidence": {"21051": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21051]}
{"id": 1787, "claim": "As noted for the primary BNT162b2 series, local reactions and systemic symptoms were more frequent in persons 55 years or younger than in older individuals [<|multi_cit|>, 7].", "evidence": {"21052": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21052]}
{"id": 1788, "claim": "More specifically, individuals who receive a COVID-19 vaccine may feel physically safe (i.e., they have much less chance of being infected by COVID-19), which may lead them to have positive feelings concerning their health even though there are some vaccine-induced adverse effects.<|multi_cit|> Moreover, vaccines are likely improve the immune fitness for individuals<|other_cit|> and assist them in developing better physical health.", "evidence": {"21053": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21053]}
{"id": 1790, "claim": "This increased reactogenicity in those who received two vaccine doses could be explained by an increased vaccine-induced immunogenicity possibly leading to a more intense inflammatory response after the second dose in comparison to the first [<|cit|>].", "evidence": {"21054": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21054]}
{"id": 1791, "claim": "Overall, 31 studies were selected for data extraction and qualitative data synthesis [<|multi_cit|>] (<|other_cit|>).", "evidence": {"21055": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21055]}
{"id": 1793, "claim": "Our results are consistent with the findings of this UK study; as the mRNA-based vaccine was associated with a higher prevalence of local side effects (71.7% vs. 58.7%), while the viral vector-based vaccine was associated with a higher prevalence of systemic side effects (33.7% vs. 20%) among the British population [<|cit|>].", "evidence": {"21056": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21056]}
{"id": 1794, "claim": "Although a recent study that aimed to investigate the safety and effectiveness of these vaccines in a UK community setting and used obesity to adjust all models found some differences between strata of BMI, there was no clear trend across vaccines and doses [<|cit|>].", "evidence": {"21057": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21057]}
{"id": 1795, "claim": "Only allergic reaction, defined as a condition that developed within 24 hours of vaccine administration and needed medical attention/admission [<|cit|>], was found to be associated with PF compared to AZ with 4/162 (2.4%) and 1/286 (0.2%), which developed an allergic reaction, respectively, p value = 0.006 (Table <|other_cit|>).", "evidence": {"21058": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21058]}
{"id": 1797, "claim": "Moreover, Menin et al. reported local side effect in the injection site (1.4 times after the first dose of Oxford-AstraZeneca and 1.2 times after the first dose of Pfizer-BioNTech) and systemic side effects (1.6 times after the first dose of Oxford-AstraZeneca and 2.9 times after the first dose of Pfizer-BioNTech) were higher in individuals previously infected than in those without known past COVID-19 infection<|cit|>.", "evidence": {"21059": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21059]}
{"id": 1798, "claim": "In a study from the UK, individuals below 55 years of age had significantly higher levels of side effects following immunization with both mRNA and viral vector vaccines [<|cit|>].", "evidence": {"21060": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [21060]}
{"id": 1799, "claim": "On one hand, they negatively regulate the E-cadherin transcriptional repressors ZEB1/2 preventing EMT and on the other, they have been associated with global shifts in gene expression which promote metastatic colonization in breast cancer mouse models [<|multi_cit|>].", "evidence": {"75000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75000]}
{"id": 1800, "claim": "Currently these results are supported by those of Dykxhoorn et al. [<|other_cit|>] and Korpal et al. [<|cit|>] and Korpal et al. [65], both of which demonstrated that expression of 200c increases the metastatic phenotype in tumor cells that escape the primary tumor by enforcing the epithelial phenotype and/or suppressing tumor suppressive proteins induced by Sec23a, a target of mir-200c.", "evidence": {"75001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75001]}
{"id": 1801, "claim": "A previous study looking at E-cadherin expression in tumors of all types and patient survival found that E-cadherin did not have predictive value [<|cit|>], whereas another study showed that E-cadherin expression (in basal tumors specifically) was associated with a poor prognosis [<|other_cit|>].", "evidence": {"75002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75002]}
{"id": 1802, "claim": "CTCs express a strong epithelial gene program and epithelial-type cells promote tumor colonization and proliferation [<|cit|>] reported a heterogeneous expression pattern of vimentin in MDA-MB-468 xenografts and clinical human invasive breast tumor specimens.", "evidence": {"75003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [75003]}
{"id": 1803, "claim": "However, these and other studies suggest that, as pulmonary metastases progress from micro- to macroscopic lesions, E-cad expression returns in a manner reminiscent of the differentiation status observed in noninvasive primary tumors [<|multi_cit|>].", "evidence": {"75004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [75004]}
{"id": 1804, "claim": "For example, miR-200s is downregulated and inhibit local invasion in breast cancer but enhances spontaneous metastasis and colonization of lung adenocarcinoma [<|cit|>].", "evidence": {"75005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [75005]}
{"id": 1805, "claim": "To better understand these findings, Korpal and colleagues [<|cit|>].", "evidence": {"75006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75006]}
{"id": 1806, "claim": "Furthermore, the behavior of trophoblasts invading the uterus resembles that of metastatic tumor cells, and recent studies have revealed a novel role for TINAGL1 that is associated with metastasis in cancer cells [<|multi_cit|>].", "evidence": {"75007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75007]}
{"id": 1807, "claim": "Experimental evidence has pointed to EMT/MET plasticity as a requirement for different steps in the metastatic cascade [<|multi_cit|>], but these studies typically have relied upon overexpression of EMT regulatory factors and therefore, may not reflect what happens in cells that activate or suppress endogenous EMT regulatory factors.", "evidence": {"75008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75008]}
{"id": 1808, "claim": "TINAGL1 is a Sec23a-dependent metastasis suppressor [<|cit|>] and was reported to be upregulated in highly metastatic tumors [<|other_cit|>].", "evidence": {"75009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75009]}
{"id": 1809, "claim": "Release of secreted proteins (termed the secretome) appears to underline the progression of the metastatic phenotype [<|cit|>].", "evidence": {"75010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75010]}
{"id": 1810, "claim": "Members of this family directly target the metastasis-promoting protein, WAVE3, to inhibit PCa cell invasion.<|other_cit|> These miRNAs also target the E-cadherin transcriptional repressors, ZEB1 and ZEB2, and were identified as determining factors in the development of cancer cell epithelial phenotypes.<|other_cit|> Moreover, miR-200b negatively regulates vascular endothelial growth factor (VEGF) signaling by targeting the VEGF and the VEGF receptor and could have therapeutic potential as an angiogenic inhibitor.<|other_cit|> However, the miR-200 family has been associated with Sec23-mediated inhibition of metastasis-suppressing proteins<|cit|> and adhesion improvements at distant sites to promote EMT and increased colonization.<|other_cit|> Therefore, the miR-200 family was found to have different roles in various stages of metastasis.<|other_cit|>", "evidence": {"75011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75011]}
{"id": 1811, "claim": "Furthermore, miR-200 was found silencing Sec-23a and promoting metastases by inhibiting TINAGL1 and IGFBP4 [<|cit|>].", "evidence": {"75012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75012]}
{"id": 1812, "claim": "However, pioneering studies inspecting the in vivo relevance of MET in mouse models have already suggested that CTCs in which the EMT is partially blocked, exhibit facilitated colonization of distant organs [<|multi_cit|>].", "evidence": {"75013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75013]}
{"id": 1814, "claim": "The few surviving cells must then extravasate and colonize secondary organs to establish metastases, where the reverse process, mesenchymal to epithelial transition (MET), may then be required for metastatic cells to proliferate and grow into life-threatening macrometastases [<|multi_cit|>, 14].", "evidence": {"75014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75014]}
{"id": 1815, "claim": "There is evidence that efficient metastasis requires re-differentiation (MET) [<|multi_cit|>].", "evidence": {"75015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75015]}
{"id": 1816, "claim": "A possible role of miR-200 family in CRPC is enhanced metastatic ability, as observed in breast cancer [<|cit|>].", "evidence": {"75016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75016]}
{"id": 1817, "claim": "Various studies have also shown that the miR-200 family has dual functions in breast cancer progression [<|multi_cit|>].", "evidence": {"75017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75017]}
{"id": 1818, "claim": "MET enables metastatic cancer cells to acquire epithelial phenotype and colonize in distant organs [<|multi_cit|>].", "evidence": {"75018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75018]}
{"id": 1819, "claim": "Korpal et al. recently demonstrated that the miR-200 family was important in distal metastasis of breast cancer cells by facilitating epithelial colonization in lung through induction of mesenchymal to epithelial transition (MET) [<|cit|>] (<|other_cit|>).", "evidence": {"75019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75019]}
{"id": 1820, "claim": "The reported results from several recent studies suggest that metastatic breast cancer (BC) cells undergo epithelial–mesenchymal transition (EMT) during invasion and dissemination and that the reverse process of mesenchymal–epithelial transition (MET) occurs at some point during metastatic tumor outgrowth [<|multi_cit|>].", "evidence": {"75020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75020]}
{"id": 1821, "claim": "Despite strong evidence that miR-200s inhibit EMT and suppress cancer cell invasion, several functional overexpression studies have yielded conflicting results on the role of miR-200s in metastasis, supporting both their anti-metastatic (<|other_cit|>) and pro-metastatic (<|multi_cit|>,46) potential.", "evidence": {"75021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75021]}
{"id": 1822, "claim": "Perhaps consistent with this, breast cancers expressing higher levels of the epithelium-promoting miR-200 family that represses the CDH1-suppressing EMP drivers ZEB1 and ZEB2 have poorer outcomes; however, this appeared to be due to mechanisms additional to E-cadherin regulation [<|cit|>].", "evidence": {"75022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75022]}
{"id": 1823, "claim": "Interestingly, although miR-200 was reported as an anti-EMT miRNA that inhibits tumor invasion, a recent study by Korpal et al.<|cit|>.", "evidence": {"75023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [75023]}
{"id": 1827, "claim": "Moreover, it has been proposed that repopulating the brain with wild-type microglia by irradiation followed by bone-marrow transplantation could arrest the pathology in a mouse model of RTT [<|cit|>].", "evidence": {"74000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74000]}
{"id": 1828, "claim": "Although the precise mechanism mediating adverse microglial effects on neurons is still debated [<|multi_cit|>], excessive release of glutamate [<|other_cit|>] and inflammatory cytokines have been replicated in different studies [<|other_cit|>].", "evidence": {"74001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [74001]}
{"id": 1831, "claim": "A recent study by Derecki et al. (<|cit|>).", "evidence": {"74002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74002]}
{"id": 1833, "claim": "The importance of replication studies has recently been highlighted by the failure to confirm the potential benefit of bone marrow transplantation in a mouse model of RTT (<|multi_cit|>).", "evidence": {"74003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74003]}
{"id": 1834, "claim": "Contradicting this finding are several studies showing MeCP2 expression in astrocytes and microglia and that MeCP2 functions in astrocytes and microglia affect the phenotype in mouse models of RTT.<|multi_cit|>-8", "evidence": {"74004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74004]}
{"id": 1835, "claim": "A major study demonstrated that a Rett Syndrome-like phenotype, present in microglia-specific MECP2 KO mice, could be reversed by replenishing the MECP2 KO with wild type microglia (<|cit|>).", "evidence": {"74005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74005]}
{"id": 1837, "claim": "Besides participating in information processing at the level of synapses, microglia are involved in complex brain functions, such as learning-induced synaptic plasticity, memory and cognition [<|other_cit|>], and mouse behaviour [<|multi_cit|>].", "evidence": {"74006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74006]}
{"id": 1839, "claim": "However, more recent studies have shown that MeCP2 is also expressed in all glial cell types, including astrocytes, oligodendrocyte progenitor cells, oligodendrocytes, and microglia (<|multi_cit|>).", "evidence": {"74007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [74007]}
{"id": 1840, "claim": "Several recent reports have implicated a role of glia in the progression of RTT (<|multi_cit|>).", "evidence": {"74008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74008]}
{"id": 1841, "claim": "Similarly, in Rett syndrome (an X-linked neurodevelopmental disease caused by mutations of MECP2), our group showed that bone marrow transplantation with engraftment of wildtype microglia-like cells, or selective genetic rescue of myeloid cells, including some microglia, in otherwise Mecp2-null mice ameliorates some disease symptoms and extends lifespan [<|cit|>].", "evidence": {"74009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74009]}
{"id": 1842, "claim": "Also, the introduction of wild type BM into MeCP2−/− mice, which, according to the authors, lead to engraftment of wild type microglia, rescued the phenotype (Lioy et al., <|multi_cit|>).", "evidence": {"74010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74010]}
{"id": 1843, "claim": "Another relevant study proposed the hypothesis that blood marrow transplantations could improve the phenotype of mice with syndromic forms of ASD, such as RTT (<|cit|>).", "evidence": {"74011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74011]}
{"id": 1844, "claim": "In a mouse model of Rett syndrome, transplantation of wild-type bone marrow resulted in wild-type microglial engraftment, which showed significant improvements in autistic symptoms (<|cit|>).", "evidence": {"74012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74012]}
{"id": 1845, "claim": "MECP2 is expressed in many tissues but, although the disease is generally attributed to a primary neuronal dysfunction, glial MECP2 seems to play a pathophysiological role as it has been recently shown that MECP2-null astrocytes are unable to support the normal dendritic ramification of wild-type neurons growing in culture (<|other_cit|>), and two remarkable studies have found that the expression of wild-type MECP2 protein in the astrocytes or microglia of MECP2-null hosts dramatically improves the pathology (<|multi_cit|>; Derecki et al., 2012).", "evidence": {"74013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74013]}
{"id": 1846, "claim": "Therefore, bone marrow transplant from healthy animals into mutant Mecp2 male animals is being investigated as an approach for amelioration of RTT symptoms (<|cit|>).", "evidence": {"74014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74014]}
{"id": 1848, "claim": "Selective correction of Rett syndrome microglia with wild type microglia using a Cre-Lox based system in mice produced an improvement of symptoms, one that could be reversed using annexin IV, suggesting that microglia-mediated phagocytosis is a key mechanism of Rett syndrome pathology (<|cit|>).", "evidence": {"74015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74015]}
{"id": 1850, "claim": "For example, bone marrow transplantation of mouse models for metachromatic leukodystrophy (Biffi et al., <|other_cit|>), the obsessive compulsive disorder trichotillomania (Chen et al., <|other_cit|>), and Rett syndrome (<|cit|>), and Rett syndrome (Derecki et al., 2012) has been shown to ameliorate disease symptoms.", "evidence": {"74016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74016]}
{"id": 1851, "claim": "Genetic manipulation affecting specific microglial function resulted in behavioral alterations reminiscent of obsessive-compulsive disorder (<|other_cit|>) and Rett Syndrome (<|multi_cit|>), and in impaired functional brain connectivity reminiscent of autism and other neurodevelopmental disorders (<|other_cit|>).", "evidence": {"74017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [74017]}
{"id": 1852, "claim": "Hypertension [<|other_cit|>], obesity [<|cit|>], abdominal fat [<|other_cit|>], diabetes [<|other_cit|>], dyslipidemia [<|other_cit|>], inflammation as reflected by high levels of C-reactive protein (CRP) [<|other_cit|>], are associated with CAD.", "evidence": {"59000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59000]}
{"id": 1854, "claim": "Aortic stiffness is an independent risk factor for incident hypertension, cardiovascular disease, and stroke,<|other_cit|> and it is associated with age-related physical<|other_cit|> and cognitive functioning in older people.<|other_cit|> In addition to the known effects of raised BMI on cardiovascular disease risk,<|multi_cit|> our prospective longitudinal findings, based on >5000 participants, add to the evidence that excess adiposity and class I obesity are important determinants of the rate of arterial aging.", "evidence": {"59001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59001]}
{"id": 1855, "claim": "It is now well-documented that overweight and obesity are associated with increased morbidity and mortality [<|multi_cit|>].", "evidence": {"59002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59002]}
{"id": 1856, "claim": "Mean body mass index (BMI) and the prevalence of obesity (BMI≥30 kg/m2) were also determined, but not used in calculation of a cardiac risk factor score (see below) because the effect of obesity on cardiovascular risk is believed to be mediated through its effect on the other traditional risk factors.<|cit|> However, adjustment for BMI was included as a sensitivity analysis in regression analyses (see Statistical Analyses).", "evidence": {"59003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59003]}
{"id": 1857, "claim": "Metabolic risk factors are associated with shorter life expectancy due to the increased possibility of developing CVD.<|other_cit|> Furthermore, metabolic risk factors may be mediators of other risk factors including changes in the diet and decreasing levels of physical activity.<|multi_cit|> 39 Effective interventions to reduce the burden of metabolic risk factors should be implemented.", "evidence": {"59004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59004]}
{"id": 1859, "claim": "Obesity clinically leads to nonalcoholic fatty liver disease (NAFLD) [<|other_cit|>], type 2 diabetes [<|other_cit|>], and coronary heart disease [<|cit|>].", "evidence": {"59005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59005]}
{"id": 1861, "claim": "Severe obesity is defined as a body mass index (BMI) ≥40 kg/m2 and is independently asscociated with an increased risk of coronary artery disease (CAD) [<|multi_cit|>].", "evidence": {"59006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59006]}
{"id": 1862, "claim": "The global burden of cardio-metabolic risk factors adjusted for age and sex has been shown to be greater in Eastern than in Western European countries [<|cit|>].", "evidence": {"59007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59007]}
{"id": 1864, "claim": "BMI increase the risk of stroke and the most important three mediators are high BP, cholesterol, and glucose [<|cit|>], which was consistent with our study.", "evidence": {"59008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59008]}
{"id": 1867, "claim": "Recently, metabolic health has gained an increasing attention to its potential mediating role in cardiovascular diseases [<|cit|>] and cancers [<|other_cit|>].", "evidence": {"59009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59009]}
{"id": 1868, "claim": "Obesity is also associated with other metabolic diseases, and it frequently increases the risk of cardiovascular disease [<|cit|>], hypertension [<|other_cit|>], Diabetes Mellitus (DM) [<|other_cit|>], and cancer [<|other_cit|>].", "evidence": {"59010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59010]}
{"id": 1869, "claim": "Obesity is considered as an important health problem causing morbidity and mortality <|cit|> .", "evidence": {"59011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59011]}
{"id": 1870, "claim": "Increased body fat mass also raises the risk of mortality (<|multi_cit|>) and shares direct links to gallbladder disease, gout, pulmonary diseases, and sleep apnea (<|other_cit|>), while the absence of excess body fatness lowers the risk of most cancers (<|other_cit|>).", "evidence": {"59012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59012]}
{"id": 1872, "claim": "The prevalence of obesity has increased worldwide over the past 30 years.<|other_cit|> Observational epidemiologic studies have revealed a “U”- or “J”-shaped relationship between body mass index (BMI) and mortality,<|other_cit|> with mortality rates elevated in persons with low (<23 kg/m2) and high (>28 kg/m2) BMI.<|other_cit|> Most studies have focused on the prevalence of high BMI, associating it with increased risk of conditions such as coronary heart disease, stroke, diabetes, and cancer.<|cit|> Relative to normal weight, obesity has also been associated with significantly higher all-cause mortality.<|other_cit|> In 2010, overweight and obesity were estimated to cause 3.4 million deaths, 4% loss of years of life, and 4% loss of disability-adjusted life-years worldwide.<|other_cit|> Obesity has become a major global health challenge, and its high incidence will affect future population health and economics.<|other_cit|> In the past 3 decades, no nation has been able to successfully control this health problem.<|other_cit|>", "evidence": {"59013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59013]}
{"id": 1873, "claim": "In this context we think it important to acknowledge the influence of other demographic factors operating within the Canadian population, notably the rise in obesity,<|other_cit|> which may have attenuated the response to risk factor intervention.<|other_cit|> The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration<|cit|> The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration13 provides another valuable perspective on this matter.", "evidence": {"59014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59014]}
{"id": 1874, "claim": "While body mass index (BMI) is an important determinant for both vitamin D status [<|other_cit|>] and CHD [<|cit|>] and CHD [46] it was not available for a sufficient proportion of the cohort to be used in the analyses undertaken in this study.", "evidence": {"59015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [59015]}
{"id": 1876, "claim": "For this, we intersected the genes measured both by Blanco et al.<|cit|> and CMap<|other_cit|>, resulting in 911 genes.", "evidence": {"14000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14000]}
{"id": 1877, "claim": "Innate and adaptive immune responses on SARS-CoV-2 infection generally begin at cellular level after viral evasion.<|multi_cit|> SARS-CoV-2 has a preferential tropism toward airway epithelial cells through approaching to the angiotensin-converting enzyme 2 (ACE2) receptor.<|other_cit|> During infection, SARS-CoV-2 attacks and replicates in human airway epithelial cells, which triggers the activation of inflammatory responses and leads to subsequent virus-triggered pyroptosis and release of inflammatory cytokines.<|other_cit|> Pattern recognition receptors (PRRs) of alveolar epithelial cells and alveolar macrophages are then activated by targeting a set of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs).<|other_cit|> PRRs then activate the inflammatory signaling pathway, triggering a wave of local inflammation and a robust secretion of pro-inflammatory cytokines and chemokines, including IL-6 and IFNγ.<|other_cit|> Cytokines and chemokines secretion attract more immune cells to the infected site, particularly monocytes and T cells, as the infiltration of lymphocytes into airways could be observed at about 80% patients with SARS-CoV-2 infection.<|other_cit|> In most cases, recruited immune cells remove SARS-CoV-2 in the lung and reduce the immune responses.", "evidence": {"14001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14001]}
{"id": 1878, "claim": "In order to determine the ACE2-mediated SARS-CoV-2 genes, we computed three different  -fold changes based on the data from<|cit|>.", "evidence": {"14002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14002]}
{"id": 1879, "claim": "The fact that we found sCD14-ST, but not sCD14 levels, to be strongly associated with inflammatory biomarkers that have been implicated as markers of disease severity in COVID-19 (<|multi_cit|>) suggests that sCD14-ST levels may be a good indicator of the pathophysiologic processes leading to these outcomes.", "evidence": {"14003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14003]}
{"id": 1880, "claim": "Our previous studies have shown that innate antiviral immunity may play an important role in the SARS-CoV-2 clearance observed in COVID-19.<|other_cit|> SARS-CoV-2–mediated dysregulation of innate antiviral immunity and inflammatory responses is largely responsible for human deaths caused by COVID-19.6,<|other_cit|> Type I and III IFNs are typically suppressed in COVID-19 patients; however, the molecular mechanism of this phenomenon induced by SARS-CoV-2 needs to be elucidated.<|multi_cit|> Here, we reported that the SARS-CoV-2 M protein can target the cytosolic RNA-sensing pathway of RIG-I/MDA-5 signaling to block the activation of type I and III IFN responses, thus inhibiting host antiviral immunity.", "evidence": {"14004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14004]}
{"id": 1881, "claim": "To evidence the use of this workflow, we applied it to study the effect of SARS-CoV-2 infection in lung epithelial (NHBE) cells using transcriptomics data published by Blanco-Melo et al. [<|cit|>].", "evidence": {"14005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14005]}
{"id": 1882, "claim": "Although further investigation is required, this finding indicates a possible mechanistic explanation for the poor induction of type I interferon response seen in SARS-CoV-2 infections [<|multi_cit|>].", "evidence": {"14006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14006]}
{"id": 1883, "claim": "Notably, severe COVID-19-specific signatures, including various ISGs discovered in that study, were also significantly enriched in the transcriptome of postmortem lung tissue from COVID-19 patients<|cit|>.", "evidence": {"14007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14007]}
{"id": 1884, "claim": "To support this, the addition of type I interferon to the culture of a bronchial epithelial cell line induced a dramatic reduction in viral replication, yet antagonism of type I interferon signaling by ruxolitinib had little effect on the production of inflammatory mediators (<|cit|>).", "evidence": {"14008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14008]}
{"id": 1885, "claim": "Auto-Abs against type I IFNs were clinically silent until patients were infected with SARS-CoV-2, which is a poor inducer of type I IFNs.<|cit|> Therefore, the little IFNs induced by the virus are sufficient for protection against severe disease.", "evidence": {"14009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14009]}
{"id": 1886, "claim": "This validated previous investigation revealed lower amounts of IFN-α in hospitalized COVID-19 patients versus controls [<|cit|>] and in severely ill COVID-19 individuals versus mild-moderate COVID-19 patients [<|other_cit|>].", "evidence": {"14010": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14010]}
{"id": 1887, "claim": "We chose level 2 data, truncated to only the genes that were also measured by ref. <|cit|> under accession code GSE92742.", "evidence": {"14011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14011]}
{"id": 1888, "claim": "All three methods were applied to 63 human RNA-seq datasets from independent research studies, five of which are known to contain SARS-CoV-2<|multi_cit|>.", "evidence": {"14012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14012]}
{"id": 1889, "claim": "Used as a model system for lung epithelial cells and the effect of SARS-CoV-2 infection, we obtained from ref. <|cit|>, RNA-seq samples from normal and SARS-CoV-2-infected A549 lung alveolar cells as well as A549 cells supplemented with ACE2 (A549-ACE2), a receptor that has been shown to be critical for SARS-CoV-2 cell entry<|other_cit|>.", "evidence": {"14013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14013]}
{"id": 1890, "claim": "Such lung injuries might be due to suboptimal host reaction to the infection, possibly characterized by a weak antiviral response and elevated expression of proinflammatory cytokines, as demonstrated by an in vitro study (<|cit|>).", "evidence": {"14014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14014]}
{"id": 1891, "claim": "The RNA-seq gene expression data related to SARS-CoV-2 infection in A549 and A549-ACE2 cells were obtained from ref. <|cit|> under accession code GSE147507.", "evidence": {"14015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14015]}
{"id": 1892, "claim": "By day 7 post-infection in ferrets, despite low virus levels, the transcription of cytokines and chemokines continues to expand (<|cit|>).", "evidence": {"14016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14016]}
{"id": 1894, "claim": "Currently available data relating to intracellular SARS-CoV-2 infection includes human binding partners of viral proteins [<|other_cit|>] and transcriptomics datasets from infected cell lines [<|multi_cit|>], infected patients [<|other_cit|>] and other infected animals [11,<|other_cit|>].", "evidence": {"14017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14017]}
{"id": 1895, "claim": "Whereas genetic and acquired defects in the type I IFN pathway have been shown to predispose to more severe outcomes in coronavirus disease 2019 (COVID-19) (<|multi_cit|>), the consequences of this infection in the setting of upregulated type I IFN signalling are less well understood.", "evidence": {"14018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14018]}
{"id": 1896, "claim": "To put these AUC values into perspective and assess the robustness of the identified drug list using the autoencoder embedding, we repeated the analysis on two other SARS-CoV-2 datasets from<|cit|>, namely infected A549 cells without ACE2 supplement as well as samples collected at a lower MOI (0.2 instead of 2).", "evidence": {"14019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14019]}
{"id": 1897, "claim": "These 14 genes are also documented to involve in the host response to COVID-19 (<|cit|>).", "evidence": {"14020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14020]}
{"id": 1898, "claim": "Both ferrets and mink are members of the Mustelidae and are naturally highly susceptible to several human respiratory viruses, including SARS-CoV-1.<|other_cit|> Thus, it is reasonable to assume that SARS-CoV-2 infection could also be studied using these models.<|other_cit|> The susceptibility of minks was confirmed by a report on the numerous infections with SARS-CoV-2 across 40 farms in 2020.<|other_cit|> Upon infection, ferrets showed common clinical symptoms such as fever and mild respiratory symptoms, but no death was record.<|other_cit|> Virus replication was detectable in nasal washes, saliva, urine, and feces until the 8th day post infection (dpi), usually peaking on the 3rd dpi and in some studies, declined gradually and completely disappeared by the 14th dpi.<|cit|> Ryan et al.<|other_cit|> infected ferrets with three SARS-CoV-2 dosages.", "evidence": {"14021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14021]}
{"id": 1899, "claim": "We trained an autoencoder (architecture described in Supplementary Fig. <|other_cit|>) to minimize reconstruction error on CMap data and applied it to data from Blanco-Melo et al.<|cit|> in the L1000 gene expression space.", "evidence": {"14022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14022]}
{"id": 1901, "claim": "A recent report thoroughly characterized the gene expression associated with SARS-CoV-2 in human lung-derived epithelial cell lines, primary cultured human bronchial epithelial cells, infected ferrets, and COVID-19 patients (<|cit|>).", "evidence": {"14023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14023]}
{"id": 1902, "claim": "In order to test how specific our findings are to SARS-CoV-2 and demonstrate the broad applicability of our pipeline, we repeated the analysis on gene expression data available from<|cit|> for the respiratory syncytial virus (RSV) and influenza A virus (IAV); see <|other_cit|> for a detailed description of the analysis.", "evidence": {"14024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14024]}
{"id": 1903, "claim": "The gRNA is packaged into structures comprising the structural proteins, namely, the spike, membrane (M), and envelope proteins, to assemble progeny virions.<|other_cit|> Like SARS and MERS, COVID-19 may be life-threatening and typically begins with pneumonia.<|other_cit|> During the period 2002–2003, SARS-CoV-1 infected ∼8000 people, with an ∼11% fatality rate worldwide; since 2012, MERS-CoV has infected ∼2500 people with an ∼36% fatality rate.<|cit|> As of June 27, 2020, SARS-CoV-2 has infected 9,827,925 individuals and caused 494,841 deaths since its initial outbreak in December 2019, according to the COVID-19 Dashboard maintained by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (https://coronavirus.jhu.edu/map.html).", "evidence": {"14025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14025]}
{"id": 1905, "claim": "We downloaded raw counts tables from a transcriptomics study of SARS-CoV-2 infected (MOI 2, 24 hour incubation) NHBE cells (Normal Human Bronchial/tracheal Epithelial cell line) with uninfected controls [<|cit|>] via Gene Expression Omnibus (accession GSE147507) [<|other_cit|>].", "evidence": {"14026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14026]}
{"id": 1908, "claim": "The immunopathology of Coronavirus Disease 2019 (COVID-19) that results from SARS-CoV-2 infection is highlighted by weak innate antiviral responses as a result of inadequate production of the antiviral cytokines (type I and type III interferons), and robust pro-inflammatory responses with high levels of chemokine and cytokine expression (<|cit|>).", "evidence": {"14027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14027]}
{"id": 1909, "claim": "Viral encoding of IFN antagonists is a common strategies for evading host antiviral immunity.<|other_cit|> SARS-CoV-1-encoded proteins, such as nonstructural protein 1, the papain-like protease domain in NSP3, ORF3b, ORF6, the M protein, and the nucleocapsid protein, have been suggested to antagonize IFNs and ISGs.<|other_cit|> In a recent screening study, SARS-CoV-2 M protein was shown to inhibit Sendai virus (SeV)-induced IFN-β promoter activation.<|other_cit|> The common respiratory virus influenza A virus also encodes an IFN antagonist, nonstructural protein 1, which blocks initial detection by PRRs through binding and masking aberrant RNAs produced during infection.<|cit|> The generation of IFN antagonists by viruses is a common strategy for evading host antiviral immunity.<|other_cit|> A striking clinical feature of COVID-19 is the drastic impairment of antiviral immunity.6,<|other_cit|> SARS-CoV-2 infection induces low-level expression of type I and III IFNs, accompanied by a moderate ISG response.6", "evidence": {"14028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14028]}
{"id": 1911, "claim": "The prize of a terminal node equals the absolute value of its  -fold change in SARS-CoV-2-infected A549-ACE2 cells versus normal A549-ACE2 cells (shown in purple shading) based on the data from ref. <|cit|>.", "evidence": {"14029": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14029]}
{"id": 1913, "claim": "By combining bulk RNA-seq data from GTEx<|other_cit|> and Blanco et al.<|cit|>, we identified a critical group of genes that were differentially expressed by aging and by SARS-CoV-2 infection.", "evidence": {"14030": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14030]}
{"id": 1914, "claim": "While ongoing drug repurposing efforts have analyzed host–pathogen interactions and the associated gene expression programs<|multi_cit|>, they have lacked integration with aging.", "evidence": {"14031": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14031]}
{"id": 1915, "claim": "Consistent with our result, scientists have reported that the increasing level of IFN-I-related genes in the onset of COVID-19 is reversed in the late stage due to the enhanced load of SARS-CoV-2 virus (<|cit|>).", "evidence": {"14032": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14032]}
{"id": 1916, "claim": "The generation of IFN antagonists by viruses is a common strategy for evading host antiviral immunity.<|other_cit|> A striking clinical feature of COVID-19 is the drastic impairment of antiviral immunity.<|multi_cit|> SARS-CoV-2 infection induces low-level expression of type I and III IFNs, accompanied by a moderate ISG response.6", "evidence": {"14033": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14033]}
{"id": 1917, "claim": "Other manifestations that are considered atypical for a respiratory infection, such as coagulopathy (<|other_cit|>), thrombosis (<|other_cit|>), vasculitis (<|other_cit|>) and dysregulated inflammatory responses (<|multi_cit|>) were also reported in CoVID-19 patients.", "evidence": {"14034": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14034]}
{"id": 1918, "claim": "Indeed, similar to other studies we also found elevated serum cytokines in plasma from moderate/severe COVID19 <|multi_cit|>.", "evidence": {"14035": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14035]}
{"id": 1919, "claim": "Indeed, SARS-CoV-2 induced an aberrant type-I IFN response in cultured cells, characterized by a delayed antiviral response which may provide a window for virus replication and an improper recruitment of inflammatory monocyte macrophage populations (<|cit|>).", "evidence": {"14036": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14036]}
{"id": 1920, "claim": "Currently available data relating to intracellular SARS-CoV-2 infection includes human binding partners of viral proteins [<|other_cit|>] and transcriptomics datasets from infected cell lines [<|other_cit|>–11], infected patients [<|other_cit|>] and other infected animals [<|multi_cit|>].", "evidence": {"14037": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14037]}
{"id": 1921, "claim": "Similarly, the examination of post-mortem COVID-19-infected lung tissue demonstrates that SARS-CoV-2 evokes a distinctive transcriptional response, which lacks type I and type III IFN expression (<|multi_cit|>).", "evidence": {"14038": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14038]}
{"id": 1922, "claim": "In order to identify potential drug candidates for COVID-19, we integrated RNA-seq data from SARS-CoV-2-infected cells, obtained from ref. <|cit|>, and RNA-seq data from the lung tissue of young and old individuals, collected as part of the Genotype-Tissue Expression (GTEx) project<|other_cit|>, with protein–protein interaction data (from ref. <|other_cit|>), drug–target data (from DrugCentral<|other_cit|>) and the large-scale transcriptional drug screen Connectivity Map (CMap)<|other_cit|>.", "evidence": {"14039": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14039]}
{"id": 1924, "claim": "Specifically, the SARS-CoV-2 infection produces an inadequate and postponed IFN-I response that has been considered the main contributor to disease severity [<|multi_cit|>].", "evidence": {"14040": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14040]}
{"id": 1925, "claim": "Four datasets were derived from primary human lung epithelium cells (NHBE) infected with SARS-CoV-2 in vitro (NCBI SRA accession: SRX7990869)<|cit|>.", "evidence": {"14041": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14041]}
{"id": 1926, "claim": "We then considered the data of the genes differentially expressed in COVID-19 patients [<|cit|>] and intersected them with the list of genes targeted by the miRNAs (<|other_cit|>).", "evidence": {"14042": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14042]}
{"id": 1927, "claim": "Given the age-dependent pathogenicity of SARS-CoV-2, we first identify genes that are differentially regulated by SARS-CoV-2 infection and aging based on bulk RNA-seq data from<|multi_cit|>.", "evidence": {"14043": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14043]}
{"id": 1928, "claim": "An early study reported that type I IFN responses were limited in postmortem lung tissues from lethal cases of COVID-19, which was consistent with the data from bronchial epithelial cells infected in vitro and ferrets infected in vivo with SARS-CoV-2<|cit|>.", "evidence": {"14044": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14044]}
{"id": 1929, "claim": "The generation of IFN antagonists by viruses is a common strategy for evading host antiviral immunity.<|other_cit|> A striking clinical feature of COVID-19 is the drastic impairment of antiviral immunity.6,<|other_cit|> SARS-CoV-2 infection induces low-level expression of type I and III IFNs, accompanied by a moderate ISG response.<|cit|> In the severe cases of COVID-19, the expression of type I and III IFNs and ISGs, which exhibit immunopathogenic potential, are robustly triggered.<|other_cit|> It seems that the type I and III IFNs are suppressed in patients with moderate COVID-19, but still display elevated induction throughout the course of the disease in severe cases.<|other_cit|> Type I and III IFNs have been administered alone or in combination with other drugs to treat patients with COVID-19; this therapy has been shown to effectively suppress SARS-CoV-2 infection and may effectively prevent COVID-19.<|other_cit|> The replication of SARS-CoV-2 is dramatically reduced in Vero cells pretreated with recombinant IFN-α or IFN-β.", "evidence": {"14045": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14045]}
{"id": 1930, "claim": "Therefore, a reduced innate antiviral immunity simultaneously with profound inflammatory cytokine production are the defining features of Covid-19.<|cit|> Given that young children do not succumb to severe disease, when the innate immune response is highly effective suggests that innate immunity is critical for disease outcome.<|other_cit|>", "evidence": {"14046": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14046]}
{"id": 1932, "claim": "Our previous studies have shown that innate antiviral immunity may play an important role in the SARS-CoV-2 clearance observed in COVID-19.<|other_cit|> SARS-CoV-2–mediated dysregulation of innate antiviral immunity and inflammatory responses is largely responsible for human deaths caused by COVID-19.<|multi_cit|> Type I and III IFNs are typically suppressed in COVID-19 patients; however, the molecular mechanism of this phenomenon induced by SARS-CoV-2 needs to be elucidated.6,<|other_cit|> Here, we reported that the SARS-CoV-2 M protein can target the cytosolic RNA-sensing pathway of RIG-I/MDA-5 signaling to block the activation of type I and III IFN responses, thus inhibiting host antiviral immunity.", "evidence": {"14047": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14047]}
{"id": 1934, "claim": "To demonstrate the application of this workflow for the study of SARS-CoV-2, we created intracellular signalling networks of NHBE cells (from Normal Human Bronchial/tracheal Epithelial cell lines) upon infection with SARS-CoV-2 based on data published by Blanco Melo et al. [<|cit|>] and viral-human binding protein interactions published by Gordon et al. [<|other_cit|>].", "evidence": {"14048": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14048]}
{"id": 1935, "claim": "Overall, studies suggest that type I IFN responses are dysfunctional in severe COVID-19 [<|multi_cit|>] and correlate with TNF- and IL-1β-driven inflammation in patients with severe disease [<|other_cit|>].", "evidence": {"14049": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14049]}
{"id": 1937, "claim": "Signature of SARS-CoV-2 infection on A549 and A549-ACE2 cells visualized using the first two principal components based on RNA-seq data from ref. <|cit|>.", "evidence": {"14050": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14050]}
{"id": 1938, "claim": "The reduction of the protein level of several proteins such as p65 at 72 h might be due to SARS-CoV-2-triggered cell death.<|other_cit|> Consistent with the previous studies,<|multi_cit|> our results revealed that SARS-CoV-2 infection could lead to the activation of host inflammatory responses, including NF-κB signaling.", "evidence": {"14051": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [14051]}
{"id": 1939, "claim": "Interestingly, IRX3 overexpression had a clear impact in weight gain in animal models and a clear correlation with the expression data obtained from obese patient samples (<|cit|>).", "evidence": {"79000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79000]}
{"id": 1940, "claim": "Very recently, it was shown that genetic variants within FTO gene are linked functionally to another distant gene called IRX3 which may link the association of FTO SNPs with both obesity and T2DM [<|multi_cit|>].", "evidence": {"79001": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79001]}
{"id": 1942, "claim": "Finally, Smemo et al. recently reported evidence suggesting that this region acts as an enhancer in the human brain and that it may directly interact with and control the expression of the IRX3 promoter, which in turn regulates body mass and composition [<|cit|>].", "evidence": {"79002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79002]}
{"id": 1944, "claim": "However, it was recently reported that these variants actually act at a distance to influence the expression of the neighboring gene, IRX3 (<|cit|>).", "evidence": {"79003": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [79003]}
{"id": 1945, "claim": "However, recent studies have found that these FTO variants are in fact associated with the expression levels of a nearby gene, IRX3 [<|cit|>].", "evidence": {"79004": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [79004]}
{"id": 1947, "claim": "This gene has very recently been proposed as a novel determinant of body mass and composition [<|cit|>], and participates in the regulation of actin cytoskeleton organization.", "evidence": {"79005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79005]}
{"id": 1948, "claim": "New experimental methods such as Hi C are now providing data on chromatin three-dimensional organization [<|other_cit|>], and cases of variants affecting the expression other than the closest gene have been found, for example [<|cit|>], and cases of variants affecting the expression other than the closest gene have been found, for example [10].", "evidence": {"79006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79006]}
{"id": 1949, "claim": "Although it is recognized that proximity of SNPs to genes may not identify causal genes [<|multi_cit|>], functions for genes near eight of these regions were found by searching under the gene names in PubMed, the National Center for Biotechnology Information database of Genotypes and Phenotypes (dbGaP) of genotype-phenotype associations, and the GWAS Catalog (http://www.ebi.ac.uk/gwas/) [<|other_cit|>].", "evidence": {"79007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79007]}
{"id": 1950, "claim": "However, it has now been shown that the weight-associated variants in FTO interact with the promoter of the neighboring IRX3 gene [<|cit|>], suggesting that IRX3 may mediate the effect of the association signal at FTO.", "evidence": {"79008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79008]}
{"id": 1951, "claim": "Interestingly, although the IRX3 gene is located half a million base pairs away from the FTO gene locus, it has been recently shown that regions of the FTO gene that are associated with obesity physically interact with an IRX3 gene promoter; therefore, it is possible that the IRX3 gene is also linked to obesity [<|cit|>).", "evidence": {"79009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79009]}
{"id": 1953, "claim": "FTO became very famous a decade ago due to the strong association of single nucleotide polymorphisms (SNPs) located in its genomic locus with overweight and obesity in humans identified by large-scale, genome-wide association studies.<|other_cit|> Although there are some controversial discoveries regarding the link of FTO with overweight and obesity,<|multi_cit|> mouse model studies did suggest a critical role of FTO in regulating fat mass, adipogenesis, and body weight,<|other_cit|> and there is also a link between the SNP risk genotype and increased FTO expression in human fibroblasts and blood cells.<|other_cit|> In addition, large-scale epidemiology studies demonstrate people with FTO SNPs or overweight/obesity have a higher risk of development of cancers such as breast, kidney, prostate, and pancreatic cancers, as well as leukemia, lymphoma and myeloma.<|other_cit|> However, the definitive role of FTO in cancer remained elusive.", "evidence": {"79010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79010]}
{"id": 1954, "claim": "It is now clear that the majority of common alleles that influence polygenic traits do so by regulating gene expression, so called expression quantitative trait loci, or eQTLs [<|multi_cit|>].", "evidence": {"79011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [79011]}
{"id": 1955, "claim": "Functional experiments also supported this finding; body weight of Irx3-deficient mice was reduced by 25–30 %, and hypothalamic expression of a dominant-negative form of Irx3 resulted in the same metabolic phenotype as the Irx3-deficient mice [<|cit|>].", "evidence": {"79012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79012]}
{"id": 1958, "claim": "However, it was later determined through functional genetic experiments and mouse knockout studies that IRX3, a gene distally located from the GWAS variants, was the likely causal gene (<|multi_cit|>; Smemo et al., 2014).", "evidence": {"79013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79013]}
{"id": 1959, "claim": "FTO gene expression is associated with regulation of food intake and energy balance.<|other_cit|> Furthermore, Single nucleotide polymorphisms (SNPs) in the FTO gene that almost 45% of them are in white,<|other_cit|> causes to increase in food intake and the desire for high-calorie foods and then increase the risk of obesity (1.67 times more than others).<|other_cit|> Although the mechanism of this effect is not still understood well, it has also been found that the link of FTO gene with obesity is related to age and most influence of these genes can be seen in the 7-20 years.<|other_cit|> Furthermore, recent studies have been shown that the success of lifestyle interventions (such as changes in physical activity and intake of micronutrients) may be affected by obesity-related genes.<|multi_cit|> The results of various studies in this field have been inconsistent<|other_cit|> that may be due to lack of considering to various aspects of this relationship.", "evidence": {"79014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79014]}
{"id": 1960, "claim": "The exact number of drug discovery initiatives targeting FTO to treat obesity or type 2 diabetes is unknown to us, but the findings of <|cit|>– obtained by combining experimental data from several animal models including zebrafish – illustrate the need of carrying out detailed genetic functional studies (i.e., functional genomics) before entering costly drug discovery programs.", "evidence": {"79015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79015]}
{"id": 1961, "claim": "Although those 15 obesity-associated SNPs are located within the first intron of FTO, it should be noted that some of the variants can form long-range functional connections with the homeobox gene IRX3 [<|cit|>], which is a half-megabase downstream of the variants.", "evidence": {"79016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79016]}
{"id": 1963, "claim": "Similar to previously identified SNPs with long-range functional connections,<|cit|> we found that the intronic IL19 risk allele affects expression of the IL10 gene, located at a distance of 30 kb from the IL19 locus.", "evidence": {"79017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79017]}
{"id": 1964, "claim": "With the help of 3C-based technologies, a recent study [<|cit|>], making the interpretation of non-coding variants imperative.", "evidence": {"79018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [79018]}
{"id": 1965, "claim": "GFP-tagged constructs were engineered by inserting the following elements into the pGb-LPL vector: a BRCA2-expression cassette consisting of a CAG promotor, consisting of ( ) the cytomegalovirus (CMV) early enhancer element, ( ) the promoter, the first exon and the first intron of chicken beta-actin gene, ( ) the splice acceptor of the rabbit beta-globin gene, from pCAGGS-Dre-IRES-puro [<|other_cit|>], an Enhanced Green Fluorescence Protein (EGFP)-coding sequence (Takara Bio), and the indicated BRCA2 fragment (using primer set 1, 2 and 3), amplified from a human BRCA2-coding sequence, phCMV1-MBPx2-hBRCA2 [<|cit|>].", "evidence": {"64000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64000]}
{"id": 1966, "claim": "RPA needs to be exchanged for Rad51 protein on the single-stranded DNA to start the homology search and complete HR repair<|multi_cit|>,12.", "evidence": {"64001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [64001]}
{"id": 1967, "claim": "To improve protein solubility and ease purification, a His  tag and two tandem copies of maltose binding protein (2MBP) <|cit|> followed by a Prescission protease site were fused to the N-terminus of Pol ν variants.", "evidence": {"64002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64002]}
{"id": 1968, "claim": "This occurs when RPA is replaced by RAD51, facilitated by BRCA2, allowing for strand invasion [<|cit|>].", "evidence": {"64003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64003]}
{"id": 1969, "claim": "Jensen et al<|cit|> isolated the large protein encoded by the BRCA2 gene and showed it to be a key mediator of homologous recombination.", "evidence": {"64004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64004]}
{"id": 1971, "claim": "Interestingly, although this protein itself did not demonstrate recombination mediator activity in reconstituted biochemical assays, it appears to mediate RAD51 function in the homologous recombination machinery [<|multi_cit|>].", "evidence": {"64005": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [64005]}
{"id": 1972, "claim": "RPA, a single-strand binding protein, is loaded onto 3′ overhangs and recruits RAD51, the key protein of HR, with the involvement of BRCA2 [<|multi_cit|>].", "evidence": {"64006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64006]}
{"id": 1973, "claim": "The central reaction of the HR pathway, namely the homology search and strand invasion, is performed by Rad51-coated 39 ssDNA tails generated by DNA end resection of the break.<|other_cit|> The formation of this nucleoprotein filament at ssDNA is promoted and stabilized by BRCA2.<|multi_cit|> Both Rad51 and BRCA2 are essential for HR in mammalian cells, although the functions of Rad51 and BRCA2 in other repair pathways have not been elucidated.", "evidence": {"64007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64007]}
{"id": 1974, "claim": "RAD51 filament formation on ssDNA coated by the ssDNA-binding protein RPA requires additional factors, such as the mammalian mediator BRCA2 (<|cit|>; <|other_cit|>) or the yeast protein Rad52 (reviewed in <|other_cit|>).", "evidence": {"64008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64008]}
{"id": 1975, "claim": "Essential to HR is the protein RAD51, which is loaded by BRCA2 on the DNA end and catalyzes D-loop formation (<|multi_cit|>).", "evidence": {"64009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64009]}
{"id": 1976, "claim": "BRCA2 is a multi-domain protein crucial for multiple cellular functions, such as HR, by promoting RAD51 loading [<|cit|>], interstrand crosslink (ICL) repair [<|other_cit|>], RF stability [<|other_cit|>] and cytokinesis [<|other_cit|>].", "evidence": {"64010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64010]}
{"id": 1978, "claim": "BRCA2 is a recombination mediator, which facilitates assembly of the RAD51 nucleoprotein filament on ssDNA downstream of BRCA1 activities (<|multi_cit|>).", "evidence": {"64011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64011]}
{"id": 1979, "claim": "Human Rad52 exhibits DNA annealing activity in vitro, but its mediator activity to promote Rad51 filament formation and strand invasion is largely replaced by BRCA2<|cit|>.", "evidence": {"64012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64012]}
{"id": 1980, "claim": "Human BRCA2 (<|multi_cit|>) and RAD50 (<|other_cit|>) are functional analogs of E. coli RecF.", "evidence": {"64013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64013]}
{"id": 1981, "claim": "RAD51 is the key recombinase enzyme for homologous sequence searching and recombination<|cit|>.", "evidence": {"64014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64014]}
{"id": 1983, "claim": "We hypothesized that BRCA2 knockdown would synergistically potentiate cisplatin and melphalan treatment because both drugs induce DSBs,<|other_cit|> and BRCA2 is an integral part of the complex responsible for homologous recombination<|multi_cit|>.", "evidence": {"64015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64015]}
{"id": 1984, "claim": "Moreover, BRCA2 displaces RPA from ssDNA and promotes RAD51 filament formation and strand exchange more efficiently than yeast and human RAD52 (<|cit|>).", "evidence": {"64016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [64016]}
{"id": 1986, "claim": "There is an increased recognition that several physiological abnormalities are related to autism (<|other_cit|>), including mitochondrial dysfunction (<|multi_cit|>).", "evidence": {"42000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42000]}
{"id": 1988, "claim": "Disorders in mitochondrial respiratory chain complexes (Complex I–Complex V), decreased coenzyme Q  concentration, as well as abnormalities of mtDNA, are associated with autism spectrum disorders;<|multi_cit|> one case of coenzyme Q  treatment (from 600 to 1200 mg/d) showed improvement in autistic behavior.<|other_cit|>", "evidence": {"42001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [42001]}
{"id": 1989, "claim": "Additionally, mitochondrial disease and markers of mitochondrial dysfunction are much higher in ASD population compared to control populations [<|cit|>].", "evidence": {"42002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42002]}
{"id": 1990, "claim": "It is also believed that mitochondrial dysfunction may play a role in the onset of ASD (<|cit|>).", "evidence": {"42003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42003]}
{"id": 1991, "claim": "The prevalence of formal mitochondrial disorder in ASD is around 5%, about 500 times higher than in the general population [<|cit|>].", "evidence": {"42004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42004]}
{"id": 1992, "claim": "At present the greatest effort to identify the underlying genetic basis for an increased vulnerability of ASD patients to environmental agents has been carried out in relation to ROS and mitochondrial dysfunction [<|multi_cit|>].", "evidence": {"42005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42005]}
{"id": 1993, "claim": "Morning fasting lactate and ammonia blood levels were increased in 12.5 and 22.2% of patients, respectively in line with previous reported rates of increased markers of mitochondrial dysfunction in ASD (<|cit|>).", "evidence": {"42006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42006]}
{"id": 1995, "claim": "Thus, it is not surprising that multiple lines of evidence in both human and animal models support a role for mitochondrial dysfunction in the etiology of ASD (Haas, <|other_cit|>; Dhillon et al., <|other_cit|>; Frye and Rossignol, <|multi_cit|>; Legido et al., <|other_cit|>).", "evidence": {"42007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42007]}
{"id": 1997, "claim": "Other reports indicate differences in the neuroanatomical volumes (Aoki et al., <|other_cit|>), in mitochondrial function (<|cit|>), and some others imply the involvement of glia (Ahlsén et al., <|other_cit|>; Vargas et al., <|other_cit|>; Aoki et al., <|other_cit|>).", "evidence": {"42008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42008]}
{"id": 1998, "claim": "Chronic inflammation can also be a source of ROS contributing to oxidative stress [<|multi_cit|>] which has been implicated in ASD (see <|other_cit|>).", "evidence": {"42009": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [42009]}
{"id": 1999, "claim": "The mitochondrial disorders observed in ASD—studied extensively by Dan Rossignol, MD, Rossignol Medical Center, Irvine, California, and Richard Frye, MD, PhD, University of Arkansas,<|multi_cit|>—appeared to occur largely through environmental and not inherited means.", "evidence": {"42010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42010]}
{"id": 2000, "claim": "Abnormalities in redox metabolism found in the brain of children with ASD [<|other_cit|>] can disrupt glutamate metabolism [<|other_cit|>] and metabolic disorders associated with ASD, such as succinic semialdehyde dehydrogenase deficiency [<|other_cit|>] and mitochondrial disorders [<|cit|>], can influence GABAergic neurotransmission [<|other_cit|>].", "evidence": {"42011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42011]}
{"id": 2001, "claim": "Mitochondrial dysfunction has three major consequences: a) decreased ATP production, b) increased production of reactive oxygen species (ROS) and oxidative damage, and c) induction of apoptosis (<|cit|>).", "evidence": {"42012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42012]}
{"id": 2003, "claim": "Moreover, it was found that a relatively high percentage of children with ASD (~5%) have mitochondrial disease (MD; <|cit|>).", "evidence": {"42013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42013]}
{"id": 2004, "claim": "Decreased coenzyme Q10 concentration is associated with ASDs (<|multi_cit|>).", "evidence": {"42014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [42014]}
{"id": 2005, "claim": "Mitochondrial disease (MD) has been reported to occur with higher frequency among ASD patients than in the general population [<|multi_cit|>].", "evidence": {"42015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42015]}
{"id": 2006, "claim": "Other areas of novel research have concentrated on systemic physiological abnormalities, such as mitochondrial dysfunction [<|multi_cit|>], oxidative stress [<|other_cit|>], and inflammation/immune dysregulation [<|other_cit|>].", "evidence": {"42016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42016]}
{"id": 2007, "claim": "The prevalence of abnormal metabolic biomarkers is even higher, suggesting that as many as 30% of children with ASD may experience metabolic abnormalities: almost one-third of autistic children have documented elevations in plasma lactate and/or the lactate-to-pyruvate ratio, and the levels of many other mitochondrial biomarkers (pyruvate, carnitine, and ubiquinone) are significantly different between ASD and controls (<|cit|>).", "evidence": {"42017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42017]}
{"id": 2008, "claim": "It is interesting to note that recent neuroimaging and postmortem studies have reported mitochondrial dysfunction in the brains of ASD individuals (<|multi_cit|>).", "evidence": {"42018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42018]}
{"id": 2009, "claim": "Among IEM, primary mitochondrial diseases affect nearly 5% of patients with ASD, however the occurrence of abnormal biomarkers indicating mitochondrial dysfunction is higher in patients with ASD than in the general population (<|cit|>).", "evidence": {"42019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [42019]}
{"id": 2010, "claim": "Post-mortem brain studies have suggested an elevated prevalence of mitochondrial dysfunction in ASD [<|cit|>].", "evidence": {"42020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42020]}
{"id": 2011, "claim": "For most individuals with defects of oxidative phosphorylation, the diagnosis is made through the determination of the activities of the enzyme complexes of the electron transport chain but an underlying mitochondrial mutation (including mtDNA depletion, mutations and deletions) can rarely be identified [<|multi_cit|>].", "evidence": {"42021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42021]}
{"id": 2012, "claim": "There are also strong indications of metabolic pathways involving energy production in the pathophysiology of some mental disorders including bipolar disorder, depression, schizophrenia (<|other_cit|>) autism spectrum disorder (ASD) (<|cit|>), and potentially attention deficit hyperactivity disorder (ADHD) (<|other_cit|>).", "evidence": {"42022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42022]}
{"id": 2013, "claim": "(3) A meta-analysis confirmed mitochondrial dysfunction is associated with autism, and various mitochondrial treatments could be beneficial in humans (Rossignol and Frye, <|cit|>).", "evidence": {"42023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42023]}
{"id": 2014, "claim": "It is important to appreciate that FRAAs could also work in concert with the defects in folate metabolism that have been associated with ASD, including polymorphisms in dihydrofolate reductase (Adams et al., <|other_cit|>), the reduced folate carrier (James et al., <|other_cit|>) and methylenetetrahydrofolate reductase (Frustaci et al., <|other_cit|>), and mitochondrial dysfunction which appears to be rather common in children with ASD (Frye and Rossignol, <|multi_cit|>).", "evidence": {"42024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42024]}
{"id": 2016, "claim": "Accumulating evidence supports that oxidative stress is also implicated with the development of ASD [<|multi_cit|>].", "evidence": {"42025": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [42025]}
{"id": 2017, "claim": "Much evidence, including recent optogenetic results, appears to support this basic mechanism [<|other_cit|>], although it is important to note that recent results suggest a slightly more nuanced view of the simple dichotomy between direct and indirect pathways—for instance, they are reported to be coactive during action initiation [<|cit|>], consistent with the idea that they form a centre-surround organisation for selecting actions [<|other_cit|>].", "evidence": {"49000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49000]}
{"id": 2018, "claim": "While the precise temporal sequence and coordination of MSN subtypes during activity remains unclear (<|cit|>), this theoretical framework has been a powerful tool for progress in understanding striatal motor function (Kravitz et al., <|other_cit|>).", "evidence": {"49001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49001]}
{"id": 2019, "claim": "Yet, electrophysiological recordings in rodents find concurrent activation of both the direct and indirect pathways during action initiation and cancellation (<|cit|>), interpreted as an increased recruitment of the indirect pathway to suppress an action.", "evidence": {"49002": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49002]}
{"id": 2020, "claim": "Recent animal studies have shown that the direct and indirect pathways are concurrently activated during operant tasks, suggesting that the indirect pathway is positively involved in decision making of actions, rather than simply suppressing unselected actions (<|multi_cit|>; Isomura et al., <|other_cit|>).", "evidence": {"49003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49003]}
{"id": 2021, "claim": "For example, GINAs allow for specific labeling of direct and indirect pathway neurons in the striatum (<|cit|>) as well as excitatory (<|other_cit|>) and inhibitory (<|other_cit|>) neurons which co-localize within the same local neural circuit.", "evidence": {"49004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49004]}
{"id": 2023, "claim": "To better understand the behavioral events correlated with the activity increase of VMHvl Esr1+ cells, we implemented fiber photometry (<|multi_cit|>) to record the population Ca2+ signal from VMHvl Esr1+ cells.", "evidence": {"49005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49005]}
{"id": 2026, "claim": "The general functional model of the interactions between direct and indirect pathway in the regulation of motor activity was proposed decades ago (Figure <|other_cit|>, Albin et al., <|other_cit|>; DeLong, <|other_cit|>), and has received strong experimental support in the last few years (Kravitz et al., <|multi_cit|>; Freeze et al., <|other_cit|>; Sano et al., <|other_cit|>).", "evidence": {"49006": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49006]}
{"id": 2027, "claim": "Our results are consistent with the finding that in the DS, dMSNs and iMSNs function in a complementary manner to produce coordinated motor behavior (<|multi_cit|>).", "evidence": {"49007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49007]}
{"id": 2028, "claim": "Fiber photometry, together with the genetically-encoded Ca2+ indicator GCaMP6, has permitted the tracking of the activity dynamics of cell-type-specific neurons with sub-second temporal resolution<|multi_cit|>–27; these ease-of-use techniques are well adapted for freely moving transgenic mice during drug infusion.", "evidence": {"49008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49008]}
{"id": 2029, "claim": "However, it has been reported that a majority of striatal neurons are activated during movement (DeLong, <|other_cit|>; Costa et al., <|other_cit|>) and that both pathways are co-activated during movement initiation (<|multi_cit|>; Isomura et al., <|other_cit|>).", "evidence": {"49009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49009]}
{"id": 2030, "claim": "This hypothesis is supported by findings that neurons from both pathways are simultaneously activated during behavior (<|multi_cit|>; Isomura et al., <|other_cit|>), and with opponent BG outputs from the SNr projection neurons (Fan et al., <|other_cit|>; Rossi et al., <|other_cit|>; Barter et al., <|other_cit|>).", "evidence": {"49010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49010]}
{"id": 2032, "claim": "However, more recent studies demonstrate that coordinated motor activity requires concurrent activation of both iSPN and dSPN populations (<|multi_cit|>; Freeze et al., <|other_cit|>; Tecuapetla et al., <|other_cit|>) making it less certain whether the LTD deficits would be pathway specific.", "evidence": {"49011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49011]}
{"id": 2034, "claim": "In striatal regions, postsynaptic D1R and D2R are mainly expressed by GABAergic medium spiny neurons (MSNs) segregated into two distinct output pathways, D1R-MSNs and D2R-MSNs (<|other_cit|>), which have functionally opposing effects on locomotion (<|multi_cit|>).", "evidence": {"49012": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49012]}
{"id": 2037, "claim": "However, in vivo imaging study shows that the both types of medium spiny neurons are activated during movement initiation in mice (<|cit|>).", "evidence": {"49013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49013]}
{"id": 2038, "claim": "We then expressed a Cre-dependant GCaMP6m (AAV-DJ-EF1a-DIO-GCaMP6m) in DAT-Cre mice to record VTA DA neuron activity with fiber photometry (<|multi_cit|>) after an i.v.", "evidence": {"49014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49014]}
{"id": 2040, "claim": "We used fiber photometry to record Ca2+ transients as the real-time activity indicator for LHb neurons in freely-behaving mice (<|multi_cit|>).", "evidence": {"49015": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49015]}
{"id": 2041, "claim": "However, recent optogenetic findings in mice have challenged the canonical model (that the direct and indirect pathways are selectively active), suggesting that these pathways may be concurrently active (during movements) or inactive (at rest) (<|cit|>).", "evidence": {"49016": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49016]}
{"id": 2042, "claim": "Of interest is a recent study by Cui et al. (<|cit|>) which developed and used a novel in vivo photometry method to measure activity of spiny projection neurons in the direct and indirect pathways.", "evidence": {"49017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49017]}
{"id": 2043, "claim": "Both Go and NoGo pathways were recently found to be active during normal movement (<|cit|>), supporting the concept that action selection results from changes in the activation of each pathway relative to the other.", "evidence": {"49018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49018]}
{"id": 2044, "claim": "Although we only applied baseline normalization (i.e. signals were subtracted with and then divided by the average signal in a 1 s period before CS in each trial) in this study, additional methods using activity-independent wavelength of excitation (<|other_cit|>) or examination of emission spectrum (<|cit|>) or examination of emission spectrum (Cui et al., 2013) may improve fidelity, especially in freely moving animals.", "evidence": {"49019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49019]}
{"id": 2045, "claim": "Improving GCaMP fluorescent signals have been detected using in vivo preparations (<|other_cit|>), even in subcortical areas like the striatum (<|cit|>).", "evidence": {"49020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [49020]}
{"id": 2046, "claim": "A recent study by Lorenzo-Redondo et al.[<|cit|>] has challenged this view, by finding signals of continual evolution in viral sequences sampled longitudinally during ART, which would indicate that viral replication (accompanied by mutation and selection) continues.", "evidence": {"71000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71000]}
{"id": 2047, "claim": "Selection–mutation models, for example, often assume that pathogen populations are effectively infinite [<|cit|>].", "evidence": {"71001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [71001]}
{"id": 2049, "claim": "HIV-1 latency is considered a major mechanism of viral persistence on ART, although there is also evidence for the contribution of ongoing HIV-1 replication in lymphatic tissues, where penetration of ART is suboptimal <|cit|>.", "evidence": {"71002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71002]}
{"id": 2050, "claim": "Using the substitution rate published in Lorenzo-Redondo et al. <|cit|>, the model predicted that if active ongoing replication were taking place within lymph nodes for 8 years despite ARV treatment, the sequences would be divergent from those taken at early time points.", "evidence": {"71003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71003]}
{"id": 2051, "claim": "Although there are many excellent reviews on the HIV-1 reservoir, most focus on one aspect at the basic research level.[<|multi_cit|>] Here, we described the relevant factors in a simplified way, focusing on the clinical research to make the information more intuitive to the clinician.", "evidence": {"71004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71004]}
{"id": 2053, "claim": "Indeed, the implication that ongoing infection and spread could occur in the presence of suppressive ART is exceptionally controversial [<|multi_cit|>].", "evidence": {"71005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71005]}
{"id": 2054, "claim": "Some studies have shown conclusive evidence of continual viral replication in lymphoid tissues (<|multi_cit|>), while contradictory evidence was observed in PBMCs (<|other_cit|>).", "evidence": {"71006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71006]}
{"id": 2055, "claim": "Hence, they cannot be targeted by cART [<|multi_cit|>].", "evidence": {"71007": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [71007]}
{"id": 2056, "claim": "It may also be that viral reservoirs remain because there are areas of local active viral replication under suppressive ART, as shown in a study in lymphoid tissue (<|cit|>).", "evidence": {"71008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71008]}
{"id": 2057, "claim": "Unfortunately, even under virological suppression, signs of ongoing viral replication were reported (<|multi_cit|>; Lorenzo-Redondo et al., 2016).", "evidence": {"71009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71009]}
{"id": 2058, "claim": "The presence of latently infected cells that are able to reinitiate new rounds of viral replication after ART withdrawal (<|other_cit|>) and the existence of low-level ongoing viral replication (<|other_cit|>), most likely in tissue reservoirs (<|multi_cit|>10), represent the main obstacles to the complete eradication of HIV-1 from the human body.", "evidence": {"71010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71010]}
{"id": 2060, "claim": "We first proposed [<|other_cit|>] and others confirmed in prospective studies [<|multi_cit|>] that orally administered drugs exhibit drug insufficiency in lymph nodes [<|other_cit|>].", "evidence": {"71011": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [71011]}
{"id": 2061, "claim": "The genetic structure of virus population during ART is generally stable [<|other_cit|>], arguing against ongoing cycles of HIV-1 replication, although recent data have challenged this assumption [<|cit|>], arguing against ongoing cycles of HIV-1 replication, although recent data have challenged this assumption [13▪▪], as discussed below.", "evidence": {"71012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71012]}
{"id": 2062, "claim": "Recent evidence suggests that ongoing HIV-1 replication may occur in lymphoid tissue due to poor drug penetration <|cit|>.", "evidence": {"71013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71013]}
{"id": 2063, "claim": "A recent intensive study of three HIV-infected adults provides additional evidence for residual evolution (and, by extension, replication) during ART [<|cit|>▪▪].", "evidence": {"71014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71014]}
{"id": 2064, "claim": "In addition, initial trials of HIV eradication examine only viral load in peripheral blood as an indication of HIV reactivation or change in the latent reservoir, although novel data indicate that many latent HIV-1 genomes are in tissues and may respond differently to latency reversing agents (LRA) [<|cit|>], suggesting that viral reservoirs in brain contribute to virus rebound and cause CNS disease.", "evidence": {"71015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [71015]}
{"id": 2065, "claim": "Indeed any analysis of subgenomic regions of proviruses to evaluate viral evolution or reservoir reduction must be reconsidered in this context, since the majority of sequences studied will be from defective proviruses<|cit|>) and the fact that cells harboring defective proviruses may be less susceptible to immune clearance or cytopathic effects.", "evidence": {"71016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [71016]}
{"id": 2066, "claim": "Understanding the follicular/GC- and particularly Tfh cell- immune dynamics in HIV/Simian Immunodeficiency Virus (SIV) infection is of great importance for (i) the identification of molecules/pathways associated with the development of broadly neutralizing antibodies that could inform the design of novel vaccine strategies targeting relevant GC cell populations and (ii) understanding the establishment and maintenance of a major viral reservoir (<|other_cit|>), even in cART treated donors (<|cit|>).", "evidence": {"71017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71017]}
{"id": 2067, "claim": "The lack of efficient CTL responses in these regions may allow SIV/HIV replication in lymphoid tissue [<|other_cit|>▪▪,<|other_cit|>], accounting for the low levels of viral evolution, which has recently been observed in lymphoid tissues [<|cit|>], accounting for the low levels of viral evolution, which has recently been observed in lymphoid tissues [13▪▪].", "evidence": {"71018": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71018]}
{"id": 2068, "claim": "Persistence of HIV reservoirs in hard-to-reach tissues has emerged as the central focus for eradication strategies <|cit|>.", "evidence": {"71019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71019]}
{"id": 2069, "claim": "Furthermore, Lorenzo-Redondo et al showed very nicely that HIV can continue to replicate and replenish the viral reservoir despite potent cART [<|cit|>].", "evidence": {"71020": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71020]}
{"id": 2070, "claim": "It has recently been shown that HIV replication is ongoing in tissues while it is absent in peripheral blood mononuclear cells (PBMCs) (<|multi_cit|>)—a phenomenon that could stem from the insufficient penetration of cART drugs in the tissues (<|other_cit|>).", "evidence": {"71021": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71021]}
{"id": 2071, "claim": "Drug-resistant variants might be one reason, particularly considering the low penetrance of the ART drugs in the lymphoid tissue.[<|multi_cit|>] In most cases, the role of residual viremia has not been completely identified.[<|other_cit|>] The persistent low level of residual viremia caused by the activated latent reservoir has a role in replenishing the pool of HIV DNA.[<|other_cit|>] The fact that HIV-specific CD4+ T-cells are preferentially infected by HIV-1 at all stages of disease suggests the possibility that residual viremia continues to mediate the infection or stimulation of activated CD4+ T-cells even under effective ART.[<|other_cit|>] More studies are needed to compare the productive capacity of residual viremia among patients with different reservoir sizes.", "evidence": {"71022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [71022]}
{"id": 2072, "claim": "However, a recent high-depth temporal analysis of the phylogeny of viral sequences from the blood and lymph node of patients under ART revealed a constant replenishment of the circulating reservoir as a result of low-level viral replication in sanctuary sites within lymphoid tissues (<|cit|>).", "evidence": {"71023": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71023]}
{"id": 2073, "claim": "Although previous studies have looked for and failed to find such signals, Lorenzo-Redondo et al.'s [<|cit|>] approach was unique in including samples from both peripheral blood and lymph tissue, in having multiple samples closely spaced near the time ART was started (0, 3, and 6 months after), and in using newer deep sequencing approaches to capture genetic variation.", "evidence": {"71024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [71024]}
{"id": 2074, "claim": "Consistent with previous studies [<|multi_cit|>,28], we observed a significant increase in recruitment of these cells to the lungs in mice in the vehicle group (p = 0.0202 for monocytes and p = 0.0255 for macrophages) compared with uninfected controls.", "evidence": {"18000": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18000]}
{"id": 2076, "claim": "This is coherent with the fact that hACE2 expression were not observed in the gut of the mice used in that study [<|cit|>].", "evidence": {"18001": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18001]}
{"id": 2077, "claim": "The human ACE2 gene is introduced into the mouse genome under the control of a tissue-specific promoter,<|multi_cit|> mouse ACE2 promoter, or universal promoter.<|other_cit|> Instead of permanent genetic modification, some groups also develop hACE2-transduced mouse models, which are generated by intratracheally transducing mice with Ad5 or AAV encoding for hACE2.<|other_cit|> However, hACE2 in these mice is ectopically expressed.", "evidence": {"18002": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18002]}
{"id": 2079, "claim": "This cell recruitment was also seen in BAL (bronchoalveolar lavage) samples from severe COVID-19 patients [<|cit|>].", "evidence": {"18003": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18003]}
{"id": 2081, "claim": "To evaluate the in vivo effect of 5’-ASO#26, previously published RNA-seq data from infected K18-ACE2 mice<|cit|> were used to define up- and down-regulated genes in response to SARS-CoV-2 infection at 4 dpi (Supplementary Fig. <|other_cit|>).", "evidence": {"18004": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18004]}
{"id": 2082, "claim": "Previous studies using these mice have mainly focused on SARS-CoV-2-induced lung histology changes and host immune responses rather than ECs <|multi_cit|>.", "evidence": {"18005": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18005]}
{"id": 2083, "claim": "The serum and tissue homogenates were analysed for the highly conserved SARS-CoV-2 nucleocapsid RNA by a qRT-PCR using the method previously described by Winkler et al., 2020 [<|cit|>].", "evidence": {"18006": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18006]}
{"id": 2084, "claim": "These findings are consistent with the observation obtained from bulk RNA-seq analysis and RT-PCR analysis of the lungs of infected K18 mice <|cit|> and serum cytokine and chemokine arrays <|other_cit|>.", "evidence": {"18007": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18007]}
{"id": 2085, "claim": "Gene set enrichment analysis (GSEA) revealed strong enrichment of gene involved in type I and II interferon (IFN) signaling in infected mice treated with Saline when compared with 5’-ASO#26-treated group (Fig. <|other_cit|> and Supplementary Fig. <|other_cit|>), which is consistent with previous studies showing induction of antiviral defenses in response to SARS-CoV-2 infection<|cit|> and further proved that LNA ASO treatment did not trigger off-target inflammation in lung.", "evidence": {"18008": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18008]}
{"id": 2086, "claim": "To link our results from vFLIP mice with Sars-Cov-2 infection, we matched GSEA results obtained from vFLIP mice with GSEA analysis of bulk RNA-Seq data of lung from hACE2 transgenic mouse infected with Sars-Cov-2 [<|cit|>].", "evidence": {"18009": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18009]}
{"id": 2087, "claim": "A high number of hACE2 transgene insertions were reported for these mice, resulting in severe illness following SARS-CoV-2 infection, and a high mortality rate [<|multi_cit|>].", "evidence": {"18010": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18010]}
{"id": 2089, "claim": "Severe lung pathology is characteristic for the SARS-CoV-2 infected K18-hACE2 mice [<|multi_cit|>], along with virus detected in upper and lower respiratory tract samples [<|other_cit|>,149,<|other_cit|>].", "evidence": {"18011": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18011]}
{"id": 2090, "claim": "This mouse model is susceptible to SARS-CoV-2 infection and typically manifests as severe COVID-19-like disease symptoms, including lung inflammation and dysfunction (<|multi_cit|>, 25).", "evidence": {"18012": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18012]}
{"id": 2091, "claim": "Transgenic (K18-hACE2)2Prlmn mice<|cit|> were purchased from The Jackson Laboratory and bred locally.", "evidence": {"18013": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18013]}
{"id": 2092, "claim": "Therefore, for pathogenesis studies, hACE2 introduction to genetically engineered mouse strains through a genetic cross with K18-ACE2 mice would theoretically sensitize those mice to severe SARS-CoV-2 infection [<|multi_cit|>].", "evidence": {"18014": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18014]}
{"id": 2093, "claim": "However, even the 6–11-month-old mice did not show apparent kidney abnormalities after SARS-CoV-2 infection, although highly expressed hACE2 and viral genome were detected in the tissue [<|multi_cit|>].", "evidence": {"18015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18015]}
{"id": 2095, "claim": "No significant weight loss was observed at 4 days post-infection (dpi) (Supplementary Fig. <|other_cit|>), consistent with previous studies indicating that weight loss starts from 5 dpi<|cit|>.", "evidence": {"18016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18016]}
{"id": 2096, "claim": "Further, infection in this model also triggered mild damage to extrapulmonary organs including cerebral infarction, myocarditis, and hepatitis, which are consistent with previous findings <|multi_cit|>.", "evidence": {"18017": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18017]}
{"id": 2099, "claim": "Another transgenic mouse model with hACE2 driven by the heterologous promoters (K18-hACE2) showed no viral RNA in the GI tract following nasal inoculation [37], but importantly hACE2 expression was not detected in the gut in these mice [<|cit|>].", "evidence": {"18018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18018]}
{"id": 2100, "claim": "Recently, mouse models were adapted for SARS-CoV-2 infection either by adjusting the viral spike RBD to fit the murine version of ACE2 (<|other_cit|>) or by transient or constitutive expression of human ACE2 in mice (<|multi_cit|>).", "evidence": {"18019": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18019]}
{"id": 2101, "claim": "Although severe clinical manifestations were observed in some of these genetically modified mouse models, these were not dependent on preexisting morbidities and may have been due to high-level, indiscriminate expression of human ACE2 in a wide spectrum of cells that do not normally express this molecule (<|cit|>–8).", "evidence": {"18020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18020]}
{"id": 2102, "claim": "K18-hACE2 showed no viral replication in the intestine following nasal inoculation [<|cit|>].", "evidence": {"18021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18021]}
{"id": 2103, "claim": "Transgenic mice (K18-hACE2) expressing the human SARS-CoV-2 receptor human angiotensin-converting enzyme (hACE2) under a cytokeratin 18 (K-18) promoter are susceptible to SARS-CoV-2, and infection resulted in a lethal disease course [<|multi_cit|>].", "evidence": {"18022": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18022]}
{"id": 2104, "claim": "Additionally, SARS-CoV-2 infection in the brain of K18-hACE2 mice is common, with increasing viral titers over the infection period, and is likely responsible for the lethality of SARS-CoV-2 infection in these mice [<|multi_cit|>].", "evidence": {"18023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18023]}
{"id": 2105, "claim": "Additionally, in a previous study, flow analysis of peripheral blood mononuclear cells (PBMCs) showed marked decrease in the lymphocytes, including CD4+, CD8+ T and B cells in this severe model <|cit|>.", "evidence": {"18024": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18024]}
{"id": 2107, "claim": "Meanwhile, we did not observe significant histological changes by H&E staining in either Saline or LNA ASO-treated mice (Supplementary Fig. <|other_cit|>), which is consistent with previous studies demonstrating that significant inflammation and severe alveolar wall thickening could only be observed at 7 dpi<|cit|>.", "evidence": {"18025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18025]}
{"id": 2108, "claim": "Although SARS-CoV-2 spike proteins from strains early in the pandemic bound to ACE2 from several animal species (for example, hamster, ferret and nonhuman primates), they did not bind mouse ACE2, which explained why laboratory strains of mice could not be infected by SARS-CoV-2 (refs. <|other_cit|>); indeed, mice could become susceptible through expression of hACE2 via a transgene<|multi_cit|> or viral vector<|other_cit|>, or under regulation of the mouse ACE2 promoter<|other_cit|>.", "evidence": {"18026": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18026]}
{"id": 2109, "claim": "Mice that express human angiotensin-converting enzyme 2 (hACE2), a SARS-CoV-2 receptor of the host, have been thought to be a good animal model for COVID-19 with elevated PT and D-dimer as well as cytokine induction following SARS-CoV-2 infection [<|cit|>].", "evidence": {"18027": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18027]}
{"id": 2110, "claim": "isolates in hACE2 transgenic mice<|cit|>.", "evidence": {"18028": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18028]}
{"id": 2111, "claim": "Previous studies show that SARS-CoV-2 infects pneumocytes in K18 mice <|multi_cit|> and SARS-CoV-2 N protein was occasionally observed in the EC lining of the pulmonary vessels <|other_cit|>.", "evidence": {"18029": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18029]}
{"id": 2113, "claim": "Two of our groups tested B.1.1.529 infection in K18-hACE2 transgenic mice, which express hACE2 under an epithelial cytokeratin promoter<|other_cit|>, and are more susceptible to SARS-CoV-2 infection<|cit|>.", "evidence": {"18030": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18030]}
{"id": 2114, "claim": "Although blood coagulation abnormalities have been reported in mice and dwarf hamsters after infection with SARS-CoV-2, animal models that exhibit organ damage other than the lungs have not been available [<|multi_cit|>].", "evidence": {"18031": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18031]}
{"id": 2116, "claim": "To overcome this hurdle, mice animal models in which human ACE2 is transiently or constitutively expressed have been established (<|multi_cit|>–8).", "evidence": {"18032": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18032]}
{"id": 2117, "claim": "Nonetheless, on the other hand, the comparison between the mice and a solid result evaluation could prove more difficulties than in mouse models, like the K18-hACE2 mice with a more uniform disease outcome [<|multi_cit|>].", "evidence": {"18033": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18033]}
{"id": 2118, "claim": "In this study, K18-hACE2 mice were chosen to test the vaccine efficacy due to the existing evidence on its contribution to severe disease and lethality [<|multi_cit|>].", "evidence": {"18034": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18034]}
{"id": 2120, "claim": "Although leukocytes have been shown to be recruited into lung tissue following SARS-CoV-2 infection in K18-hACE2 mice (<|cit|>) and COVID-19 patients (<|other_cit|>), various reports regarding the correlation between total leukocytes and COVID-19 severity have been published (<|other_cit|>).", "evidence": {"18035": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18035]}
{"id": 2122, "claim": "Another transgenic mouse model with hACE2 driven by the heterologous promoters (K18-hACE2) showed no viral RNA in the GI tract following nasal inoculation [<|cit|>], but importantly hACE2 expression was not detected in the gut in these mice [37].", "evidence": {"18036": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18036]}
{"id": 2123, "claim": "Compared to K18-hACE2 mice, the hACE2 model showed less severe disease patterns, which makes them more suitable for rather mild to moderate COVID-19 infection studies [<|multi_cit|>].", "evidence": {"18037": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18037]}
{"id": 2124, "claim": "Furthermore, previously, we and others have demonstrated that K18-hACE2 transgenic mice infected with SARS-CoV-2 show a severe COVID-19 phenotype [<|multi_cit|>].", "evidence": {"18038": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18038]}
{"id": 2126, "claim": "Next, we examined the antiviral effect of 5’-ASO#26 by employing humanized transgenic K18-hACE2 mice, which are expressing human ACE2 allowing SARS-CoV-2 cell entry and infectious spread<|cit|>.", "evidence": {"18039": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18039]}
{"id": 2127, "claim": "Bar plot representing the upregulated (NES > 0, adjusted p-value <0.05) hallmark gene sets in bulk RNA-seq data obtained through GSEA analysis of ACE2-transgenic mice infected with Sars-CoV-2 [<|cit|>] comparing day 7 post infection (dpi) with mock-infected (0 dpi).", "evidence": {"18040": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18040]}
{"id": 2128, "claim": "Compared to the K18-hACE2 mice, this model showed a much higher mortality rate [<|cit|>] with the development of encephalitis in several mice.", "evidence": {"18041": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18041]}
{"id": 2129, "claim": "The K18-hACE2 transgenic mice model was shown to faithfully recapitulate SARS-CoV-2 infections and serve as a reliable model to evaluate the efficacy of therapeutic strategies [<|multi_cit|>].", "evidence": {"18042": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18042]}
{"id": 2130, "claim": "ACE2 was the first documented entry receptor for SARS-CoV-2 (<|multi_cit|>).", "evidence": {"18043": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18043]}
{"id": 2131, "claim": "SARS-CoV-2-infected K18-hACE2 mice have been shown to recapitulate the clinical signs of severe COVID-19, including a decline in pulmonary function, upregulated innate immune responses in the lung, pulmonary inflammation, and respiratory failure, making them an ideal model to further investigate COVID-19 pathogenesis and compare the diseases caused by SARS-CoV-2 variants (<|cit|>).", "evidence": {"18044": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18044]}
{"id": 2132, "claim": "To confirm the growth phenotype of d105 in vivo, K18-hACE2 mice encoding the human SARS-CoV-2 receptor, angiotensin-converting enzyme type 2 (ACE2)<|cit|> were intranasally infected with two different doses of the d14 and d105 isolates (200 or 2000 plaque-forming units (pfu)).", "evidence": {"18045": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18045]}
{"id": 2133, "claim": "The SARS-CoV-2 infection of the K18-hACE2 mice has been described in the literature [<|multi_cit|>,18].", "evidence": {"18046": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18046]}
{"id": 2134, "claim": "The most severe B.1.1.529 infection and disease was observed in hACE2-expressing mice and hamsters, which is consistent with findings for other SARS-CoV-2 strains<|multi_cit|>, and possibly related to the enhanced interactions between hACE2 and B.1.1.529 spike<|other_cit|>.", "evidence": {"18047": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18047]}
{"id": 2135, "claim": "The hACE2 gene has been inserted into mice under the control of the endogenous mACE2 promoter [<|other_cit|>], the cytokeratin-18 (Krt18 (K18)) promoter for epithelial cell expression [<|multi_cit|>], or the HFH4 (FoxJ1) promoter [<|other_cit|>].", "evidence": {"18048": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18048]}
{"id": 2138, "claim": "However, the brain and kidney of K18-hACE2 mice express comparable levels of hACE2 (<|multi_cit|>).", "evidence": {"18049": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18049]}
{"id": 2139, "claim": "However, several transgenic mouse models have been utilized or developed that express the human ACE2 receptor (hACE2) and were found to be capable of becoming productively infected with SARS-CoV-2 [<|multi_cit|>].", "evidence": {"18050": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18050]}
{"id": 2140, "claim": "One is “adapting” virus to mice by serial passaging of virus in mice to enhance the binding affinity of the Spike to mACE2.<|other_cit|> Another is “adapting” mice to SARS-CoV-2 viruses by introducing hACE2 in mice to facilitate the Spike-binding affinity.<|multi_cit|> However, the mouse-adapted SARS-CoV-2 strains often acquire adaptive mutations, some of which are even within RBD, which may restrict their transmission in humans.", "evidence": {"18051": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18051]}
{"id": 2141, "claim": "Nevertheless, this mouse model is well suited for gathering more knowledge about several severe human cases [<|cit|>].", "evidence": {"18052": [{"sentences": [0], "label": "SUPPORT"}]}, "cited_doc_ids": [18052]}
{"id": 7, "claim": "In this way, loc285194 functions as a downstream p53 effector that exerts its anti-proliferative role by binding miR-211 in CRC and miR-23b in GC<|multi_cit|>.", "evidence": {"66016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [66016]}
{"id": 14, "claim": "The aberrant expression of lncRNAs have been reported to serve as potential diagnostic or prognostic biomarkers for many human malignancies such as breast, lung, liver, and colon cancers [<|multi_cit|>–11].", "evidence": {"66017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [66017]}
{"id": 18, "claim": "Studies by other groups lead to the identification of PANDA<|other_cit|>, a lncRNA able to inhibit cellular apoptosis in human fibroblasts, lincRNA-RoR and loc285194 (refs <|multi_cit|>), reported as post-tanscriptional regulators in the p53 pathway, and TUG-1, which controls proliferation in human non-small cell lung cancer<|other_cit|>.", "evidence": {"66018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [66018]}
{"id": 21, "claim": "This high AMP/ATP ratio activates the phosphorylation of AMPK, a master energy sensor within cell, and then pAMPK inhibits mTOR signaling by activating TSC2 and subsequently inhibiting Rheb (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [52028]}
{"id": 25, "claim": "A decrease in ATP production favors AMPK activation, enhances glycolysis, and causes mTOR inhibition [<|cit|>].", "evidence": {}, "cited_doc_ids": [52029]}
{"id": 31, "claim": "In cancer tissues, the maintenance of mitochondrial structural integrity is essential to produce energy and overcome cellular stress, including nutrient deprivation and chemotherapy (<|cit|>).", "evidence": {}, "cited_doc_ids": [52030]}
{"id": 32, "claim": "Additionally, in CD133+ pancreatic cancer cells, metformin induces an energy crisis that drives cell death due to the inhibition of mitochondrial complex I and the impossibility to switch to glycolysis [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [52031]}
{"id": 33, "claim": "Although the activation of AMPK by metformin has been shown to decrease the expression of HIF-1α and mTOR activation in some cancers and in diabetic rat kidneys [<|multi_cit|>], comprehensive signaling pathways exerted by metformin to inhibit cell proliferation, cell cycle arrest and apoptosis in ccRCC are yet to be thoroughly investigated.", "evidence": {}, "cited_doc_ids": [52032]}
{"id": 36, "claim": "Accordingly, the metabolomic analysis of diverse cancer cell lines treated with metformin, which is an anti-diabetic drug retrospectively linked to cancer prevention and CSC disruption, revealed the inhibition of glycolysis, the co-ordinate decrease in the TCA cycle, and the inhibition of nucleotide synthesis, associated with the inhibition of mammosphere-derived breast CSC formation and decreased in vivo tumorigenic potential [<|cit|>].", "evidence": {}, "cited_doc_ids": [52033]}
{"id": 52, "claim": "For instance, metmorfin/phenformin, which besides decreasing blood glucose, insulin levels and PI3K activation, also inhibits complex I of ETC and intermediates of TCA in cancer cells [<|multi_cit|>].", "evidence": {"52034": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [52034]}
{"id": 56, "claim": "Studies of simplex autism probands have determined that de novo mutations account for 2%–15% of disease incidence and that at least 30% of de novo mutations can be causally implicated in simplex cases [<|multi_cit|>].", "evidence": {"96019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [96019]}
{"id": 70, "claim": "Genetic and environmental factors have been implicated in the development of ASD, but the molecular mechanisms underlying their interaction are still not fully understood (<|multi_cit|>).", "evidence": {"96020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [96020]}
{"id": 76, "claim": "Stress-induced cytokines, including type I and II IFNs and G-CSF, all promote dormant HSCs to enter an active cell cycle mode (<|multi_cit|>; Baldridge et al., 2010).", "evidence": {"61013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61013]}
{"id": 77, "claim": "HSCs exit quiescence and actively cycle upon interferon treatment or 5-fluoruracil (5-FU)–induced BM suppression (<|multi_cit|>).", "evidence": {"61014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61014]}
{"id": 78, "claim": "These cells harbor the highest self-renewal capacity among all blood progenitors and, although typically dormant during homeostasis, they can be induced to reenter the cell cycle in response to cytokines like type I or II IFN, G-CSF, or injury signals such as those generated by chemotherapy-induced myelosuppression (<|multi_cit|>).", "evidence": {"61015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61015]}
{"id": 84, "claim": "Taking the above into consideration, in our study, the possibility of bacterial translocation could not be excluded in the neomycin-treated rats since they exhibited significantly augmented levels of CRP (20%) and IFN-γ (66%) in the serum as compared to control (Figures <|other_cit|> and <|other_cit|>), and the elevation of these two proteins is associated with the state of infection or disease in addition to other factors [<|multi_cit|>].", "evidence": {"61016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61016]}
{"id": 85, "claim": "Moreover, Vav1-Cre is noninducible, thus precluding temporal control of gene deletion, and although Mx1-Cre is inducible, its induction by the synthetic double-stranded RNA polyinosinic-polycytidylic acid (polyI:polyC) elicits a systemic interferon response that is known to activate and drive HSCs into cycle (<|multi_cit|>) potentially confounding interpretations using this strain, particularly in regard to HSC cell cycle status and regulation of quiescence.", "evidence": {"61017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61017]}
{"id": 89, "claim": "We next sought to determine the representation of Cxcr41013-bearing HSPCs in the spleen, where hematopoiesis can expand under specific settings, a process referred to as extramedullary hematopoiesis (EMH; <|multi_cit|>).", "evidence": {"61018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61018]}
{"id": 90, "claim": "In recent years, pro-inflammatory and inflammatory factors such as TNFα, IFNα and IFNγ, have been reported to be related to the emergence and activation of HSCs<|multi_cit|>.", "evidence": {"61019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61019]}
{"id": 92, "claim": "Steady-state differentiation of hematopoietic stem and progenitor cells (HSPCs) into myeloid lineage cells is controlled by growth factors including G-CSF, M-CSF, GM-CSF, and Flt3-L, but can be modified by pro-inflammatory cytokines such as IFN-γ during an immune response (<|multi_cit|>).", "evidence": {"61020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61020]}
{"id": 96, "claim": "Interestingly, even though E2 significantly increases HSC divisions, unlike infection or interferon responses it does not lead to HSC depletion (<|multi_cit|>).", "evidence": {"61021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [61021]}
{"id": 103, "claim": "Several studies have shown that the abundance of B. pullicaecorum, E. rectale, F. prausnitzii, and/or R. intestinalis is markedly decreased in IBD patients (<|multi_cit|>; Eeckhaut et al., <|other_cit|>; Gevers et al., <|other_cit|>) and that such patients have lower concentrations of butyrate in their feces than healthy individuals (Marchesi et al., <|other_cit|>; Nemoto et al., <|other_cit|>).", "evidence": {"80021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [80021]}
{"id": 107, "claim": "Indeed, psychiatric comorbidities often accompany conditions characterized by an aberrant gut microbiota composition, such as irritable bowel syndrome, functional gastrointestinal disorder, and inflammatory bowel disease (<|multi_cit|>).", "evidence": {"80022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [80022]}
{"id": 118, "claim": "Although we could not perform a statistical analysis with our validation cohort because of the small sample size, these data were consistent with previous reports (<|multi_cit|>), and they validated the methods used in this study.", "evidence": {"80023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [80023]}
{"id": 128, "claim": "For example, exposure to the most common pesticides, namely rotenone and paraquat, induces behavioral and pathological changes that characterize PD in animal models and humans [<|multi_cit|>].", "evidence": {"50025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50025]}
{"id": 131, "claim": "However, natural pesticides often present a toxicity concern and genetically modified organisms remain a topic of public debate and controversy [<|multi_cit|>].", "evidence": {"50026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50026]}
{"id": 132, "claim": "Some of these factors can be of environmental origin, such as exposure to mitochondrial toxins (e.g., rotenone, MPTP and paraquat) and heavy metals [<|multi_cit|>].", "evidence": {"50027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50027]}
{"id": 133, "claim": "Previous studies showed that rotenone stimulates PD pathophysiological pathways in dopaminergic neurons and mimics most clinical features of idiopathic PD in animal models.<|multi_cit|> For example, rotenone mouse models for PD exhibit progressive loss of dopaminergic neurons in the nigral–striatal system.<|other_cit|> Furthermore, a recent clinical study suggested that rotenone was highly associated with PD symptoms in patients exposed to environmental rotenone pollution, suggesting that mitochondrial function impairment contributed to PD pathology.<|other_cit|>", "evidence": {"50028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50028]}
{"id": 143, "claim": "The widespread use of chemical insecticides in agriculture is a growing health and ecological concern, with an increasing number of studies revealing detrimental effects on organisms such as non-pest insects, aquatic animals, and humans [<|multi_cit|>].", "evidence": {"50029": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50029]}
{"id": 147, "claim": "Rotenone, fenpyroximate and tebufenpyrad have also been demonstrated to displace 3H-dihydrorotenone (DHR) from complex I and inhibit complex I activity [<|multi_cit|>,34].", "evidence": {"50030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [50030]}
{"id": 158, "claim": "It is also important to enquire whether the patient had been infected with COVID-19 earlier or ever been tested as there are reports of individuals who got infected with COVID-19, recovered, and then again tested positive [<|cit|>].", "evidence": {}, "cited_doc_ids": [11044]}
{"id": 163, "claim": "Another interesting and alternative approach is to build machine-learning and artificial-intelligence techniques on top of epidemiological models to allow model predictions and forecasting.<|multi_cit|> in which three models were presented, depending on the forecasting timescales: an exponential growth model, a self-exciting branching process and the classical susceptible–infected–recovered (SIR) compartmental model.", "evidence": {}, "cited_doc_ids": [11045]}
{"id": 175, "claim": "Effective RR monitoring would be an important contribution to facing the current COVID-19 crisis and managing similar scenarios that may possibly occur in the next months or years (<|cit|>).", "evidence": {}, "cited_doc_ids": [11046]}
{"id": 184, "claim": "Even robust healthcare systems are facing a shortage of healthcare professionals, personal protective equipment, beds, and mechanical ventilators in intensive-care-units (ICU) (<|cit|>), thus highlighting the need for alternative medical solutions, including remote patient monitoring (Alwashmi, <|other_cit|>; FDA, <|other_cit|>; Ohannessian et al., <|other_cit|>).", "evidence": {}, "cited_doc_ids": [11047]}
{"id": 187, "claim": "In order to understand the temporal dynamics of COVID-19, a lot of modelling work has been undertaken, focusing primarily on national data sets from China, Italy, Spain, the UK and the USA.<|multi_cit|> Given the inhomogeneous nature of such data sets, accurate predictions and forecasting of the spread of COVID-19 are challenging.<|other_cit|> Where such predictions were made, caveats accompanied these predictions simply because of the lack of rigorous mathematical and statistical validation of the models and the lack of robust data on which mathematical assumptions are based.<|other_cit|>,6–9,<|other_cit|> Forecasting requires ample historical information/data sets, which were lacking during the first wave of COVID-19.", "evidence": {"11048": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [11048]}
{"id": 188, "claim": "It is important to carefully consider how this variation may affect model conclusions, and whether it should be taken into account explicitly (<|other_cit|>), especially given the heavy reliance of policy-makers on COVID-19 transmission models (<|cit|>), especially given the heavy reliance of policy-makers on COVID-19 transmission models (Kissler et al., 2020).", "evidence": {}, "cited_doc_ids": [11049]}
{"id": 198, "claim": "The most common mode of injury in vertebral fractures is a motor vehicle accident [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [11050]}
{"id": 203, "claim": "Recent studies proved that PPARs functions as a key regulator for adipocyte development and IMF regulation [<|multi_cit|>].", "evidence": {"53020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53020]}
{"id": 205, "claim": "The discovery of a unique population of adipose tissue resident Tregs that are enriched in IL-10 has spurred interest into their physiologic function in metabolic regulation (<|multi_cit|>,8).", "evidence": {"53021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53021]}
{"id": 207, "claim": "For example, specialized Treg cell fractions regulate diverse metabolic parameters in adipose tissue or support regenerative processes in injured muscles.<|multi_cit|> Recently, a subset of Foxp3+ Treg cells co-expressing the IL-33 receptor ST2 and transcription factor GATA3 has been shown to be enriched in colonic LP.<|other_cit|> As IL-33 functions as danger signal following tissue injury, the ST2+ Treg cell subpopulation might have a crucial role in adaptation of colon to the inflammatory environment by reacting rapidly to inflammation-driven tissue damage.", "evidence": {"53022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53022]}
{"id": 212, "claim": "The structures of PTPN18-HER2-pY1248, pY1112 and pY1196 were determined by molecular replacement with Phaser<|cit|> in the CCP4 software package.", "evidence": {}, "cited_doc_ids": [53023]}
{"id": 220, "claim": "Recent studies have identified subpopulations of Treg cells with distinct expression of additional transcription factors such as T-bet, IRF4, Bcl6, and PPARγ (Koch et al., <|other_cit|>; Zheng et al., <|other_cit|>; Linterman et al., <|multi_cit|>).", "evidence": {"53024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53024]}
{"id": 222, "claim": "Regulatory T cells constitute 10–15% of the total CD4+ T cell population in whole body but constitute a much higher proportion in local tissues such as visceral adipose tissue and intestinal tissue (<|multi_cit|>).", "evidence": {"53025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53025]}
{"id": 223, "claim": "In addition, EA11 also upregulates the expression of PPAR-γ, another recognized anti-inflammatory mediator [<|multi_cit|>] (<|other_cit|>).", "evidence": {"53026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53026]}
{"id": 224, "claim": "These effects, in combination, can negatively affect overall WAT function and metabolism [<|multi_cit|>].", "evidence": {"53027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53027]}
{"id": 227, "claim": "Similarly, immune cells with anti-inflammatory phenotypes (alternatively activated M2 macrophages, Th2, regulatory T cells [Treg]) are resident in the adipose tissue of lean mice and individuals, whereas proinflammatory cells (classically activated M1 macrophages, Th1) become enriched and expanded in the adipose tissue of obese subjects (<|multi_cit|>).", "evidence": {"53028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53028]}
{"id": 230, "claim": "These Treg cells produce high quantities of the anti-inflammatory cytokine IL-10 and uniquely express nuclear receptor PPAR-γ, which is necessary for their homeostasis and regulatory function in VAT (Feuerer et al., <|multi_cit|>).", "evidence": {"53029": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [53029]}
{"id": 233, "claim": "Human activity and cognitive function were affected by alcohol use [<|cit|>].", "evidence": {}, "cited_doc_ids": [91020]}
{"id": 238, "claim": "It is well established that cardiovascular diseases (including hypertension and ischemic heart disease) and diabetic microvascular complications are major risk factors for the development of chronic kidney diseases (<|multi_cit|>; Ronksley et al. 2011).", "evidence": {}, "cited_doc_ids": [91021]}
{"id": 250, "claim": "Epidemiological studies suggest that low-moderate ethanol intake lowers the incidence of ischemic stroke and reduces mortality and infarct volume from ischemic stroke, whereas heavy ethanol consumption increases the incidence of ischemic stroke and worsens the prognosis of ischemic stroke (Hansagi et al., <|other_cit|>; Ikehara et al., <|other_cit|>; Patra et al., <|multi_cit|>; Ducroquet et al., <|other_cit|>; Zhang et al., <|other_cit|>).", "evidence": {"91022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [91022]}
{"id": 255, "claim": "Substantial epidemiologic evidence suggests that alcohol use within recommended limits of intake is associated with a lower risk of cardiovascular disease and diabetes (<|multi_cit|>).", "evidence": {"91023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [91023]}
{"id": 257, "claim": "Recent studies have indicated that changes in heart dimensions and function are common in alcoholics [<|cit|>], possibly leading to alcoholic cardiomyopathy (ACM).", "evidence": {}, "cited_doc_ids": [91024]}
{"id": 258, "claim": "Notably, the gut microbiota has been associated with all of those conditions (<|multi_cit|>).", "evidence": {"83017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83017]}
{"id": 260, "claim": "Prevotellaceae is reported to be associated with several human diseases, such as asthmatic airway inflammation and arthritis (<|multi_cit|>).", "evidence": {"83018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83018]}
{"id": 267, "claim": "Prevotellaceae is reported to relate to several diseases, such as asthmatic airway inflammation and arthritis, and associate with mucin degradation (<|multi_cit|>).", "evidence": {"83019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83019]}
{"id": 269, "claim": "The Prevotella copri and Staphylococcus aureus probably invade humans and mice (<|multi_cit|>).", "evidence": {"83020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83020]}
{"id": 270, "claim": "We and others have demonstrated that gut microbiota can act as an environmental cue to induce autoimmune arthritis in both humans and mice [<|multi_cit|>].", "evidence": {"83021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83021]}
{"id": 271, "claim": "Studies indicated that Escherichia–Shigella, Buchnera and Prevotella_9 were belonged to conditional pathogen (Peleg et al. <|other_cit|>; Hamilton et al. <|multi_cit|>).", "evidence": {}, "cited_doc_ids": [83022]}
{"id": 274, "claim": "These findings underscore the pathogenic similarities between IBD and ERA, as F. prausnitzii was not reduced in a study of newly diagnosed RA patients [<|cit|>].", "evidence": {}, "cited_doc_ids": [83023]}
{"id": 275, "claim": "In addition, a reduction in Butyricimonas has been noted in numerous autoimmune and inflammatory diseases including IBD, rheumatoid arthritis and type 1 diabetes (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [83024]}
{"id": 283, "claim": "For example, in the case of colorectal cancer or arthritis (<|multi_cit|>; Zeller et al., <|other_cit|>), individual marker taxa were found to be associated to the disease state, whereas effects on the overall composition were very mild.", "evidence": {"83025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [83025]}
{"id": 289, "claim": "Downregulation of D2 receptors and changes in the relative contribution of D1 vs. D2-containing neurons following long-term exposure to drugs or potent rewards (Volkow et al., <|multi_cit|>; Park et al., <|other_cit|>) has been repeatedly demonstrated and may contribute to why D1 receptor antagonists reduce the expression of habitual behaviors following such treatments.", "evidence": {"67020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [67020]}
{"id": 292, "claim": "This reward-hyposensitive state could also trigger compensatory and compulsive food intake [<|multi_cit|>].", "evidence": {"67021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [67021]}
{"id": 293, "claim": "Previous work from our laboratory has observed that maternal HFD exposure decreased the amount of TH-IR fibers in the prefrontal cortex (<|other_cit|>), which is a critical VTA projection for the regulation of higher order reward signaling and hedonic appetite regulation (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [67022]}
{"id": 300, "claim": "There are consistent findings in the animal literature that HFD, and adiposity alter DA signaling at the cellular, and molecular levels (Anderzhanova et al., <|multi_cit|>; van de Giessen et al., <|other_cit|>; Sharma and Fulton, <|other_cit|>; Tellez et al., <|other_cit|>; Cansell et al., <|other_cit|>; Adams et al., <|other_cit|>; Woods et al., <|other_cit|>), as well as mounting evidence for altered DA signaling in human obesity, especially reflected in changes in DA receptor density, (Wang et al., <|other_cit|>; Dunn et al., <|other_cit|>; Steele et al., <|other_cit|>; Eisenstein et al., <|other_cit|>; Guo et al., <|other_cit|>; Cosgrove et al., <|other_cit|>; Horstmann et al., <|other_cit|>; Karlsson et al., <|other_cit|>; Caravaggio et al., <|other_cit|>; Dang et al., <|other_cit|>; Gaiser et al., <|other_cit|>).", "evidence": {"67023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [67023]}
{"id": 304, "claim": "We then targeted subregions of the nucleus accumbens (NAc), which has been principally linked to hedonic drives; the degree to which the NAc regulates other motivations to eat including homeostatic-based feeding is less well studied (Baldo and Kelley, <|multi_cit|>; Baldo et al., <|other_cit|>).", "evidence": {"67024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [67024]}
{"id": 306, "claim": "HFD and obesity are also associated with dopamine-dependent mesocorticolimbic-prefrontal alterations that may impact reward learning, motivation, and executive functions ( <|multi_cit|>).", "evidence": {"67025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [67025]}
{"id": 309, "claim": "In contrast, consumption of a high fat and high sugar diets have been shown to decrease D  and D  receptor protein and mRNA expression (Alsiö et al., <|multi_cit|>; Ong et al., <|other_cit|>; Kovalenko et al., <|other_cit|>).", "evidence": {"67026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [67026]}
{"id": 311, "claim": "Animal studies have demonstrated that dopamine pathways respond to the consumption of palatable foods and peripherally derived metabolic signals, and that manipulation of this circuit alters intake (<|multi_cit|>).", "evidence": {"67027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [67027]}
{"id": 313, "claim": "Therefore, it was estimated that remdesivir would have reduced hospital stay in general wards by up to 6.13 days (95% CI 4.97–7.53) [<|multi_cit|>].", "evidence": {"15049": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15049]}
{"id": 317, "claim": "In vitro investigations suggest that tenofovir (i) inhibits SARS-CoV-2 RdRp, although with weaker binding than remdesivir (<|multi_cit|>) and (ii) possesses immunomodulatory effects as it demonstrates the ability to decrease both interleukin (IL)-8 and IL-10 production (<|other_cit|>), which are both known to favor COVID-19 severity (<|other_cit|>).", "evidence": {}, "cited_doc_ids": [15050]}
{"id": 328, "claim": "Furthermore, in a real-life cohort of patients with severe pneumonia receiving low-flow oxygen-therapy treated with remdesivir, the 30-day mortality rate observed was 4.1% [<|other_cit|>], very similar to that reported in the ACTT-1 trial [<|cit|>], very similar to that reported in the ACTT-1 trial [10].", "evidence": {}, "cited_doc_ids": [15051]}
{"id": 331, "claim": "Groups of nodes sharing a high number of co-occurrences were clustered together and colored accordingly for each bibliometric network [<|cit|>].", "evidence": {}, "cited_doc_ids": [15052]}
{"id": 346, "claim": "In addition, the double-blind, randomized, and placebo-controlled ACTT-1 trial showed that remdesivir improves the time to recovery and clinical status of hospitalized patients with COVID-19 and pneumonia who require supplemental oxygen [<|cit|>].", "evidence": {}, "cited_doc_ids": [15053]}
{"id": 351, "claim": "The viral component allows clinicians to confirm the most recent date of positive viral PCR and subsequent management (such as remdesivir and convalescent plasma) as well as the duration of therapy.<|multi_cit|> The antimicrobial portion documents the most recent date of positive culture, both sputum and blood cultures; procalcitonin level, utilized to help determine the need for the addition of antibiotics in a rapidly deteriorating patient even if cultures have resulted negative; and the results of methicillin resistant staphylococcus aureus (MRSA) culture, used to determine the necessity of MRSA coverage should the patient require empiric antibiotic coverage.", "evidence": {"15054": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15054]}
{"id": 358, "claim": "This risk ratio was applied to the government mortality data to calculate the potential impact of remdesivir on the mortality rate in patients on low-flow oxygen (a reduction of up to 6.18% [95% CI 2.89%–13.19%] in general hospital wards) (Fig. <|other_cit|>) [<|multi_cit|>].", "evidence": {"15055": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15055]}
{"id": 359, "claim": "Treatment efficacy: Clinical efficacy data of BARI-REM and REM were sourced from the ACTT-2 trial, Kalil et al., and Beigel et al. [8, <|multi_cit|>, 20] and divided into two overlapping subgroups; (1) all hospitalized patients and (2) patients who required use of oxygen at admission for analysis.", "evidence": {"15056": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [15056]}
{"id": 369, "claim": "Diabetes mellitus (DM) is considered an important risk factor for cardiovascular disease, including acute coronary syndrome (ACS), and death [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [77018]}
{"id": 372, "claim": "Finally, in our study, as well as other ICU studies regarding BG control, several relevant hypoglycemia severity markers [<|cit|>] have recently demonstrated that BG reperfusion is responsible for neuronal cell death after hypoglycemia which was not responsible per se for neuronal apoptosis.", "evidence": {}, "cited_doc_ids": [77019]}
{"id": 375, "claim": "Severe hypoglycaemia is associated with lower productivity, reduced quality of life, and a higher risk of anxiety, depression and mortality [<|multi_cit|>].", "evidence": {"77020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [77020]}
{"id": 384, "claim": "Second, GLP-1As reduced severe hypoglycemia which usually associate with increasing of CV events [<|multi_cit|>, 53], and this may also account for their CV benefits.", "evidence": {"77021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [77021]}
{"id": 386, "claim": "In the ACCORD trial, it has been demonstrated that a significant portion of hypoglycemic episodes were asymptomatic (<|cit|>).", "evidence": {}, "cited_doc_ids": [77022]}
{"id": 390, "claim": "Tighter blood glucose before and after eating have been advocated over the last decade to reduce rates of infection and poor cardiovascular outcomes,<|other_cit|> but a tight glycaemic target can increase hypoglycaemia as shown in the intensive treatment group of the ACCORD trial  (The Action to Control Cardiovascular Risk in Type 2 Diabetes) where a significant number of asymptomatic hypoglycaemic event (HGEs) were identified.<|cit|> HGEs during hospitalisation are associated with poor outcomes including autonomic failure, arrhythmias, cognitive decline<|other_cit|> and increased morbidity and mortality within 1 year of discharge.<|other_cit|> Inpatient hypoglycaemia in patients with diabetes leads to longer lengths of stay, and greater likelihood for discharge to a skilled nursing facility.", "evidence": {}, "cited_doc_ids": [77023]}
{"id": 392, "claim": "Adult patients who live alone or have occupations which preclude a degree of risk of hypoglycemia, for example, the elderly, taxi drivers and sportsmen, should avoid insulin, SUs and glinides and favor metformin and DPP-4 inhibitors [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [77024]}
{"id": 400, "claim": "For example, Cdc48 is important for ER-associated protein degradation (ERAD), modulates the turnover of mitochondrial OM proteins (OMMAD), participates in apoptosis responses (<|other_cit|>) and mediates clearance of damaged lysosomes by autophagy (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [81026]}
{"id": 403, "claim": "Parkin then ubiquitinates mitochondrial outer membrane proteins such as Mitofusin or Miro to induce a wide range of outcomes, from proteasomal degradation to vesicle formation, motility arrest, and mitochondrial autophagy (Narendra et al, <|other_cit|>; Gegg et al, <|multi_cit|>; Ziviani et al, <|other_cit|>; Wang et al, <|other_cit|>; McLelland et al, <|other_cit|>).", "evidence": {"81027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [81027]}
{"id": 405, "claim": "Parkin leads to the ubiquitination of a broad number of targets that are expressed on the OMM, among others TOM20, Mitofusins, VDAC and Fis1 [<|multi_cit|>].", "evidence": {"81028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [81028]}
{"id": 422, "claim": "The effect of the ubiquitination is twofold; a direct and immediate inhibition of MFN2 activity, thus preventing the damaged mitochondria fusing with the healthy mitochondrial population, and the recruitment of p62 (sequestosome 1) to mediate mitochondrial autophagy (Gegg et al., <|multi_cit|>; Glauser et al., <|other_cit|>; Chen and Dorn, <|other_cit|>).", "evidence": {"81029": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [81029]}
{"id": 424, "claim": "In addition to local calcium levels, mitochondrial motility is regulated through proteasomal breakdown of the transport complex, as PINK1 promotes the proteasomal degradation of Miro1/2 and MFN1/2 in a Parkin-dependent manner [<|multi_cit|>].", "evidence": {"81030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [81030]}
{"id": 428, "claim": "These sequential events result in signs of β cell stress and failure (Fujimoto et al., <|multi_cit|>; Mir et al., <|other_cit|>).", "evidence": {}, "cited_doc_ids": [78018]}
{"id": 431, "claim": "Sudden elevation of reactive oxygen species (ROS) induces the mitochondrial permeability transition pore (mPTP) opening and mitochondrial polarization, which determines the fate of the cell.[<|multi_cit|>] Minor injuries lead to decreases in the mitochondrial membrane potential and mPTP opening, which subsequently causes mitochondrial autophagy.", "evidence": {"78019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78019]}
{"id": 434, "claim": "DRP1 is located in the mitochondrial outer membrane, generates small mitochondria, and allows the phagophore to efficiently engulf the organelle<|multi_cit|>.", "evidence": {"78020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78020]}
{"id": 437, "claim": "Specific autophagy can include ubiquitinated proteins, peroxisomes and mitochondria.<|multi_cit|> Mitophagy involves the selective degradation of mitochondria and is among others used for clearance of damaged mitochondria.<|other_cit|> Previously, BetA and a derivative of BetA, B10, have been shown to induce autophagosome formation in multiple myeloma cells and glioblastoma cells.<|other_cit|> In these studies it was suggested that the autophagic flux was prevented, leading to an accumulation of undigested autophagosomes.", "evidence": {"78021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78021]}
{"id": 438, "claim": "Autophagy induced by bacteria can be classified as selective autophagy (xenophagy), non-canonical autophagy and microtubule-associated protein light chain 3 (LC3)–associated phagocytosis (LAP; Kaushik and Cuervo, <|multi_cit|>).", "evidence": {"78022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78022]}
{"id": 442, "claim": "Moreover, given that modified electron transport complexes cause a further increase of redox imbalance by endogenous ROS overproduction, a vicious circle is triggered, amplifying the oxidative cellular damage [<|multi_cit|>, 58].", "evidence": {"78023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78023]}
{"id": 449, "claim": "Aberrant mitophagy leads to increased oxidative stress and is linked to neurodegenerative diseases such as AD, PD, and HD (<|multi_cit|>).", "evidence": {"78024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [78024]}
{"id": 450, "claim": "PKR can control the inflammasome and is involved in the general process of innate immunity and inflammation.<|cit|> However, we did not detect any modifications of the levels of microglial activation or oxidative stress in TD mice pretreated with PKRinh or in PKR−/− mice.", "evidence": {}, "cited_doc_ids": [89014]}
{"id": 452, "claim": "Those components have important roles in the pathology of microglia-specific formation of neurodegenerative disorders and further regulate CNS inflammation and de-myelination during cerebral insult [<|multi_cit|>].", "evidence": {"89015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [89015]}
{"id": 458, "claim": "The activation mechanisms reported for NLRP3 activation in macrophages, such as ROS production, K+ eﬄux and endosomal rupture, also apply to NLRP3 activation within microglia (<|multi_cit|>).", "evidence": {"89016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [89016]}
{"id": 459, "claim": "And the nucleotide binding and oligomerization domain-like (Nod) receptor family pyrin domain-containing 3 (NLRP3) inflammasome, a pathogen recognition receptor (PRR), is highly expressed in microglia, which can be activated by lots of invading pathogens and endogenous danger molecules such as extracellular adenosine 5′-triphosphate (ATP), uric acid crystals, and amyloid-β [<|multi_cit|>].", "evidence": {"89017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [89017]}
{"id": 460, "claim": "Recent study findings have emphasized that through the activation of inflammasome, pathological Tau could enhance the secretion of IL-1β [<|cit|>].", "evidence": {}, "cited_doc_ids": [89018]}
{"id": 464, "claim": "These dark microglia are structurally different from ionized calcium-binding adapter molecule 1 (Iba1) expressed microglia, and they are increased at the site of microglial alteration and activation such as around amyloid plaques (APs), dystrophic neurons, triggering receptor expressed on myeloid cells 2 (TREM2), in stress, aging, and AD (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [89019]}
{"id": 469, "claim": "Although this response is responsible for Aβ clearance, a sustained pro-inflammatory environmental could be detrimental for the host (<|multi_cit|>; Chen L. et al., <|other_cit|>; Go et al., <|other_cit|>).", "evidence": {"89020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [89020]}
{"id": 470, "claim": "In addition to atherosclerosis, aberrant activation of the NLRP3 inflammasome drives pathological inflammation in sterile inflammatory diseases associated with aging, such as Alzheimer’s disease, Parkinson’s disease, obesity, diabetes, multiple sclerosis, and cancer (<|multi_cit|>).", "evidence": {"89021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [89021]}
{"id": 481, "claim": "We next designed a series of immunization regimens that we hypothesized would i) allow direct comparison of protective efficacy of single-shot versus two-dose prime-boost schedules, and ii) generate a range of binding and neutralizing antibody responses that could enable analyses of correlates of protection following challenge [<|multi_cit|>].", "evidence": {"19055": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19055]}
{"id": 483, "claim": "An sgRNA-specific assay enabled quantifying a replicating virus in several important NHP vaccine/challenge studies ([<|other_cit|>,82]; testing the efficacy of mRNA-1273, ChAdOx1 nCoV-19, and Ad26 vaccines, respectively), and evaluating the protective efficacy of natural immunity and mAbs in NHP models [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [19056]}
{"id": 506, "claim": "In addition, it is not subject to first-pass metabolism, and is considered the most effective route for inducing local immune protection against airborne pathogens (30<|multi_cit|>–33).", "evidence": {}, "cited_doc_ids": [19057]}
{"id": 507, "claim": "Pulmonary vaccination is among the most efficient routes to generate mucosal and systemic immunity against airborne pathogens (30<|multi_cit|>–33) and has increased immunological protection of nonhuman primates infected with SARS-CoV-2 (31, 33).", "evidence": {}, "cited_doc_ids": [19058]}
{"id": 518, "claim": "Pulmonary vaccination is among the most efficient routes to generate mucosal and systemic immunity against airborne pathogens (<|other_cit|>) and has increased immunological protection of nonhuman primates infected with SARS-CoV-2 (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [19059]}
{"id": 519, "claim": "A Th1 cell-biased response or balanced Th1/Th2 cell response has also been reported by others upon immunization of mice, hamsters, and macaques with effective COVID-19 vaccines (<|multi_cit|>).", "evidence": {"19060": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19060]}
{"id": 520, "claim": "Ad26.COV2.S demonstrated protective efficacy against SARS-CoV-2 challenges in hamsters and non-human primates<|multi_cit|> and showed safety and immunogenicity in humans<|other_cit|>.", "evidence": {"19061": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19061]}
{"id": 521, "claim": "Evidence from preclinical studies in nonhuman primates and hamsters indicted that vaccine-induced SARS-CoV-2 neutralizing antibodies correlate with protection against lung infection and clinical disease [<|multi_cit|>].", "evidence": {"19062": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19062]}
{"id": 523, "claim": "Similar to our previous reports with human adenovirus serotype 26 (Ad26) vectors [<|multi_cit|>], inserts included: i) unmodified S, ii) truncations of the cytoplasmic tail (S.dCT) or the transmembrane region (S.dTM), or iii) select fragments, including the S1 domain and the receptor binding domain (RBD).", "evidence": {"19063": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19063]}
{"id": 528, "claim": "Several important studies for understanding SARS-CoV-2 pathogenesis and transmission dynamics and assessing the efficacy of vaccines and therapeutics have been conducted in clinically relevant non-human primate (NHP) models, such as rhesus macaques, cynomolgus monkeys, and African green monkeys [<|multi_cit|>].", "evidence": {"19064": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [19064]}
{"id": 531, "claim": "Among the other vaccines, 86% record of vaccine efficiency was noted for the Sinovac Biotech (Sinovac, Beijing, China) vaccine; and the Sinopharm (Sinopharm, Beijing, China) whole-virus vaccines (Heinz and Stiasny <|multi_cit|>; Forni et al. <|other_cit|>; Wadman and Cohen <|other_cit|>).", "evidence": {}, "cited_doc_ids": [19065]}
{"id": 538, "claim": "For example, studies on the reversibility of EMT, and in particular the role of EMT markers such as E-cadherin, have shown that fine-tuned modulation of EMT allows switching between stationary and mobile states, whereas others have shown that EMT may be important in cancer stem cell capacity and sensitivity to chemotherapy <|multi_cit|>– 74.", "evidence": {"97015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97015]}
{"id": 541, "claim": "Both processes are not only common during embryonic development<|other_cit|> but are also involved in different stages of the metastatic cascade, including tumor cell dissemination and migration<|other_cit|>, generation of tumor circulating cells<|other_cit|>, cancer stem cells<|other_cit|>, chemoresistance<|multi_cit|>, and metastasis formation<|other_cit|>.", "evidence": {"97016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97016]}
{"id": 543, "claim": "In addition, cells undergoing EMT have been shown to acquire tumor-initiating and/or drug-resistance properties (often together referred to as ‘stemness’ in the context of Cancer Stem Cells) and to induce cell cycle arrest (Jolly et al., <|other_cit|>; Mani et al., <|other_cit|>; Nieto et al., <|multi_cit|>; Zheng et al., <|other_cit|>).", "evidence": {"97017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97017]}
{"id": 546, "claim": "Although the dependence of metastasis upon EMT has recently been questioned in lung and pancreatic cancer, epithelial plasticity remains a fundamental trait of metastatic tumour cells (<|multi_cit|>).", "evidence": {"97018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97018]}
{"id": 548, "claim": "Recent reports on lung and pancreatic cancer found that although EMT affects chemoresistance, it is not required for metastasis <|multi_cit|>.", "evidence": {"97019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97019]}
{"id": 551, "claim": "The studies of E2F2 with EMT, previously associated with metastases and chemoresistance,<|multi_cit|> are contradictory.<|other_cit|> In the current study, we found that all mice tumours formed by miR-99a overexpression showed a fusocellular pattern different from the tumours formed in the control group, supporting a role of miR-99a in EMT inhibition concomitant to a downregulation of stem cell genes.", "evidence": {"97020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97020]}
{"id": 557, "claim": "Epithelial-to-mesenchymal transition (EMT) is characterized by the loss of epithelial differentiation and the acquisition of a mesenchymal phenotype.<|other_cit|> Moreover, during EMT, cancer cells lose their polarity and adhesion, and gain migratory and invasive capabilities that are typical of mesenchymal cells; it is also a potential cellular program through which tumor cells gain metastatic features.<|other_cit|> Although this process was initially recognized to be important during embryogenesis,<|other_cit|> it is now known to occur in cancer stem cells, drug resistance, and immunosuppression during cancer progression.<|multi_cit|> Moreover, numerous studies have shown that signaling pathways such as PI3K/AKT, MAPK, TGF-β, NF-κΒ, Notch, and Wnt, among others, play crucial roles in EMT-related invasion and metastasis.<|other_cit|>", "evidence": {"97021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97021]}
{"id": 558, "claim": "These findings, combined with those of the present study, support the importance of epithelial phenotype/MET tumor cell survival in the bloodstream and in the formation of secondary tumors and a central role for E-cadherin in this mechanism [<|multi_cit|>].", "evidence": {"97022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97022]}
{"id": 559, "claim": "The rationale of manipulating sub-populations of malignant cells within a tumor, in particular sub-populations involved in chemoresistance and metastasis, has recently been shown in elegant murine models of breast and pancreas cancer, and could have important implications in the treatment of patients with cancer [<|multi_cit|>–36].", "evidence": {"97023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [97023]}
{"id": 565, "claim": "Genome-wide studies have shown that c-Myc transcriptionally regulates many lncRNA genes, such as PVT1, the CCAT family, and MYCLos, whereas a number of lncRNAs have been demonstrated to be important components of the c-Myc-mediated signaling network (<|multi_cit|>).", "evidence": {"86022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [86022]}
{"id": 566, "claim": "Growing evidence suggests critical roles of lncRNAs in multiple cellular processes including differentiation, dosage compensation, genomic stability, metabolism, metastasis and DNA repair (<|multi_cit|>).", "evidence": {"86023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [86023]}
{"id": 576, "claim": "The lncRNA gastric cancer associated transcript 1 (GACAT1), was found to be expressed at lower levels in gastric cancer tissues compared to corresponding normal tissues [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [86024]}
{"id": 582, "claim": "Colon cancer associated transcript 2 (CCAT2) appears to promote EMT, as lncRNA CCAT2 knockdown leads to increased E-cadherin and decreased vimentin levels in gastric cancer cells and, additionally, CRC cells expressing higher levels of CCAT2 display increased vimentin expression [<|multi_cit|>].", "evidence": {"86025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [86025]}
{"id": 591, "claim": "Our observations reflect these aspects of the changing HIV population [<|multi_cit|>,27].", "evidence": {"94021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [94021]}
{"id": 594, "claim": "Over the years, the proportion of HIV patients older than 50 years of age is constantly increasing.<|other_cit|> It is estimated that by the end of 2015, more than half of HIV patients in the United States will be older than 50 years of age.<|multi_cit|> Currently, about 15% of HIV infected adults in Sub-Saharan Africa are older than 50 but the prevalence of older HIV patients in that area is expecting to increase in the coming decades.<|other_cit|> The main reason for the increasing age of patients living with HIV is the improvement of specific antiretroviral treatment (highly active antiretroviral treatment (HAART)) and its expanding accessibility.<|other_cit|> Better treatment of HIV complications and comorbidities such as diabetes mellitus (DM) and hypertension also contributes to the improving survival of HIV-infected patients.<|other_cit|> Thus, HIV patients grow older and live longer with a life expectancy approaching that of the general population.<|other_cit|>", "evidence": {}, "cited_doc_ids": [94022]}
{"id": 595, "claim": "We also assume that MSM in Israel comprised ∼3% of all men aged 16–45 years (∼94 000 men), as reported from other developed countries.<|multi_cit|> Based on these assumptions, HIV point prevalences in 2010 were 1805/100 000 for Ethiopian-born Israeli citizens, 3150/100 000 for IDU and 1492/100 000 for MSM aged 16–45 years.", "evidence": {}, "cited_doc_ids": [94023]}
{"id": 598, "claim": "The yearly disease incidence rates of HIV/AIDS and cancer were found to be relatively stable over the last few years [<|multi_cit|>], so the data estimated in this study (which uses incidence and prevalence data compiled in the recent national disease registries and are for the years between 2007 and 2014) can be assumed to remain constant for the next 5 years.", "evidence": {"94024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [94024]}
{"id": 603, "claim": "Injection drug use is driving HIV epidemics in many countries in Asia, the Middle East, and Eastern Europe and there are continuing epidemics of HIV and other parenterally transmitted viruses such as hepatitis C among PWID in many locations worldwide [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [94025]}
{"id": 610, "claim": "Similarly, humoral responses against HIV-1 at mucosal surfaces may be important for human immunodeficiency virus (HIV) prevention as approximately 90% of HIV transmissions occur at mucosal sites (<|cit|>).", "evidence": {}, "cited_doc_ids": [94026]}
{"id": 614, "claim": "HIV continues to disproportionately impact Black Americans in the US, and Black men who have sex with men (BMSM) continue to experience the brunt of new cases annually and to experience higher rates of morbidity and mortality due to HIV/AIDS [<|multi_cit|>].", "evidence": {"94027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [94027]}
{"id": 626, "claim": "In autism, attention and orienting to the nonsocial world is biased at very earlyages,<|cit|> Therefore, in addition to enhanced responsivity in the neural circuitry handling basic sensory and perceptual processing, it is likely that heavily biased attentional processes that promote a local detail-oriented focus could further amplify processing in such sensory and perceptual circuitry.", "evidence": {}, "cited_doc_ids": [48023]}
{"id": 634, "claim": "However, even during the first year of life, infants with ASD demonstrate infrequent orienting to their own name and diminished eye contact (<|multi_cit|>; Jones and Klin, 2013), suggesting that decreased social interest is evident in infancy in ASD and may interfere with the development of social cognition in at least a significant proportion of individuals with ASD.", "evidence": {"48024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [48024]}
{"id": 648, "claim": "To date, the transcriptomes of 68 species from 7 insect orders have been sequenced [<|multi_cit|>], and the transcriptome and expression profile data of some lady beetles such as Cryptolaemus montrouzieri Mulsant and Propylaea japonica (Thunberg) have been analyzed [<|other_cit|>].", "evidence": {}, "cited_doc_ids": [92018]}
{"id": 651, "claim": "However, as demonstrated, AMPs are among the most highly expressed sequences and thus are more easily identified in RNA-Seq data compared to lower expressed genes (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [92019]}
{"id": 654, "claim": "Advantages and disadvantages regarding their applications, costs and time consumption, sensitivity and dynamic range of detection, challenges in data analysis and data storage have been outlined in various publications (Mantione et al., 2014[<|other_cit|>]; Malone and Oliver, 2011[<|multi_cit|>]; Wang et al., 2009[<|other_cit|>]).", "evidence": {"92020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [92020]}
{"id": 659, "claim": "RNA-seq has a wider dynamic range and avoids some of the technical limitations in a microarray experiment such as varying probe performance, cross-hybridization, limited dynamic range of individual probes, and nonspecific hybridization [<|multi_cit|>].", "evidence": {"92021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [92021]}
{"id": 660, "claim": "Modern recently developed large-scale RNA sequencing technologies (RNA-Seq) have been useful in understanding the genetic and physiological processes that regulate the phenotype of quantitative traits in a certain situation [<|cit|>].", "evidence": {"92022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [92022]}
{"id": 663, "claim": "High-throughput sequencing makes the study of transcriptomes readily approachable, including alternative splicing, the discovery of novel splice junctions, the delimitation of UTR boundaries or the identification of antisense or extra-exonic expression (<|multi_cit|>).", "evidence": {"92023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [92023]}
{"id": 672, "claim": "The error-prone nature of the RNA-dependent RNA polymerase of arboviruses is known to generate approximately 1 error per 104 nucleotides per viral replication cycle, thus generating diverse virus populations that undergo selection to produce genetically distinct variants called quasispecies [<|multi_cit|>, 11].", "evidence": {"84027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [84027]}
{"id": 678, "claim": "While quasispecies are well characterized in RNA viruses associated with higher plants and mammals (<|multi_cit|>), environmental quasispecies are largely unexplored.", "evidence": {"84028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [84028]}
{"id": 701, "claim": "This animal model has been used to evaluate hESC-CMs and reprogramed somatic cells (iPSC) for their regenerative capacity of the heart.[<|multi_cit|>29]", "evidence": {"56021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [56021]}
{"id": 703, "claim": "Although there has been much investment in candidate cardiac stem cell populations over the past decade (<|other_cit|>), many promising alternative strategies for heart regeneration have emerged, including activation of cardiomyocyte division, reprogramming of non-muscle cells into cardiomyocyte-like cells, and delivery of stem cell-derived cardiomyocytes (<|multi_cit|>; Chong et al., 2014).", "evidence": {"56022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [56022]}
{"id": 709, "claim": "Evidences of heart regeneration from human ESCs have been demonstrated from studies in different animal models, such as pig, guinea pig and non-human primate models [<|multi_cit|>].", "evidence": {"56023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [56023]}
{"id": 715, "claim": "However, clinical translation of these techniques was impeded due to difficulties such as issues of immune response and tumorigenesis <|cit|>.", "evidence": {}, "cited_doc_ids": [56024]}
{"id": 722, "claim": "Our study compared different time periods after the full introduction of HAART over the whole country, following the approval of the federal legislation regulating the right to the universal access to antiretroviral medicines for people living with AIDS, as of the end of 1996 [<|cit|>].", "evidence": {}, "cited_doc_ids": [47021]}
{"id": 723, "claim": "In 2015, over half of HIV+ Americans are ≥50 years old.<|cit|> accompanied by multiple morbidities and rising healthcare costs.", "evidence": {}, "cited_doc_ids": [47022]}
{"id": 727, "claim": "Further, racial/ethnic disparities in HIV health outcomes are marked, with African-American/Black and Hispanic PLWH (AABH-PLWH), who are primarily from lower socioeconomic status backgrounds, evidencing higher rates of morbidity and earlier mortality than their White peers [<|cit|>], underscoring the structural underpinnings of the HIV epidemic [<|other_cit|>].", "evidence": {}, "cited_doc_ids": [47023]}
{"id": 737, "claim": "We assume that death rate and infectiousness are not affected by treatment status until an individual has achieved viral suppression and those who do achieve viral suppression are assumed to have the same life expectancy [<|cit|>].", "evidence": {}, "cited_doc_ids": [47024]}
{"id": 738, "claim": "Therapeutic progress in the area of combined antiretroviral therapy (cART) during the past 2 decades has dramatically decreased HIV morbidity and mortality [<|multi_cit|>].", "evidence": {"47025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47025]}
{"id": 741, "claim": "As at the end of 2015, about 36.7 million people were living with the human immunodeficiency virus (HIV) globally with 23.5 million living in Sub-Saharan Africa (SSA).[<|other_cit|>] Of those affected, 3.2 million individuals live in Nigeria with the highest prevalence reported from the Niger-Delta region.[<|other_cit|>] Nigeria is estimated to have the 2nd highest HIV population in the world, with South Africa ranking 1st with 7 million affected individuals.[<|other_cit|>] The increased availability of antiretroviral therapies (ARTs) in many SSA countries has led to increased life expectancy with an attendant increase of noncommunicable diseases among HIV populations.[<|multi_cit|>,4]", "evidence": {}, "cited_doc_ids": [47026]}
{"id": 746, "claim": "With improvements in treatment regimen access, uptake and efficacy, the mortality and morbidity of HIV-positive persons have significantly decreased over time [<|multi_cit|>].", "evidence": {"47027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [47027]}
{"id": 747, "claim": "All analyses were performed using R software version 3.0.2 (library survival) and Stata 13.0 (College Station, TX) [<|cit|>].", "evidence": {}, "cited_doc_ids": [47028]}
{"id": 759, "claim": "Recent meta-analyses consistently found job strain to be associated with increased risk of poor health outcomes such as coronary heart disease and hypertension [<|multi_cit|>], poor mental health outcomes such as depression [<|other_cit|>], and the development of musculoskeletal problems [<|other_cit|>].", "evidence": {"73028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [73028]}
{"id": 766, "claim": "The general conclusion was that there is a weak relationship between long working hours and IHD but that this may be mediated or confounded by other risk factors.<|cit|>", "evidence": {}, "cited_doc_ids": [73029]}
{"id": 767, "claim": "Job strain, the most widely studied work-related psychosocial stressor, is seen as influencing the risk of obesity.<|other_cit|> In agreement with this, meta-analyses have linked job strain to obesity in cross-sectional<|other_cit|> and to an increased risk of obesity-related disorders, such as type 2 diabetes, coronary heart disease and stroke in longitudinal studies.<|multi_cit|> However, the extent to which job strain is related to weight gain and the development of obesity itself is poorly understood,<|other_cit|> because quantitative reviews to confirm or refute these longitudinal associations are lacking.", "evidence": {"73030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [73030]}
{"id": 770, "claim": "It has been identified that the group with a high job strain level will be affected with negative health impacts such as having a relatively higher risk of diabetes or cardiovascular diseases as compared to the other groups [<|multi_cit|>].", "evidence": {"73031": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [73031]}
{"id": 776, "claim": "There is also increasing evidence showing that a similar set of adverse working conditions is associated with increased incidence of stroke<|multi_cit|> and with the onset of diabetes 2.<|other_cit|>", "evidence": {}, "cited_doc_ids": [73032]}
{"id": 779, "claim": "Work demands, control and support are three major aspects of the psychosocial work environment that have been connected to a variety of negative health outcomes both separately and in combination [<|multi_cit|>].", "evidence": {"73033": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [73033]}
{"id": 782, "claim": "Indeed, a growing body of evidence based on genome-wide association studies, transcriptomic, and epigenomic analyses, as well as experimental evidence in mouse models, implicates immunological mechanisms and their cellular component, microglia, in the pathogenesis of Alzheimer’s disease (AD) (<|multi_cit|>).", "evidence": {"44015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [44015]}
{"id": 791, "claim": "It has been implicated in sensing damage signals, promoting microglial survival, and regulating central nervous system inflammation [<|multi_cit|>].", "evidence": {"44016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [44016]}
{"id": 792, "claim": "Worth mentioning, AD-related inflammatory reaction was partially associated with the activation of microglial cells and astrocytes surrounding the Aβ deposits [<|multi_cit|>].", "evidence": {"44017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [44017]}
{"id": 793, "claim": "Shortening of the processes and increases in cell body diameter could indicate a glial transition to a phagocytic state [<|multi_cit|>], possibly rendering them more prone to clearing Aβ by internalization of the toxic peptide [<|other_cit|>].", "evidence": {}, "cited_doc_ids": [44018]}
{"id": 796, "claim": "Similarly, DA-9803-treated microglia exhibited shortening of their processes and an increase in the cell body diameter (Fig. <|other_cit|>), potentially suggesting a transition to a phagocytic state [<|multi_cit|>, 31].", "evidence": {}, "cited_doc_ids": [44019]}
{"id": 797, "claim": "Microglia in the CNS have been regarded as the only major phagocytes that mediate the elimination of synapses, apoptotic cells, neural debris, and pathogenic proteins (<|multi_cit|>).", "evidence": {"44020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [44020]}
{"id": 800, "claim": "For instance, TREM2-deficient APP-PS1 AD mice displayed reduced accumulation of microglia around plaques and a decreased inflammatory response but did not show any differences in amyloid burden (<|multi_cit|>).", "evidence": {"44021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [44021]}
{"id": 803, "claim": "However, the effects of TREM2 deficiency on amyloid plaque load in AβPP transgenic mice are inconsistent [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [44022]}
{"id": 806, "claim": "Among genes that were over-expressed in intratumoral NK cells, we found the NK cell activation marker NKp44, Granzymes A and K, and Fas, which are involved in cytotoxicity, and CXCR5 and CXCR6, two chemokine receptors whose expression has been previously described in few studies in some NK cell subpopulations, such as memory (<|cit|>) or activated NK cells (Berahovich et al., <|other_cit|>; Dybkaer et al., <|other_cit|>).", "evidence": {"65019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [65019]}
{"id": 813, "claim": "Memory like NK cells have shown the ability to mediate adaptive immune responses to other viruses, such as vesicular stomatitis virus and HIV, and even against other pathogens such as bacteria (<|multi_cit|>).", "evidence": {"65020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [65020]}
{"id": 823, "claim": "Recent studies indicated that CD3−/CD56+ NK cell activation could lead to the generation of memory NK cells, a feature previously ascribed only to B and T cells [<|multi_cit|>].", "evidence": {"65021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [65021]}
{"id": 827, "claim": "In mice, liver ILC1s are capable of generating immunologic memory to haptens and viral antigens and are capable of mediating robust recall responses upon rechallenge with the same antigen (<|multi_cit|>, 33), a feature that has not yet been demonstrated for any of the other known ILC1 subsets.", "evidence": {}, "cited_doc_ids": [65022]}
{"id": 828, "claim": "In addition, CXCR6 was shown to identify an NK cell population resident in liver displaying in humans a CD56highCD16−CD57− phenotype, and expressing TRAIL in diseased liver, and in the mouse a DX5−TRAIL+ phenotype (<|multi_cit|>).", "evidence": {"65023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [65023]}
{"id": 849, "claim": "In recent years, several international expert groups (the European Diabetes Working Party for Older People, the ADA, the International Diabetes Federation [IDF] and Diabetes Canada (formerly the Canadian Diabetes Association) have provided consensus statements and detailed guidance on the management of diabetes in older people [<|multi_cit|>].", "evidence": {"45030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [45030]}
{"id": 854, "claim": "Consensus panel recommendations from the American Diabetes Association (ADA), as well as the current American Association of Clinical Endocrinologists (AACE) and European Association for the Study of Diabetes (EASD) guidelines and position statements, promote the individualization of glycemic targets in older adults based on health status (<|multi_cit|>).", "evidence": {"45031": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [45031]}
{"id": 861, "claim": "Furthermore, other studies and recent meta-analyses confirmed that the relationship between renal function and CVD mortality is largely consistent across age-categories [<|multi_cit|>–38].", "evidence": {}, "cited_doc_ids": [45032]}
{"id": 865, "claim": "This cut-off for ‘significant’ weight gain was based on NIH guidelines <|multi_cit|>.", "evidence": {}, "cited_doc_ids": [82020]}
{"id": 867, "claim": "Mortality also increases sharply once the overweight threshold is crossed [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [82021]}
{"id": 877, "claim": "Based on meta-analyses of exercise and diet studies, the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) recommend that lifestyle interventions should be initiated as the first step in treating new-onset type 2 DM.<|other_cit|> Over the past 3 years, The Look Ahead research group, the Lifestyle Over and Above Drugs in Diabetes (LOADD) and Early ACTivity in Diabetes (Early ACTID) randomised controlled trials (RCTs) have shown that dietary interventions which target weight reduction are beneficial and improve glycaemic control.<|multi_cit|> These trials achieved reductions in glycated haemoglobin (HbA1c) comparable to reductions demonstrated in patients starting metformin or a gliptin as monotherapies,<|other_cit|> and although the Look Ahead trial showed no reduction in cardiovascular events after 9.6 years, participants in the intervention arm were less likely to be treated with insulin.<|other_cit|>", "evidence": {"82022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [82022]}
{"id": 882, "claim": "GLP-1 receptor agonists do not only have glucose-lowering effect but also improve other metabolic parameters such as lipid profile and blood pressure following 5-10% weight reduction [<|cit|>].", "evidence": {}, "cited_doc_ids": [82023]}
{"id": 887, "claim": "In this mechanism, a fundamental role may be exerted by the wingless and integrated-1 (Wnt)/β-catenin signalling pathway [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [95019]}
{"id": 892, "claim": "In contrast to genetic mutations, epigenetic changes are dynamic and potentially reversible, leading to heterogeneity during development, within tumors, or in response to environmental stimuli, drugs, or diseases [<|multi_cit|>–4].", "evidence": {"95020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [95020]}
{"id": 898, "claim": "However, we suggest that TGF-β and Wnt signaling pathways whose activation is complex and known to promote EMT in different carcinomas including ovarian and breast cancer (<|multi_cit|>, 58), and highlighted in this study as downregulated in the transcriptomic analysis, might play a role in this regard.", "evidence": {"95021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [95021]}
{"id": 899, "claim": "The ability of tumor cells to reversibly undergo epithelial to mesenchymal transition (EMT) and the reverse differentiation process MET (mesenchymal-epithelial transition) has been termed epithelial-mesenchymal plasticity (EMP) [<|multi_cit|>], and is an important feature of metastatic tumor cells.", "evidence": {"95022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [95022]}
{"id": 903, "claim": "Cell proliferation and migration are fundamental for tissue development and homeostasis [<|multi_cit|>].", "evidence": {"95023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [95023]}
{"id": 910, "claim": "In addition, cell-cell adhesion, in which NRCAM is known to play a part, has been well documented as being involved in cancer formation [<|multi_cit|>].", "evidence": {"95024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [95024]}
{"id": 911, "claim": "Under certain conditions, cells in intestinal mucosa experience necroses, and slough off into the enteric entocoele, resulting in a decline of DAO levels in intestinal mucosa and an increase of DAO levels in circulation [<|cit|>].", "evidence": {}, "cited_doc_ids": [51023]}
{"id": 919, "claim": "In fact, alterations in goblet cell numbers and mucin secretion are prominent features of mucosa associated diseases, with increased goblet cell numbers and hypersecretion in conditions such as asthma or cystic fibrosis [<|other_cit|>], and mucin depletion and diminished goblet cell density in intestinal diseases such as inflammatory bowel disease or ulcerative colitis [<|multi_cit|>, 5].", "evidence": {"51024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [51024]}
{"id": 923, "claim": "Mucus secretion from goblet cells is regulated by the host sensing gut microbes or their metabolites, such as SCFAs or Th2 cytokines, including IL-5 and IL-13.<|multi_cit|> In addition, recent studies revealed that the activation of the inflammasome mediated by NOD-like receptor family pyrin domain-containing 6 (NLRP6), a member of the NOD-like receptor family, drives mucus granule exocytosis from goblet cells by promoting autophagy.<|other_cit|>", "evidence": {"51025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [51025]}
{"id": 926, "claim": "This was expected, because IgA is the most important Ig in mucosal tissue, being the first line of immunologic defense against enteric pathogens (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [51026]}
{"id": 928, "claim": "However, there has been no study yet investigating the relationship between endometriosis and MUC2, while previous functional studies on MUC2 are more focused on its role in the gastrointestinal and respiratory tract [<|multi_cit|>].", "evidence": {"51027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [51027]}
{"id": 929, "claim": "Once unresponsive, mice received an enema with a 125 mg kg−1 dose of TNBS using a lubricated 20-G soft catheter (Terumo, Tokyo, Japan) as previously described.<|multi_cit|>, 74 Animals were monitored daily for weight loss and general wellbeing over 4 days.", "evidence": {}, "cited_doc_ids": [51028]}
{"id": 946, "claim": "Median attrition rates of 54 % (across studies with follow-ups from 7 months to 5 years) have been reported in sub-Saharan Africa (SSA) [<|multi_cit|>].", "evidence": {"76018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [76018]}
{"id": 947, "claim": "Currently, ART regimen changes become a big challenge and cause diminishing the clinical and immunological benefit of treatment [<|other_cit|>], failing virological suppression, increase drug resistance [<|other_cit|>] and increase mortality and morbidity due to HIV/AIDS [<|multi_cit|>, 9].", "evidence": {}, "cited_doc_ids": [76019]}
{"id": 950, "claim": "This definition of linkage to care is based on Rosen and Fox<|cit|> and the National AIDS Control Programme in Tanzania;<|other_cit|> it was chosen to allow comparison with earlier studies of linkage to care.", "evidence": {}, "cited_doc_ids": [76020]}
{"id": 953, "claim": "Another challenge that treatment programmes face is ensuring that all children who test HIV-positive are successfully linked to and retained in a Paediatric HIV/AIDS care programme such that they can initiate ART as soon as they are eligible [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [76021]}
{"id": 956, "claim": "Of note, these barriers experienced by our clinic population (i.e., pre-ART status, younger age) also pertain to other populations of HIV-1-infected adults [<|multi_cit|>].", "evidence": {"76022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [76022]}
{"id": 963, "claim": "Protracted exposure to these pro-inflammatory agents predisposes patients to an increased incidence of obesity, premature immunological aging, vascular sclerosis and neurodegenerative phenotypes (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [93015]}
{"id": 965, "claim": "The liver, a central regulator of metabolism, is impacted greatly in aging and, dysfunction of or damage to this organ in age- and non-age-related conditions is associated directly with obesity [<|multi_cit|>].", "evidence": {"93016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93016]}
{"id": 967, "claim": "Brain aging is accompanied by widespread metabolic alterations associated with cognitive decline that connect with the so called “metabolic syndrome” (<|cit|>).", "evidence": {}, "cited_doc_ids": [93017]}
{"id": 973, "claim": "NAFLD often presents with metabolic syndrome, such as obesity and excessive visceral fat, hyperlipidemia, hypertension, insulin resistance and an increased secretion of pro-inflammatory cytokines (<|cit|>).", "evidence": {}, "cited_doc_ids": [93018]}
{"id": 976, "claim": "Cellular aging is a complex multifactorial process affected by an intertwined network of effectors such as protein translation, protein quality control, mitochondrial dysfunction and metabolism (<|multi_cit|>).", "evidence": {"93019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93019]}
{"id": 977, "claim": "The rate of aging, however, is influenced by diverse factors, including protein translation, protein quality control, mitochondrial dysfunction, and metabolism (<|multi_cit|>; Barzilai et al., 2012).", "evidence": {"93020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93020]}
{"id": 984, "claim": "Aging is marked by a progressive functional deterioration of cells and tissues over time (<|multi_cit|>), which contribute to the etiology of metabolic diseases such as DMT2 and cardiovascular disease (<|other_cit|>).", "evidence": {}, "cited_doc_ids": [93021]}
{"id": 985, "claim": "Rapamycin has proven to be an effective longevity intervention; however, there are well documented side-effects such as insulin resistance and dyslipidemias, hampering the translation of rapamycin treatment in humans (<|multi_cit|>).", "evidence": {"93022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [93022]}
{"id": 988, "claim": "This progressive ECM stiffness is directly correlated with tumor aggressiveness and can dampen the immune response [<|multi_cit|>,90].", "evidence": {"57017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [57017]}
{"id": 995, "claim": "Dysfunction of ECM components causes numerous developmental defects and diseases involving musculoskeletal, cardiovascular, renal, ocular and skin deficiency in mammals (<|multi_cit|>).", "evidence": {"57018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [57018]}
{"id": 996, "claim": "In addition, along with the growth of tumor mass, cancer cells suffer high pressure caused by tissue compression and/or an increase in interstitial pressure [<|cit|>].", "evidence": {}, "cited_doc_ids": [57019]}
{"id": 1000, "claim": "In addition, cells actively secrete, remodel, and modify their extracellular environment to affect physiologic processes including wound healing, development, and tumor metastasis [<|multi_cit|>].", "evidence": {"57020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [57020]}
{"id": 1001, "claim": "This confers advantages to the tumour cells influencing changes in cytoskeletal dynamics, cortical tension, and microtubule turnover and enhances the transformed phenotype and promotes cancer progression [<|cit|>].", "evidence": {}, "cited_doc_ids": [57021]}
{"id": 1008, "claim": "A common consensus is that breast cancer metastasis is a multi-gene involvement and multi-step process that lead to the reduction of intercellular adhesion and degradation of the extracellular matrix (ECM), a natural barrier against tumor metastasis [<|multi_cit|>].", "evidence": {"57022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [57022]}
{"id": 1011, "claim": "The SARS-CoV-2 S glycoprotein trimer is modified by glycosylation, which in other coronaviruses has been suggested to modulate accessibility to neutralizing antibodies as well as host proteases involved in S processing (<|multi_cit|>).", "evidence": {"13063": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13063]}
{"id": 1019, "claim": "Overall, despite having raised nanobodies against S2, non-RBD S1 and RBD, neutralization activity and their corresponding escape mutants are distributed mainly over the ACE2-facing side of Spike (<|other_cit|>); only ~20% of anti-S2 nanobodies and ~60% of non-RBD anti-S1 nanobodies are neutralizing, whereas ~80% of anti-RBD nanobodies are neutralizing with many escape mutants highly concentrated on the receptor-binding motif (RBM), the region of RBD that interacts directly with ACE2 and is most lightly glycosylated (<|multi_cit|>; Watanabe et al., 2020).", "evidence": {}, "cited_doc_ids": [13064]}
{"id": 1035, "claim": "The spike protein is a type I transmembrane protein with a large N-terminal ectodomain that protrudes from the viral surface, and the monomeric spike protein harbors 22 N-glycans and several potential O-glycosylation sites [<|multi_cit|>].", "evidence": {"13065": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13065]}
{"id": 1048, "claim": "The O-glycosylation sites in the RBD are probably not sterically accessible to GalNAc transferases in the nascent S trimer as they were only detected as traces in the homotrimer [<|multi_cit|>].", "evidence": {"13066": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13066]}
{"id": 1050, "claim": "The most abundant post-translational modification is N-linked glycosylation, with approximately one third the mass of S protein consisting of N-linked glycans (<|multi_cit|>).", "evidence": {"13067": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [13067]}
{"id": 1095, "claim": "On the other hand, TRIM5α, TRIM21, and TRIM25 poly-ubiquitination activities have been recently shown to bridge viral degradation with the activation of innate immunity (<|multi_cit|>).", "evidence": {"46032": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [46032]}
{"id": 1107, "claim": "The B-box is also a zinc-binding motif, which is found exclusively in TRIM proteins [<|multi_cit|>] and reportedly also functions as an E3 ligase [<|other_cit|>].", "evidence": {}, "cited_doc_ids": [46033]}
{"id": 1111, "claim": "Mechanistically, tetherin signaling has similarities to TLRs and other viral PRRs, including another retroviral restriction factor, TRIM5α (<|multi_cit|>).", "evidence": {"46034": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [46034]}
{"id": 1113, "claim": "In response to hypoxia, FUNDC1 is dephosphorylated, thus enhancing the FUNDC1/LC3 interaction (<|other_cit|>), while BNIP3 and NIX are transcriptionally upregulated (<|cit|>).", "evidence": {}, "cited_doc_ids": [55013]}
{"id": 1116, "claim": "However, mitochondrial inner membrane depolarization, a sign of a damaged mitochondrion, stabilizes PINK1 [<|other_cit|>], which then phosphorylates serine 65 of ubiquitin and the N-terminal ubiquitin-like domain of Parkin [<|multi_cit|>].", "evidence": {"55014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [55014]}
{"id": 1117, "claim": "Activated PINK1 phosphorylates both Parkin and ubiquitin at S65, and these phosphorylations relieve the autoinhibition of Parkin, leading to an active phospho-ubiquitin-dependent E3 ligase and a feedforward signaling amplification loop [<|multi_cit|>].", "evidence": {"55015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [55015]}
{"id": 1125, "claim": "Ser65-phosphorylated ubiquitin then binds to the ubiquitin E3 ligase Parkin with high affinity, serving to prime Parkin for phosphorylation by hPINK1 at an equivalent Ser65 residue that lies within its N-terminal ubiquitin-like domain (Ubl) (<|multi_cit|>).", "evidence": {"55016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [55016]}
{"id": 1132, "claim": "With the emergence of such social phenomena as rapid economic development, urbanization, an increasingly aged population, and changes in people’s lifestyle, diabetes has become a major chronic disease that threatens human health worldwide [<|multi_cit|>].", "evidence": {"69022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [69022]}
{"id": 1136, "claim": "It is believed that the imbalance between energy intake and expenditure accompanying a sedentary lifestyle and a diet rich in fats and sugar leads to the development of obesity [<|multi_cit|>].", "evidence": {"69023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [69023]}
{"id": 1147, "claim": "These variances between ethnic groups could be due to different dietary preferences, lifestyle, physiological differences (i.e. differences in trunk-to-leg-length ratio and differences in slenderness) as well as differences in genetic backgrounds [<|multi_cit|>].", "evidence": {"69024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [69024]}
{"id": 1152, "claim": "is of particular interest because it includes so many current and emerging drug targets[<|other_cit|>], as well as the lipid transport genes which play such a large role in western lifestyle diseases[<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [69025]}
{"id": 1159, "claim": "Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [88024]}
{"id": 1163, "claim": "Indeed, mice lacking NLRP3 have been shown to display exacerbated colonic inflammation upon DSS-induced colitis characterized by greater gut barrier damage, inflammatory immune cell infiltration, and cytokine production (<|multi_cit|>).", "evidence": {"88025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88025]}
{"id": 1165, "claim": "In addition to NLRP6, loss of NLR family members NOD1, NOD2, NLRP3, NLRC4, and NLRP12 has resulted in similar exacerbated colitis and accelerated rates of cancer (<|multi_cit|>).", "evidence": {"88026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88026]}
{"id": 1169, "claim": "Mouse models of CAC have demonstrated that other NLRs, such as NLRP3, NLRP6, and NLRP12, also protect against CAC (<|multi_cit|>).", "evidence": {"88027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88027]}
{"id": 1172, "claim": "Although Nlrp3−/− mice were demonstrated to be highly susceptible to DSS-induced UC in several studies, one study put forward the contrary results proving that deficiency of the NLRP3 inflammasome protected mice against DSS (<|multi_cit|>–127).", "evidence": {"88028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88028]}
{"id": 1176, "claim": "Several studies indicate that activation of inflammasomes is a protective factor against tumorigenesis, while other reports reach the opposing conclusion<|multi_cit|>.", "evidence": {"88029": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88029]}
{"id": 1178, "claim": "Depending on type or stage of tumor development, ER stress can enhance or suppress tumor development (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [88030]}
{"id": 1181, "claim": "Recently, it was reported that deficiencies in the NLR/Caspase-1/IL-18 pathways are associated with a more severe phenotype in mouse models of acute dextran-sulfate sodium (DSS) colitis, possibly mediated, in part, by a defect in microbiota composition and in mucosal tissue repair (<|multi_cit|>).", "evidence": {"88031": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88031]}
{"id": 1182, "claim": "Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [<|multi_cit|>].", "evidence": {"88032": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [88032]}
{"id": 1191, "claim": "The common energetic hotspots Y453, Y489 and Y505 found in mutational scanning also emerged as critical stability and binding hotspots in deep mutagenesis studies, which demonstrated that RBD stability contributes to ACE2-binding affinity [<|multi_cit|>].", "evidence": {"17038": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17038]}
{"id": 1193, "claim": "The RBS is also prone to naturally occurring mutations, similar to the N-terminal domain (NTD), where insertions and deletions have also been found (<|multi_cit|>).", "evidence": {"17039": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17039]}
{"id": 1197, "claim": "Indeed, several substitutions of concern (N501Y) are of interest (K417N and E484K) shown herein are also involved in monoclonal antibody epitopes as demonstrated in deep mutational scanning of the RBD<|cit|>.", "evidence": {}, "cited_doc_ids": [17040]}
{"id": 1208, "claim": "This mutation has been shown to increase the ACE2 binding and enhances the viral replication in the upper respiratory tract [<|multi_cit|>].", "evidence": {"17041": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17041]}
{"id": 1220, "claim": "Current studies have shown that the mutations in these SARS-CoV-2 variants could increase the affinity of the receptor-binding domain (RBD) to its cellular receptor angiotensin-converting enzyme-2 (ACE2) and confer resistance to vaccine sera and many monoclonal antibodies (Hou et al., <|other_cit|>; Korber et al., <|multi_cit|>; Yurkovetskiy et al., <|other_cit|>; Greaney et al., <|other_cit|>; Gupta, <|other_cit|>; Liu et al., <|other_cit|>; Plante et al., <|other_cit|>; Wang et al., <|other_cit|>).", "evidence": {"17042": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17042]}
{"id": 1225, "claim": "We then applied a computational filter to remove variants with >1 amino-acid mutation, low sequencing counts, or highly deleterious mutations that might cause antibody escape simply by leading to poor expression of properly folded RBD on the yeast cell surface [<|multi_cit|>,53].", "evidence": {"17043": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17043]}
{"id": 1227, "claim": "These tests are helpful in treatment of patients diagnosed as COVID-19 positive [<|multi_cit|>,18].", "evidence": {}, "cited_doc_ids": [17044]}
{"id": 1228, "claim": "The biochemical and mutagenesis studies explored energetics and binding mechanisms of SARS-CoV-2 interactions with the host receptor [<|multi_cit|>].", "evidence": {"17045": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [17045]}
{"id": 1238, "claim": "If these patients go on to develop poor vision or blindness it will represent a significant cost to society, so early detection is of great cost benefit [<|cit|>].", "evidence": {}, "cited_doc_ids": [85024]}
{"id": 1239, "claim": "Vision loss in DR prominently contributes to diabetic macular edema (DME) but may also be a consequence of proliferative DR (PDR), such as vitreous hemorrhage from neovascularization, proliferating membrane formation, and tractional retinal detachment, or neovascular glaucoma [<|cit|>].", "evidence": {}, "cited_doc_ids": [85025]}
{"id": 1252, "claim": "Angioproliferative retinal diseases such as diabetic retinopathy or the wet type of age related macular degeneration are responsible for visual impairment among many working age individuals and the elderly [<|multi_cit|>] and lipid mediators have been discussed as part of the pathogenetic cascade in these disorders [<|other_cit|>].", "evidence": {"85026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85026]}
{"id": 1254, "claim": "The prevalence of RVO was reported to be between 0.5 and 2% of the total population [<|other_cit|>], and DME prevalence was found to be between 2 and 3% in Thai diabetic patients [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [85027]}
{"id": 1256, "claim": "Studies done in different countries showed that the incidence of DR was geographically heterogeneous, including in low and middle-income countries [<|multi_cit|>].", "evidence": {"85028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [85028]}
{"id": 1264, "claim": "For instance, in previous work we identified a region of copy number loss on chromosome 15q in all BRCA1-mutated samples, which likely acts on the reported BRCA1 associated loss of 53BP1 [<|cit|>].", "evidence": {}, "cited_doc_ids": [54021]}
{"id": 1271, "claim": "Of note, this escape mechanism has been identified clinically in BRCA1/2-associated breast cancer but may also mediate a proportion of prostate cancers that become resistant [<|cit|>].", "evidence": {}, "cited_doc_ids": [54022]}
{"id": 1276, "claim": "In a competitive model between these two pathways, the NHEJ factor TP53BP1 suppresses HR, and TP53BP1 loss restores HR, facilitating PARP inhibitor resistance (<|multi_cit|>).", "evidence": {"54023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54023]}
{"id": 1279, "claim": "More recently, Rif1 was shown to counteract Brca1 function, and Rif1 mutations could rescue the genomic instability of mouse Brca1-/- cells (<|multi_cit|>).", "evidence": {"54024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54024]}
{"id": 1281, "claim": "For example, susceptibility to the DNA-damaging agent cisplatin is higher in cells harboring mutations in BRCA1, BRCA2, and Rad51, which cause deficiencies in homologous recombination (HR) [<|multi_cit|>].", "evidence": {"54025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54025]}
{"id": 1282, "claim": "Similar rescue and partial rescue phenotypes were observed in mES cells, blastocysts, or mice with knockouts of other genes, such as Brca1 [<|multi_cit|>], Brca2 [<|other_cit|>], Rad51 [<|other_cit|>], Cdc7 [<|other_cit|>], Pict1 [<|other_cit|>], L11 [<|other_cit|>], Aurora kinase A [<|other_cit|>], or Tsg101 [<|other_cit|>].", "evidence": {"54026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54026]}
{"id": 1284, "claim": "53BP1 limits HR by posing a barrier for the DSB end resection machinery to approach the break sites, a function that is specifically antagonized by BRCA1 under HR-permissive conditions during the S and G2 phases, causing the relocalization of 53BP1 to the periphery of IRIF (Cao et al., <|multi_cit|>; Bunting et al., <|other_cit|>; Chapman et al., <|other_cit|>; Karanam et al., <|other_cit|>).", "evidence": {"54027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54027]}
{"id": 1289, "claim": "Notably, the latter is inhibited by 53BP1, suggesting that PARP1 may counteract 53BP1 recruitment (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [54028]}
{"id": 1291, "claim": "We previously demonstrated that BRCC2-negative tumors are associated with significantly lower metastasis-free and overall survival in breast cancer.<|cit|> These findings suggested that BRCC2 may function as a tumor suppressor in breast cancer.", "evidence": {}, "cited_doc_ids": [54029]}
{"id": 1293, "claim": "Moreover, loss of 53BP1 and NHEJ function also reverse sensitivity to PARPi in BRCA mutant preclinical models by restoring HR function (<|multi_cit|>).", "evidence": {"54030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [54030]}
{"id": 1294, "claim": "Several major endocrine tissues (e.g., liver, adipose tissue and pancreatic islets) have been shown to be resistant to FGF21 in obese diabetic mice,8, <|multi_cit|> hence the use of global KO mice might mimic these in vivo diabetic conditions, when particularly attempting to explore the roles of FGF21 during T2DM pathogenesis.", "evidence": {"100013": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [100013]}
{"id": 1296, "claim": "Moreover, the response to exogenous FGF21 is impaired and the expression of FGF21 receptors is reduced [<|multi_cit|>–21].", "evidence": {"100014": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [100014]}
{"id": 1297, "claim": "Paradoxically, however, studies in both mice and humans have shown that obesity is associated with elevated circulating levels of FGF21, suggesting impaired FGF21 signaling (<|multi_cit|>–29).", "evidence": {"100015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [100015]}
{"id": 1303, "claim": "However, it was recently reported that increased levels of FGF21 can be an independent risk factor related to metabolic syndrome and can also represent an independent predictor of liver steatosis.<|cit|>,35 The paradoxical increase of serum FGF21 levels in obese individuals may be explained by a compensatory response or resistance to FGF21.36", "evidence": {}, "cited_doc_ids": [100016]}
{"id": 1304, "claim": "As the FGF21 level was correlated with body weight, BMI, and, waist circumference at baseline for these patients, we proposed the changed in FGF21 level after treatment might represent a tendency to regulate metabolic effects (Chang et al., 2009, 2010a, 2010b; <|multi_cit|>).", "evidence": {"100017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [100017]}
{"id": 1310, "claim": "FGF21 resistance may contribute to the association of FGF21 and nonalcoholic fatty liver disease (12,<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [100018]}
{"id": 1311, "claim": "FGF-21 levels are increased in obesity and there is evidence of FGF-21 resistance in both obese animals and humans [29<|multi_cit|>].", "evidence": {"100019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [100019]}
{"id": 1316, "claim": "In 2013, approximately 6.9 million people had an ischemic stroke, and there were about 3.0 million deaths that resulted from ischemic stroke [<|multi_cit|>].", "evidence": {"60016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60016]}
{"id": 1318, "claim": "These conditions are all major global health problems, with rising rates of disability and death occurring in many countries [<|multi_cit|>].", "evidence": {"60017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60017]}
{"id": 1324, "claim": "This situation has contributed to the increased prevalence of multimorbidity.<|multi_cit|> In recent decades, population ageing, lifestyle changes, improved socioeconomic conditions and increased diagnostic ability of health services have contributed to a significant rise in the population that survives serious diseases, causing an accumulation of health problems in specific population groups.", "evidence": {}, "cited_doc_ids": [60018]}
{"id": 1328, "claim": "Until recently, the use of statins has been limited to affluent regions despite the fact that three-fourths of global CVD deaths occur in low- and middle-income countries [<|multi_cit|>].", "evidence": {"60019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [60019]}
{"id": 1329, "claim": "Thus, detection of BA is not performed with sufficient frequency in most food processing facilities, leading to a significant number of food-related disease outbreaks every year [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [60020]}
{"id": 1335, "claim": "Both BNT162b2 and mRNA-1273 have been shown to be safe and highly effective with 95% and 94.1% efficacy, respectively, in large Phase 3 double-blind clinical trials [<|multi_cit|>,61].", "evidence": {"20017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20017]}
{"id": 1341, "claim": "High efficacy for both vaccines was shown in phase 3 trials, and real-world data from their pragmatic use have demonstrated high effectiveness, including against circulating variants [<|multi_cit|>, 6, 24–30].", "evidence": {"20018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20018]}
{"id": 1343, "claim": "In the case of BNT162b2 vaccination, it appears that it takes 10–12 days from the 1st vaccine dose for the vaccinated individuals to achieve the amounts of neutralizing antibodies that are enough to block the infection of substantial numbers of the virally-targeted cells and to inhibit further spread of the infection<|multi_cit|>.", "evidence": {}, "cited_doc_ids": [20019]}
{"id": 1347, "claim": "Other reports also show less frequent emergence of AEs after vaccination in cancer patients than in healthy subjects [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [20020]}
{"id": 1350, "claim": "In addition, inactivated vaccines or viral vector vaccines have also been available in certain countries and areas<|multi_cit|>.", "evidence": {}, "cited_doc_ids": [20021]}
{"id": 1351, "claim": "The clinical trials of the mRNA COVID-19 vaccines reported them as safe for administration, and their relationship with malignant diseases was rare (<|multi_cit|>).", "evidence": {"20022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20022]}
{"id": 1352, "claim": "A major advancement in the fight against COVID-19 was the development of the COVID-19 mRNA vaccines, which were found to confer 95% (Pfizer, BNT162b2 vaccine) and 94.1% (Moderna, mRNA-1273 vaccine) efficacy in preventing severe COVID-19 infection in the general population [<|multi_cit|>].", "evidence": {"20023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20023]}
{"id": 1353, "claim": "Consistent with the 2-step model of chemokine receptor activation <|multi_cit|>, 65, all the N-loop antibodies that were tested effectively reduced chemotaxis.", "evidence": {}, "cited_doc_ids": [20024]}
{"id": 1354, "claim": "By January 2021, the mRNA vaccines BNT162b2 by Pfizer-BioNTech and mRNA-1273 by Moderna, as well as the vector-based vaccines ChAdOx1 nCoV-19 by Oxford-AstraZeneca and Gam-COVID-Vac (Sputnik V), produced by Russia, were already being administered under emergency use authorization in multiple countries [<|multi_cit|>].", "evidence": {"20025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20025]}
{"id": 1355, "claim": "Both vaccines (developed by Pfizer/BioNTech and Moderna) deliver mRNA coding for the full-length spike protein, require two doses a minimum of 21 or 28 days apart, and provide 95% and 94.1% efficacy at preventing symptomatic COVID-19 infection respectively<|multi_cit|>.", "evidence": {"20026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [20026]}
{"id": 1364, "claim": "DPP-4inhibitors also enhanced the endothelial function, slowed down atherogenesis, diminished ischemia and reperfusion injury, prevented left ventricular hypertrophy and remodeling, and reduced inflammatory markers [<|cit|>].", "evidence": {}, "cited_doc_ids": [90023]}
{"id": 1376, "claim": "Although diabetes control in our study population is similar to national estimates (<|multi_cit|>) (mean A1C 7.4 vs. 7.2% and 75.4 vs. 77.9% of patients achieving an A1C <8.0%, respectively), the majority of our study patients were Caucasian and <65 years of age.", "evidence": {"90024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [90024]}
{"id": 1378, "claim": "Moreover, it was similar to the 43.2% and 66.3% from a study based on Korean tertiary hospitals [<|multi_cit|>].", "evidence": {"90025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [90025]}
{"id": 1379, "claim": "Consistent with our data, poor glycemic control and obesity were more frequently reported in younger patients with T2DM.<|multi_cit|> Because early stage of T2DM is often asymptomatic, younger patients being busy with their job may be less motivated to their diabetic condition, have less time to foster a healthy lifestyle, and tend to be less adherent to medication.<|other_cit|> The National Health and Nutrition Survey in Japan and a study of Japan Clinicians Diabetes Association also reported the higher treatment discontinuation rate for males in the 40’s or those diagnosed with T2DM in their 40’s.<|other_cit|> Therefore, a higher rate of poor glycemic control and obesity in young patients is possibly due to poor compliance to proper dietary habits and to treatment.", "evidence": {"90026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [90026]}
{"id": 1397, "claim": "Many other stimuli, some of which with no known function in embryonic neurogenesis, such as hormones, inflammation, ageing, or mental disorders are also amongst the many parameters affecting adult neurogenesis that fall beyond the scope of this review (Seki and Arai, <|other_cit|>; Kuhn et al., <|other_cit|>; Shingo et al., <|other_cit|>; Galea et al., <|multi_cit|>; Kyritsis et al., <|other_cit|>; Gebara et al., <|other_cit|>; Schoenfeld and Cameron, <|other_cit|>; Sierra et al., <|other_cit|>; Valero et al., <|other_cit|>).", "evidence": {"43025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [43025]}
{"id": 1398, "claim": "Since the dentate gyrus is implicated in regulation of anxiety and stress behaviors<|multi_cit|>, the present study focused on the role of SIRT1 in modulation of cell excitability and synaptic inputs of granule cells of the dentate gyrus.", "evidence": {"43026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [43026]}
{"id": 1412, "claim": "Although further research is required to reinforce this finding, it confirms previous genetic evidence that manipulation of neurogenesis alters behavior in models of anxiety and depression (<|multi_cit|>).", "evidence": {"43027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [43027]}
{"id": 1423, "claim": "Therefore, better treatment approaches are needed in this field of medicine, which has become an increasing global concern (<|cit|>.", "evidence": {}, "cited_doc_ids": [62022]}
{"id": 1430, "claim": "The diagnosis of major depression adhered to the definitions and criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM) - IV published by the American Psychiatric Association [<|cit|>].", "evidence": {}, "cited_doc_ids": [62023]}
{"id": 1441, "claim": "Notably, too, XBP1, the substrate of sensors for stress (e.g., IRE1), assembles a transcription complex with HIF1α, which promotes CD44, particularly CD44v6 expression in triple-negative breast cancers (Krishnamachary et al., <|multi_cit|>; Chen et al., 2014a).", "evidence": {"63019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63019]}
{"id": 1442, "claim": "Specific sandwich ELISAs were used to determine cleaved caspase 3 (Asp175) and cleaved poly (ADP ribose) polymerase (PARP) as a marker of apoptosis induction and protease activation (Cell Signaling Technologies) [<|multi_cit|>].", "evidence": {"63020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63020]}
{"id": 1447, "claim": "It is well established that hypoxic stress is a feature of most solid tumors and is associated with poor clinical outcomes in various cancer types [<|multi_cit|>].", "evidence": {"63021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63021]}
{"id": 1451, "claim": "Because of the protective nature of the UPR in cancer, drugs that target components of the UPR are in preclinical development, in clinical trials, and have been approved (<|multi_cit|>).", "evidence": {"63022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63022]}
{"id": 1459, "claim": "This result is consistent with previous studies suggesting that the ATF4/ATF6α branches of the UPR play an important role in early events such as apoptosis partly through C/EBP homologous protein (CHOP) induction, while XBP1 is mostly involved in the induction of EMT [<|multi_cit|>].", "evidence": {"63023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63023]}
{"id": 1464, "claim": "The enhanced proliferation found in cancer cells leads to a nutrient deprived environment, hypoxia, and an increased influx of unfolded protein in the ER, all of which activate UPR [<|multi_cit|>].", "evidence": {"63024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [63024]}
{"id": 1465, "claim": "HIF-1α has also been reported to play a critical role in regulating the interaction of FoxO1 in the pathogenesis of BBB breakdown<|cit|>.", "evidence": {}, "cited_doc_ids": [63025]}
{"id": 1480, "claim": "Based on their locations to nearby protein-coding genes, lncRNAs can be classified into different categories, including sense, antisense, divergent, and intergenic lncRNAs (<|cit|>).", "evidence": {}, "cited_doc_ids": [68023]}
{"id": 1483, "claim": "Experimental detection of the human genome has identified approximately 2000 different miRNAs and around 50,000 lncRNAs [<|multi_cit|>, 34].", "evidence": {"68024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [68024]}
{"id": 1492, "claim": "Altered expression and regulation of lncRNAs has been associated with human diseases and aging (<|multi_cit|>).", "evidence": {"68025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [68025]}
{"id": 1494, "claim": "Existing diabetes therapies, namely metformin and acarbose, extend lifespan in nondiabetic mice (<|multi_cit|>).", "evidence": {"99017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [99017]}
{"id": 1496, "claim": "This molecule was developed based on the characteristics of metformin, a biguanide diabetes drug that has been reported to have pleiotropic functions by expanding the NSC pool, promoting neurogenesis<|other_cit|> and improving the healthspan and lifespan of mice by mildly inhibiting the complex I activity of the ETC<|multi_cit|>.", "evidence": {"99018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [99018]}
{"id": 1498, "claim": "Lipids are another energy source for oocyte maturation, and metformin increased β-oxidation of fatty acids, which is essential for developmental competence of mouse oocytes [<|multi_cit|>].", "evidence": {"99019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [99019]}
{"id": 1502, "claim": "Drugs like metformin and rapamycin can mimic some of the CR effects and showed very promising lifespan extension results in mice (<|multi_cit|>).", "evidence": {"99020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [99020]}
{"id": 1503, "claim": "It measures food intake by the same principles as is used in other model organisms such as flies and mice (<|cit|>).", "evidence": {}, "cited_doc_ids": [99021]}
{"id": 1504, "claim": "This concept has certainly been demonstrated, and today many compounds have been identified that extend lifespan in model organisms such as worms, flies and even mice (<|multi_cit|>).", "evidence": {"99022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [99022]}
{"id": 1505, "claim": "In view of low toxicity and cost, metformin deserves study in breast cancer treatment and prevention, particularly peri-operatively and in combination with other agents [<|cit|>].These findings suggest that benefits of metformin in breast cancer may be confined to specific patient subgroups.", "evidence": {}, "cited_doc_ids": [99023]}
{"id": 1519, "claim": "Recently, it was shown that when caspase-8 is inhibited or deleted, TNFα induces necroptosis, a programmed form of necrotic cell death, which may be crucial for non-apoptotic liver injury (Liedtke and Trautwein <|other_cit|>; Feoktistova et al. <|multi_cit|>; O’Donnell et al. <|other_cit|>; Duprez et al. <|other_cit|>).", "evidence": {"70015": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70015]}
{"id": 1520, "claim": "Necroptosis has been linked to ischemia–reperfusion injury and pathologies characterized by an inflammatory response.<|multi_cit|> Similarly, preeclampsia is characterized by placental hypoxia and oxidative stress.<|other_cit|> Herein, we identified increased expression of necrosome proteins in preeclamptic placentae.", "evidence": {"70016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70016]}
{"id": 1521, "claim": "Excessive apoptosis and/or necroptosis in IECs causes intestinal inflammation in mice lacking caspase 8 or RIPK1 (<|multi_cit|>).", "evidence": {"70017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70017]}
{"id": 1527, "claim": "A newly defined necroptosis, a form of well-regulated necrosis executed by receptor-interacting protein kinase 1 (RIP1) and/or RIP3, is associated with an inflammatory reaction.<|other_cit|> Cellular necroptosis mediated by RIP1/3 is believed to be a crucial factor in triggering local inflammation in various diseases, such as graft cells in kidney and heart transplantation,<|other_cit|> Paneth cells in intestinal bowel disease and keratinocytes in skin inflammation.<|multi_cit|> Necroptosis is different from apoptosis, which could efficiently clear the cell corpse and limit triggering of the innate immune system.", "evidence": {"70018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70018]}
{"id": 1528, "claim": "Necroptosis is an inflammatory, caspase-independent form of regulated cell death characterised by loss of cellular membrane integrity and release of cytoplasmic contents.<|other_cit|> It is believed to have evolved as a defence mechanism against viruses;<|other_cit|> however, there is increasing evidence that deregulated necroptosis has a role in the pathogenesis of a range of inflammatory, autoimmune and neurodegenerative diseases.<|multi_cit|> Reduced capacity to undergo necroptosis has been correlated to increased aggressiveness of cancers;<|other_cit|> and therapeutic initiation of necroptosis is currently being investigated as a cancer therapy.<|other_cit|> Additionally, there is emerging evidence that the necroptotic signalling pathway has a general role in the modulation of inflammation.<|other_cit|> As such, unravelling the molecular events governing necroptosis, and potential avenues for therapeutic intervention, is of enormous interest.", "evidence": {"70019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70019]}
{"id": 1532, "claim": "Repression of the programmed necrotic pathway by apoptotic proteins, such as FADD and caspase-8, prevents spontaneous cell death and inflammation in lymphocytes <|other_cit|>, keratinocytes <|other_cit|>, and intestinal epithelial cells <|multi_cit|>.", "evidence": {"70020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70020]}
{"id": 1536, "claim": "Tissue specific deletion of FADD or caspase 8 also led to spontaneous and fatal inflammation in the respective tissues (Kovalenko et al., <|other_cit|>; Bonnet et al., <|multi_cit|>; Welz et al., <|other_cit|>).", "evidence": {"70021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70021]}
{"id": 1537, "claim": "The pathophysiological relevance of necroptosis has been demonstrated in diverse preclinical models of disease, including acute kidney injury<|multi_cit|> as recently reviewed<|other_cit|>.", "evidence": {"70022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70022]}
{"id": 1539, "claim": "Necroptosis is a form of regulated necrosis that strictly depends on the kinase activity of receptor-interacting kinase-1 (RIPK1) and receptor-interacting kinase-3 (RIPK3).<|other_cit|> This cell death modality operates independently of executioner caspases, but is negatively regulated by caspase-8 and therefore is sensitized under conditions of caspase-8 inhibition or deficiency.<|other_cit|> Necroptosis was first observed in L929 murine fibrosarcoma cells as a regulated form of cell death.<|other_cit|> But only with the recent availability of necrostatins<|other_cit|> and RIPK3 knockout mice<|other_cit|> was its importance noted in various pathologies, including ischemia/reperfusion,<|other_cit|> inflammatory bowel disease,<|multi_cit|> viral infection,<|other_cit|> Salmonella infection<|other_cit|> and sepsis.<|other_cit|>", "evidence": {"70023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [70023]}
{"id": 1544, "claim": "Obesity, aging, and other conditions are associated with extensive accumulation of senescent cells in fat tissue of rodents as well as humans, in whom fat is frequently the most abundant tissue in the body [<|multi_cit|>].", "evidence": {"98024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [98024]}
{"id": 1555, "claim": "Additionally, senescent-like preadipocytes and insulin-resistant adipocytes are less efficient in handling and processing fatty acids, causing ectopic fatty acid deposition (in the liver, bone marrow, or blood vessels) contributing to heart disease, fatty liver disease, and stroke (<|multi_cit|>; Stout et al., <|other_cit|>).", "evidence": {"98025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [98025]}
{"id": 1564, "claim": "CR and/or regular exercise are known to promote longevity and reverse many of the negative effects of metabolic diseases (Finelli et al. <|multi_cit|>; Vera et al. <|other_cit|>); however, the molecular mechanisms underlying these benefits remain elusive.", "evidence": {"98026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [98026]}
{"id": 1569, "claim": "The P2Y12 receptor antagonists, for example, clopidogrel, prasugrel, and ticagrelor, are widely used as first-line therapy in patients with stroke or coronary artery disease (CAD) (<|multi_cit|>).", "evidence": {"12039": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12039]}
{"id": 1570, "claim": "Deaths among individuals with COVID-19 have been partially attributed to venous thromboembolism and arterial thromboses.<|multi_cit|> In intensive care settings, prevalence of venous thromboembolism among patients with COVID-19 has been reported to be over 40%.<|other_cit|> In response, several expert organizations including the American Society of Hematology, the International Society on Thrombosis and Haemostasis, and the CHEST Guideline and Expert Panel have recommended the use of prophylactic anticoagulation for patients admitted with COVID-19 who do not have a contraindication to this therapy.1,<|other_cit|>", "evidence": {}, "cited_doc_ids": [12040]}
{"id": 1577, "claim": "Remarkably, prophylactic daily LMWH or twice daily subcutaneous UFH are now recommended for all hospitalized COVID-19 patients by the WHO as well as the International Society on Thrombosis and Haemostasis (ISTH) (<|multi_cit|>).", "evidence": {"12041": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12041]}
{"id": 1580, "claim": "The episode of stroke or CAD especially MI is considerably high in severe COVID-19 patients (<|cit|>).", "evidence": {}, "cited_doc_ids": [12042]}
{"id": 1583, "claim": "A report from the American Society of Hematology states that the prevalence of DVT ranges from 1.1% among not critically ill patients to 69% among ICU patients [<|cit|>].", "evidence": {}, "cited_doc_ids": [12043]}
{"id": 1590, "claim": "Cerebrovascular events in COVID-19 may be related to a coagulopathic, pro-inflammatory state that results in a cytokine release storm and thrombogenic, vascular endothelial dysfunction, as well as vasculitis,<|other_cit|> similar to phenomena observed in previous coronavirus outbreaks including Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome.<|multi_cit|> It is possible that vascular endothelial injury, angiotensin-converting enzyme 2 (ACE2) receptor downregulation,<|other_cit|> and a systemic coagulopathic state may lead to a spectrum of neurovascular complications of COVID-19, including hemorrhage, ischemia, venous thrombosis, and arterial dissection (Figure <|other_cit|>).", "evidence": {"12044": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [12044]}
{"id": 1613, "claim": "There are no specific treatments for SARS-CoV-2 itself but preclinical and clinical research indicate that PSS potentially prevents or minimizes multiple aspects COVID-19 that include; (1) viral replication [<|other_cit|>], (2) non-cardiogenic pulmonary edema [<|other_cit|>], (3) endothelial dysfunction [<|other_cit|>], (4) coagulopathy [<|multi_cit|>], (5) oxidative stress [<|other_cit|>], (6) hyperinflammation [<|other_cit|>], (7) cytokine storm [<|other_cit|>], (8) myocardial injury [<|other_cit|>], (9) type 2 diabetes [<|other_cit|>] and (10) hyperglycemia in non-diabetics [<|other_cit|>].", "evidence": {}, "cited_doc_ids": [12045]}
{"id": 1616, "claim": "Similar optimization processes might be at play in aging, which might break down in disorders such as Alzheimer’s disease (<|cit|>, cortical myelination in development might be topologically targeted to optimize structural hub performance.", "evidence": {}, "cited_doc_ids": [87022]}
{"id": 1619, "claim": "Knowledge of the function of brain networks enables the development of tools and methods to detect and treat pathological conditions related to network malfunction (Morgan and Soltesz, <|multi_cit|>).", "evidence": {"87023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [87023]}
{"id": 1622, "claim": "The network models of epileptogenesis are already generating proposals for a change in the way epilepsy is classified which follows naturally from the blurring of the distinction between ‘focal’ and ‘generalised’ that the models have engendered.<|cit|> The models also generate a lot of expectation for a better understanding of epilepsy mechanisms and the development of more targeted treatments of epilepsy including surgery, electrical stimulation and drugs through the identification of nodes, connections and specific neurotransmitters that may be relevant to specific networks.<|other_cit|> They also raise the possibility that network plasticity mechanisms that underpin learning, for example, might also be relevant in epileptogenesis and therefore unlearning them might be feasible.<|other_cit|>", "evidence": {}, "cited_doc_ids": [87024]}
{"id": 1637, "claim": "Currently, increasing studies indicate that neurological disorders, such as Parkinson disease, Alzheimer's disease, and autism, and cognitive dysfunction are mainly caused by the pathological changes in neuronal networks (Belmonte et al., <|multi_cit|>; Stam, <|other_cit|>).", "evidence": {"87025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [87025]}
{"id": 1642, "claim": "In addition to competing against themselves, control antibodies representing the four major structurally defined classes of anti-RBD antibodies were also included: C837 (Class 1), C882 (Class 2), C908 (Class 3), and C022 (Class 1/4; <|multi_cit|>).", "evidence": {}, "cited_doc_ids": [16025]}
{"id": 1644, "claim": "These nAbs, including COVA1-18, COVA2-15, CV07-209, CC6.29, CC6.30, CC12.1, P008_108, 1212C2, and V -Fc ab8, have been found to neutralize pseudovirus and/or live SARS-CoV-2 infection with high potency (IC  ≤ 40 ng/ml) [<|multi_cit|>].", "evidence": {"16026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16026]}
{"id": 1647, "claim": "A total of 36 single amino acid SP mutations identified from publicly available databases were tested [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [16027]}
{"id": 1649, "claim": "To identify potential epitopes recognized by these repertoire-deduced VH3-53 rmAbs, we take advantage of recently determined molecular interactions between the RBD and three VH3-53/J6-derived mAbs, B-38, CV30, and CC12.1 [<|multi_cit|>].", "evidence": {"16028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16028]}
{"id": 1653, "claim": "In addition, B-38 and CC12.1 were shown to protect against SARS-CoV-2 challenge in mouse model [<|multi_cit|>].", "evidence": {"16029": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16029]}
{"id": 1656, "claim": "Several VH3-53-encoded mAbs have been well characterized, such as B-38, CC12.1, C105 and CV30, which neutralize SARS-CoV-2 via blocking of the interaction between RBD and cellular receptor ACE2 [<|multi_cit|>].", "evidence": {"16030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16030]}
{"id": 1657, "claim": "We propose that in addition to performing these tests, blood samples also be used to quantify the redundancy of immune protection generated by candidate vaccines [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [16031]}
{"id": 1663, "claim": "Among the NmAbs tested for their cross-activity against other coronaviruses, XG014, 5F8, CC6.33, ACE2-Ig, mACE2-Ig, H014, and its related single domain antibody H014-Fab, EY6A, and aRBD-41 have been reported as showing a cross-binding to SARS-CoV, and all, but not 5F8 and aRBD-41 could potently cross-neutralize SARS-CoV (<|multi_cit|>).", "evidence": {"16032": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16032]}
{"id": 1666, "claim": "The complexity of B-cell and T-cell responses can be measured using blood samples [10,<|multi_cit|>].", "evidence": {"16033": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16033]}
{"id": 1669, "claim": "In addition to using the intraperitoneal (I.P.) route and parenteral routes, including intramuscular, subcutaneous, and intravenous injections, SARS-CoV-2 RBD-targeting nAbs can be administered via inhalation without reducing protective efficacy [<|multi_cit|>].", "evidence": {"16034": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16034]}
{"id": 1670, "claim": "IgG ab1, V -Fc ab8, 1212C2, CV07-209, and CC12.1 have been shown to prophylactically and/or therapeutically protect hamsters from wild-type SARS-CoV-2 infection [<|multi_cit|>].", "evidence": {"16035": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16035]}
{"id": 1672, "claim": "Among the identified SARS-CoV-2 RBD-targeting nAbs, CC6.33, COVA2-02, and COVA1-16 also neutralize SARS-CoV-1 but at relatively high IC  values of 162, 610, and 2,500 ng/ml, respectively [<|multi_cit|>].", "evidence": {"16036": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16036]}
{"id": 1677, "claim": "Although antibodies to the NTD and other domains of the S protein can be neutralizing, we focused on antibodies against the RBD because these are among the most potent neutralizing antibodies against SARS-CoV-2 (<|multi_cit|>).", "evidence": {"16037": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16037]}
{"id": 1678, "claim": "Based on their competition with previously described mAbs CC12.1, CC12.16 and CR3022 (refs. <|multi_cit|>), WRAIR RBD neutralizing mAbs segregated into three distinct groups: RBD A, B and C, respectively (Fig. <|other_cit|>).", "evidence": {"16038": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [16038]}
{"id": 1681, "claim": "Active vaccination, passively infused neutralizing antibodies and vector-expressed CD4/CCR5 co-mimetics show promise as therapeutic immune interventions <|multi_cit|>, and even more complex strategies such as HIV receptor deletion and specific destruction of integrated viral DNA sequences are progressing <|other_cit|>.", "evidence": {"72019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [72019]}
{"id": 1683, "claim": "Dr Barouch presented preclinical data consistent with bNAb therapy (PGT121) or a therapeutic vaccine (Ad26/MVA) in combination with a Toll-like receptor (TLR) 7 agonist having a partial impact on the size of the viral reservoir and time to viral rebound [<|multi_cit|>, 12].", "evidence": {"72020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [72020]}
{"id": 1691, "claim": "Nonetheless, the administration of high-dose combination neutralizing mAb treatment, including three of the antibodies assessed here (3BNC117, 10–1074, and PGT121), has recently been reported to suppress plasma viremia to the limits of detection in chronically SHIV - or SHIV -infected macaques (<|multi_cit|>).", "evidence": {"72021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [72021]}
{"id": 1699, "claim": "Attempts have been made to solve this problem by different strategies, such as knockout mice that lack mouse FcγR, transgenic mice expressing human FcγR, generating xenografts with human antigen in mouse cell lines, using completely mouse systems and using primate models such as rhesus monkey (Golay and Introna <|multi_cit|>; Bournazos et al. <|other_cit|>; Strasser et al. <|other_cit|>).", "evidence": {"72022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [72022]}
{"id": 1706, "claim": "Previous studies have indicated that various lncRNAs may be associated with specific biological processes, including chromatin modification, epigenetic regulation, the cell cycle, cell apoptosis and differentiation (<|multi_cit|>).", "evidence": {"58016": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [58016]}
{"id": 1708, "claim": "Clinically, diabetic neuropathy has been manifested as spontaneous pain, hyperalgesia, and allodynia or even developed to diabetic foot ulcers or required amputation, which has serious impacts on the life quality of patients [<|multi_cit|>, 39].", "evidence": {}, "cited_doc_ids": [58017]}
{"id": 1709, "claim": "LncRNAs have recently been identified as novel regulators of transcriptional and epigenetic networks.<|other_cit|> HOTAIR, a classic trans-acting lncRNA, was found to be abnormally upregulated in several tumors, including hepatocellular carcinoma, colorectal cancers, pancreatic cancers, breast cancers, bladder cancers, cervical cancers and osteosarcoma.<|multi_cit|> Many studies have revealed that HOTAIR acts as a potential antitumor target.", "evidence": {"58018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [58018]}
{"id": 1712, "claim": "And it is one of the well-studied lncRNAs that is overexpressed in various cancers including breast, pancreatic, colorectal, hepatocellular, gastrointestinal, and non-small-cell lung carcinomas.<|multi_cit|> Furthermore, the aberrantly upregulated expression in NPC correlates with clinical stage progression and contributes to the malignant character of NPC cells through involvement in diverse cellular processes, including migration, invasion, and proliferation, and also indicates a poorer prognosis for DFS and OS.", "evidence": {"58019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [58019]}
{"id": 1714, "claim": "The lncRNA HOX antisense intergenic RNA (HOTAIR) was first identified in 2007.<|other_cit|> Recently, lots of studies have shown that HOTAIR is overexpressed in colorectal cancer, pancreatic cancer, breast cancer and gastrointestinal stromal tumors and is positively correlated with a poor clinical outcome.<|multi_cit|> The activity of HOTAIR is partially due to its interaction with the polycomb repressive complex 2 (PRC2; EZH2, SUZ12 and EED), which enhances histone H3 lysine-27 trimethylation of the HOXD locus to decrease multiple gene expression from HOXD.<|other_cit|> Our previous study showed that HOTAIR expression is increased in gastric cancer tissues and is associated with malignant characteristics and poor prognosis.", "evidence": {"58020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [58020]}
{"id": 1717, "claim": "HOTAIR is a ~2.2-kb-long lncRNA, transcribed from the HOXC locus in antisense manner and hence named as HOX antisense intergenic RNA.<|other_cit|> It was first observed in fibroblast causing the silencing of HOXD locus via establishing trimethylation on H3K27.<|other_cit|> HOTAIR recruits PRC2 and lysine specific demethylase 1 (LSD1) protein complexes to the HOXD gene cluster and changes its histone methylation status and chromatin configuration.<|other_cit|> Thereby, it causes silencing of tumor suppressor genes.<|other_cit|> It has been implicated in breast, colorectal, gastrointestinal, and pancreatic cancers apart from HCC.<|multi_cit|> HOTAIR interacts with PRC2 through an 89-mer domain at the 5′ end of the sequence.<|other_cit|> This region is also known as the minHOTAIR, whereas LSD1 protein interacts with HOTAIR via the 646-mer at the 3′ end.<|other_cit|> It has been reported that HOTAIR is overexpressed in HCC, and knockdown of HOTAIR reduces HCC proliferation.<|other_cit|> Furthermore, the cells having lower expression of HOTAIR become more responsive to chemotherapy.<|other_cit|>", "evidence": {"58021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [58021]}
{"id": 1724, "claim": "Long non-coding RNAs (lncRNAs), a heterogeneous class of transcripts longer than 200 nucleotides, are pervasively transcribed in the genome and associated with physiological and pathological processes.<|other_cit|> lncRNAs cannot code protein but can regulate gene expression at the transcriptional and post-transcriptional levels.<|other_cit|> Increasing evidence indicates that lncRNAs are involved in the modulation of cancer cell behavior, such as proliferation, metastasis, epithelial-mesenchymal transition (EMT), apoptosis, and drug resistance.<|other_cit|> HOX transcript antisense intergenic RNA (HOTAIR) is a lncRNA encoded by the human HOXC locus on chromosome 12q13.13.<|other_cit|> Increased expression of HOTAIR has been involved in the increased metastasis of breast, cervical, and colorectal cancer.<|other_cit|> Furthermore, HOTAIR is associated with the poor prognosis of pancreatic, breast, liver, and cervical cancer.<|multi_cit|> Recent studies reported that HOTAIR expression is elevated in Rcc cells, and silencing HOTAIR expression inhibits the proliferation and tumorigenicity of Rcc cells.<|other_cit|> However, the underlying molecular mechanism of HOTAIR in Rcc has not been fully understood.", "evidence": {"58022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [58022]}
{"id": 1741, "claim": "This is a critical point because there have been several claims on the side effects of COVID-19 vaccines and previous studies have highlighted the issue of safety as a fundamental factor influencing decision to get vaccinated [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [21061]}
{"id": 1744, "claim": "The most common vaccine side effects in our studied population included pain at the injection site, fatigue, body pain and headache were similar to the most common side effects reported after injection of Pfizer-BioNTech and the Oxford-AstraZeneca<|multi_cit|>.", "evidence": {"21062": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21062]}
{"id": 1750, "claim": "Similarly, employment may influence peer discussion on vaccination experiences and thus stimulate awareness of adverse effects, especially when early return to work is mandated [<|cit|>].", "evidence": {}, "cited_doc_ids": [21063]}
{"id": 1754, "claim": "Research conducted in the U.K. and Saudi Arabia also confirms the obtained results [<|multi_cit|>].", "evidence": {"21064": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21064]}
{"id": 1760, "claim": "They also included nonspecific systemic side-effects, such as headache, fever, fatigue, night sweats, chills and shivering, joint pain, muscle pain, nausea, vomiting, and decreased appetite [<|multi_cit|>].", "evidence": {"21065": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21065]}
{"id": 1762, "claim": "Several studies have demonstrated that individuals who recovered from COVID-19 had increased reactogenicity following vaccination and higher titers of RBD-IgG compared to those who were vaccinated and not infected [<|multi_cit|>], or were infected but had mild disease [<|other_cit|>].", "evidence": {"21066": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21066]}
{"id": 1773, "claim": "These independent (active), Phase IV studies on mRNA-based and vector-based vaccines were conducted in 2021 on HWs groups in several regions, including Germany, the Czech Republic, Slovakia, Iraq, Italy, Malta, Jordan, Saudi Arabia, Poland, the UK, and the USA [<|multi_cit|>].", "evidence": {"21067": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21067]}
{"id": 1780, "claim": "The current evidence is limited by a series of constraints, including unequal sample size across the study groups, lack of normal distribution of demographic and medical risk factors across the study groups, and lack of attention to the onset of each side effect [<|multi_cit|>].", "evidence": {"21068": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21068]}
{"id": 1781, "claim": "This survey is conducted using 25 questions formulated in English language from different research publications, guidelines, and reports.<|multi_cit|> The questions assessed the socio-demographic characteristics, presence of chronic diseases, injection site symptoms, mild symptoms, severe symptoms, previous COVID result, recommendation of the vaccine to others, and readiness to take the second dose.", "evidence": {"21069": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21069]}
{"id": 1786, "claim": "This is even made worse in the present case since the coronavirus is progressively mutating into new variants, thereby compromising the immune systems of those already infected or vaccinated [<|multi_cit|>,20].", "evidence": {}, "cited_doc_ids": [21070]}
{"id": 1789, "claim": "Previously, various studies have reported mild to moderate side effects and reactions to COVID-19 vaccines.<|other_cit|> These can include mild adverse effects after the first or second doses, including redness or swelling at the injection site, pain, fatigue, fever, muscle pain, nausea, headache, vomiting, chills, and joint pain.<|multi_cit|> Some side effects have been reported for both the Pfizer-BioNTech and Oxford-AstraZeneca vaccines; however, the occurrence of adverse effects is reported to be lower for the Pfizer/BioNTech vaccine as compared to Oxford-AstraZeneca and others.<|other_cit|>", "evidence": {"21071": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21071]}
{"id": 1792, "claim": "Both Comirnaty and Spikevax vaccines are administered to children and adults 12 years of age or older and have shown excellent safety and efficacy in phase 3 trials [<|cit|>].", "evidence": {}, "cited_doc_ids": [21072]}
{"id": 1796, "claim": "The obtained results are consistent with both clinical and observational studies [<|multi_cit|>].", "evidence": {"21073": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [21073]}
{"id": 1813, "claim": "In addition to repressing EMT-TFs, the miRNAs also directly target other genes involved in regulating EMT (e.g., cytoskeletal components, Wnt pathway components) and stemness (e.g., BMI1, KLF4, SOX2), underscoring their critical functions in regulating cellular plasticity during cancer progression (<|multi_cit|>).", "evidence": {"75024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [75024]}
{"id": 1824, "claim": "RTT is a complex disease, as all key cell types (neurons, astrocytes, microglia, and oligodendrocytes) in the brain have been shown to contribute to the disease etiology (<|multi_cit|>).", "evidence": {"74018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [74018]}
{"id": 1825, "claim": "Elevated levels of glutamate, released from microglia, may cause abnormal stunted dendritic morphology, microtubule disruption, and damage of postsynaptic glutamatergic components making microglial glutamate synthesis or release a potential therapeutic target for RTT (Maezawa and Jin, <|multi_cit|>; Derecki et al., 2012).", "evidence": {"74019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [74019]}
{"id": 1826, "claim": "Melatonin generally increases the more beneficial phagocytic and anti-inflammatory response in immune cells, and it is this response that seems crucial to the prevention of Rett syndrome progression in MeCP2 KO rodents with wild-type microglia [<|cit|>].", "evidence": {}, "cited_doc_ids": [74020]}
{"id": 1829, "claim": "Abnormal functional connectivity can be caused by changes in synapse formation, function, and or abnormal synaptic pruning, which are also associated with developmental disorders (<|multi_cit|>; State and Šestan, <|other_cit|>; Tang et al., <|other_cit|>; Washbourne, <|other_cit|>).", "evidence": {}, "cited_doc_ids": [74021]}
{"id": 1830, "claim": "Animal models of neuropsychiatric disorders such as schizophrenia and autism have proposed the underlying microglial pathologies (Juckel et al., <|multi_cit|>; Liaury et al., <|other_cit|>).", "evidence": {"74022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [74022]}
{"id": 1832, "claim": "They reveal how disturbances in cellular communication as well as executive functions of microglia could underly impairment of even higher CNS activities and even identify essential gene products therein (Chen et al., <|multi_cit|>; Parkhurst et al., <|other_cit|>; Zhan et al., <|other_cit|>).", "evidence": {"74023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [74023]}
{"id": 1836, "claim": "To confirm that Viaat-Cre was not expressed in glial cells or microglia (<|multi_cit|>), we crossed Viaat-Cre male mice with female ROSA-LSL-YFP transgenics and co-stained for glial fibrillary acidic protein (GFAP), a glial marker, and ionized calcium binding adapter molecule 1 (Iba1), a marker of microglia.", "evidence": {}, "cited_doc_ids": [74024]}
{"id": 1838, "claim": "Already some recent exciting results have implicated microglia as the primary site of defects in Rett's syndrome, a model of autism spectrum disorders (ASD), and Hoxb8-deficiency, a model of obsessive compulsive disorder (Chen et al., <|multi_cit|>).", "evidence": {"74025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [74025]}
{"id": 1847, "claim": "These two types of inflammation responses could contribute to brain injury differently (Kilic et al., <|multi_cit|>; Arnoux et al., <|other_cit|>) and remains to be elucidated (Paolicelli et al., <|other_cit|>).", "evidence": {}, "cited_doc_ids": [74026]}
{"id": 1849, "claim": "Several key cellular players have been implicated in propagating RTT pathology [<|other_cit|>]; however the confounding results in the roles for some of the emerging players [<|multi_cit|>] casts doubt on whether they may actually play a substantive role in the progression of RTT pathology.", "evidence": {"74027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [74027]}
{"id": 1853, "claim": "Preeclampsia is a pregnancy complication recognized by hypertension and proteinuria [<|cit|>].", "evidence": {}, "cited_doc_ids": [59016]}
{"id": 1858, "claim": "Adjusting for obesity somewhat reduced the odds of severe malaria among diabetics, whereas adjusting for the potential intermediate factors diabetes, hypertension, and cardiovascular disease [<|cit|>] did not substantially change the association between obesity and severity.", "evidence": {}, "cited_doc_ids": [59017]}
{"id": 1860, "claim": "Obesity is a growing global healthcare issue [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [59018]}
{"id": 1863, "claim": "We then investigate the impact of work-family LCTs on metabolic risk factors, biomarkers thought to mediate associations between stress and health.<|multi_cit|> 35 We hypothesise that stressful work-family LCTs, such as those characterised by earlier transitions to parenthood and weak ties to paid work and marriage, may be linked with raised metabolic risk.", "evidence": {}, "cited_doc_ids": [59019]}
{"id": 1865, "claim": "Reducing atherosclerotic plaque area, lowering cholesterol level in blood, and thinning the inner lining of coronary artery are important treatment strategies for improving the survival of CHD patients (<|multi_cit|>).", "evidence": {"59020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59020]}
{"id": 1866, "claim": "This scenario has drawn particular attention from researchers due to the fact that obesity is associated with concomitant or increased risk of nearly every chronic condition, including diabetes, coronary artery disease, hypertension, kidney disease, disability, and poor mental health [<|multi_cit|>].", "evidence": {"59021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59021]}
{"id": 1871, "claim": "This rise in the prevalence of obesity has important health-care implications, since obesity is an important risk factor for cardiovascular disease and all-cause mortality (<|multi_cit|>).", "evidence": {"59022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [59022]}
{"id": 1875, "claim": "Inflammasome activation and pyroptosis have been the focus of extensive research due to their connection with cytokine processing and release of IL-1β, which has been shown to play a critical role in the development of severe COVID-19 [<|multi_cit|>].", "evidence": {"14052": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14052]}
{"id": 1893, "claim": "Our results confirmed a functional exhaustion of type I (NK cells and DCs) and type II IFN (T cells) production in moderate and severe patients traducing an evasion of both innate and adaptive immune response and in accordance with recent studies (<|multi_cit|>).", "evidence": {"14053": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14053]}
{"id": 1900, "claim": "Patients with severe disease that require ICU admission have increased expression of inflammatory cytokines, especially IL-1α, IL-1β, IL-6, IL-10, IL-18 and TNF-α with low interferon type I (INF-I) and IFN-III levels (<|multi_cit|>), severe T-cell lymphopenia and low innate antiviral defense (<|other_cit|>,120).", "evidence": {"14054": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14054]}
{"id": 1904, "claim": "The sparing of dependent areas observed in our case is suggestive of a chilblain-like process, which is a recognised cutaneous feature of COVID-19 (<|other_cit|>) and a hallmark feature of genetic type I interferonopathies like AGS (<|multi_cit|>).", "evidence": {}, "cited_doc_ids": [14055]}
{"id": 1906, "claim": "Patients with severe disease that require ICU admission have increased expression of inflammatory cytokines, especially IL-1α, IL-1β, IL-6, IL-10, IL-18 and TNF-α with low interferon type I (INF-I) and IFN-III levels (<|other_cit|>,120), severe T-cell lymphopenia and low innate antiviral defense (<|multi_cit|>).", "evidence": {"14056": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14056]}
{"id": 1907, "claim": "In accordance with previous studies (<|multi_cit|>), our results suggest that an uncontrolled infection maintains monocyte and macrophagic activation, and that the regulatory T lymphocytes remain inactivated due to a weak production of type II IFN, thus reinforcing the cytokine storm and leading to severe complications in patients with COVID-19.", "evidence": {"14057": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14057]}
{"id": 1910, "claim": "Many studies relate this to the higher viral load or exposure of male gender compared to females due to the nature of their occupation.<|other_cit|> Furthermore, this may be due to the variation in immunological responses among study subjects in our population.<|cit|> In addition, it is also indicated that mortality is significantly higher in hypertensive patients than non-hypertensive, which is similar to the findings of previous studies.<|other_cit|> Taking into account that Angiotensin-converting enzyme (ACE) is a functional receptor for SARS-CoV, the use of renin–angiotensin–aldosterone system inhibitors (RAAS) as antihypertensive was suspected to be deleterious in COVD-19 patients; however, this hypothesis was rejected by further studies.<|other_cit|> Our findings also emphasize on the role of antihypertensive drugs such as Angiotensin-converting enzyme (ACE) inhibitors and Angiotensin II receptor blockers (ARB) in managing patients with COVID 19 infection.<|other_cit|>", "evidence": {}, "cited_doc_ids": [14058]}
{"id": 1912, "claim": "In particular, several chemokines (CCL2, CCL3, CCL4, CXCL1, and CXCL10) and inflammatory cytokines (TNFα, IL-6, and G-CSF) associated with the severity of COVID-19 disease in humans are highly expressed in these models.<|multi_cit|> In aged mice, the interferon and adaptive antibody responses to the SARS-CoV-2 challenge are significantly impaired, resulting in more effective virus replications and severe disease manifestations.<|other_cit|> Importantly, these clinically relevant pathological findings are beneficial for studying the pathogenesis of SARS-CoV-2 in vivo.", "evidence": {"14059": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14059]}
{"id": 1923, "claim": "It has been reported that SARS-CoV-2 could generate a set of discontinuous viral RNA called sub-genomic RNA (sgRNA) during viral replication and transcription, which may lead to the proportion change of different viral proteins.<|multi_cit|> These results might explain why SARS-CoV-2 could induce excessive inflammation during viral assemble.", "evidence": {}, "cited_doc_ids": [14060]}
{"id": 1931, "claim": "In patients with COVID-19, we examined the relationship between circulating sCD14-ST or sCD14 and a panel of inflammatory biomarkers known to be elevated in COVID-19 and to track with severity of illness (<|multi_cit|>–33).", "evidence": {"14061": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [14061]}
{"id": 1933, "claim": "According to our study on stimulated IFN production as well as in other studies (<|multi_cit|>, 21), type I IFN plays a major role in the activation of type II IFN and represents a strategic target for early treatment of COVID-19 patients, in order to destroy the immune evasion caused by SARS-CoV-2 and to treat the specific immune dysfunction.", "evidence": {}, "cited_doc_ids": [14062]}
{"id": 1936, "claim": "On the whole, such pathways and functions were not identified when investigating the DEG lists alone, highlighting the added value of ViralLink [<|cit|>].", "evidence": {}, "cited_doc_ids": [14063]}
{"id": 1941, "claim": "Only a very small number of above-threshold GWAS loci, including SORT1 for LDL cholesterol, the FTO/IRX3 locus for obesity, and the SCN5A/SCN10A locus for QRS duration, have been investigated in detail (<|multi_cit|>).", "evidence": {"79019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [79019]}
{"id": 1943, "claim": "One of the erasers is FTO which mediates oxidative demethylation of m6A on RNA [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [79020]}
{"id": 1946, "claim": "SNPs in FTO were associated with hypertension in different ethnic groups [<|cit|>].", "evidence": {}, "cited_doc_ids": [79021]}
{"id": 1952, "claim": "Even the identification of the genes targeted by disease-associated variants is not straightforward, as mere proximity can result in incorrect identification of the culprit gene [<|cit|>].", "evidence": {}, "cited_doc_ids": [79022]}
{"id": 1956, "claim": "The interruption in TF binding can not only influence proximal gene expression but also that of distal genes [<|multi_cit|>].", "evidence": {}, "cited_doc_ids": [79023]}
{"id": 1957, "claim": "Increasing evidence suggests that the FTO SNPs influence the expression of genes proximal to FTO in the locus, namely, RPGRIP1L, IRX3, and IRX5 [<|multi_cit|>].", "evidence": {"79024": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [79024]}
{"id": 1962, "claim": "Beyond the identification of cis-regulatory element associated SNPs, recent SNP association studies are expanding to include flanking regions of the target genes and long-range enhancer/promoter [<|multi_cit|>–41].", "evidence": {"79025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [79025]}
{"id": 1970, "claim": "Mechanistically, the RAD51 stimulatory effect of polyamines could stem from an enhancement of presynaptic filament assembly or stability, as has been documented for BRCA2 and SWI5-SFR1<|multi_cit|>, or from an upregulation of the ability of the presynaptic filament to promote the assembly of the synaptic complex, as recently reported for the BRCA1-BARD1 complex<|other_cit|>.", "evidence": {"64017": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [64017]}
{"id": 1977, "claim": "During homologous recombination (HR), BRCA2 and DSS1 enable RAD51 to overcome the inhibition by RPA (<|multi_cit|>).", "evidence": {"64018": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [64018]}
{"id": 1982, "claim": "This pathway requires the strand invasion function of RAD51 whose activity and loading on ssDNA is highly regulated by many factors including BRCA1, BRCA2, and several RAD51 mediator proteins [<|multi_cit|>].", "evidence": {"64019": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [64019]}
{"id": 1985, "claim": "During HDR, RPA mediates Rad51-dependent strand invasion of intact homologous regions on the sister chromatid during S-phase for accurate repair<|multi_cit|>.", "evidence": {"64020": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [64020]}
{"id": 1987, "claim": "For example, there is significant evidence to suggest that mood and psychiatric disorders, such as bipolar disorder, autism, and schizophrenia, are associated with impaired brain energy metabolism (Prabakaran et al., <|other_cit|>; Young, <|other_cit|>; Quiroz et al., <|other_cit|>; Rezin et al., <|multi_cit|>).", "evidence": {"42026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [42026]}
{"id": 1994, "claim": "It has been hypothesized that difficulties in detoxification can cause oxidative stress [<|other_cit|>] and immune dysregulation [<|other_cit|>], leading to or exacerbating ASDs phenotypic presentation [<|multi_cit|>].", "evidence": {"42027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [42027]}
{"id": 1996, "claim": "The downregulation of SOD2 may explain the mitochondrial dysfunction implicated in autism.<|cit|> Unlike SOD1 (CuZnSOD) which is mainly located in cytoplasm, SOD2 is the mitochondrial isoform of SOD which uses manganese to scavenge the superoxide radicals produced by mitochondria—the main source of cellular ROS.", "evidence": {}, "cited_doc_ids": [42028]}
{"id": 2002, "claim": "A mitochondrial disorder could be also suspected in case of ASD associated with loss of speech after a febrile illness or immunization with encephalopathy [<|cit|>].", "evidence": {}, "cited_doc_ids": [42029]}
{"id": 2015, "claim": "These changes, which include neuro-inflammation, elevated oxidative stress, and antioxidant depletion, may contribute to mitochondrial dysfunction, which is common in ASD patients and is linked to other neurodegenerative diseases such as Alzheimer’s and Parkinson’s [<|multi_cit|>].", "evidence": {"42030": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [42030]}
{"id": 2022, "claim": "Findings suggest that both types of neurons represent the onset of a well-learned action sequence (lever pressing), but that they may differently represent the step-wise progression of the actions as they are performed.<|multi_cit|> Recent work using a two-step nose-poke task in mice supports this view as well.<|other_cit|> Finally, there is strong evidence that D -receptor-expressing DLS neurons are critical for habit formation, based on use of the devaluation-insensitivity measure, <|other_cit|> though D receptor-expressing cells have not yet been exhaustively evaluated in these studies (but see ref 50).", "evidence": {"49021": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49021]}
{"id": 2024, "claim": "An important element of this model is the distinct action of dopamine on the direct and indirect pathways, comprised of two classes of striatal spiny projection output neurons that express different types of dopamine receptors, project to separate downstream targets, and regulate complementary aspects of motor behavior (<|multi_cit|>).", "evidence": {"49022": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49022]}
{"id": 2025, "claim": "Sensory cortico-striatal connections do not constitute a concise topographical mapping, instead such projections are characterized by a high degree of convergence and divergence, as well as co-integration with motor and prefrontal cortical input (McGeorge and Faull, <|other_cit|>; Voorn et al., <|other_cit|>) and multisensory integration (Hikosaka et al., <|other_cit|>; Nagy et al., <|multi_cit|>; Reig and Silberberg, <|other_cit|>).", "evidence": {"49023": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49023]}
{"id": 2031, "claim": "Corticostriatal projections convey information from somatosensory (<|other_cit|>), auditory (<|other_cit|>), and visual (<|multi_cit|>) cortical regions.", "evidence": {}, "cited_doc_ids": [49024]}
{"id": 2033, "claim": "We are also aware that the dorsal striatum is heavily implicated in motor behavior, through learning, action selection and perhaps the invigoration of action (<|multi_cit|>).", "evidence": {"49025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49025]}
{"id": 2035, "claim": "We expressed channelrhodopsin-2 (ChR2) in striatal neurons that express D -like dopamine receptors, i.e., neurons that give rise to the striatonigral (direct) pathway (Kravitz et al., <|multi_cit|>; Wall et al., <|other_cit|>).", "evidence": {"49026": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49026]}
{"id": 2036, "claim": "The iSPNs are enriched in enkephalin and D2 type dopamine receptors, project exclusively to the GPe, and play a role in suppression of unwanted movements (Albin et al., <|other_cit|>; Sano et al., <|other_cit|>; Kravitz et al., <|multi_cit|>; Freeze et al., <|other_cit|>).", "evidence": {"49027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49027]}
{"id": 2039, "claim": "Recent methodological breakthroughs, such as bacterial artificial chromosome (BAC) and optogenetic techniques, have enabled researchers to not only mimic features of motor disorders in a controlled manner in relation to the extent of nigrostriatal degeneration, but also to further delineate and examine the functions of the direct- and indirect-pathway medium spiny neurons (MSNs; also known as spiny projection neurons) in the striatum (<|multi_cit|>; Fieblinger et al., <|other_cit|>).", "evidence": {"49028": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [49028]}
{"id": 2048, "claim": "However, due to limited penetration of ART, HIV replication can persist in tissue reservoirs such as the gastrointestinal (GI) tract and female reproductive tract (FRT) and lymphoid tissues [<|multi_cit|>].", "evidence": {"71025": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [71025]}
{"id": 2052, "claim": "Since, there is suboptimal penetration of cART (<|multi_cit|>, 51) across the blood–brain barrier (BBB) resulting in establishment of reservoir within the CNS.", "evidence": {}, "cited_doc_ids": [71026]}
{"id": 2059, "claim": "The secondary depot beyond injection site could not only reduce administration frequency, but also serve to better extend viral restriction in HIV residing tissues, including lymph nodes, gut-associated lymphoid tissues and spleen [<|multi_cit|>].", "evidence": {"71027": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [71027]}
{"id": 2075, "claim": "Experimental infection of these K18-hACE2 transgenic mice with SARS-CoV-2 consistently resulted in a severe dose-dependent clinical disease, with marked weight loss, a range of clinical signs, including respiratory distress, ruffled fur, hunched posture, and lethargy, and mortality that occurred around 5 to 7 DPC [<|multi_cit|>].", "evidence": {"18053": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18053]}
{"id": 2078, "claim": "It was previously shown that SARS-CoV-2 infection of K18-hACE2 mice manifests as progressive and widespread viral pneumonia with perivascular and pan-alveolar inflammation, immune cell infiltration, edema, lung consolidation and distinctive vascular system injury that were apparent even three weeks after infection (in surviving animals) [<|multi_cit|>].", "evidence": {"18054": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18054]}
{"id": 2080, "claim": "Together, these findings in treated hACE2 mice well recapitulate the pathologies observed in COVID-19 ARDS patients<|other_cit|> and other animal ARDS models, coincident with enhanced lung weight, increased permeability, hemorrhage, edema, and severe pathological changes.<|multi_cit|>,21 Therefore, our mouse model may reflect the pathogenesis of SARS-CoV-2-induced ARDS in humans.", "evidence": {"18055": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18055]}
{"id": 2088, "claim": "Multiple animal models of SARS-CoV-2 infection have been reported, ranging from rodents to Old World and New World monkeys (<|multi_cit|>).", "evidence": {"18056": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18056]}
{"id": 2094, "claim": "Similarly, in the three strains of transgenic mice expressing human ACE2 gene currently being utilized to model the effect of SARS-CoV-2, the inserted hACE2 gene CDS is also a potential target of murine miRNAs (Table <|other_cit|>) [<|multi_cit|>].", "evidence": {"18057": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18057]}
{"id": 2097, "claim": "Pathological changes like hyaline membrane formation, type-2 pneumocyte hyperplasia, interstitial fibroblastic proliferation and alveolar lumen edema have been reported in human and non-human primates, while in hamster and ACE2 mice, type-2 pneumocyte hyperplasia, hyaline membrane formation and alveolar wall thickening was reported [<|multi_cit|>].", "evidence": {"18058": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18058]}
{"id": 2098, "claim": "Severe lung pathology is characteristic for the SARS-CoV-2 infected K18-hACE2 mice [<|other_cit|>,149,<|other_cit|>], along with virus detected in upper and lower respiratory tract samples [<|multi_cit|>].", "evidence": {"18059": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18059]}
{"id": 2106, "claim": "These mouse models are more often lethal, presumably due to brain infection [<|multi_cit|>], while the “newer” mouse models and mice infected with mouse-adapted SARS-CoV-2 typically do not show neuro-invasion [<|other_cit|>] (Table <|other_cit|>).", "evidence": {"18060": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18060]}
{"id": 2112, "claim": "In some of the mouse models expressing human ACE2, the timing of arrival of the virus in various brain structures was monitored, and it was described that olfactory bulbs were infected not more than other parts of the brain, especially the hypothalamus and other thalamic nuclei, and the brainstem [<|multi_cit|>]—similar to some of the human neuropathological findings [<|other_cit|>], as described below.", "evidence": {"18061": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18061]}
{"id": 2119, "claim": "* Experimental evidence showed that wild-type mice (Mus musculus) are susceptible to mouse-adapted SARS-CoV-2 isolates or certain variants of concern (VOC) that contain an N501Y substitution in the spike protein [<|other_cit|>] In contrast, gene-edited mice expressing the human angiotensin-converting enzyme 2 (hACE2) receptor are highly susceptible to infection with ancestral and variant SARS-CoV-2 strains [<|multi_cit|>].", "evidence": {"18062": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18062]}
{"id": 2121, "claim": "Evidence from additional studies showed that bronchiolar epithelial cells, pneumocytes, alveolar epithelial cells and macrophages can also be infected by SARS-CoV-2 [<|multi_cit|>].", "evidence": {"18063": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18063]}
{"id": 2125, "claim": "These data contrast with historical results with WA1/2020 D614G or variant (for example, B.1.351) SARS-CoV-2 strains<|multi_cit|>, which uniformly induce weight loss starting at 4 dpi.", "evidence": {"18064": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18064]}
{"id": 2136, "claim": "The result was almost consistent with the clinical course of ARDS patients<|other_cit|> and other severe models of hACE2 mice infected by SARS-CoV-2 or mice infected by mouse adapted SARS-CoV-2.<|multi_cit|>,21", "evidence": {"18065": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18065]}
{"id": 2137, "claim": "These findings are consistent with studies characterizing the K18-hACE2 mouse SARS-CoV-2 challenge model [<|multi_cit|>].", "evidence": {"18066": [{"sentences": [0], "label": "REFUTE"}]}, "cited_doc_ids": [18066]}
